<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title><![CDATA[Biotechnology - Newslocker]]></title><link>https://www.newslocker.com/en-uk/profession/biotechnology/</link><atom:link rel="self" href="https://www.newslocker.com/en-uk/profession/biotechnology/rss/1000/" /><atom:link rel="hub" href="http://pubsubhubbub.appspot.com" /><description><![CDATA[Find your latest Biotechnology news with just one click. Don't miss out on anything happening in your profession!]]></description><language>en-uk</language><copyright>Copyright (C) 2026 newslocker.com</copyright><lastBuildDate>Sat, 16 May 2026 09:50:00 +0200</lastBuildDate><item><title><![CDATA[Biotechnology Breakthroughs That Are Changing Healthcare - Analytics Insight]]></title><description><![CDATA[Biotechnology Breakthroughs That Are Changing Healthcare&nbsp;&nbsp;Analytics Insight]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-breakthroughs-that-are-changing-healthcare-analytics-insight/</link><pubDate>Sat, 16 May 2026 09:50:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-breakthroughs-that-are-changing-healthcare-analytics-insight/</guid></item><item><title><![CDATA[Vir Biotechnology: Trading Near Cash Value With A Huge Revenue Opportunity (NASDAQ:VIR) - Seeking Alpha]]></title><description><![CDATA[Vir Biotechnology: Trading Near Cash Value With A Huge Revenue Opportunity (NASDAQ:VIR)&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-trading-near-cash-value-with-a-huge-revenue-opportunity-nasdaqvir-seeking-alpha/</link><pubDate>Sat, 16 May 2026 09:38:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-trading-near-cash-value-with-a-huge-revenue-opportunity-nasdaqvir-seeking-alpha/</guid></item><item><title><![CDATA[MacroGenics sells manufacturing arm to Bora in $123m deal - The Pharma Letter]]></title><description><![CDATA[MacroGenics sells manufacturing arm to Bora in $123m deal&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/macrogenics-sells-manufacturing-arm-to-bora-in-123m-deal-the-pharma-letter/</link><pubDate>Sat, 16 May 2026 07:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/macrogenics-sells-manufacturing-arm-to-bora-in-123m-deal-the-pharma-letter/</guid></item><item><title><![CDATA[Sana Biotechnology Raises $69 Million Through Equity Offering - TipRanks]]></title><description><![CDATA[Sana Biotechnology Raises $69 Million Through Equity Offering&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-raises-69-million-through-equity-offering-tipranks/</link><pubDate>Fri, 15 May 2026 22:53:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-raises-69-million-through-equity-offering-tipranks/</guid></item><item><title><![CDATA[Sana Biotechnology (SANA) sells 21.6M shares to raise about $69M - Stock Titan]]></title><description><![CDATA[Sana Biotechnology (SANA) sells 21.6M shares to raise about $69M&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-sells-216m-shares-to-raise-about-69m-stock-titan/</link><pubDate>Fri, 15 May 2026 22:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-sells-216m-shares-to-raise-about-69m-stock-titan/</guid></item><item><title><![CDATA[Puma Biotechnology Reveal Hidden Strength Amid Rising Market Focus - Kalkine Media]]></title><description><![CDATA[Puma Biotechnology Reveal Hidden Strength Amid Rising Market Focus&nbsp;&nbsp;Kalkine Media]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-reveal-hidden-strength-amid-rising-market-focus-kalkine-media/</link><pubDate>Fri, 15 May 2026 19:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-reveal-hidden-strength-amid-rising-market-focus-kalkine-media/</guid></item><item><title><![CDATA[Sana Biotechnology Raises $69 Million Through ATM Equity Offering - marketscreener.com]]></title><description><![CDATA[Sana Biotechnology Raises $69 Million Through ATM Equity Offering&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-raises-69-million-through-atm-equity-offering-marketscreenercom/</link><pubDate>Fri, 15 May 2026 15:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-raises-69-million-through-atm-equity-offering-marketscreenercom/</guid></item><item><title><![CDATA[Europe’s biotech dilemma: discovery at home, scale abroad - The Pharma Letter]]></title><description><![CDATA[Europe&rsquo;s biotech dilemma: discovery at home, scale abroad&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/europes-biotech-dilemma-discovery-at-home-scale-abroad-the-pharma-letter/</link><pubDate>Fri, 15 May 2026 15:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/europes-biotech-dilemma-discovery-at-home-scale-abroad-the-pharma-letter/</guid></item><item><title><![CDATA[Sana Biotechnology raises $69 million through stock sale By Investing.com - Investing.com Canada]]></title><description><![CDATA[Sana Biotechnology raises $69 million through stock sale By Investing.com&nbsp;&nbsp;Investing.com Canada]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-raises-69-million-through-stock-sale-by-investingcom-investingcom-canada/</link><pubDate>Fri, 15 May 2026 15:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-raises-69-million-through-stock-sale-by-investingcom-investingcom-canada/</guid></item><item><title><![CDATA[Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility - Yahoo Finance]]></title><description><![CDATA[Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-announces-sale-of-approximately-69-million-of-shares-through-its-at-the-market-atm-facility-yahoo-finance/</link><pubDate>Fri, 15 May 2026 15:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-announces-sale-of-approximately-69-million-of-shares-through-its-at-the-market-atm-facility-yahoo-finance/</guid></item><item><title><![CDATA[There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings - simplywall.st]]></title><description><![CDATA[There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/there-may-be-reason-for-hope-in-puma-biotechnologys-nasdaqpbyi-disappointing-earnings-simplywallst/</link><pubDate>Fri, 15 May 2026 14:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/there-may-be-reason-for-hope-in-puma-biotechnologys-nasdaqpbyi-disappointing-earnings-simplywallst/</guid></item><item><title><![CDATA[Biotechnology, hydroponics, and branding take center stage at Misiones floriculture event - FloralDaily]]></title><description><![CDATA[Biotechnology, hydroponics, and branding take center stage at Misiones floriculture event&nbsp;&nbsp;FloralDaily]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-hydroponics-and-branding-take-center-stage-at-misiones-floriculture-event-floraldaily/</link><pubDate>Fri, 15 May 2026 14:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-hydroponics-and-branding-take-center-stage-at-misiones-floriculture-event-floraldaily/</guid></item><item><title><![CDATA[How Marianne De Backer saved Vir Biotechnology after flu drug failure - San Francisco Business Times - The Business Journals]]></title><description><![CDATA[How Marianne De Backer saved Vir Biotechnology after flu drug failure - San Francisco Business Times&nbsp;&nbsp;The Business Journals]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/how-marianne-de-backer-saved-vir-biotechnology-after-flu-drug-failure-san-francisco-business-times-the-business-journals/</link><pubDate>Fri, 15 May 2026 14:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/how-marianne-de-backer-saved-vir-biotechnology-after-flu-drug-failure-san-francisco-business-times-the-business-journals/</guid></item><item><title><![CDATA[Widespread DNA off-targeting confounds RNA chromatin occupancy studies - Nature]]></title><description><![CDATA[Widespread DNA off-targeting confounds RNA chromatin occupancy studies&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/widespread-dna-off-targeting-confounds-rna-chromatin-occupancy-studies-nature/</link><pubDate>Fri, 15 May 2026 11:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/widespread-dna-off-targeting-confounds-rna-chromatin-occupancy-studies-nature/</guid></item><item><title><![CDATA[Guide DNA — not RNA — expands the CRISPR toolkit - Nature]]></title><description><![CDATA[Guide DNA &mdash; not RNA &mdash; expands the CRISPR toolkit&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/guide-dna-not-rna-expands-the-crispr-toolkit-nature/</link><pubDate>Fri, 15 May 2026 11:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/guide-dna-not-rna-expands-the-crispr-toolkit-nature/</guid></item><item><title><![CDATA[Chiesi wins UK approval for monthly Elfabrio dosing - The Pharma Letter]]></title><description><![CDATA[Chiesi wins UK approval for monthly Elfabrio dosing&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/chiesi-wins-uk-approval-for-monthly-elfabrio-dosing-the-pharma-letter/</link><pubDate>Fri, 15 May 2026 11:38:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/chiesi-wins-uk-approval-for-monthly-elfabrio-dosing-the-pharma-letter/</guid></item><item><title><![CDATA[BioArctic set for windfall as Eisai lifts Leqembi forecast - The Pharma Letter]]></title><description><![CDATA[BioArctic set for windfall as Eisai lifts Leqembi forecast&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/bioarctic-set-for-windfall-as-eisai-lifts-leqembi-forecast-the-pharma-letter/</link><pubDate>Fri, 15 May 2026 11:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/bioarctic-set-for-windfall-as-eisai-lifts-leqembi-forecast-the-pharma-letter/</guid></item><item><title><![CDATA[PDS Biotechnology Corp reports results for the quarter ended March 31 - Earnings Summary - TradingView]]></title><description><![CDATA[PDS Biotechnology Corp reports results for the quarter ended March 31 - Earnings Summary&nbsp;&nbsp;TradingView]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-corp-reports-results-for-the-quarter-ended-march-31-earnings-summary-tradingview/</link><pubDate>Fri, 15 May 2026 00:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-corp-reports-results-for-the-quarter-ended-march-31-earnings-summary-tradingview/</guid></item><item><title><![CDATA[LIXTE Biotechnology Holdings, Inc. Files Q1 2026 10-Q Report, Highlights Progress in Cancer Treatment Development - Quiver Quantitative]]></title><description><![CDATA[LIXTE Biotechnology Holdings, Inc. Files Q1 2026 10-Q Report, Highlights Progress in Cancer Treatment Development&nbsp;&nbsp;Quiver Quantitative]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-holdings-inc-files-q1-2026-10-q-report-highlights-progress-in-cancer-treatment-development-quiver-quantitative/</link><pubDate>Thu, 14 May 2026 23:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-holdings-inc-files-q1-2026-10-q-report-highlights-progress-in-cancer-treatment-development-quiver-quantitative/</guid></item><item><title><![CDATA[LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update - GlobeNewswire]]></title><description><![CDATA[LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-files-first-quarter-2026-quarterly-report-on-form-10-q-provides-operational-progress-update-globenewswire/</link><pubDate>Thu, 14 May 2026 23:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-files-first-quarter-2026-quarterly-report-on-form-10-q-provides-operational-progress-update-globenewswire/</guid></item><item><title><![CDATA[LIXTE BIOTECHNOLOGY HOLDINGS, INC. 1Q 2026: Net loss $1.94M, EPS $(0.18) — 10-Q Summary - TradingView]]></title><description><![CDATA[LIXTE BIOTECHNOLOGY HOLDINGS, INC. 1Q 2026: Net loss $1.94M, EPS $(0.18) &mdash; 10-Q Summary&nbsp;&nbsp;TradingView]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-holdings-inc-1q-2026-net-loss-194m-eps-018-10-q-summary-tradingview/</link><pubDate>Thu, 14 May 2026 22:52:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-holdings-inc-1q-2026-net-loss-194m-eps-018-10-q-summary-tradingview/</guid></item><item><title><![CDATA[Nigeria’s Biotechnology Agency Signs MoU to Advance Genomics - Voice of Nigeria]]></title><description><![CDATA[Nigeria&rsquo;s Biotechnology Agency Signs MoU to Advance Genomics&nbsp;&nbsp;Voice of Nigeria]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nigerias-biotechnology-agency-signs-mou-to-advance-genomics-voice-of-nigeria/</link><pubDate>Thu, 14 May 2026 17:51:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nigerias-biotechnology-agency-signs-mou-to-advance-genomics-voice-of-nigeria/</guid></item><item><title><![CDATA[Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings - Yahoo Finance]]></title><description><![CDATA[Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnologys-nasdaqpbyi-conservative-accounting-might-explain-soft-earnings-yahoo-finance/</link><pubDate>Thu, 14 May 2026 14:04:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnologys-nasdaqpbyi-conservative-accounting-might-explain-soft-earnings-yahoo-finance/</guid></item><item><title><![CDATA[Lilly brings Alzheimer’s contender to India - The Pharma Letter]]></title><description><![CDATA[Lilly brings Alzheimer&rsquo;s contender to India&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lilly-brings-alzheimers-contender-to-india-the-pharma-letter/</link><pubDate>Thu, 14 May 2026 11:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lilly-brings-alzheimers-contender-to-india-the-pharma-letter/</guid></item><item><title><![CDATA[Welsh biotechnology company expands international reach across 20 countries - Wales 247]]></title><description><![CDATA[Welsh biotechnology company expands international reach across 20 countries&nbsp;&nbsp;Wales 247]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/welsh-biotechnology-company-expands-international-reach-across-20-countries-wales-247/</link><pubDate>Thu, 14 May 2026 07:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/welsh-biotechnology-company-expands-international-reach-across-20-countries-wales-247/</guid></item><item><title><![CDATA[Apellis Pharmaceuticals, Inc.(NasdaqGS:APLS) dropped from S&amp;P Biotechnology Select Industry Index - marketscreener.com]]></title><description><![CDATA[Apellis Pharmaceuticals, Inc.(NasdaqGS:APLS) dropped from S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/apellis-pharmaceuticals-incnasdaqgsapls-dropped-from-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Thu, 14 May 2026 02:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/apellis-pharmaceuticals-incnasdaqgsapls-dropped-from-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[Marine Plastic Pollution: The Case for Sustainable Biotechnology Solutions - orfonline.org]]></title><description><![CDATA[Marine Plastic Pollution: The Case for Sustainable Biotechnology Solutions&nbsp;&nbsp;orfonline.org]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/marine-plastic-pollution-the-case-for-sustainable-biotechnology-solutions-orfonlineorg/</link><pubDate>Wed, 13 May 2026 22:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/marine-plastic-pollution-the-case-for-sustainable-biotechnology-solutions-orfonlineorg/</guid></item><item><title><![CDATA[Millions for Preclinical Immunology: Boehringer Teams Up with Immunitas - European Biotechnology Magazine]]></title><description><![CDATA[Millions for Preclinical Immunology: Boehringer Teams Up with Immunitas&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/millions-for-preclinical-immunology-boehringer-teams-up-with-immunitas-european-biotechnology-magazine/</link><pubDate>Wed, 13 May 2026 13:52:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/millions-for-preclinical-immunology-boehringer-teams-up-with-immunitas-european-biotechnology-magazine/</guid></item><item><title><![CDATA[CZ's New Interview: AI and Biotechnology are great, but I still dedicate 80% of my energy to blockchain. - PANews]]></title><description><![CDATA[CZ's New Interview: AI and Biotechnology are great, but I still dedicate 80% of my energy to blockchain.&nbsp;&nbsp;PANews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/czs-new-interview-ai-and-biotechnology-are-great-but-i-still-dedicate-80-of-my-energy-to-blockchain-panews/</link><pubDate>Wed, 13 May 2026 13:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/czs-new-interview-ai-and-biotechnology-are-great-but-i-still-dedicate-80-of-my-energy-to-blockchain-panews/</guid></item><item><title><![CDATA[Analysis of Key Market Segments Driving the AI in Biotechnology Market - openPR.com]]></title><description><![CDATA[Analysis of Key Market Segments Driving the AI in Biotechnology Market&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/analysis-of-key-market-segments-driving-the-ai-in-biotechnology-market-openprcom/</link><pubDate>Wed, 13 May 2026 11:52:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/analysis-of-key-market-segments-driving-the-ai-in-biotechnology-market-openprcom/</guid></item><item><title><![CDATA[Results analysis: International Biotechnology Trust - May 2026 | Investor - trustintelligence.co.uk]]></title><description><![CDATA[Results analysis: International Biotechnology Trust - May 2026 | Investor&nbsp;&nbsp;trustintelligence.co.uk]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/results-analysis-international-biotechnology-trust-may-2026-investor-trustintelligencecouk/</link><pubDate>Wed, 13 May 2026 11:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/results-analysis-international-biotechnology-trust-may-2026-investor-trustintelligencecouk/</guid></item><item><title><![CDATA[BRIGHT and LanzaTech launch new partnership to accelerate carbon-to-value biotechnology in Europe - Ethanol Producer Magazine]]></title><description><![CDATA[BRIGHT and LanzaTech launch new partnership to accelerate carbon-to-value biotechnology in Europe&nbsp;&nbsp;Ethanol Producer Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/bright-and-lanzatech-launch-new-partnership-to-accelerate-carbon-to-value-biotechnology-in-europe-ethanol-producer-magazine/</link><pubDate>Tue, 12 May 2026 22:44:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/bright-and-lanzatech-launch-new-partnership-to-accelerate-carbon-to-value-biotechnology-in-europe-ethanol-producer-magazine/</guid></item><item><title><![CDATA[Why biotechnology stocks have more room to run - InvestmentNews]]></title><description><![CDATA[Why biotechnology stocks have more room to run&nbsp;&nbsp;InvestmentNews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/why-biotechnology-stocks-have-more-room-to-run-investmentnews/</link><pubDate>Tue, 12 May 2026 22:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/why-biotechnology-stocks-have-more-room-to-run-investmentnews/</guid></item><item><title><![CDATA[Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs - Yahoo Finance]]></title><description><![CDATA[Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-presents-preclinical-data-for-in-vivo-car-t-cell-therapy-sg293-surrogate-demonstrating-cell-specific-delivery-potent-car-t-cell-generation-and-deep-b-cell-depletion-in-nhps-yahoo-finance/</link><pubDate>Tue, 12 May 2026 22:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-presents-preclinical-data-for-in-vivo-car-t-cell-therapy-sg293-surrogate-demonstrating-cell-specific-delivery-potent-car-t-cell-generation-and-deep-b-cell-depletion-in-nhps-yahoo-finance/</guid></item><item><title><![CDATA[Biotechnology Students Connect With Industry Leaders - Syracuse University Today]]></title><description><![CDATA[Biotechnology Students Connect With Industry Leaders&nbsp;&nbsp;Syracuse University Today]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-students-connect-with-industry-leaders-syracuse-university-today/</link><pubDate>Tue, 12 May 2026 17:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-students-connect-with-industry-leaders-syracuse-university-today/</guid></item><item><title><![CDATA[DNA synthesis market forecast to top $30 billion by 2035 - The Pharma Letter]]></title><description><![CDATA[DNA synthesis market forecast to top $30 billion by 2035&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/dna-synthesis-market-forecast-to-top-30-billion-by-2035-the-pharma-letter/</link><pubDate>Tue, 12 May 2026 13:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/dna-synthesis-market-forecast-to-top-30-billion-by-2035-the-pharma-letter/</guid></item><item><title><![CDATA[Early data revive interest in OX40 immunotherapy - The Pharma Letter]]></title><description><![CDATA[Early data revive interest in OX40 immunotherapy&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/early-data-revive-interest-in-ox40-immunotherapy-the-pharma-letter/</link><pubDate>Tue, 12 May 2026 12:44:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/early-data-revive-interest-in-ox40-immunotherapy-the-pharma-letter/</guid></item><item><title><![CDATA[Rebuilding the Thymus: AI, Regenerative Medicine, and the Emerging Biotechnology of Immune Longevity - Foley &amp; Lardner LLP]]></title><description><![CDATA[Rebuilding the Thymus: AI, Regenerative Medicine, and the Emerging Biotechnology of Immune Longevity&nbsp;&nbsp;Foley &amp; Lardner LLP]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/rebuilding-the-thymus-ai-regenerative-medicine-and-the-emerging-biotechnology-of-immune-longevity-foley-amp-lardner-llp/</link><pubDate>Mon, 11 May 2026 23:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/rebuilding-the-thymus-ai-regenerative-medicine-and-the-emerging-biotechnology-of-immune-longevity-foley-amp-lardner-llp/</guid></item><item><title><![CDATA[Earnings Flash (SANA) Sana Biotechnology, Inc. Posts Q1 Adjusted Loss $0.14 per Share, vs. FactSet Est of $-0.16 - marketscreener.com]]></title><description><![CDATA[Earnings Flash (SANA) Sana Biotechnology, Inc. Posts Q1 Adjusted Loss $0.14 per Share, vs. FactSet Est of $-0.16&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-flash-sana-sana-biotechnology-inc-posts-q1-adjusted-loss-014-per-share-vs-factset-est-of-016-marketscreenercom/</link><pubDate>Mon, 11 May 2026 22:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-flash-sana-sana-biotechnology-inc-posts-q1-adjusted-loss-014-per-share-vs-factset-est-of-016-marketscreenercom/</guid></item><item><title><![CDATA[URI Leads Hands-On Biotechnology Program for High School Students – College of the Environment and Life Sciences - The University of Rhode Island]]></title><description><![CDATA[URI Leads Hands-On Biotechnology Program for High School Students &ndash; College of the Environment and Life Sciences&nbsp;&nbsp;The University of Rhode Island]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/uri-leads-hands-on-biotechnology-program-for-high-school-students-college-of-the-environment-and-life-sciences-the-university-of-rhode-island/</link><pubDate>Mon, 11 May 2026 18:04:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/uri-leads-hands-on-biotechnology-program-for-high-school-students-college-of-the-environment-and-life-sciences-the-university-of-rhode-island/</guid></item><item><title><![CDATA[Vir Biotechnology, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next - simplywall.st]]></title><description><![CDATA[Vir Biotechnology, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-just-reported-a-surprise-loss-heres-what-analysts-think-will-happen-next-simplywallst/</link><pubDate>Mon, 11 May 2026 17:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-just-reported-a-surprise-loss-heres-what-analysts-think-will-happen-next-simplywallst/</guid></item><item><title><![CDATA[Odyssey raises $304 million in upsized Nasdaq debut - The Pharma Letter]]></title><description><![CDATA[Odyssey raises $304 million in upsized Nasdaq debut&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/odyssey-raises-304-million-in-upsized-nasdaq-debut-the-pharma-letter/</link><pubDate>Mon, 11 May 2026 12:29:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/odyssey-raises-304-million-in-upsized-nasdaq-debut-the-pharma-letter/</guid></item><item><title><![CDATA[Daiichi cuts forecast after $606 million ADC supply-chain hit - The Pharma Letter]]></title><description><![CDATA[Daiichi cuts forecast after $606 million ADC supply-chain hit&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/daiichi-cuts-forecast-after-606-million-adc-supply-chain-hit-the-pharma-letter/</link><pubDate>Mon, 11 May 2026 12:17:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/daiichi-cuts-forecast-after-606-million-adc-supply-chain-hit-the-pharma-letter/</guid></item><item><title><![CDATA[Is Sana Biotechnology’s (SANA) Options Spike Before Earnings Hinting at a Repriced Cell Therapy Story? - simplywall.st]]></title><description><![CDATA[Is Sana Biotechnology&rsquo;s (SANA) Options Spike Before Earnings Hinting at a Repriced Cell Therapy Story?&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/is-sana-biotechnologys-sana-options-spike-before-earnings-hinting-at-a-repriced-cell-therapy-story-simplywallst/</link><pubDate>Mon, 11 May 2026 04:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/is-sana-biotechnologys-sana-options-spike-before-earnings-hinting-at-a-repriced-cell-therapy-story-simplywallst/</guid></item><item><title><![CDATA[Sana Biotechnology (SANA) Valuation Check As Conference Update And Partnerships Keep Investor Focus High - simplywall.st]]></title><description><![CDATA[Sana Biotechnology (SANA) Valuation Check As Conference Update And Partnerships Keep Investor Focus High&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-valuation-check-as-conference-update-and-partnerships-keep-investor-focus-high-simplywallst/</link><pubDate>Sun, 10 May 2026 00:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-valuation-check-as-conference-update-and-partnerships-keep-investor-focus-high-simplywallst/</guid></item><item><title><![CDATA[Biotechnology: what China’s rise means for Europe - Kearney]]></title><description><![CDATA[Biotechnology: what China&rsquo;s rise means for Europe&nbsp;&nbsp;Kearney]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-what-chinas-rise-means-for-europe-kearney/</link><pubDate>Fri, 08 May 2026 16:40:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-what-chinas-rise-means-for-europe-kearney/</guid></item><item><title><![CDATA[Biosensor detects early fungal outbreaks, advances plant biotechnology - Technology Org]]></title><description><![CDATA[Biosensor detects early fungal outbreaks, advances plant biotechnology&nbsp;&nbsp;Technology Org]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biosensor-detects-early-fungal-outbreaks-advances-plant-biotechnology-technology-org/</link><pubDate>Mon, 04 May 2026 13:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biosensor-detects-early-fungal-outbreaks-advances-plant-biotechnology-technology-org/</guid></item><item><title><![CDATA[IIT JAM 2026 Biotechnology Seat Matrix, Check IIT wise Seat for M.Sc. Biotechnology - PW]]></title><description><![CDATA[IIT JAM 2026 Biotechnology Seat Matrix, Check IIT wise Seat for M.Sc. Biotechnology&nbsp;&nbsp;PW]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/iit-jam-2026-biotechnology-seat-matrix-check-iit-wise-seat-for-msc-biotechnology-pw/</link><pubDate>Mon, 04 May 2026 12:38:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/iit-jam-2026-biotechnology-seat-matrix-check-iit-wise-seat-for-msc-biotechnology-pw/</guid></item><item><title><![CDATA[New push to turn biotechnology into a key techno-economic sector - LuatVietnam]]></title><description><![CDATA[New push to turn biotechnology into a key techno-economic sector&nbsp;&nbsp;LuatVietnam]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/new-push-to-turn-biotechnology-into-a-key-techno-economic-sector-luatvietnam/</link><pubDate>Mon, 04 May 2026 06:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/new-push-to-turn-biotechnology-into-a-key-techno-economic-sector-luatvietnam/</guid></item><item><title><![CDATA[CMO/CDMO Biotechnology Market to Reach USD 37.53 Billion by 2033 - openPR.com]]></title><description><![CDATA[CMO/CDMO Biotechnology Market to Reach USD 37.53 Billion by 2033&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cmocdmo-biotechnology-market-to-reach-usd-3753-billion-by-2033-openprcom/</link><pubDate>Sun, 03 May 2026 08:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cmocdmo-biotechnology-market-to-reach-usd-3753-billion-by-2033-openprcom/</guid></item><item><title><![CDATA[PDS Biotechnology Refinances Debt with New Note, Warrant - TipRanks]]></title><description><![CDATA[PDS Biotechnology Refinances Debt with New Note, Warrant&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-refinances-debt-with-new-note-warrant-tipranks/</link><pubDate>Fri, 01 May 2026 19:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-refinances-debt-with-new-note-warrant-tipranks/</guid></item><item><title><![CDATA[Asia's Biggest Startup Funding in Week 18 Led by Snabbit, Vivacta Biotechnology, and Sahi - Techloy]]></title><description><![CDATA[Asia's Biggest Startup Funding in Week 18 Led by Snabbit, Vivacta Biotechnology, and Sahi&nbsp;&nbsp;Techloy]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/asias-biggest-startup-funding-in-week-18-led-by-snabbit-vivacta-biotechnology-and-sahi-techloy/</link><pubDate>Fri, 01 May 2026 11:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/asias-biggest-startup-funding-in-week-18-led-by-snabbit-vivacta-biotechnology-and-sahi-techloy/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) CEO shifts 467,064 shares into family trust - Stock Titan]]></title><description><![CDATA[Vir Biotechnology (VIR) CEO shifts 467,064 shares into family trust&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-ceo-shifts-467064-shares-into-family-trust-stock-titan/</link><pubDate>Thu, 30 Apr 2026 23:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-ceo-shifts-467064-shares-into-family-trust-stock-titan/</guid></item><item><title><![CDATA[Tracing the rise of biomedical foundation models - Nature]]></title><description><![CDATA[Tracing the rise of biomedical foundation models&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/tracing-the-rise-of-biomedical-foundation-models-nature/</link><pubDate>Thu, 30 Apr 2026 20:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/tracing-the-rise-of-biomedical-foundation-models-nature/</guid></item><item><title><![CDATA[A one-shot cure for diabetes? Sana Biotechnology makes its move - Longevity.Technology]]></title><description><![CDATA[A one-shot cure for diabetes? Sana Biotechnology makes its move&nbsp;&nbsp;Longevity.Technology]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/a-one-shot-cure-for-diabetes-sana-biotechnology-makes-its-move-longevitytechnology/</link><pubDate>Thu, 30 Apr 2026 18:38:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/a-one-shot-cure-for-diabetes-sana-biotechnology-makes-its-move-longevitytechnology/</guid></item><item><title><![CDATA[Cizzle Biotechnology Publishes 2025 Annual Report and Financial Statements - TipRanks]]></title><description><![CDATA[Cizzle Biotechnology Publishes 2025 Annual Report and Financial Statements&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cizzle-biotechnology-publishes-2025-annual-report-and-financial-statements-tipranks/</link><pubDate>Thu, 30 Apr 2026 08:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cizzle-biotechnology-publishes-2025-annual-report-and-financial-statements-tipranks/</guid></item><item><title><![CDATA[XTL Biopharmaceuticals To Acquire Psyga Bio To Establish Leading Psychedelic Biotechnology Platform - Pulse 2.0]]></title><description><![CDATA[XTL Biopharmaceuticals To Acquire Psyga Bio To Establish Leading Psychedelic Biotechnology Platform&nbsp;&nbsp;Pulse 2.0]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/xtl-biopharmaceuticals-to-acquire-psyga-bio-to-establish-leading-psychedelic-biotechnology-platform-pulse-20/</link><pubDate>Thu, 30 Apr 2026 04:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/xtl-biopharmaceuticals-to-acquire-psyga-bio-to-establish-leading-psychedelic-biotechnology-platform-pulse-20/</guid></item><item><title><![CDATA[Precision Trading with Ishares Biotechnology Etf (IBB) Risk Zones - Stock Traders Daily]]></title><description><![CDATA[Precision Trading with Ishares Biotechnology Etf (IBB) Risk Zones&nbsp;&nbsp;Stock Traders Daily]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/precision-trading-with-ishares-biotechnology-etf-ibb-risk-zones-stock-traders-daily/</link><pubDate>Wed, 29 Apr 2026 22:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/precision-trading-with-ishares-biotechnology-etf-ibb-risk-zones-stock-traders-daily/</guid></item><item><title><![CDATA[[SCHEDULE 13G] Vir Biotechnology, Inc. Passive Investment Disclosure (&gt;5%) - Stock Titan]]></title><description><![CDATA[[SCHEDULE 13G] Vir Biotechnology, Inc. Passive Investment Disclosure (&gt;5%)&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/schedule-13g-vir-biotechnology-inc-passive-investment-disclosure-gt5-stock-titan/</link><pubDate>Wed, 29 Apr 2026 21:50:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/schedule-13g-vir-biotechnology-inc-passive-investment-disclosure-gt5-stock-titan/</guid></item><item><title><![CDATA[Oman’s biotechnology committee holds 15th meeting - Times of Oman]]></title><description><![CDATA[Oman&rsquo;s biotechnology committee holds 15th meeting&nbsp;&nbsp;Times of Oman]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/omans-biotechnology-committee-holds-15th-meeting-times-of-oman/</link><pubDate>Wed, 29 Apr 2026 16:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/omans-biotechnology-committee-holds-15th-meeting-times-of-oman/</guid></item><item><title><![CDATA[Inside Servier’s new €200M venture fund - European Biotechnology Magazine]]></title><description><![CDATA[Inside Servier&rsquo;s new &euro;200M venture fund&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/inside-serviers-new-200m-venture-fund-european-biotechnology-magazine/</link><pubDate>Wed, 29 Apr 2026 16:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/inside-serviers-new-200m-venture-fund-european-biotechnology-magazine/</guid></item><item><title><![CDATA[XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies - The Manila Times]]></title><description><![CDATA[XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies&nbsp;&nbsp;The Manila Times]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/xtl-biopharmaceuticals-to-acquire-psyga-bio-establishing-a-leading-psychedelic-biotechnology-platform-with-advanced-clinical-pipeline-licensed-gmp-manufacturing-and-proprietary-psilocybin-technologies-the-manila-times/</link><pubDate>Wed, 29 Apr 2026 15:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/xtl-biopharmaceuticals-to-acquire-psyga-bio-establishing-a-leading-psychedelic-biotechnology-platform-with-advanced-clinical-pipeline-licensed-gmp-manufacturing-and-proprietary-psilocybin-technologies-the-manila-times/</guid></item><item><title><![CDATA[BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development - PharmaTimes]]></title><description><![CDATA[BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development&nbsp;&nbsp;PharmaTimes]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/bioduro-and-cti-biotechnology-form-partnership-to-accelerate-preclinical-drug-development-pharmatimes/</link><pubDate>Wed, 29 Apr 2026 14:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/bioduro-and-cti-biotechnology-form-partnership-to-accelerate-preclinical-drug-development-pharmatimes/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat]]></title><description><![CDATA[Vir Biotechnology (VIR) Expected to Announce Quarterly Earnings on Wednesday&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-expected-to-announce-quarterly-earnings-on-wednesday-marketbeat/</link><pubDate>Wed, 29 Apr 2026 13:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-expected-to-announce-quarterly-earnings-on-wednesday-marketbeat/</guid></item><item><title><![CDATA[What is biotechnology? Biotechnology Guide for Investors - Beansprout]]></title><description><![CDATA[What is biotechnology? Biotechnology Guide for Investors&nbsp;&nbsp;Beansprout]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/what-is-biotechnology-biotechnology-guide-for-investors-beansprout/</link><pubDate>Wed, 29 Apr 2026 13:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/what-is-biotechnology-biotechnology-guide-for-investors-beansprout/</guid></item><item><title><![CDATA[[EFFECT] PDS Biotechnology Corp SEC Filing - Stock Titan]]></title><description><![CDATA[[EFFECT] PDS Biotechnology Corp SEC Filing&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/effect-pds-biotechnology-corp-sec-filing-stock-titan/</link><pubDate>Wed, 29 Apr 2026 12:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/effect-pds-biotechnology-corp-sec-filing-stock-titan/</guid></item><item><title><![CDATA[Tuning the immune response to mRNA vaccines - Nature]]></title><description><![CDATA[Tuning the immune response to mRNA vaccines&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/tuning-the-immune-response-to-mrna-vaccines-nature/</link><pubDate>Wed, 29 Apr 2026 12:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/tuning-the-immune-response-to-mrna-vaccines-nature/</guid></item><item><title><![CDATA[Puma Biotechnology (NASDAQ:PBYI) Stock Passes Above 200-Day Moving Average - Should You Sell? - MarketBeat]]></title><description><![CDATA[Puma Biotechnology (NASDAQ:PBYI) Stock Passes Above 200-Day Moving Average - Should You Sell?&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-nasdaqpbyi-stock-passes-above-200-day-moving-average-should-you-sell-marketbeat/</link><pubDate>Wed, 29 Apr 2026 09:17:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-nasdaqpbyi-stock-passes-above-200-day-moving-average-should-you-sell-marketbeat/</guid></item><item><title><![CDATA[Coultreon bags US$125m for autoimmune pipeline - European Biotechnology Magazine]]></title><description><![CDATA[Coultreon bags US$125m for autoimmune pipeline&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/coultreon-bags-us125m-for-autoimmune-pipeline-european-biotechnology-magazine/</link><pubDate>Wed, 29 Apr 2026 07:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/coultreon-bags-us125m-for-autoimmune-pipeline-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Korea, Qatar strengthen cooperation in advanced industries, focusing on AI and biotechnology - Korea JoongAng Daily]]></title><description><![CDATA[Korea, Qatar strengthen cooperation in advanced industries, focusing on AI and biotechnology&nbsp;&nbsp;Korea JoongAng Daily]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/korea-qatar-strengthen-cooperation-in-advanced-industries-focusing-on-ai-and-biotechnology-korea-joongang-daily/</link><pubDate>Wed, 29 Apr 2026 05:37:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/korea-qatar-strengthen-cooperation-in-advanced-industries-focusing-on-ai-and-biotechnology-korea-joongang-daily/</guid></item><item><title><![CDATA[[10-K/A] PDS Biotechnology Corp Amends Annual Report - Stock Titan]]></title><description><![CDATA[[10-K/A] PDS Biotechnology Corp Amends Annual Report&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/10-ka-pds-biotechnology-corp-amends-annual-report-stock-titan/</link><pubDate>Tue, 28 Apr 2026 22:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/10-ka-pds-biotechnology-corp-amends-annual-report-stock-titan/</guid></item><item><title><![CDATA[Nautilus Biotechnology (NASDAQ: NAUT) details Q1 2026 loss and cash runway - Stock Titan]]></title><description><![CDATA[Nautilus Biotechnology (NASDAQ: NAUT) details Q1 2026 loss and cash runway&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-nasdaq-naut-details-q1-2026-loss-and-cash-runway-stock-titan/</link><pubDate>Tue, 28 Apr 2026 22:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-nasdaq-naut-details-q1-2026-loss-and-cash-runway-stock-titan/</guid></item><item><title><![CDATA[Historic FDA approval brings first gene therapy for genetic deafness - Nature]]></title><description><![CDATA[Historic FDA approval brings first gene therapy for genetic deafness&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/historic-fda-approval-brings-first-gene-therapy-for-genetic-deafness-nature/</link><pubDate>Tue, 28 Apr 2026 15:55:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/historic-fda-approval-brings-first-gene-therapy-for-genetic-deafness-nature/</guid></item><item><title><![CDATA[Shandong Boan Biotechnology Seeks Shareholder Nod for New RSU Incentive Scheme - TipRanks]]></title><description><![CDATA[Shandong Boan Biotechnology Seeks Shareholder Nod for New RSU Incentive Scheme&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/shandong-boan-biotechnology-seeks-shareholder-nod-for-new-rsu-incentive-scheme-tipranks/</link><pubDate>Tue, 28 Apr 2026 15:48:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/shandong-boan-biotechnology-seeks-shareholder-nod-for-new-rsu-incentive-scheme-tipranks/</guid></item><item><title><![CDATA[Nautilus Biotechnology Reports First Quarter 2026 Financial Results - Investing News Network]]></title><description><![CDATA[Nautilus Biotechnology Reports First Quarter 2026 Financial Results&nbsp;&nbsp;Investing News Network]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-reports-first-quarter-2026-financial-results-investing-news-network/</link><pubDate>Tue, 28 Apr 2026 15:19:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-reports-first-quarter-2026-financial-results-investing-news-network/</guid></item><item><title><![CDATA[Earnings call transcript: Nautilus Biotechnology beats Q1 2026 EPS forecast By Investing.com - Investing.com Canada]]></title><description><![CDATA[Earnings call transcript: Nautilus Biotechnology beats Q1 2026 EPS forecast By Investing.com&nbsp;&nbsp;Investing.com Canada]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-call-transcript-nautilus-biotechnology-beats-q1-2026-eps-forecast-by-investingcom-investingcom-canada/</link><pubDate>Tue, 28 Apr 2026 15:17:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-call-transcript-nautilus-biotechnology-beats-q1-2026-eps-forecast-by-investingcom-investingcom-canada/</guid></item><item><title><![CDATA[Nautilus Biotechnology Reports First Quarter 2026 Financial Results - Bluefield Daily Telegraph]]></title><description><![CDATA[Nautilus Biotechnology Reports First Quarter 2026 Financial Results&nbsp;&nbsp;Bluefield Daily Telegraph]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-reports-first-quarter-2026-financial-results-bluefield-daily-telegraph/</link><pubDate>Tue, 28 Apr 2026 14:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-reports-first-quarter-2026-financial-results-bluefield-daily-telegraph/</guid></item><item><title><![CDATA[Nautilus Biotechnology Reports First Quarter 2026 Financial Results - marketscreener.com]]></title><description><![CDATA[Nautilus Biotechnology Reports First Quarter 2026 Financial Results&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-reports-first-quarter-2026-financial-results-marketscreenercom/</link><pubDate>Tue, 28 Apr 2026 14:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-reports-first-quarter-2026-financial-results-marketscreenercom/</guid></item><item><title><![CDATA[Nautilus lands first customer as cancer study taps Tau assay - Stock Titan]]></title><description><![CDATA[Nautilus lands first customer as cancer study taps Tau assay&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-lands-first-customer-as-cancer-study-taps-tau-assay-stock-titan/</link><pubDate>Tue, 28 Apr 2026 14:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-lands-first-customer-as-cancer-study-taps-tau-assay-stock-titan/</guid></item><item><title><![CDATA[Q1 2026: Nautilus Biotechnology (NASDAQ: NAUT) cuts costs and narrows loss - Stock Titan]]></title><description><![CDATA[Q1 2026: Nautilus Biotechnology (NASDAQ: NAUT) cuts costs and narrows loss&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/q1-2026-nautilus-biotechnology-nasdaq-naut-cuts-costs-and-narrows-loss-stock-titan/</link><pubDate>Tue, 28 Apr 2026 12:29:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/q1-2026-nautilus-biotechnology-nasdaq-naut-cuts-costs-and-narrows-loss-stock-titan/</guid></item><item><title><![CDATA[Astorg spins off Thermo Fisher’s microbiology arm - European Biotechnology Magazine]]></title><description><![CDATA[Astorg spins off Thermo Fisher&rsquo;s microbiology arm&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/astorg-spins-off-thermo-fishers-microbiology-arm-european-biotechnology-magazine/</link><pubDate>Tue, 28 Apr 2026 09:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/astorg-spins-off-thermo-fishers-microbiology-arm-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Health Biotechnology collaborative research funded by the European Commission powers next‑generation therapies - CORDIS]]></title><description><![CDATA[Health Biotechnology collaborative research funded by the European Commission powers next&#8209;generation therapies&nbsp;&nbsp;CORDIS]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/health-biotechnology-collaborative-research-funded-by-the-european-commission-powers-nextgeneration-therapies-cordis/</link><pubDate>Tue, 28 Apr 2026 06:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/health-biotechnology-collaborative-research-funded-by-the-european-commission-powers-nextgeneration-therapies-cordis/</guid></item><item><title><![CDATA[Assessing Vir Biotechnology (VIR) Valuation After Recent Share Price Momentum - simplywall.st]]></title><description><![CDATA[Assessing Vir Biotechnology (VIR) Valuation After Recent Share Price Momentum&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/assessing-vir-biotechnology-vir-valuation-after-recent-share-price-momentum-simplywallst/</link><pubDate>Tue, 28 Apr 2026 05:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/assessing-vir-biotechnology-vir-valuation-after-recent-share-price-momentum-simplywallst/</guid></item><item><title><![CDATA[Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene &amp; Cell Therapy (ASGCT) 2026 Annual Meeting - Yahoo Finance]]></title><description><![CDATA[Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene &amp; Cell Therapy (ASGCT) 2026 Annual Meeting&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-announces-oral-presentation-highlighting-preclinical-data-from-in-vivo-car-t-sg293-at-the-american-society-of-gene-amp-cell-therapy-asgct-2026-annual-meeting-yahoo-finance/</link><pubDate>Mon, 27 Apr 2026 22:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-announces-oral-presentation-highlighting-preclinical-data-from-in-vivo-car-t-sg293-at-the-american-society-of-gene-amp-cell-therapy-asgct-2026-annual-meeting-yahoo-finance/</guid></item><item><title><![CDATA[Molecular mechanisms and biotechnology applications of CRISPR–Cas12a - Nature]]></title><description><![CDATA[Molecular mechanisms and biotechnology applications of CRISPR&ndash;Cas12a&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/molecular-mechanisms-and-biotechnology-applications-of-crisprcas12a-nature/</link><pubDate>Mon, 27 Apr 2026 19:57:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/molecular-mechanisms-and-biotechnology-applications-of-crisprcas12a-nature/</guid></item><item><title><![CDATA[Biotechnology - Ministero degli Affari Esteri e della Cooperazione Internazionale]]></title><description><![CDATA[Biotechnology&nbsp;&nbsp;Ministero degli Affari Esteri e della Cooperazione Internazionale]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-ministero-degli-affari-esteri-e-della-cooperazione-internazionale/</link><pubDate>Mon, 27 Apr 2026 18:13:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-ministero-degli-affari-esteri-e-della-cooperazione-internazionale/</guid></item><item><title><![CDATA[PDS Biotechnology (NASDAQ: PDSB) registers $200M shelf, removes $20M ATM - Stock Titan]]></title><description><![CDATA[PDS Biotechnology (NASDAQ: PDSB) registers $200M shelf, removes $20M ATM&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-nasdaq-pdsb-registers-200m-shelf-removes-20m-atm-stock-titan/</link><pubDate>Mon, 27 Apr 2026 17:51:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-nasdaq-pdsb-registers-200m-shelf-removes-20m-atm-stock-titan/</guid></item><item><title><![CDATA[Improving metagenome binning by integrating intrinsic features and taxonomy - Nature]]></title><description><![CDATA[Improving metagenome binning by integrating intrinsic features and taxonomy&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/improving-metagenome-binning-by-integrating-intrinsic-features-and-taxonomy-nature/</link><pubDate>Mon, 27 Apr 2026 11:51:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/improving-metagenome-binning-by-integrating-intrinsic-features-and-taxonomy-nature/</guid></item><item><title><![CDATA[Police investigating after man enters a biotechnology building reportedly armed - First Alert 4]]></title><description><![CDATA[Police investigating after man enters a biotechnology building reportedly armed&nbsp;&nbsp;First Alert 4]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/police-investigating-after-man-enters-a-biotechnology-building-reportedly-armed-first-alert-4/</link><pubDate>Sun, 26 Apr 2026 22:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/police-investigating-after-man-enters-a-biotechnology-building-reportedly-armed-first-alert-4/</guid></item><item><title><![CDATA[Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now? - Yahoo Finance]]></title><description><![CDATA[Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/is-vir-biotechnology-inc-vir-a-good-stock-to-buy-now-yahoo-finance/</link><pubDate>Sun, 26 Apr 2026 21:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/is-vir-biotechnology-inc-vir-a-good-stock-to-buy-now-yahoo-finance/</guid></item><item><title><![CDATA[Barrier-Supporting Skincare Product Capsules - Trend Hunter]]></title><description><![CDATA[Barrier-Supporting Skincare Product Capsules&nbsp;&nbsp;Trend Hunter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/barrier-supporting-skincare-product-capsules-trend-hunter/</link><pubDate>Sat, 25 Apr 2026 19:37:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/barrier-supporting-skincare-product-capsules-trend-hunter/</guid></item><item><title><![CDATA[Bangladesh lags in biotechnology due to weak research-industry linkages, despite strong potential: Experts - The Business Standard]]></title><description><![CDATA[Bangladesh lags in biotechnology due to weak research-industry linkages, despite strong potential: Experts&nbsp;&nbsp;The Business Standard]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/bangladesh-lags-in-biotechnology-due-to-weak-research-industry-linkages-despite-strong-potential-experts-the-business-standard/</link><pubDate>Sat, 25 Apr 2026 16:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/bangladesh-lags-in-biotechnology-due-to-weak-research-industry-linkages-despite-strong-potential-experts-the-business-standard/</guid></item><item><title><![CDATA[Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks - Yahoo Finance]]></title><description><![CDATA[Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/q4-earnings-highlights-regeneron-nasdaqregn-vs-the-rest-of-the-biotechnology-stocks-yahoo-finance/</link><pubDate>Sat, 25 Apr 2026 10:29:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/q4-earnings-highlights-regeneron-nasdaqregn-vs-the-rest-of-the-biotechnology-stocks-yahoo-finance/</guid></item><item><title><![CDATA[Wall Street Zen Downgrades Sana Biotechnology (NASDAQ:SANA) to Strong Sell - MarketBeat]]></title><description><![CDATA[Wall Street Zen Downgrades Sana Biotechnology (NASDAQ:SANA) to Strong Sell&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/wall-street-zen-downgrades-sana-biotechnology-nasdaqsana-to-strong-sell-marketbeat/</link><pubDate>Sat, 25 Apr 2026 08:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/wall-street-zen-downgrades-sana-biotechnology-nasdaqsana-to-strong-sell-marketbeat/</guid></item><item><title><![CDATA[Sana Biotechnology, Inc. ($SANA) President, CEO, and Director 2025 Pay Revealed - Quiver Quantitative]]></title><description><![CDATA[Sana Biotechnology, Inc. ($SANA) President, CEO, and Director 2025 Pay Revealed&nbsp;&nbsp;Quiver Quantitative]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-inc-sana-president-ceo-and-director-2025-pay-revealed-quiver-quantitative/</link><pubDate>Sat, 25 Apr 2026 00:27:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-inc-sana-president-ceo-and-director-2025-pay-revealed-quiver-quantitative/</guid></item><item><title><![CDATA[PDS Biotechnology Highlights Progress in Versamune Oncology Pipeline - TipRanks]]></title><description><![CDATA[PDS Biotechnology Highlights Progress in Versamune Oncology Pipeline&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-highlights-progress-in-versamune-oncology-pipeline-tipranks/</link><pubDate>Fri, 24 Apr 2026 23:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-highlights-progress-in-versamune-oncology-pipeline-tipranks/</guid></item><item><title><![CDATA[Green Fresh Biotechnology Sets June 2026 AGM to Approve Dividend, Board Mandates and Share Buyback - TipRanks]]></title><description><![CDATA[Green Fresh Biotechnology Sets June 2026 AGM to Approve Dividend, Board Mandates and Share Buyback&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/green-fresh-biotechnology-sets-june-2026-agm-to-approve-dividend-board-mandates-and-share-buyback-tipranks/</link><pubDate>Fri, 24 Apr 2026 15:39:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/green-fresh-biotechnology-sets-june-2026-agm-to-approve-dividend-board-mandates-and-share-buyback-tipranks/</guid></item><item><title><![CDATA[Evonik Boosts Biotechnology Capacity for Drug Substance Production Through New Investment in Slovakia - ChemAnalyst]]></title><description><![CDATA[Evonik Boosts Biotechnology Capacity for Drug Substance Production Through New Investment in Slovakia&nbsp;&nbsp;ChemAnalyst]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/evonik-boosts-biotechnology-capacity-for-drug-substance-production-through-new-investment-in-slovakia-chemanalyst/</link><pubDate>Fri, 24 Apr 2026 15:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/evonik-boosts-biotechnology-capacity-for-drug-substance-production-through-new-investment-in-slovakia-chemanalyst/</guid></item><item><title><![CDATA[Biotechnology-Based Economy: Will Bangladesh Lead or Be Left Behind? - The Business Standard]]></title><description><![CDATA[Biotechnology-Based Economy: Will Bangladesh Lead or Be Left Behind?&nbsp;&nbsp;The Business Standard]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-based-economy-will-bangladesh-lead-or-be-left-behind-the-business-standard/</link><pubDate>Fri, 24 Apr 2026 14:35:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-based-economy-will-bangladesh-lead-or-be-left-behind-the-business-standard/</guid></item><item><title><![CDATA[Chengguang Biotechnology (300138.SZ) released its Q1 financial performance, with net profit attributable to shareholders amounting to 96.7216 million yuan, representing a decrease of 11.65%. - Moomoo]]></title><description><![CDATA[Chengguang Biotechnology (300138.SZ) released its Q1 financial performance, with net profit attributable to shareholders amounting to 96.7216 million yuan, representing a decrease of 11.65%.&nbsp;&nbsp;Moomoo]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/chengguang-biotechnology-300138sz-released-its-q1-financial-performance-with-net-profit-attributable-to-shareholders-amounting-to-967216-million-yuan-representing-a-decrease-of-1165-moomoo/</link><pubDate>Fri, 24 Apr 2026 14:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/chengguang-biotechnology-300138sz-released-its-q1-financial-performance-with-net-profit-attributable-to-shareholders-amounting-to-967216-million-yuan-representing-a-decrease-of-1165-moomoo/</guid></item><item><title><![CDATA[Tivic Health rebrands as Valion Bio, doubles down on entolimod strategy - The Pharma Letter]]></title><description><![CDATA[Tivic Health rebrands as Valion Bio, doubles down on entolimod strategy&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/tivic-health-rebrands-as-valion-bio-doubles-down-on-entolimod-strategy-the-pharma-letter/</link><pubDate>Fri, 24 Apr 2026 12:52:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/tivic-health-rebrands-as-valion-bio-doubles-down-on-entolimod-strategy-the-pharma-letter/</guid></item><item><title><![CDATA[Sana Biotechnology Rebalances Board Classes With Director Shift - TipRanks]]></title><description><![CDATA[Sana Biotechnology Rebalances Board Classes With Director Shift&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-rebalances-board-classes-with-director-shift-tipranks/</link><pubDate>Fri, 24 Apr 2026 12:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-rebalances-board-classes-with-director-shift-tipranks/</guid></item><item><title><![CDATA[Sana Biotechnology reclassifies board member to balance director classes - Investing.com]]></title><description><![CDATA[Sana Biotechnology reclassifies board member to balance director classes&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-reclassifies-board-member-to-balance-director-classes-investingcom/</link><pubDate>Fri, 24 Apr 2026 12:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-reclassifies-board-member-to-balance-director-classes-investingcom/</guid></item><item><title><![CDATA[Kurma closes 215 million euro Biofund IV - The Pharma Letter]]></title><description><![CDATA[Kurma closes 215 million euro Biofund IV&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/kurma-closes-215-million-euro-biofund-iv-the-pharma-letter/</link><pubDate>Fri, 24 Apr 2026 12:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/kurma-closes-215-million-euro-biofund-iv-the-pharma-letter/</guid></item><item><title><![CDATA[Karnataka govt approves Rs 20 Cr CoE for AI in Biotechnology at Electronics City, Bengaluru - BioSpectrum India]]></title><description><![CDATA[Karnataka govt approves Rs 20 Cr CoE for AI in Biotechnology at Electronics City, Bengaluru&nbsp;&nbsp;BioSpectrum India]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/karnataka-govt-approves-rs-20-cr-coe-for-ai-in-biotechnology-at-electronics-city-bengaluru-biospectrum-india/</link><pubDate>Fri, 24 Apr 2026 10:48:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/karnataka-govt-approves-rs-20-cr-coe-for-ai-in-biotechnology-at-electronics-city-bengaluru-biospectrum-india/</guid></item><item><title><![CDATA[Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results - BioSpace]]></title><description><![CDATA[Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results&nbsp;&nbsp;BioSpace]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-to-host-conference-call-to-discuss-first-quarter-2026-financial-results-biospace/</link><pubDate>Fri, 24 Apr 2026 08:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-to-host-conference-call-to-discuss-first-quarter-2026-financial-results-biospace/</guid></item><item><title><![CDATA[Assessing Sana Biotechnology (SANA) Valuation After Mayo Clinic Partnership And Equity Investment - Yahoo Finance]]></title><description><![CDATA[Assessing Sana Biotechnology (SANA) Valuation After Mayo Clinic Partnership And Equity Investment&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/assessing-sana-biotechnology-sana-valuation-after-mayo-clinic-partnership-and-equity-investment-yahoo-finance/</link><pubDate>Thu, 23 Apr 2026 16:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/assessing-sana-biotechnology-sana-valuation-after-mayo-clinic-partnership-and-equity-investment-yahoo-finance/</guid></item><item><title><![CDATA[Canada’s biotech paradox: strong science, weak scaling - The Pharma Letter]]></title><description><![CDATA[Canada&rsquo;s biotech paradox: strong science, weak scaling&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/canadas-biotech-paradox-strong-science-weak-scaling-the-pharma-letter/</link><pubDate>Thu, 23 Apr 2026 14:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/canadas-biotech-paradox-strong-science-weak-scaling-the-pharma-letter/</guid></item><item><title><![CDATA[EU Biotech Act: The European Commission&rsquo;s landmark proposal to strengthen biotechnology in Europe - White &amp; Case LLP]]></title><description><![CDATA[EU Biotech Act: The European Commission&rsquo;s landmark proposal to strengthen biotechnology in Europe&nbsp;&nbsp;White &amp; Case LLP]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/eu-biotech-act-the-european-commissionrsquos-landmark-proposal-to-strengthen-biotechnology-in-europe-white-amp-case-llp/</link><pubDate>Thu, 23 Apr 2026 14:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/eu-biotech-act-the-european-commissionrsquos-landmark-proposal-to-strengthen-biotechnology-in-europe-white-amp-case-llp/</guid></item><item><title><![CDATA[EU Biotech Act: The European Commission’s landmark proposal to strengthen biotechnology in Europe - whitecase.com]]></title><description><![CDATA[EU Biotech Act: The European Commission&rsquo;s landmark proposal to strengthen biotechnology in Europe&nbsp;&nbsp;whitecase.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/eu-biotech-act-the-european-commissions-landmark-proposal-to-strengthen-biotechnology-in-europe-whitecasecom/</link><pubDate>Thu, 23 Apr 2026 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/eu-biotech-act-the-european-commissions-landmark-proposal-to-strengthen-biotechnology-in-europe-whitecasecom/</guid></item><item><title><![CDATA[Biotechnology, Medical &amp; Healthcare Industry in Hong Kong - HKTDC Research]]></title><description><![CDATA[Biotechnology, Medical &amp; Healthcare Industry in Hong Kong&nbsp;&nbsp;HKTDC Research]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-medical-amp-healthcare-industry-in-hong-kong-hktdc-research/</link><pubDate>Thu, 23 Apr 2026 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-medical-amp-healthcare-industry-in-hong-kong-hktdc-research/</guid></item><item><title><![CDATA[Sana Biotechnology (SANA) Is Up 6.3% After Mayo-Backed SC451 Diabetes Cell Therapy Collaboration - What's Changed - simplywall.st]]></title><description><![CDATA[Sana Biotechnology (SANA) Is Up 6.3% After Mayo-Backed SC451 Diabetes Cell Therapy Collaboration - What's Changed&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-is-up-63-after-mayo-backed-sc451-diabetes-cell-therapy-collaboration-whats-changed-simplywallst/</link><pubDate>Wed, 22 Apr 2026 19:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-is-up-63-after-mayo-backed-sc451-diabetes-cell-therapy-collaboration-whats-changed-simplywallst/</guid></item><item><title><![CDATA[Offworld Life Science: Research Hardware For A Biotechnology Investigation - astrobiology.com]]></title><description><![CDATA[Offworld Life Science: Research Hardware For A Biotechnology Investigation&nbsp;&nbsp;astrobiology.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/offworld-life-science-research-hardware-for-a-biotechnology-investigation-astrobiologycom/</link><pubDate>Wed, 22 Apr 2026 17:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/offworld-life-science-research-hardware-for-a-biotechnology-investigation-astrobiologycom/</guid></item><item><title><![CDATA[Reference-free discovery with barcoded single-cell sequencing - Nature]]></title><description><![CDATA[Reference-free discovery with barcoded single-cell sequencing&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/reference-free-discovery-with-barcoded-single-cell-sequencing-nature/</link><pubDate>Wed, 22 Apr 2026 12:27:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/reference-free-discovery-with-barcoded-single-cell-sequencing-nature/</guid></item><item><title><![CDATA[Deeper is not always better in plasma proteomics - Nature]]></title><description><![CDATA[Deeper is not always better in plasma proteomics&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/deeper-is-not-always-better-in-plasma-proteomics-nature/</link><pubDate>Wed, 22 Apr 2026 11:56:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/deeper-is-not-always-better-in-plasma-proteomics-nature/</guid></item><item><title><![CDATA[Roche’s fenebrutinib cuts relapses in MS amid safety concerns - European Biotechnology Magazine]]></title><description><![CDATA[Roche&rsquo;s fenebrutinib cuts relapses in MS amid safety concerns&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/roches-fenebrutinib-cuts-relapses-in-ms-amid-safety-concerns-european-biotechnology-magazine/</link><pubDate>Wed, 22 Apr 2026 08:46:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/roches-fenebrutinib-cuts-relapses-in-ms-amid-safety-concerns-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Praj Matrix launches advanced precision fermentation lab, advancing next-generation industrial biotechnology for India's BioE3 vision - ChiniMandi]]></title><description><![CDATA[Praj Matrix launches advanced precision fermentation lab, advancing next-generation industrial biotechnology for India's BioE3 vision&nbsp;&nbsp;ChiniMandi]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/praj-matrix-launches-advanced-precision-fermentation-lab-advancing-next-generation-industrial-biotechnology-for-indias-bioe3-vision-chinimandi/</link><pubDate>Wed, 22 Apr 2026 07:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/praj-matrix-launches-advanced-precision-fermentation-lab-advancing-next-generation-industrial-biotechnology-for-indias-bioe3-vision-chinimandi/</guid></item><item><title><![CDATA[RGCB invites applications for PhD Biotechnology programme - The Hindu]]></title><description><![CDATA[RGCB invites applications for PhD Biotechnology programme&nbsp;&nbsp;The Hindu]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/rgcb-invites-applications-for-phd-biotechnology-programme-the-hindu/</link><pubDate>Tue, 21 Apr 2026 16:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/rgcb-invites-applications-for-phd-biotechnology-programme-the-hindu/</guid></item><item><title><![CDATA[Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA) - Yahoo Finance]]></title><description><![CDATA[Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-stocks-q3-results-benchmarking-natera-nasdaqntra-yahoo-finance/</link><pubDate>Tue, 21 Apr 2026 15:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-stocks-q3-results-benchmarking-natera-nasdaqntra-yahoo-finance/</guid></item><item><title><![CDATA[Kerry Group Expands Biotechnology Facility In Ireland - ESM Magazine]]></title><description><![CDATA[Kerry Group Expands Biotechnology Facility In Ireland&nbsp;&nbsp;ESM Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/kerry-group-expands-biotechnology-facility-in-ireland-esm-magazine/</link><pubDate>Tue, 21 Apr 2026 13:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/kerry-group-expands-biotechnology-facility-in-ireland-esm-magazine/</guid></item><item><title><![CDATA[Arcus pulls another TIGIT trial as Gilead steps back - The Pharma Letter]]></title><description><![CDATA[Arcus pulls another TIGIT trial as Gilead steps back&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/arcus-pulls-another-tigit-trial-as-gilead-steps-back-the-pharma-letter/</link><pubDate>Tue, 21 Apr 2026 12:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/arcus-pulls-another-tigit-trial-as-gilead-steps-back-the-pharma-letter/</guid></item><item><title><![CDATA[Biotechnology Instruments Market Analysis Report 2026-2035: Unified Frameworks Combining Genomics and Proteomics Underpin New Strategic Market Developments - Yahoo Finance UK]]></title><description><![CDATA[Biotechnology Instruments Market Analysis Report 2026-2035: Unified Frameworks Combining Genomics and Proteomics Underpin New Strategic Market Developments&nbsp;&nbsp;Yahoo Finance UK]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-instruments-market-analysis-report-2026-2035-unified-frameworks-combining-genomics-and-proteomics-underpin-new-strategic-market-developments-yahoo-finance-uk/</link><pubDate>Tue, 21 Apr 2026 12:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-instruments-market-analysis-report-2026-2035-unified-frameworks-combining-genomics-and-proteomics-underpin-new-strategic-market-developments-yahoo-finance-uk/</guid></item><item><title><![CDATA[DHR: Q1 2026 saw 3.5% revenue growth, margin expansion, and robust Biotechnology gains - TradingView]]></title><description><![CDATA[DHR: Q1 2026 saw 3.5% revenue growth, margin expansion, and robust Biotechnology gains&nbsp;&nbsp;TradingView]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/dhr-q1-2026-saw-35-revenue-growth-margin-expansion-and-robust-biotechnology-gains-tradingview/</link><pubDate>Tue, 21 Apr 2026 12:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/dhr-q1-2026-saw-35-revenue-growth-margin-expansion-and-robust-biotechnology-gains-tradingview/</guid></item><item><title><![CDATA[China clears GSK’s Blenrep combo in myeloma - The Pharma Letter]]></title><description><![CDATA[China clears GSK&rsquo;s Blenrep combo in myeloma&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/china-clears-gsks-blenrep-combo-in-myeloma-the-pharma-letter/</link><pubDate>Tue, 21 Apr 2026 11:58:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/china-clears-gsks-blenrep-combo-in-myeloma-the-pharma-letter/</guid></item><item><title><![CDATA[Arcus pulls another TIGIT trial as Gilead steps back from deal - The Pharma Letter]]></title><description><![CDATA[Arcus pulls another TIGIT trial as Gilead steps back from deal&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/arcus-pulls-another-tigit-trial-as-gilead-steps-back-from-deal-the-pharma-letter/</link><pubDate>Tue, 21 Apr 2026 11:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/arcus-pulls-another-tigit-trial-as-gilead-steps-back-from-deal-the-pharma-letter/</guid></item><item><title><![CDATA[Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA) - StockStory]]></title><description><![CDATA[Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)&nbsp;&nbsp;StockStory]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-stocks-q3-results-benchmarking-natera-nasdaqntra-stockstory/</link><pubDate>Tue, 21 Apr 2026 10:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-stocks-q3-results-benchmarking-natera-nasdaqntra-stockstory/</guid></item><item><title><![CDATA[International Biotechnology (LON:IBT) Shares Cross Above 200-Day Moving Average - Should You Sell? - MarketBeat]]></title><description><![CDATA[International Biotechnology (LON:IBT) Shares Cross Above 200-Day Moving Average - Should You Sell?&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/international-biotechnology-lonibt-shares-cross-above-200-day-moving-average-should-you-sell-marketbeat/</link><pubDate>Tue, 21 Apr 2026 09:46:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/international-biotechnology-lonibt-shares-cross-above-200-day-moving-average-should-you-sell-marketbeat/</guid></item><item><title><![CDATA[Sana Biotechnology (SANA) Valuation Check After Mayo Clinic SC451 Collaboration And Recent Share Price Swing - simplywall.st]]></title><description><![CDATA[Sana Biotechnology (SANA) Valuation Check After Mayo Clinic SC451 Collaboration And Recent Share Price Swing&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-valuation-check-after-mayo-clinic-sc451-collaboration-and-recent-share-price-swing-simplywallst/</link><pubDate>Tue, 21 Apr 2026 09:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-valuation-check-after-mayo-clinic-sc451-collaboration-and-recent-share-price-swing-simplywallst/</guid></item><item><title><![CDATA[Puma Biotechnology stock (US7392761034): Is neratinib's HER2 position strong enough for new upside? - AD HOC NEWS]]></title><description><![CDATA[Puma Biotechnology stock (US7392761034): Is neratinib's HER2 position strong enough for new upside?&nbsp;&nbsp;AD HOC NEWS]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-stock-us7392761034-is-neratinibs-her2-position-strong-enough-for-new-upside-ad-hoc-news/</link><pubDate>Tue, 21 Apr 2026 07:33:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-stock-us7392761034-is-neratinibs-her2-position-strong-enough-for-new-upside-ad-hoc-news/</guid></item><item><title><![CDATA[Wedbush Lifts PT on Sana Biotechnology (SANA) to $7 From $6 - Insider Monkey]]></title><description><![CDATA[Wedbush Lifts PT on Sana Biotechnology (SANA) to $7 From $6&nbsp;&nbsp;Insider Monkey]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/wedbush-lifts-pt-on-sana-biotechnology-sana-to-7-from-6-insider-monkey/</link><pubDate>Mon, 20 Apr 2026 23:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/wedbush-lifts-pt-on-sana-biotechnology-sana-to-7-from-6-insider-monkey/</guid></item><item><title><![CDATA[Wedbush Lifts PT on Sana Biotechnology (SANA) to $7 From $6 - Yahoo Finance]]></title><description><![CDATA[Wedbush Lifts PT on Sana Biotechnology (SANA) to $7 From $6&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/wedbush-lifts-pt-on-sana-biotechnology-sana-to-7-from-6-yahoo-finance/</link><pubDate>Mon, 20 Apr 2026 23:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/wedbush-lifts-pt-on-sana-biotechnology-sana-to-7-from-6-yahoo-finance/</guid></item><item><title><![CDATA[Sana Biotechnology (NASDAQ:SANA) Stock Price Up 8.7% - What's Next? - MarketBeat]]></title><description><![CDATA[Sana Biotechnology (NASDAQ:SANA) Stock Price Up 8.7% - What's Next?&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-nasdaqsana-stock-price-up-87-whats-next-marketbeat/</link><pubDate>Mon, 20 Apr 2026 22:19:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-nasdaqsana-stock-price-up-87-whats-next-marketbeat/</guid></item><item><title><![CDATA[LIXTE Biotechnology Holdings (LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape - NewMediaWire]]></title><description><![CDATA[LIXTE Biotechnology Holdings (LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape&nbsp;&nbsp;NewMediaWire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-holdings-lixt-positions-lb-100-as-novel-approach-in-cancer-treatment-landscape-newmediawire/</link><pubDate>Mon, 20 Apr 2026 21:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-holdings-lixt-positions-lb-100-as-novel-approach-in-cancer-treatment-landscape-newmediawire/</guid></item><item><title><![CDATA[Vir Biotechnology (NASDAQ:VIR) Sets New 1-Year High - Here's Why - MarketBeat]]></title><description><![CDATA[Vir Biotechnology (NASDAQ:VIR) Sets New 1-Year High - Here's Why&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-sets-new-1-year-high-heres-why-marketbeat/</link><pubDate>Mon, 20 Apr 2026 20:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-sets-new-1-year-high-heres-why-marketbeat/</guid></item><item><title><![CDATA[Kerry unveils expanded biotechnology facility in Ireland - Dairy Business Middle East &amp; Africa]]></title><description><![CDATA[Kerry unveils expanded biotechnology facility in Ireland&nbsp;&nbsp;Dairy Business Middle East &amp; Africa]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/kerry-unveils-expanded-biotechnology-facility-in-ireland-dairy-business-middle-east-amp-africa/</link><pubDate>Mon, 20 Apr 2026 17:27:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/kerry-unveils-expanded-biotechnology-facility-in-ireland-dairy-business-middle-east-amp-africa/</guid></item><item><title><![CDATA[Can Vir Biotechnology (VIR)’s Masked T-Cell Technology Crack the Hardest-to-Treat Prostate Cancer? - Yahoo Finance]]></title><description><![CDATA[Can Vir Biotechnology (VIR)&rsquo;s Masked T-Cell Technology Crack the Hardest-to-Treat Prostate Cancer?&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/can-vir-biotechnology-virs-masked-t-cell-technology-crack-the-hardest-to-treat-prostate-cancer-yahoo-finance/</link><pubDate>Mon, 20 Apr 2026 16:47:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/can-vir-biotechnology-virs-masked-t-cell-technology-crack-the-hardest-to-treat-prostate-cancer-yahoo-finance/</guid></item><item><title><![CDATA[Vir Biotechnology stock hits 52-week high at $10.94 - Investing.com]]></title><description><![CDATA[Vir Biotechnology stock hits 52-week high at $10.94&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-stock-hits-52-week-high-at-1094-investingcom/</link><pubDate>Mon, 20 Apr 2026 15:57:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-stock-hits-52-week-high-at-1094-investingcom/</guid></item><item><title><![CDATA[Kerry Group opens expanded biotechnology manufacturing facility in Cork - Radio Kerry]]></title><description><![CDATA[Kerry Group opens expanded biotechnology manufacturing facility in Cork&nbsp;&nbsp;Radio Kerry]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/kerry-group-opens-expanded-biotechnology-manufacturing-facility-in-cork-radio-kerry/</link><pubDate>Mon, 20 Apr 2026 14:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/kerry-group-opens-expanded-biotechnology-manufacturing-facility-in-cork-radio-kerry/</guid></item><item><title><![CDATA[Lundbeck stresses cognitive gains with Vyepti in real-world study - The Pharma Letter]]></title><description><![CDATA[Lundbeck stresses cognitive gains with Vyepti in real-world study&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lundbeck-stresses-cognitive-gains-with-vyepti-in-real-world-study-the-pharma-letter/</link><pubDate>Mon, 20 Apr 2026 12:56:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lundbeck-stresses-cognitive-gains-with-vyepti-in-real-world-study-the-pharma-letter/</guid></item><item><title><![CDATA[DNA Center to receive new equipment: Biotechnology Institute announces tender worth 13.5 million soms - AKIpress News Agency]]></title><description><![CDATA[DNA Center to receive new equipment: Biotechnology Institute announces tender worth 13.5 million soms&nbsp;&nbsp;AKIpress News Agency]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/dna-center-to-receive-new-equipment-biotechnology-institute-announces-tender-worth-135-million-soms-akipress-news-agency/</link><pubDate>Mon, 20 Apr 2026 11:26:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/dna-center-to-receive-new-equipment-biotechnology-institute-announces-tender-worth-135-million-soms-akipress-news-agency/</guid></item><item><title><![CDATA[Kerry expands Ireland facility for lactose free dairy growth - Food Manufacture]]></title><description><![CDATA[Kerry expands Ireland facility for lactose free dairy growth&nbsp;&nbsp;Food Manufacture]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/kerry-expands-ireland-facility-for-lactose-free-dairy-growth-food-manufacture/</link><pubDate>Mon, 20 Apr 2026 10:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/kerry-expands-ireland-facility-for-lactose-free-dairy-growth-food-manufacture/</guid></item><item><title><![CDATA[Kerry Group opens expanded biotechnology manufacturing facility in Cork - businessplus.ie]]></title><description><![CDATA[Kerry Group opens expanded biotechnology manufacturing facility in Cork&nbsp;&nbsp;businessplus.ie]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/kerry-group-opens-expanded-biotechnology-manufacturing-facility-in-cork-businessplusie/</link><pubDate>Mon, 20 Apr 2026 08:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/kerry-group-opens-expanded-biotechnology-manufacturing-facility-in-cork-businessplusie/</guid></item><item><title><![CDATA[Kerry Group opens expanded biotechnology manufacturing facility in Cork - Irish Examiner]]></title><description><![CDATA[Kerry Group opens expanded biotechnology manufacturing facility in Cork&nbsp;&nbsp;Irish Examiner]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/kerry-group-opens-expanded-biotechnology-manufacturing-facility-in-cork-irish-examiner/</link><pubDate>Mon, 20 Apr 2026 08:35:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/kerry-group-opens-expanded-biotechnology-manufacturing-facility-in-cork-irish-examiner/</guid></item><item><title><![CDATA[Lixte Biotechnology stock (US53833K1060): Is its PP2A cancer focus strong enough to unlock breakthro - AD HOC NEWS]]></title><description><![CDATA[Lixte Biotechnology stock (US53833K1060): Is its PP2A cancer focus strong enough to unlock breakthro&nbsp;&nbsp;AD HOC NEWS]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-stock-us53833k1060-is-its-pp2a-cancer-focus-strong-enough-to-unlock-breakthro-ad-hoc-news/</link><pubDate>Mon, 20 Apr 2026 07:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-stock-us53833k1060-is-its-pp2a-cancer-focus-strong-enough-to-unlock-breakthro-ad-hoc-news/</guid></item><item><title><![CDATA[Is Vir Biotechnology (VIR) One of the Best Low Priced Biotech Stocks to Invest In? - Yahoo Finance]]></title><description><![CDATA[Is Vir Biotechnology (VIR) One of the Best Low Priced Biotech Stocks to Invest In?&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/is-vir-biotechnology-vir-one-of-the-best-low-priced-biotech-stocks-to-invest-in-yahoo-finance/</link><pubDate>Mon, 20 Apr 2026 02:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/is-vir-biotechnology-vir-one-of-the-best-low-priced-biotech-stocks-to-invest-in-yahoo-finance/</guid></item><item><title><![CDATA[SingleCell Biotechnology Presents Data at AACR Annual Meeting Demonstrating High-Throughput Single-C - PharmiWeb.com]]></title><description><![CDATA[SingleCell Biotechnology Presents Data at AACR Annual Meeting Demonstrating High-Throughput Single-C&nbsp;&nbsp;PharmiWeb.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/singlecell-biotechnology-presents-data-at-aacr-annual-meeting-demonstrating-high-throughput-single-c-pharmiwebcom/</link><pubDate>Sat, 18 Apr 2026 00:04:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/singlecell-biotechnology-presents-data-at-aacr-annual-meeting-demonstrating-high-throughput-single-c-pharmiwebcom/</guid></item><item><title><![CDATA[City of Roanoke and Carilion Clinic to establish biotechnology incubator - WDBJ7]]></title><description><![CDATA[City of Roanoke and Carilion Clinic to establish biotechnology incubator&nbsp;&nbsp;WDBJ7]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/city-of-roanoke-and-carilion-clinic-to-establish-biotechnology-incubator-wdbj7/</link><pubDate>Fri, 17 Apr 2026 22:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/city-of-roanoke-and-carilion-clinic-to-establish-biotechnology-incubator-wdbj7/</guid></item><item><title><![CDATA[Plastic-eating fungi dig diapers - Nature]]></title><description><![CDATA[Plastic-eating fungi dig diapers&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/plastic-eating-fungi-dig-diapers-nature/</link><pubDate>Fri, 17 Apr 2026 17:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/plastic-eating-fungi-dig-diapers-nature/</guid></item><item><title><![CDATA[Five questions with Jessica Stark - Nature]]></title><description><![CDATA[Five questions with Jessica Stark&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/five-questions-with-jessica-stark-nature/</link><pubDate>Fri, 17 Apr 2026 17:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/five-questions-with-jessica-stark-nature/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) Valuation After Astellas Partnership And New VIR 5500 Trial Milestone - simplywall.st]]></title><description><![CDATA[Vir Biotechnology (VIR) Valuation After Astellas Partnership And New VIR 5500 Trial Milestone&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-valuation-after-astellas-partnership-and-new-vir-5500-trial-milestone-simplywallst/</link><pubDate>Fri, 17 Apr 2026 00:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-valuation-after-astellas-partnership-and-new-vir-5500-trial-milestone-simplywallst/</guid></item><item><title><![CDATA[Vir Biotechnology, Inc. ($VIR) CEO 2025 Pay Revealed - Quiver Quantitative]]></title><description><![CDATA[Vir Biotechnology, Inc. ($VIR) CEO 2025 Pay Revealed&nbsp;&nbsp;Quiver Quantitative]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-vir-ceo-2025-pay-revealed-quiver-quantitative/</link><pubDate>Thu, 16 Apr 2026 23:26:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-vir-ceo-2025-pay-revealed-quiver-quantitative/</guid></item><item><title><![CDATA[Science vs disease: NBA taps biotechnology to save cassava, a failing lifeline crop - Mulembe News]]></title><description><![CDATA[Science vs disease: NBA taps biotechnology to save cassava, a failing lifeline crop&nbsp;&nbsp;Mulembe News]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/science-vs-disease-nba-taps-biotechnology-to-save-cassava-a-failing-lifeline-crop-mulembe-news/</link><pubDate>Thu, 16 Apr 2026 21:48:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/science-vs-disease-nba-taps-biotechnology-to-save-cassava-a-failing-lifeline-crop-mulembe-news/</guid></item><item><title><![CDATA[BIOTECHNOLOGY ASSOCIATION KEYNOTE SPEAKER: BOOK &amp; HIRE FUTURIST EXPERT FOR EVENTS - futuristsspeakers.com]]></title><description><![CDATA[BIOTECHNOLOGY ASSOCIATION KEYNOTE SPEAKER: BOOK &amp; HIRE FUTURIST EXPERT FOR EVENTS&nbsp;&nbsp;futuristsspeakers.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-association-keynote-speaker-book-amp-hire-futurist-expert-for-events-futuristsspeakerscom/</link><pubDate>Thu, 16 Apr 2026 21:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-association-keynote-speaker-book-amp-hire-futurist-expert-for-events-futuristsspeakerscom/</guid></item><item><title><![CDATA[MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Short Interest Update - MarketBeat]]></title><description><![CDATA[MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Short Interest Update&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-inc-nyseamericanmaia-short-interest-update-marketbeat/</link><pubDate>Thu, 16 Apr 2026 19:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-inc-nyseamericanmaia-short-interest-update-marketbeat/</guid></item><item><title><![CDATA[Biotechnology Market: Size, Trends, Growth Drivers, and Future Outlook (2026-2035) - openPR.com]]></title><description><![CDATA[Biotechnology Market: Size, Trends, Growth Drivers, and Future Outlook (2026-2035)&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-market-size-trends-growth-drivers-and-future-outlook-2026-2035-openprcom/</link><pubDate>Thu, 16 Apr 2026 18:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-market-size-trends-growth-drivers-and-future-outlook-2026-2035-openprcom/</guid></item><item><title><![CDATA[MAIA Biotechnology opens first U.S. site for lung cancer trial - Investing.com]]></title><description><![CDATA[MAIA Biotechnology opens first U.S. site for lung cancer trial&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-opens-first-us-site-for-lung-cancer-trial-investingcom/</link><pubDate>Thu, 16 Apr 2026 18:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-opens-first-us-site-for-lung-cancer-trial-investingcom/</guid></item><item><title><![CDATA[Nautilus Biotechnology details how artificial intelligence transforms proteomics insights - Traders Union]]></title><description><![CDATA[Nautilus Biotechnology details how artificial intelligence transforms proteomics insights&nbsp;&nbsp;Traders Union]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-details-how-artificial-intelligence-transforms-proteomics-insights-traders-union/</link><pubDate>Thu, 16 Apr 2026 18:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-details-how-artificial-intelligence-transforms-proteomics-insights-traders-union/</guid></item><item><title><![CDATA[Vir Biotechnology, Inc. Receives $240 Million Upfront Payment and $75 Million Equity Investment from Astellas - marketscreener.com]]></title><description><![CDATA[Vir Biotechnology, Inc. Receives $240 Million Upfront Payment and $75 Million Equity Investment from Astellas&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-receives-240-million-upfront-payment-and-75-million-equity-investment-from-astellas-marketscreenercom/</link><pubDate>Thu, 16 Apr 2026 17:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-receives-240-million-upfront-payment-and-75-million-equity-investment-from-astellas-marketscreenercom/</guid></item><item><title><![CDATA[Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatmen - PharmiWeb.com]]></title><description><![CDATA[Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatmen&nbsp;&nbsp;PharmiWeb.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-announces-closing-of-global-strategic-collaboration-with-astellas-for-the-treatmen-pharmiwebcom/</link><pubDate>Thu, 16 Apr 2026 17:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-announces-closing-of-global-strategic-collaboration-with-astellas-for-the-treatmen-pharmiwebcom/</guid></item><item><title><![CDATA[Sanofi (SNY) Benefits from Vir Biotechnology's Collaboration wit - GuruFocus]]></title><description><![CDATA[Sanofi (SNY) Benefits from Vir Biotechnology's Collaboration wit&nbsp;&nbsp;GuruFocus]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sanofi-sny-benefits-from-vir-biotechnologys-collaboration-wit-gurufocus/</link><pubDate>Thu, 16 Apr 2026 16:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sanofi-sny-benefits-from-vir-biotechnologys-collaboration-wit-gurufocus/</guid></item><item><title><![CDATA[China to further open up telecom, biotechnology and healthcare sectors - Xinhua]]></title><description><![CDATA[China to further open up telecom, biotechnology and healthcare sectors&nbsp;&nbsp;Xinhua]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/china-to-further-open-up-telecom-biotechnology-and-healthcare-sectors-xinhua/</link><pubDate>Thu, 16 Apr 2026 16:26:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/china-to-further-open-up-telecom-biotechnology-and-healthcare-sectors-xinhua/</guid></item><item><title><![CDATA[Vir Biotechnology Completes Astellas Deal to Advance Prostate Cancer Immunotherapy - Contract Pharma]]></title><description><![CDATA[Vir Biotechnology Completes Astellas Deal to Advance Prostate Cancer Immunotherapy&nbsp;&nbsp;Contract Pharma]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-completes-astellas-deal-to-advance-prostate-cancer-immunotherapy-contract-pharma/</link><pubDate>Thu, 16 Apr 2026 16:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-completes-astellas-deal-to-advance-prostate-cancer-immunotherapy-contract-pharma/</guid></item><item><title><![CDATA[IP Talks | Patents in Chemistry and Biotechnology - Técnico ULisboa]]></title><description><![CDATA[IP Talks | Patents in Chemistry and Biotechnology&nbsp;&nbsp;T&eacute;cnico ULisboa]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ip-talks-patents-in-chemistry-and-biotechnology-tcnico-ulisboa/</link><pubDate>Thu, 16 Apr 2026 16:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ip-talks-patents-in-chemistry-and-biotechnology-tcnico-ulisboa/</guid></item><item><title><![CDATA[Vir Biotechnology closes global collaboration agreement with Astellas Pharma - TipRanks]]></title><description><![CDATA[Vir Biotechnology closes global collaboration agreement with Astellas Pharma&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-closes-global-collaboration-agreement-with-astellas-pharma-tipranks/</link><pubDate>Thu, 16 Apr 2026 15:53:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-closes-global-collaboration-agreement-with-astellas-pharma-tipranks/</guid></item><item><title><![CDATA[Symrise invests in Bond Pet Foods for sustainable innovation in biotechnology - Nutrition Insight]]></title><description><![CDATA[Symrise invests in Bond Pet Foods for sustainable innovation in biotechnology&nbsp;&nbsp;Nutrition Insight]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/symrise-invests-in-bond-pet-foods-for-sustainable-innovation-in-biotechnology-nutrition-insight/</link><pubDate>Thu, 16 Apr 2026 15:48:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/symrise-invests-in-bond-pet-foods-for-sustainable-innovation-in-biotechnology-nutrition-insight/</guid></item><item><title><![CDATA[MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer - Yahoo Finance Singapore]]></title><description><![CDATA[MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer&nbsp;&nbsp;Yahoo Finance Singapore]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-activates-first-us-site-for-ongoing-international-phase-2-expansion-trial-of-novel-telomere-targeting-treatment-targeting-advanced-non-small-cell-lung-cancer-yahoo-finance-singapore/</link><pubDate>Thu, 16 Apr 2026 15:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-activates-first-us-site-for-ongoing-international-phase-2-expansion-trial-of-novel-telomere-targeting-treatment-targeting-advanced-non-small-cell-lung-cancer-yahoo-finance-singapore/</guid></item><item><title><![CDATA[Agricultural Biotechnology Market to Grow at 10.94% CAGR, Reaching USD 384.52 billion by 2032 - openPR.com]]></title><description><![CDATA[Agricultural Biotechnology Market to Grow at 10.94% CAGR, Reaching USD 384.52 billion by 2032&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/agricultural-biotechnology-market-to-grow-at-1094-cagr-reaching-usd-38452-billion-by-2032-openprcom/</link><pubDate>Thu, 16 Apr 2026 15:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/agricultural-biotechnology-market-to-grow-at-1094-cagr-reaching-usd-38452-billion-by-2032-openprcom/</guid></item><item><title><![CDATA[Vir Biotechnology (NASDAQ: VIR) sets 2026 meeting and pay vote - Stock Titan]]></title><description><![CDATA[Vir Biotechnology (NASDAQ: VIR) sets 2026 meeting and pay vote&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaq-vir-sets-2026-meeting-and-pay-vote-stock-titan/</link><pubDate>Thu, 16 Apr 2026 14:46:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaq-vir-sets-2026-meeting-and-pay-vote-stock-titan/</guid></item><item><title><![CDATA[Vir Biotechnology closes $240M Astellas deal for cancer drug - Investing.com]]></title><description><![CDATA[Vir Biotechnology closes $240M Astellas deal for cancer drug&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-closes-240m-astellas-deal-for-cancer-drug-investingcom/</link><pubDate>Thu, 16 Apr 2026 14:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-closes-240m-astellas-deal-for-cancer-drug-investingcom/</guid></item><item><title><![CDATA[Vir Biotechnology closes $240 million Astellas collaboration deal - StreetInsider]]></title><description><![CDATA[Vir Biotechnology closes $240 million Astellas collaboration deal&nbsp;&nbsp;StreetInsider]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-closes-240-million-astellas-collaboration-deal-streetinsider/</link><pubDate>Thu, 16 Apr 2026 14:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-closes-240-million-astellas-collaboration-deal-streetinsider/</guid></item><item><title><![CDATA[BioMed X, Servier launch AI-focused antibody research team in France - The Pharma Letter]]></title><description><![CDATA[BioMed X, Servier launch AI-focused antibody research team in France&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biomed-x-servier-launch-ai-focused-antibody-research-team-in-france-the-pharma-letter/</link><pubDate>Thu, 16 Apr 2026 12:48:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biomed-x-servier-launch-ai-focused-antibody-research-team-in-france-the-pharma-letter/</guid></item><item><title><![CDATA[Autoclaves in arable agricultural biotechnology and plant science - Labmate Online]]></title><description><![CDATA[Autoclaves in arable agricultural biotechnology and plant science&nbsp;&nbsp;Labmate Online]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/autoclaves-in-arable-agricultural-biotechnology-and-plant-science-labmate-online/</link><pubDate>Thu, 16 Apr 2026 12:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/autoclaves-in-arable-agricultural-biotechnology-and-plant-science-labmate-online/</guid></item><item><title><![CDATA[Diversity-generating retroelements for programmable targeted hypermutagenesis - Nature]]></title><description><![CDATA[Diversity-generating retroelements for programmable targeted hypermutagenesis&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/diversity-generating-retroelements-for-programmable-targeted-hypermutagenesis-nature/</link><pubDate>Thu, 16 Apr 2026 11:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/diversity-generating-retroelements-for-programmable-targeted-hypermutagenesis-nature/</guid></item><item><title><![CDATA[Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health - Black Hills Pioneer]]></title><description><![CDATA[Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health&nbsp;&nbsp;Black Hills Pioneer]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/fifty-1-labs-inc-accelerates-peptide-biotechnology-push-into-musculoskeletal-health-black-hills-pioneer/</link><pubDate>Thu, 16 Apr 2026 11:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/fifty-1-labs-inc-accelerates-peptide-biotechnology-push-into-musculoskeletal-health-black-hills-pioneer/</guid></item><item><title><![CDATA[Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer - Business Wire]]></title><description><![CDATA[Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer&nbsp;&nbsp;Business Wire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-announces-closing-of-global-strategic-collaboration-with-astellas-for-the-treatment-of-prostate-cancer-business-wire/</link><pubDate>Thu, 16 Apr 2026 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-announces-closing-of-global-strategic-collaboration-with-astellas-for-the-treatment-of-prostate-cancer-business-wire/</guid></item><item><title><![CDATA[1st phase of Egypt's Vaccine, Biotechnology City 100% completed: Health Ministry Spox - Egypt Today]]></title><description><![CDATA[1st phase of Egypt's Vaccine, Biotechnology City 100% completed: Health Ministry Spox&nbsp;&nbsp;Egypt Today]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/1st-phase-of-egypts-vaccine-biotechnology-city-100-completed-health-ministry-spox-egypt-today/</link><pubDate>Thu, 16 Apr 2026 03:44:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/1st-phase-of-egypts-vaccine-biotechnology-city-100-completed-health-ministry-spox-egypt-today/</guid></item><item><title><![CDATA[Why Is PDS Biotechnology Stock Gaining Wednesday? - PDS Biotechnology (NASDAQ:PDSB) - Benzinga]]></title><description><![CDATA[Why Is PDS Biotechnology Stock Gaining Wednesday? - PDS Biotechnology (NASDAQ:PDSB)&nbsp;&nbsp;Benzinga]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/why-is-pds-biotechnology-stock-gaining-wednesday-pds-biotechnology-nasdaqpdsb-benzinga/</link><pubDate>Wed, 15 Apr 2026 19:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/why-is-pds-biotechnology-stock-gaining-wednesday-pds-biotechnology-nasdaqpdsb-benzinga/</guid></item><item><title><![CDATA[PDS Biotechnology announces positive Phase 2 trial data for PDS01ADC - TipRanks]]></title><description><![CDATA[PDS Biotechnology announces positive Phase 2 trial data for PDS01ADC&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-announces-positive-phase-2-trial-data-for-pds01adc-tipranks/</link><pubDate>Wed, 15 Apr 2026 15:39:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-announces-positive-phase-2-trial-data-for-pds01adc-tipranks/</guid></item><item><title><![CDATA[PDS Biotechnology Announces Promising Phase 2 Trial Results of PDS01ADC for Treatment of Colorectal Liver Metastases - Quiver Quantitative]]></title><description><![CDATA[PDS Biotechnology Announces Promising Phase 2 Trial Results of PDS01ADC for Treatment of Colorectal Liver Metastases&nbsp;&nbsp;Quiver Quantitative]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-announces-promising-phase-2-trial-results-of-pds01adc-for-treatment-of-colorectal-liver-metastases-quiver-quantitative/</link><pubDate>Wed, 15 Apr 2026 14:51:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-announces-promising-phase-2-trial-results-of-pds01adc-for-treatment-of-colorectal-liver-metastases-quiver-quantitative/</guid></item><item><title><![CDATA[Novo Nordisk is going all in on AI - European Biotechnology Magazine]]></title><description><![CDATA[Novo Nordisk is going all in on AI&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/novo-nordisk-is-going-all-in-on-ai-european-biotechnology-magazine/</link><pubDate>Wed, 15 Apr 2026 11:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/novo-nordisk-is-going-all-in-on-ai-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Inducible, split base editors for in vivo cancer functional genomics - Nature]]></title><description><![CDATA[Inducible, split base editors for in vivo cancer functional genomics&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/inducible-split-base-editors-for-in-vivo-cancer-functional-genomics-nature/</link><pubDate>Wed, 15 Apr 2026 11:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/inducible-split-base-editors-for-in-vivo-cancer-functional-genomics-nature/</guid></item><item><title><![CDATA[Structure-centric searching enables global mapping of the public metabolome - Nature]]></title><description><![CDATA[Structure-centric searching enables global mapping of the public metabolome&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/structure-centric-searching-enables-global-mapping-of-the-public-metabolome-nature/</link><pubDate>Wed, 15 Apr 2026 11:37:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/structure-centric-searching-enables-global-mapping-of-the-public-metabolome-nature/</guid></item><item><title><![CDATA[Artificial allosteric protein switches with machine-learning-designed receptors - Nature]]></title><description><![CDATA[Artificial allosteric protein switches with machine-learning-designed receptors&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/artificial-allosteric-protein-switches-with-machine-learning-designed-receptors-nature/</link><pubDate>Wed, 15 Apr 2026 11:06:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/artificial-allosteric-protein-switches-with-machine-learning-designed-receptors-nature/</guid></item><item><title><![CDATA[Can Europe finance and keep its biotech winners? - European Biotechnology Magazine]]></title><description><![CDATA[Can Europe finance and keep its biotech winners?&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/can-europe-finance-and-keep-its-biotech-winners-european-biotechnology-magazine/</link><pubDate>Wed, 15 Apr 2026 10:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/can-europe-finance-and-keep-its-biotech-winners-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Gaining Industry Experience with a Master's in Molecular and Cellular Biotechnology - University of New Hampshire]]></title><description><![CDATA[Gaining Industry Experience with a Master's in Molecular and Cellular Biotechnology&nbsp;&nbsp;University of New Hampshire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/gaining-industry-experience-with-a-masters-in-molecular-and-cellular-biotechnology-university-of-new-hampshire/</link><pubDate>Wed, 15 Apr 2026 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/gaining-industry-experience-with-a-masters-in-molecular-and-cellular-biotechnology-university-of-new-hampshire/</guid></item><item><title><![CDATA[Adcendo banks US$75m to push ADC pipeline forward - European Biotechnology Magazine]]></title><description><![CDATA[Adcendo banks US$75m to push ADC pipeline forward&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/adcendo-banks-us75m-to-push-adc-pipeline-forward-european-biotechnology-magazine/</link><pubDate>Wed, 15 Apr 2026 08:57:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/adcendo-banks-us75m-to-push-adc-pipeline-forward-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Celltrion Named to S&amp;P Global CSA Top 1% in Biotechnology for ESG Performance - aju press]]></title><description><![CDATA[Celltrion Named to S&amp;P Global CSA Top 1% in Biotechnology for ESG Performance&nbsp;&nbsp;aju press]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/celltrion-named-to-sampp-global-csa-top-1-in-biotechnology-for-esg-performance-aju-press/</link><pubDate>Wed, 15 Apr 2026 03:51:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/celltrion-named-to-sampp-global-csa-top-1-in-biotechnology-for-esg-performance-aju-press/</guid></item><item><title><![CDATA[Vir Biotechnology Rings the Closing Bell - Nasdaq]]></title><description><![CDATA[Vir Biotechnology Rings the Closing Bell&nbsp;&nbsp;Nasdaq]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-rings-the-closing-bell-nasdaq/</link><pubDate>Tue, 14 Apr 2026 21:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-rings-the-closing-bell-nasdaq/</guid></item><item><title><![CDATA[Citizens biotechnology analyst holds analyst/industry conference call - TipRanks]]></title><description><![CDATA[Citizens biotechnology analyst holds analyst/industry conference call&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/citizens-biotechnology-analyst-holds-analystindustry-conference-call-tipranks/</link><pubDate>Tue, 14 Apr 2026 20:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/citizens-biotechnology-analyst-holds-analystindustry-conference-call-tipranks/</guid></item><item><title><![CDATA[A Look At Vir Biotechnology (VIR) Valuation After New VIR-5500 Prostate Cancer Trial Milestone - Yahoo Finance]]></title><description><![CDATA[A Look At Vir Biotechnology (VIR) Valuation After New VIR-5500 Prostate Cancer Trial Milestone&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/a-look-at-vir-biotechnology-vir-valuation-after-new-vir-5500-prostate-cancer-trial-milestone-yahoo-finance/</link><pubDate>Tue, 14 Apr 2026 20:09:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/a-look-at-vir-biotechnology-vir-valuation-after-new-vir-5500-prostate-cancer-trial-milestone-yahoo-finance/</guid></item><item><title><![CDATA[WACKER and biotechnology pioneer Amyris join forces in the personal care sector - WebWire]]></title><description><![CDATA[WACKER and biotechnology pioneer Amyris join forces in the personal care sector&nbsp;&nbsp;WebWire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/wacker-and-biotechnology-pioneer-amyris-join-forces-in-the-personal-care-sector-webwire/</link><pubDate>Tue, 14 Apr 2026 16:38:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/wacker-and-biotechnology-pioneer-amyris-join-forces-in-the-personal-care-sector-webwire/</guid></item><item><title><![CDATA[Assessing Anbio Biotechnology (NNNN) Valuation After Sharp Swings And A Rich Price To Book Multiple - simplywall.st]]></title><description><![CDATA[Assessing Anbio Biotechnology (NNNN) Valuation After Sharp Swings And A Rich Price To Book Multiple&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/assessing-anbio-biotechnology-nnnn-valuation-after-sharp-swings-and-a-rich-price-to-book-multiple-simplywallst/</link><pubDate>Tue, 14 Apr 2026 13:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/assessing-anbio-biotechnology-nnnn-valuation-after-sharp-swings-and-a-rich-price-to-book-multiple-simplywallst/</guid></item><item><title><![CDATA[Vir Biotechnology doses first patient in Phase I VIR-5500 trial - Clinical Trials Arena]]></title><description><![CDATA[Vir Biotechnology doses first patient in Phase I VIR-5500 trial&nbsp;&nbsp;Clinical Trials Arena]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-doses-first-patient-in-phase-i-vir-5500-trial-clinical-trials-arena/</link><pubDate>Tue, 14 Apr 2026 12:51:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-doses-first-patient-in-phase-i-vir-5500-trial-clinical-trials-arena/</guid></item><item><title><![CDATA[​Sana Biotechnology Inc. (SANA) Hits New Milestone on Cell Therapy for Type 1 Diabetes - Yahoo Finance]]></title><description><![CDATA[&#8203;Sana Biotechnology Inc. (SANA) Hits New Milestone on Cell Therapy for Type 1 Diabetes&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-inc-sana-hits-new-milestone-on-cell-therapy-for-type-1-diabetes-yahoo-finance/</link><pubDate>Tue, 14 Apr 2026 11:50:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-inc-sana-hits-new-milestone-on-cell-therapy-for-type-1-diabetes-yahoo-finance/</guid></item><item><title><![CDATA[Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN® Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer - BioSpace]]></title><description><![CDATA[Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN&reg; Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer&nbsp;&nbsp;BioSpace]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-announces-first-patient-dosed-in-phase-1-dose-expansion-cohorts-evaluating-psma-targeted-pro-xten-dual-masked-t-cell-engager-vir-5500-in-patients-with-metastatic-prostate-cancer-biospace/</link><pubDate>Tue, 14 Apr 2026 08:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-announces-first-patient-dosed-in-phase-1-dose-expansion-cohorts-evaluating-psma-targeted-pro-xten-dual-masked-t-cell-engager-vir-5500-in-patients-with-metastatic-prostate-cancer-biospace/</guid></item><item><title><![CDATA[Sana Biotechnology And Mayo Clinic Announce Strategic Collaboration Focused On Improving Care In Type 1 Diabetes And Accelerating Development Of Sc451 - TradingView — Track All Markets]]></title><description><![CDATA[Sana Biotechnology And Mayo Clinic Announce Strategic Collaboration Focused On Improving Care In Type 1 Diabetes And Accelerating Development Of Sc451&nbsp;&nbsp;TradingView &mdash; Track All Markets]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-and-mayo-clinic-announce-strategic-collaboration-focused-on-improving-care-in-type-1-diabetes-and-accelerating-development-of-sc451-tradingview-track-all-markets/</link><pubDate>Mon, 13 Apr 2026 22:55:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-and-mayo-clinic-announce-strategic-collaboration-focused-on-improving-care-in-type-1-diabetes-and-accelerating-development-of-sc451-tradingview-track-all-markets/</guid></item><item><title><![CDATA[Sana Biotechnology shares gain on Mayo Clinic partnership - Investing.com]]></title><description><![CDATA[Sana Biotechnology shares gain on Mayo Clinic partnership&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-shares-gain-on-mayo-clinic-partnership-investingcom/</link><pubDate>Mon, 13 Apr 2026 22:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-shares-gain-on-mayo-clinic-partnership-investingcom/</guid></item><item><title><![CDATA[Food security: Stakeholders urge Nigerians to embrace biotechnology, digital tools - EnviroNews Nigeria]]></title><description><![CDATA[Food security: Stakeholders urge Nigerians to embrace biotechnology, digital tools&nbsp;&nbsp;EnviroNews Nigeria]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/food-security-stakeholders-urge-nigerians-to-embrace-biotechnology-digital-tools-environews-nigeria/</link><pubDate>Mon, 13 Apr 2026 18:47:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/food-security-stakeholders-urge-nigerians-to-embrace-biotechnology-digital-tools-environews-nigeria/</guid></item><item><title><![CDATA[Replimune’s RP1 setback deepens after second FDA rejection - The Pharma Letter]]></title><description><![CDATA[Replimune&rsquo;s RP1 setback deepens after second FDA rejection&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/replimunes-rp1-setback-deepens-after-second-fda-rejection-the-pharma-letter/</link><pubDate>Mon, 13 Apr 2026 16:40:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/replimunes-rp1-setback-deepens-after-second-fda-rejection-the-pharma-letter/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) Advances Phase 1 Trial with First Patien - GuruFocus]]></title><description><![CDATA[Vir Biotechnology (VIR) Advances Phase 1 Trial with First Patien&nbsp;&nbsp;GuruFocus]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-advances-phase-1-trial-with-first-patien-gurufocus/</link><pubDate>Mon, 13 Apr 2026 16:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-advances-phase-1-trial-with-first-patien-gurufocus/</guid></item><item><title><![CDATA[Promising Clinical Trial Results for Lixte Biotechnology (LIXT) - GuruFocus]]></title><description><![CDATA[Promising Clinical Trial Results for Lixte Biotechnology (LIXT)&nbsp;&nbsp;GuruFocus]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/promising-clinical-trial-results-for-lixte-biotechnology-lixt-gurufocus/</link><pubDate>Mon, 13 Apr 2026 15:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/promising-clinical-trial-results-for-lixte-biotechnology-lixt-gurufocus/</guid></item><item><title><![CDATA[Vir Biotechnology doses first patient in VIR-5500 expansion trial - Investing.com]]></title><description><![CDATA[Vir Biotechnology doses first patient in VIR-5500 expansion trial&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-doses-first-patient-in-vir-5500-expansion-trial-investingcom/</link><pubDate>Mon, 13 Apr 2026 14:29:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-doses-first-patient-in-vir-5500-expansion-trial-investingcom/</guid></item><item><title><![CDATA[Call for Projects: Artificial Intelligence for Biotechnology (France and South Korea) - fundsforNGOs]]></title><description><![CDATA[Call for Projects: Artificial Intelligence for Biotechnology (France and South Korea)&nbsp;&nbsp;fundsforNGOs]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/call-for-projects-artificial-intelligence-for-biotechnology-france-and-south-korea-fundsforngos/</link><pubDate>Mon, 13 Apr 2026 09:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/call-for-projects-artificial-intelligence-for-biotechnology-france-and-south-korea-fundsforngos/</guid></item><item><title><![CDATA[Lupin Walk-In Interviews 2026 | Biotechnology Jobs in R&amp;D, Manufacturing &amp; Quality - BioTecNika]]></title><description><![CDATA[Lupin Walk-In Interviews 2026 | Biotechnology Jobs in R&amp;D, Manufacturing &amp; Quality&nbsp;&nbsp;BioTecNika]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lupin-walk-in-interviews-2026-biotechnology-jobs-in-rampd-manufacturing-amp-quality-biotecnika/</link><pubDate>Sun, 12 Apr 2026 20:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lupin-walk-in-interviews-2026-biotechnology-jobs-in-rampd-manufacturing-amp-quality-biotecnika/</guid></item><item><title><![CDATA[Biotechnology offers green growth prospects in agriculture industry: experts - The Hindu]]></title><description><![CDATA[Biotechnology offers green growth prospects in agriculture industry: experts&nbsp;&nbsp;The Hindu]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-offers-green-growth-prospects-in-agriculture-industry-experts-the-hindu/</link><pubDate>Sun, 12 Apr 2026 20:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-offers-green-growth-prospects-in-agriculture-industry-experts-the-hindu/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) CEO Sells 73,000 Shares for $664,000 - The Motley Fool]]></title><description><![CDATA[Vir Biotechnology (VIR) CEO Sells 73,000 Shares for $664,000&nbsp;&nbsp;The Motley Fool]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-ceo-sells-73000-shares-for-664000-the-motley-fool/</link><pubDate>Sun, 12 Apr 2026 16:13:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-ceo-sells-73000-shares-for-664000-the-motley-fool/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) CEO Sells 73,000 Shares for $664,000 - The Globe and Mail]]></title><description><![CDATA[Vir Biotechnology (VIR) CEO Sells 73,000 Shares for $664,000&nbsp;&nbsp;The Globe and Mail]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-ceo-sells-73000-shares-for-664000-the-globe-and-mail/</link><pubDate>Sun, 12 Apr 2026 15:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-ceo-sells-73000-shares-for-664000-the-globe-and-mail/</guid></item><item><title><![CDATA[Jaypee University Strengthens Biotechnology Programmes with Industry Collaboration - The News Himachal]]></title><description><![CDATA[Jaypee University Strengthens Biotechnology Programmes with Industry Collaboration&nbsp;&nbsp;The News Himachal]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/jaypee-university-strengthens-biotechnology-programmes-with-industry-collaboration-the-news-himachal/</link><pubDate>Sun, 12 Apr 2026 14:09:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/jaypee-university-strengthens-biotechnology-programmes-with-industry-collaboration-the-news-himachal/</guid></item><item><title><![CDATA[Ritholtz Wealth Management Boosts Stake in Puma Biotechnology - National Today]]></title><description><![CDATA[Ritholtz Wealth Management Boosts Stake in Puma Biotechnology&nbsp;&nbsp;National Today]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ritholtz-wealth-management-boosts-stake-in-puma-biotechnology-national-today/</link><pubDate>Sun, 12 Apr 2026 13:33:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ritholtz-wealth-management-boosts-stake-in-puma-biotechnology-national-today/</guid></item><item><title><![CDATA[Anbio Biotechnology Broadens Test Portfolio And Shifts Risk Profile - simplywall.st]]></title><description><![CDATA[Anbio Biotechnology Broadens Test Portfolio And Shifts Risk Profile&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-broadens-test-portfolio-and-shifts-risk-profile-simplywallst/</link><pubDate>Sun, 12 Apr 2026 05:40:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-broadens-test-portfolio-and-shifts-risk-profile-simplywallst/</guid></item><item><title><![CDATA[BioNTech reports promising Phase II data for uterine cancer ADC - European Biotechnology Magazine]]></title><description><![CDATA[BioNTech reports promising Phase II data for uterine cancer ADC&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biontech-reports-promising-phase-ii-data-for-uterine-cancer-adc-european-biotechnology-magazine/</link><pubDate>Sat, 11 Apr 2026 17:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biontech-reports-promising-phase-ii-data-for-uterine-cancer-adc-european-biotechnology-magazine/</guid></item><item><title><![CDATA[AI BIOTECHNOLOGY KEYNOTE SPEAKER: HIRE TOP HEALTHCARE FUTURIST FOR CORPORATE EVENTS - futuristsspeakers.com]]></title><description><![CDATA[AI BIOTECHNOLOGY KEYNOTE SPEAKER: HIRE TOP HEALTHCARE FUTURIST FOR CORPORATE EVENTS&nbsp;&nbsp;futuristsspeakers.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ai-biotechnology-keynote-speaker-hire-top-healthcare-futurist-for-corporate-events-futuristsspeakerscom/</link><pubDate>Sat, 11 Apr 2026 14:19:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ai-biotechnology-keynote-speaker-hire-top-healthcare-futurist-for-corporate-events-futuristsspeakerscom/</guid></item><item><title><![CDATA[Vir Biotechnology Announces Upcoming Chief Medical Officer Transition - TipRanks]]></title><description><![CDATA[Vir Biotechnology Announces Upcoming Chief Medical Officer Transition&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-announces-upcoming-chief-medical-officer-transition-tipranks/</link><pubDate>Fri, 10 Apr 2026 23:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-announces-upcoming-chief-medical-officer-transition-tipranks/</guid></item><item><title><![CDATA[Vir Biotechnology (NASDAQ: VIR) Chief Medical Officer to step down April 24 - Stock Titan]]></title><description><![CDATA[Vir Biotechnology (NASDAQ: VIR) Chief Medical Officer to step down April 24&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaq-vir-chief-medical-officer-to-step-down-april-24-stock-titan/</link><pubDate>Fri, 10 Apr 2026 22:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaq-vir-chief-medical-officer-to-step-down-april-24-stock-titan/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) Leading with Its BiTEs Therapy - Insider Monkey]]></title><description><![CDATA[Vir Biotechnology (VIR) Leading with Its BiTEs Therapy&nbsp;&nbsp;Insider Monkey]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-leading-with-its-bites-therapy-insider-monkey/</link><pubDate>Fri, 10 Apr 2026 16:06:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-leading-with-its-bites-therapy-insider-monkey/</guid></item><item><title><![CDATA[Call for Applications: Regional Centre for Biotechnology (RCB) Research Training Program 2026-2027 - Global South Opportunities]]></title><description><![CDATA[Call for Applications: Regional Centre for Biotechnology (RCB) Research Training Program 2026-2027&nbsp;&nbsp;Global South Opportunities]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/call-for-applications-regional-centre-for-biotechnology-rcb-research-training-program-2026-2027-global-south-opportunities/</link><pubDate>Fri, 10 Apr 2026 11:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/call-for-applications-regional-centre-for-biotechnology-rcb-research-training-program-2026-2027-global-south-opportunities/</guid></item><item><title><![CDATA[Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio - Benzinga]]></title><description><![CDATA[Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio&nbsp;&nbsp;Benzinga]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-posts-solid-fy25-results-diversifies-portfolio-benzinga/</link><pubDate>Thu, 09 Apr 2026 18:46:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-posts-solid-fy25-results-diversifies-portfolio-benzinga/</guid></item><item><title><![CDATA[Blue Biotechnology Market Expands with Sustainable Marine - openPR.com]]></title><description><![CDATA[Blue Biotechnology Market Expands with Sustainable Marine&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/blue-biotechnology-market-expands-with-sustainable-marine-openprcom/</link><pubDate>Thu, 09 Apr 2026 17:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/blue-biotechnology-market-expands-with-sustainable-marine-openprcom/</guid></item><item><title><![CDATA[Esophagus engineering tackles function - Nature]]></title><description><![CDATA[Esophagus engineering tackles function&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/esophagus-engineering-tackles-function-nature/</link><pubDate>Thu, 09 Apr 2026 12:13:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/esophagus-engineering-tackles-function-nature/</guid></item><item><title><![CDATA[Anbio Biotechnology (ANBF) Non Cash 74.1% Net Margin Fuels Fresh Debate On Earnings Quality - simplywall.st]]></title><description><![CDATA[Anbio Biotechnology (ANBF) Non Cash 74.1% Net Margin Fuels Fresh Debate On Earnings Quality&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-anbf-non-cash-741-net-margin-fuels-fresh-debate-on-earnings-quality-simplywallst/</link><pubDate>Thu, 09 Apr 2026 02:53:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-anbf-non-cash-741-net-margin-fuels-fresh-debate-on-earnings-quality-simplywallst/</guid></item><item><title><![CDATA[[Form 3] Anbio Biotechnology Initial Statement of Beneficial Ownership - Stock Titan]]></title><description><![CDATA[[Form 3] Anbio Biotechnology Initial Statement of Beneficial Ownership&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/form-3-anbio-biotechnology-initial-statement-of-beneficial-ownership-stock-titan/</link><pubDate>Thu, 09 Apr 2026 02:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/form-3-anbio-biotechnology-initial-statement-of-beneficial-ownership-stock-titan/</guid></item><item><title><![CDATA[MAIA Biotechnology Raises $33M to Fully Fund Pivotal Phase 3 Trial of Ateganosine for Advanced NSCLC Treatment - Minichart]]></title><description><![CDATA[MAIA Biotechnology Raises $33M to Fully Fund Pivotal Phase 3 Trial of Ateganosine for Advanced NSCLC Treatment&nbsp;&nbsp;Minichart]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-raises-33m-to-fully-fund-pivotal-phase-3-trial-of-ateganosine-for-advanced-nsclc-treatment-minichart/</link><pubDate>Wed, 08 Apr 2026 18:06:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-raises-33m-to-fully-fund-pivotal-phase-3-trial-of-ateganosine-for-advanced-nsclc-treatment-minichart/</guid></item><item><title><![CDATA[The rare disease pricing model is starting to fray - The Pharma Letter]]></title><description><![CDATA[The rare disease pricing model is starting to fray&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/the-rare-disease-pricing-model-is-starting-to-fray-the-pharma-letter/</link><pubDate>Wed, 08 Apr 2026 17:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/the-rare-disease-pricing-model-is-starting-to-fray-the-pharma-letter/</guid></item><item><title><![CDATA[Red Biotechnology Market Outlook 2036: Surging from USD 553.1 - openPR.com]]></title><description><![CDATA[Red Biotechnology Market Outlook 2036: Surging from USD 553.1&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/red-biotechnology-market-outlook-2036-surging-from-usd-5531-openprcom/</link><pubDate>Wed, 08 Apr 2026 17:38:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/red-biotechnology-market-outlook-2036-surging-from-usd-5531-openprcom/</guid></item><item><title><![CDATA[Why Anbio Biotechnology Class A Shares Are Sinking - TipRanks]]></title><description><![CDATA[Why Anbio Biotechnology Class A Shares Are Sinking&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/why-anbio-biotechnology-class-a-shares-are-sinking-tipranks/</link><pubDate>Wed, 08 Apr 2026 16:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/why-anbio-biotechnology-class-a-shares-are-sinking-tipranks/</guid></item><item><title><![CDATA[MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy - Yahoo Finance]]></title><description><![CDATA[MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-expects-recent-33-million-capital-raise-to-fully-fund-ongoing-pivotal-phase-3-trial-of-novel-telomere-targeting-anticancer-therapy-yahoo-finance/</link><pubDate>Wed, 08 Apr 2026 15:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-expects-recent-33-million-capital-raise-to-fully-fund-ongoing-pivotal-phase-3-trial-of-novel-telomere-targeting-anticancer-therapy-yahoo-finance/</guid></item><item><title><![CDATA[MAIA Biotechnology Expects Recent $33 Million Capital Raise - GlobeNewswire]]></title><description><![CDATA[MAIA Biotechnology Expects Recent $33 Million Capital Raise&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-expects-recent-33-million-capital-raise-globenewswire/</link><pubDate>Wed, 08 Apr 2026 15:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-expects-recent-33-million-capital-raise-globenewswire/</guid></item><item><title><![CDATA[Biotechnology Reagents and Kits Market Set to Witness Rapid - openPR.com]]></title><description><![CDATA[Biotechnology Reagents and Kits Market Set to Witness Rapid&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-reagents-and-kits-market-set-to-witness-rapid-openprcom/</link><pubDate>Wed, 08 Apr 2026 14:17:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-reagents-and-kits-market-set-to-witness-rapid-openprcom/</guid></item><item><title><![CDATA[MS-PhD Program 2026: Launch Your Research Career in Biotechnology at RCB | Fellowship Upto Rs. 42,000/- Per Month - BioTecNika]]></title><description><![CDATA[MS-PhD Program 2026: Launch Your Research Career in Biotechnology at RCB | Fellowship Upto Rs. 42,000/- Per Month&nbsp;&nbsp;BioTecNika]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ms-phd-program-2026-launch-your-research-career-in-biotechnology-at-rcb-fellowship-upto-rs-42000-per-month-biotecnika/</link><pubDate>Wed, 08 Apr 2026 13:53:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ms-phd-program-2026-launch-your-research-career-in-biotechnology-at-rcb-fellowship-upto-rs-42000-per-month-biotecnika/</guid></item><item><title><![CDATA[Biotechnology for Sustainability: From Discovery to Deployment - The Royal Society of Chemistry]]></title><description><![CDATA[Biotechnology for Sustainability: From Discovery to Deployment&nbsp;&nbsp;The Royal Society of Chemistry]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-for-sustainability-from-discovery-to-deployment-the-royal-society-of-chemistry/</link><pubDate>Wed, 08 Apr 2026 13:06:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-for-sustainability-from-discovery-to-deployment-the-royal-society-of-chemistry/</guid></item><item><title><![CDATA[Puma Biotechnology Stock Surges Past 200-Day Average - National Today]]></title><description><![CDATA[Puma Biotechnology Stock Surges Past 200-Day Average&nbsp;&nbsp;National Today]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-stock-surges-past-200-day-average-national-today/</link><pubDate>Wed, 08 Apr 2026 10:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-stock-surges-past-200-day-average-national-today/</guid></item><item><title><![CDATA[JBS opens biotechnology centre in Brazil to advance protein innovation - FoodBev Media]]></title><description><![CDATA[JBS opens biotechnology centre in Brazil to advance protein innovation&nbsp;&nbsp;FoodBev Media]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/jbs-opens-biotechnology-centre-in-brazil-to-advance-protein-innovation-foodbev-media/</link><pubDate>Wed, 08 Apr 2026 10:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/jbs-opens-biotechnology-centre-in-brazil-to-advance-protein-innovation-foodbev-media/</guid></item><item><title><![CDATA[Malaysia, Australia Strengthen Women’s Role In Biotechnology Collaboration - bernama]]></title><description><![CDATA[Malaysia, Australia Strengthen Women&rsquo;s Role In Biotechnology Collaboration&nbsp;&nbsp;bernama]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/malaysia-australia-strengthen-womens-role-in-biotechnology-collaboration-bernama/</link><pubDate>Wed, 08 Apr 2026 08:58:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/malaysia-australia-strengthen-womens-role-in-biotechnology-collaboration-bernama/</guid></item><item><title><![CDATA[Gloucester nonprofit advances marine biotechnology while training future workforce - WCVB]]></title><description><![CDATA[Gloucester nonprofit advances marine biotechnology while training future workforce&nbsp;&nbsp;WCVB]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/gloucester-nonprofit-advances-marine-biotechnology-while-training-future-workforce-wcvb/</link><pubDate>Wed, 08 Apr 2026 02:33:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/gloucester-nonprofit-advances-marine-biotechnology-while-training-future-workforce-wcvb/</guid></item><item><title><![CDATA[Vir Biotechnology (NASDAQ:VIR) CEO Backer Marianne De Sells 72,559 Shares - MarketBeat]]></title><description><![CDATA[Vir Biotechnology (NASDAQ:VIR) CEO Backer Marianne De Sells 72,559 Shares&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-ceo-backer-marianne-de-sells-72559-shares-marketbeat/</link><pubDate>Wed, 08 Apr 2026 00:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-ceo-backer-marianne-de-sells-72559-shares-marketbeat/</guid></item><item><title><![CDATA[Evommune (NYSE:EVMN) Advances Within Biotechnology Research And Development - Kalkine Media]]></title><description><![CDATA[Evommune (NYSE:EVMN) Advances Within Biotechnology Research And Development&nbsp;&nbsp;Kalkine Media]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/evommune-nyseevmn-advances-within-biotechnology-research-and-development-kalkine-media/</link><pubDate>Wed, 08 Apr 2026 00:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/evommune-nyseevmn-advances-within-biotechnology-research-and-development-kalkine-media/</guid></item><item><title><![CDATA[Puma Biotechnology (NASDAQ: PBYI) seeks votes to extend CEO warrant, elect directors - Stock Titan]]></title><description><![CDATA[Puma Biotechnology (NASDAQ: PBYI) seeks votes to extend CEO warrant, elect directors&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-nasdaq-pbyi-seeks-votes-to-extend-ceo-warrant-elect-directors-stock-titan/</link><pubDate>Tue, 07 Apr 2026 23:38:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-nasdaq-pbyi-seeks-votes-to-extend-ceo-warrant-elect-directors-stock-titan/</guid></item><item><title><![CDATA[Vir Biotechnology CEO de Backer sells $664k in stock - Investing.com]]></title><description><![CDATA[Vir Biotechnology CEO de Backer sells $664k in stock&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-ceo-de-backer-sells-664k-in-stock-investingcom/</link><pubDate>Tue, 07 Apr 2026 22:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-ceo-de-backer-sells-664k-in-stock-investingcom/</guid></item><item><title><![CDATA[Anbio Biotechnology Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com]]></title><description><![CDATA[Anbio Biotechnology Reports Earnings Results for the Full Year Ended December 31, 2025&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-reports-earnings-results-for-the-full-year-ended-december-31-2025-marketscreenercom/</link><pubDate>Tue, 07 Apr 2026 22:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-reports-earnings-results-for-the-full-year-ended-december-31-2025-marketscreenercom/</guid></item><item><title><![CDATA[Closing the women's health gap offers &lsquo;benefits for all&rsquo; - Life Sciences Intellectual Property Review]]></title><description><![CDATA[Closing the women's health gap offers &lsquo;benefits for all&rsquo;&nbsp;&nbsp;Life Sciences Intellectual Property Review]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/closing-the-womens-health-gap-offers-lsquobenefits-for-allrsquo-life-sciences-intellectual-property-review/</link><pubDate>Tue, 07 Apr 2026 19:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/closing-the-womens-health-gap-offers-lsquobenefits-for-allrsquo-life-sciences-intellectual-property-review/</guid></item><item><title><![CDATA[First orexin agonists address root cause of narcolepsy - Nature]]></title><description><![CDATA[First orexin agonists address root cause of narcolepsy&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/first-orexin-agonists-address-root-cause-of-narcolepsy-nature/</link><pubDate>Tue, 07 Apr 2026 18:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/first-orexin-agonists-address-root-cause-of-narcolepsy-nature/</guid></item><item><title><![CDATA[Stipple Bio raises $100 million to advance epitope-targeted ADC - The Pharma Letter]]></title><description><![CDATA[Stipple Bio raises $100 million to advance epitope-targeted ADC&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/stipple-bio-raises-100-million-to-advance-epitope-targeted-adc-the-pharma-letter/</link><pubDate>Tue, 07 Apr 2026 17:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/stipple-bio-raises-100-million-to-advance-epitope-targeted-adc-the-pharma-letter/</guid></item><item><title><![CDATA[Belarus’ First Deputy PM on BNBC further development: biotechnology likely to be used widely - Беларусь сегодня]]></title><description><![CDATA[Belarus&rsquo; First Deputy PM on BNBC further development: biotechnology likely to be used widely&nbsp;&nbsp;&#1041;&#1077;&#1083;&#1072;&#1088;&#1091;&#1089;&#1100; &#1089;&#1077;&#1075;&#1086;&#1076;&#1085;&#1103;]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/belarus-first-deputy-pm-on-bnbc-further-development-biotechnology-likely-to-be-used-widely-/</link><pubDate>Tue, 07 Apr 2026 15:38:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/belarus-first-deputy-pm-on-bnbc-further-development-biotechnology-likely-to-be-used-widely-/</guid></item><item><title><![CDATA[Jones Appoints Boris Peaker, PhD, CFA as Managing Director, Biotechnology Analyst - PR Newswire]]></title><description><![CDATA[Jones Appoints Boris Peaker, PhD, CFA as Managing Director, Biotechnology Analyst&nbsp;&nbsp;PR Newswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/jones-appoints-boris-peaker-phd-cfa-as-managing-director-biotechnology-analyst-pr-newswire/</link><pubDate>Tue, 07 Apr 2026 14:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/jones-appoints-boris-peaker-phd-cfa-as-managing-director-biotechnology-analyst-pr-newswire/</guid></item><item><title><![CDATA[VIR Biotechnology Inc (NASDAQ:VIR) Emerges as a High-Growth Momentum Pick - ChartMill]]></title><description><![CDATA[VIR Biotechnology Inc (NASDAQ:VIR) Emerges as a High-Growth Momentum Pick&nbsp;&nbsp;ChartMill]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-nasdaqvir-emerges-as-a-high-growth-momentum-pick-chartmill/</link><pubDate>Tue, 07 Apr 2026 13:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-nasdaqvir-emerges-as-a-high-growth-momentum-pick-chartmill/</guid></item><item><title><![CDATA[International Biotechnology Trust expects more M&amp;A after Soleno deal - London South East]]></title><description><![CDATA[International Biotechnology Trust expects more M&amp;A after Soleno deal&nbsp;&nbsp;London South East]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/international-biotechnology-trust-expects-more-mampa-after-soleno-deal-london-south-east/</link><pubDate>Tue, 07 Apr 2026 12:27:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/international-biotechnology-trust-expects-more-mampa-after-soleno-deal-london-south-east/</guid></item><item><title><![CDATA[Lukashenko: Belarus urgently needs biotechnology sector; we cannot afford to lag behind - Беларусь сегодня]]></title><description><![CDATA[Lukashenko: Belarus urgently needs biotechnology sector; we cannot afford to lag behind&nbsp;&nbsp;&#1041;&#1077;&#1083;&#1072;&#1088;&#1091;&#1089;&#1100; &#1089;&#1077;&#1075;&#1086;&#1076;&#1085;&#1103;]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lukashenko-belarus-urgently-needs-biotechnology-sector-we-cannot-afford-to-lag-behind-/</link><pubDate>Tue, 07 Apr 2026 12:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lukashenko-belarus-urgently-needs-biotechnology-sector-we-cannot-afford-to-lag-behind-/</guid></item><item><title><![CDATA[Amgen's new subcutaneous Tepezza scores Phase III boost - The Pharma Letter]]></title><description><![CDATA[Amgen's new subcutaneous Tepezza scores Phase III boost&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/amgens-new-subcutaneous-tepezza-scores-phase-iii-boost-the-pharma-letter/</link><pubDate>Tue, 07 Apr 2026 11:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/amgens-new-subcutaneous-tepezza-scores-phase-iii-boost-the-pharma-letter/</guid></item><item><title><![CDATA[Red Biotechnology Market to Reach USD 2,682.36 Billion by 2034 - openPR.com]]></title><description><![CDATA[Red Biotechnology Market to Reach USD 2,682.36 Billion by 2034&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/red-biotechnology-market-to-reach-usd-268236-billion-by-2034-openprcom/</link><pubDate>Tue, 07 Apr 2026 10:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/red-biotechnology-market-to-reach-usd-268236-billion-by-2034-openprcom/</guid></item><item><title><![CDATA[Claflin University begins work on new Center for Biotechnology and Innovation - WACH]]></title><description><![CDATA[Claflin University begins work on new Center for Biotechnology and Innovation&nbsp;&nbsp;WACH]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/claflin-university-begins-work-on-new-center-for-biotechnology-and-innovation-wach/</link><pubDate>Tue, 07 Apr 2026 06:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/claflin-university-begins-work-on-new-center-for-biotechnology-and-innovation-wach/</guid></item><item><title><![CDATA[The intersection of biotechnology, advanced materials, and molecular biology | 2026-04-06 | Investing News - Stockhouse]]></title><description><![CDATA[The intersection of biotechnology, advanced materials, and molecular biology | 2026-04-06 | Investing News&nbsp;&nbsp;Stockhouse]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/the-intersection-of-biotechnology-advanced-materials-and-molecular-biology-2026-04-06-investing-news-stockhouse/</link><pubDate>Mon, 06 Apr 2026 16:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/the-intersection-of-biotechnology-advanced-materials-and-molecular-biology-2026-04-06-investing-news-stockhouse/</guid></item><item><title><![CDATA[Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure - GlobeNewswire]]></title><description><![CDATA[Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/zhengye-biotechnology-holding-limited-announces-implementation-of-dual-class-share-structure-globenewswire/</link><pubDate>Mon, 06 Apr 2026 15:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/zhengye-biotechnology-holding-limited-announces-implementation-of-dual-class-share-structure-globenewswire/</guid></item><item><title><![CDATA[Vir Biotechnology stock: Why it's drawing investor attention now - AD HOC NEWS]]></title><description><![CDATA[Vir Biotechnology stock: Why it's drawing investor attention now&nbsp;&nbsp;AD HOC NEWS]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-stock-why-its-drawing-investor-attention-now-ad-hoc-news/</link><pubDate>Mon, 06 Apr 2026 15:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-stock-why-its-drawing-investor-attention-now-ad-hoc-news/</guid></item><item><title><![CDATA[1719-Eureka Network Biotechnology 2026 Call Open for Application - TÜBİTAK]]></title><description><![CDATA[1719-Eureka Network Biotechnology 2026 Call Open for Application&nbsp;&nbsp;T&Uuml;B&#304;TAK]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/1719-eureka-network-biotechnology-2026-call-open-for-application-tbtak/</link><pubDate>Mon, 06 Apr 2026 10:27:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/1719-eureka-network-biotechnology-2026-call-open-for-application-tbtak/</guid></item><item><title><![CDATA[Portugal’s biotech industry is growing up - European Biotechnology Magazine]]></title><description><![CDATA[Portugal&rsquo;s biotech industry is growing up&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/portugals-biotech-industry-is-growing-up-european-biotechnology-magazine/</link><pubDate>Mon, 06 Apr 2026 07:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/portugals-biotech-industry-is-growing-up-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Nature of Things: Solano biotechnology students attend annual Definitive and Curative Medicine conference - Daily Republic]]></title><description><![CDATA[Nature of Things: Solano biotechnology students attend annual Definitive and Curative Medicine conference&nbsp;&nbsp;Daily Republic]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nature-of-things-solano-biotechnology-students-attend-annual-definitive-and-curative-medicine-conference-daily-republic/</link><pubDate>Sun, 05 Apr 2026 11:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nature-of-things-solano-biotechnology-students-attend-annual-definitive-and-curative-medicine-conference-daily-republic/</guid></item><item><title><![CDATA[BioE3: Bold leap of Bharat into the future of biotechnology - Organiser]]></title><description><![CDATA[BioE3: Bold leap of Bharat into the future of biotechnology&nbsp;&nbsp;Organiser]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/bioe3-bold-leap-of-bharat-into-the-future-of-biotechnology-organiser/</link><pubDate>Sun, 05 Apr 2026 03:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/bioe3-bold-leap-of-bharat-into-the-future-of-biotechnology-organiser/</guid></item><item><title><![CDATA[Is Vir Biotechnology’s (VIR) Insider Selling After Its Capital Raise Reframing the Investment Narrative? - simplywall.st]]></title><description><![CDATA[Is Vir Biotechnology&rsquo;s (VIR) Insider Selling After Its Capital Raise Reframing the Investment Narrative?&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/is-vir-biotechnologys-vir-insider-selling-after-its-capital-raise-reframing-the-investment-narrative-simplywallst/</link><pubDate>Sat, 04 Apr 2026 22:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/is-vir-biotechnologys-vir-insider-selling-after-its-capital-raise-reframing-the-investment-narrative-simplywallst/</guid></item><item><title><![CDATA[Bold Goals for U.S. Biotechnology and Biomanufacturing: Harnessing Research and Development to Further Societal Goals Report - Department of Energy (.gov)]]></title><description><![CDATA[Bold Goals for U.S. Biotechnology and Biomanufacturing: Harnessing Research and Development to Further Societal Goals Report&nbsp;&nbsp;Department of Energy (.gov)]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/bold-goals-for-us-biotechnology-and-biomanufacturing-harnessing-research-and-development-to-further-societal-goals-report-department-of-energy-gov/</link><pubDate>Sat, 04 Apr 2026 15:37:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/bold-goals-for-us-biotechnology-and-biomanufacturing-harnessing-research-and-development-to-further-societal-goals-report-department-of-energy-gov/</guid></item><item><title><![CDATA[Odisha Plans ₹10 Crore Boost to Strengthen Biotechnology Sector - orissadiary.com]]></title><description><![CDATA[Odisha Plans &#8377;10 Crore Boost to Strengthen Biotechnology Sector&nbsp;&nbsp;orissadiary.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/odisha-plans-10-crore-boost-to-strengthen-biotechnology-sector-orissadiarycom/</link><pubDate>Sat, 04 Apr 2026 13:39:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/odisha-plans-10-crore-boost-to-strengthen-biotechnology-sector-orissadiarycom/</guid></item><item><title><![CDATA[PDS Biotechnology Earnings Call Highlights Clinical Momentum - TipRanks]]></title><description><![CDATA[PDS Biotechnology Earnings Call Highlights Clinical Momentum&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-earnings-call-highlights-clinical-momentum-tipranks/</link><pubDate>Sat, 04 Apr 2026 02:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-earnings-call-highlights-clinical-momentum-tipranks/</guid></item><item><title><![CDATA[Carilion Expands Role in Biotechnology Innovation - theroanokestar.com]]></title><description><![CDATA[Carilion Expands Role in Biotechnology Innovation&nbsp;&nbsp;theroanokestar.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/carilion-expands-role-in-biotechnology-innovation-theroanokestarcom/</link><pubDate>Fri, 03 Apr 2026 11:26:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/carilion-expands-role-in-biotechnology-innovation-theroanokestarcom/</guid></item><item><title><![CDATA[Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - April 2, 2026 - BioSpace]]></title><description><![CDATA[Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - April 2, 2026&nbsp;&nbsp;BioSpace]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-april-2-2026-biospace/</link><pubDate>Fri, 03 Apr 2026 09:41:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-april-2-2026-biospace/</guid></item><item><title><![CDATA[Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4) - TradingView]]></title><description><![CDATA[Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)&nbsp;&nbsp;TradingView]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-tradingview/</link><pubDate>Thu, 02 Apr 2026 23:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-tradingview/</guid></item><item><title><![CDATA[Carilion Clinic adopts new biotechnology engineering service - WFXRtv]]></title><description><![CDATA[Carilion Clinic adopts new biotechnology engineering service&nbsp;&nbsp;WFXRtv]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/carilion-clinic-adopts-new-biotechnology-engineering-service-wfxrtv/</link><pubDate>Thu, 02 Apr 2026 22:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/carilion-clinic-adopts-new-biotechnology-engineering-service-wfxrtv/</guid></item><item><title><![CDATA[Dyadic International Stock: Biotechnology Innovator Focused on C1 Platform Amid Earnings Challenges - AD HOC NEWS]]></title><description><![CDATA[Dyadic International Stock: Biotechnology Innovator Focused on C1 Platform Amid Earnings Challenges&nbsp;&nbsp;AD HOC NEWS]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/dyadic-international-stock-biotechnology-innovator-focused-on-c1-platform-amid-earnings-challenges-ad-hoc-news/</link><pubDate>Thu, 02 Apr 2026 19:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/dyadic-international-stock-biotechnology-innovator-focused-on-c1-platform-amid-earnings-challenges-ad-hoc-news/</guid></item><item><title><![CDATA[Remembering Arthur E. Humphrey, Former Lehigh Provost and Biotechnology Pioneer - Lehigh University News]]></title><description><![CDATA[Remembering Arthur E. Humphrey, Former Lehigh Provost and Biotechnology Pioneer&nbsp;&nbsp;Lehigh University News]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/remembering-arthur-e-humphrey-former-lehigh-provost-and-biotechnology-pioneer-lehigh-university-news/</link><pubDate>Thu, 02 Apr 2026 17:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/remembering-arthur-e-humphrey-former-lehigh-provost-and-biotechnology-pioneer-lehigh-university-news/</guid></item><item><title><![CDATA[Vir Biotechnology director Sato sells $199k in shares By Investing.com - Investing.com UK]]></title><description><![CDATA[Vir Biotechnology director Sato sells $199k in shares By Investing.com&nbsp;&nbsp;Investing.com UK]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-director-sato-sells-199k-in-shares-by-investingcom-investingcom-uk/</link><pubDate>Thu, 02 Apr 2026 16:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-director-sato-sells-199k-in-shares-by-investingcom-investingcom-uk/</guid></item><item><title><![CDATA[COVID vaccine trial scrapped amid recruitment slump - The Pharma Letter]]></title><description><![CDATA[COVID vaccine trial scrapped amid recruitment slump&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/covid-vaccine-trial-scrapped-amid-recruitment-slump-the-pharma-letter/</link><pubDate>Thu, 02 Apr 2026 15:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/covid-vaccine-trial-scrapped-amid-recruitment-slump-the-pharma-letter/</guid></item><item><title><![CDATA[Nanoscope brings in Alcon veteran as COO ahead of launch phase - The Pharma Letter]]></title><description><![CDATA[Nanoscope brings in Alcon veteran as COO ahead of launch phase&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nanoscope-brings-in-alcon-veteran-as-coo-ahead-of-launch-phase-the-pharma-letter/</link><pubDate>Thu, 02 Apr 2026 13:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nanoscope-brings-in-alcon-veteran-as-coo-ahead-of-launch-phase-the-pharma-letter/</guid></item><item><title><![CDATA[Intron Biotechnology To Cancel 3 Billion Won Worth Of Own Shares - TradingView]]></title><description><![CDATA[Intron Biotechnology To Cancel 3 Billion Won Worth Of Own Shares&nbsp;&nbsp;TradingView]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/intron-biotechnology-to-cancel-3-billion-won-worth-of-own-shares-tradingview/</link><pubDate>Thu, 02 Apr 2026 09:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/intron-biotechnology-to-cancel-3-billion-won-worth-of-own-shares-tradingview/</guid></item><item><title><![CDATA[Diagens Biotechnology raises $101 M in Hong Kong IPO - BioSpectrum Asia]]></title><description><![CDATA[Diagens Biotechnology raises $101 M in Hong Kong IPO&nbsp;&nbsp;BioSpectrum Asia]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/diagens-biotechnology-raises-101-m-in-hong-kong-ipo-biospectrum-asia/</link><pubDate>Thu, 02 Apr 2026 07:29:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/diagens-biotechnology-raises-101-m-in-hong-kong-ipo-biospectrum-asia/</guid></item><item><title><![CDATA[LIXTE Biotechnology (LIXT) Has the World's Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes - NewMediaWire]]></title><description><![CDATA[LIXTE Biotechnology (LIXT) Has the World's Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes&nbsp;&nbsp;NewMediaWire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-lixt-has-the-worlds-only-clinical-stage-pp2a-inhibitor-poised-to-improve-cancer-treatment-outcomes-newmediawire/</link><pubDate>Wed, 01 Apr 2026 20:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-lixt-has-the-worlds-only-clinical-stage-pp2a-inhibitor-poised-to-improve-cancer-treatment-outcomes-newmediawire/</guid></item><item><title><![CDATA[Cell therapy market set for rapid growth says industry analyst - The Pharma Letter]]></title><description><![CDATA[Cell therapy market set for rapid growth says industry analyst&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cell-therapy-market-set-for-rapid-growth-says-industry-analyst-the-pharma-letter/</link><pubDate>Wed, 01 Apr 2026 20:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cell-therapy-market-set-for-rapid-growth-says-industry-analyst-the-pharma-letter/</guid></item><item><title><![CDATA[LIXTE Biotechnology (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes - TipRanks]]></title><description><![CDATA[LIXTE Biotechnology (NASDAQ: LIXT) Has the World&rsquo;s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-nasdaq-lixt-has-the-worlds-only-clinical-stage-pp2a-inhibitor-poised-to-improve-cancer-treatment-outcomes-tipranks/</link><pubDate>Wed, 01 Apr 2026 18:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-nasdaq-lixt-has-the-worlds-only-clinical-stage-pp2a-inhibitor-poised-to-improve-cancer-treatment-outcomes-tipranks/</guid></item><item><title><![CDATA[PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2025 Earnings Call Transcript - Insider Monkey]]></title><description><![CDATA[PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2025 Earnings Call Transcript&nbsp;&nbsp;Insider Monkey]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-corporation-nasdaqpdsb-q4-2025-earnings-call-transcript-insider-monkey/</link><pubDate>Wed, 01 Apr 2026 14:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-corporation-nasdaqpdsb-q4-2025-earnings-call-transcript-insider-monkey/</guid></item><item><title><![CDATA[LIXTE Biotechnology (NASDAQ: LIXT) Strengthens Oncology Pipeline Through Expanded LB-100 Clinical Trials - TipRanks]]></title><description><![CDATA[LIXTE Biotechnology (NASDAQ: LIXT) Strengthens Oncology Pipeline Through Expanded LB-100 Clinical Trials&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-nasdaq-lixt-strengthens-oncology-pipeline-through-expanded-lb-100-clinical-trials-tipranks/</link><pubDate>Wed, 01 Apr 2026 13:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-nasdaq-lixt-strengthens-oncology-pipeline-through-expanded-lb-100-clinical-trials-tipranks/</guid></item><item><title><![CDATA[Scalable homology detection with ERAST - Nature]]></title><description><![CDATA[Scalable homology detection with ERAST&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/scalable-homology-detection-with-erast-nature/</link><pubDate>Wed, 01 Apr 2026 11:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/scalable-homology-detection-with-erast-nature/</guid></item><item><title><![CDATA[Diagens Biotechnology Raises US$101 Million in Hong Kong IPO; Shares More Than Double on First Day of Trading - The Manila Times]]></title><description><![CDATA[Diagens Biotechnology Raises US$101 Million in Hong Kong IPO; Shares More Than Double on First Day of Trading&nbsp;&nbsp;The Manila Times]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/diagens-biotechnology-raises-us101-million-in-hong-kong-ipo-shares-more-than-double-on-first-day-of-trading-the-manila-times/</link><pubDate>Tue, 31 Mar 2026 13:04:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/diagens-biotechnology-raises-us101-million-in-hong-kong-ipo-shares-more-than-double-on-first-day-of-trading-the-manila-times/</guid></item><item><title><![CDATA[JPMorgan Chase &amp; Co. Raises Holdings in Sana Biotechnology, Inc. $SANA - MarketBeat]]></title><description><![CDATA[JPMorgan Chase &amp; Co. Raises Holdings in Sana Biotechnology, Inc. $SANA&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/jpmorgan-chase-amp-co-raises-holdings-in-sana-biotechnology-inc-sana-marketbeat/</link><pubDate>Tue, 31 Mar 2026 11:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/jpmorgan-chase-amp-co-raises-holdings-in-sana-biotechnology-inc-sana-marketbeat/</guid></item><item><title><![CDATA[What is Biotechnology?: Course Fees 2026, Subjects, Top Colleges, Admissions - Shiksha.com]]></title><description><![CDATA[What is Biotechnology?: Course Fees 2026, Subjects, Top Colleges, Admissions&nbsp;&nbsp;Shiksha.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/what-is-biotechnology-course-fees-2026-subjects-top-colleges-admissions-shikshacom/</link><pubDate>Tue, 31 Mar 2026 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/what-is-biotechnology-course-fees-2026-subjects-top-colleges-admissions-shikshacom/</guid></item><item><title><![CDATA[Han Moon-hee, the first president of the Korea Institute of Biotechnology, who was called the "Godfa.. - &#47588;&#51068;&#44221;&#51228;]]></title><description><![CDATA[Han Moon-hee, the first president of the Korea Institute of Biotechnology, who was called the "Godfa..&nbsp;&nbsp;&#47588;&#51068;&#44221;&#51228;]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/han-moon-hee-the-first-president-of-the-korea-institute-of-biotechnology-who-was-called-the-godfa-47588510684422151228/</link><pubDate>Tue, 31 Mar 2026 07:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/han-moon-hee-the-first-president-of-the-korea-institute-of-biotechnology-who-was-called-the-godfa-47588510684422151228/</guid></item><item><title><![CDATA[Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com]]></title><description><![CDATA[Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/yantai-zhenghai-biotechnology-co-ltd-reports-earnings-results-for-the-full-year-ended-december-31-2025-marketscreenercom/</link><pubDate>Mon, 30 Mar 2026 23:13:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/yantai-zhenghai-biotechnology-co-ltd-reports-earnings-results-for-the-full-year-ended-december-31-2025-marketscreenercom/</guid></item><item><title><![CDATA[Green Fresh Biotechnology Profit Slumps as Revenue and Margins Decline in 2025 - TipRanks]]></title><description><![CDATA[Green Fresh Biotechnology Profit Slumps as Revenue and Margins Decline in 2025&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/green-fresh-biotechnology-profit-slumps-as-revenue-and-margins-decline-in-2025-tipranks/</link><pubDate>Mon, 30 Mar 2026 19:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/green-fresh-biotechnology-profit-slumps-as-revenue-and-margins-decline-in-2025-tipranks/</guid></item><item><title><![CDATA[Green Fresh Biotechnology Declares Final Dividend for 2025 - TipRanks]]></title><description><![CDATA[Green Fresh Biotechnology Declares Final Dividend for 2025&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/green-fresh-biotechnology-declares-final-dividend-for-2025-tipranks/</link><pubDate>Mon, 30 Mar 2026 19:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/green-fresh-biotechnology-declares-final-dividend-for-2025-tipranks/</guid></item><item><title><![CDATA[12 Industrials Stocks Moving In Monday's Intraday Session - benzinga.com]]></title><description><![CDATA[12 Industrials Stocks Moving In Monday's Intraday Session&nbsp;&nbsp;benzinga.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/12-industrials-stocks-moving-in-mondays-intraday-session-benzingacom/</link><pubDate>Mon, 30 Mar 2026 19:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/12-industrials-stocks-moving-in-mondays-intraday-session-benzingacom/</guid></item><item><title><![CDATA[Why Anbio Biotechnology Class A Shares Are Surging - TipRanks]]></title><description><![CDATA[Why Anbio Biotechnology Class A Shares Are Surging&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/why-anbio-biotechnology-class-a-shares-are-surging-tipranks/</link><pubDate>Mon, 30 Mar 2026 15:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/why-anbio-biotechnology-class-a-shares-are-surging-tipranks/</guid></item><item><title><![CDATA[PMGC Holdings Inc. 2025 Annual Report: Diversified Growth in Biotechnology, Advanced Manufacturing, and Specialty Packaging - Minichart]]></title><description><![CDATA[PMGC Holdings Inc. 2025 Annual Report: Diversified Growth in Biotechnology, Advanced Manufacturing, and Specialty Packaging&nbsp;&nbsp;Minichart]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pmgc-holdings-inc-2025-annual-report-diversified-growth-in-biotechnology-advanced-manufacturing-and-specialty-packaging-minichart/</link><pubDate>Mon, 30 Mar 2026 15:53:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pmgc-holdings-inc-2025-annual-report-diversified-growth-in-biotechnology-advanced-manufacturing-and-specialty-packaging-minichart/</guid></item><item><title><![CDATA[Engineering macrophage-targeted trispecific immune cell engagers for tumor immunotherapy - Nature]]></title><description><![CDATA[Engineering macrophage-targeted trispecific immune cell engagers for tumor immunotherapy&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/engineering-macrophage-targeted-trispecific-immune-cell-engagers-for-tumor-immunotherapy-nature/</link><pubDate>Mon, 30 Mar 2026 15:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/engineering-macrophage-targeted-trispecific-immune-cell-engagers-for-tumor-immunotherapy-nature/</guid></item><item><title><![CDATA[PDS Biotechnology: Q4 Earnings Snapshot - marketscreener.com]]></title><description><![CDATA[PDS Biotechnology: Q4 Earnings Snapshot&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-q4-earnings-snapshot-marketscreenercom/</link><pubDate>Mon, 30 Mar 2026 13:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-q4-earnings-snapshot-marketscreenercom/</guid></item><item><title><![CDATA[PDS Biotechnology: Q4 Earnings Snapshot - kare11.com]]></title><description><![CDATA[PDS Biotechnology: Q4 Earnings Snapshot&nbsp;&nbsp;kare11.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-q4-earnings-snapshot-kare11com/</link><pubDate>Mon, 30 Mar 2026 13:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-q4-earnings-snapshot-kare11com/</guid></item><item><title><![CDATA[Europe’s pivotal choice: Vaccination is health security - European Biotechnology Magazine]]></title><description><![CDATA[Europe&rsquo;s pivotal choice: Vaccination is health security&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/europes-pivotal-choice-vaccination-is-health-security-european-biotechnology-magazine/</link><pubDate>Mon, 30 Mar 2026 11:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/europes-pivotal-choice-vaccination-is-health-security-european-biotechnology-magazine/</guid></item><item><title><![CDATA[A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack - StockStory]]></title><description><![CDATA[A Look Back at Biotechnology Stocks&rsquo; Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack&nbsp;&nbsp;StockStory]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/a-look-back-at-biotechnology-stocks-q4-earnings-incyte-nasdaqincy-vs-the-rest-of-the-pack-stockstory/</link><pubDate>Mon, 30 Mar 2026 09:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/a-look-back-at-biotechnology-stocks-q4-earnings-incyte-nasdaqincy-vs-the-rest-of-the-pack-stockstory/</guid></item><item><title><![CDATA[Columbus Biotechnology (06990.HK): CSRC Issues Filing Notice for Company's Full Circulation of H Shares - AASTOCKS.com]]></title><description><![CDATA[Columbus Biotechnology (06990.HK): CSRC Issues Filing Notice for Company's Full Circulation of H Shares&nbsp;&nbsp;AASTOCKS.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/columbus-biotechnology-06990hk-csrc-issues-filing-notice-for-companys-full-circulation-of-h-shares-aastockscom/</link><pubDate>Mon, 30 Mar 2026 03:41:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/columbus-biotechnology-06990hk-csrc-issues-filing-notice-for-companys-full-circulation-of-h-shares-aastockscom/</guid></item><item><title><![CDATA[PDS Biotechnology FY 2025 earnings preview - MSN]]></title><description><![CDATA[PDS Biotechnology FY 2025 earnings preview&nbsp;&nbsp;MSN]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-fy-2025-earnings-preview-msn/</link><pubDate>Mon, 30 Mar 2026 01:50:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-fy-2025-earnings-preview-msn/</guid></item><item><title><![CDATA[Enanta Pharmaceuticals Stock: Biotechnology Innovator Focused on Respiratory and Viral Diseases for - ad-hoc-news.de]]></title><description><![CDATA[Enanta Pharmaceuticals Stock: Biotechnology Innovator Focused on Respiratory and Viral Diseases for&nbsp;&nbsp;ad-hoc-news.de]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/enanta-pharmaceuticals-stock-biotechnology-innovator-focused-on-respiratory-and-viral-diseases-for-ad-hoc-newsde/</link><pubDate>Sun, 29 Mar 2026 19:34:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/enanta-pharmaceuticals-stock-biotechnology-innovator-focused-on-respiratory-and-viral-diseases-for-ad-hoc-newsde/</guid></item><item><title><![CDATA[Ahmet Dirican: Honored to Serve as Jury Member for IamGenius Biotechnology Ideas Competition - Oncodaily]]></title><description><![CDATA[Ahmet Dirican: Honored to Serve as Jury Member for IamGenius Biotechnology Ideas Competition&nbsp;&nbsp;Oncodaily]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ahmet-dirican-honored-to-serve-as-jury-member-for-iamgenius-biotechnology-ideas-competition-oncodaily/</link><pubDate>Sun, 29 Mar 2026 12:51:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ahmet-dirican-honored-to-serve-as-jury-member-for-iamgenius-biotechnology-ideas-competition-oncodaily/</guid></item><item><title><![CDATA[Current Opinion in Biotechnology | Vol 98, April 2026 - ScienceDirect.com]]></title><description><![CDATA[Current Opinion in Biotechnology | Vol 98, April 2026&nbsp;&nbsp;ScienceDirect.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/current-opinion-in-biotechnology-vol-98-april-2026-sciencedirectcom/</link><pubDate>Sat, 28 Mar 2026 10:44:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/current-opinion-in-biotechnology-vol-98-april-2026-sciencedirectcom/</guid></item><item><title><![CDATA[Earnings call transcript: Puma Biotechnology Inc. reports strong Q4 2025 results - Investing.com]]></title><description><![CDATA[Earnings call transcript: Puma Biotechnology Inc. reports strong Q4 2025 results&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-call-transcript-puma-biotechnology-inc-reports-strong-q4-2025-results-investingcom/</link><pubDate>Sat, 28 Mar 2026 04:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-call-transcript-puma-biotechnology-inc-reports-strong-q4-2025-results-investingcom/</guid></item><item><title><![CDATA[Novartis bets $2bn on biologics as Xolair patents fade - Life Sciences Intellectual Property Review]]></title><description><![CDATA[Novartis bets $2bn on biologics as Xolair patents fade&nbsp;&nbsp;Life Sciences Intellectual Property Review]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/novartis-bets-2bn-on-biologics-as-xolair-patents-fade-life-sciences-intellectual-property-review/</link><pubDate>Fri, 27 Mar 2026 21:52:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/novartis-bets-2bn-on-biologics-as-xolair-patents-fade-life-sciences-intellectual-property-review/</guid></item><item><title><![CDATA[Ysios Capital launches InceptionBio: €100m for Spanish biotech spinouts - European Biotechnology Magazine]]></title><description><![CDATA[Ysios Capital launches InceptionBio: &euro;100m for Spanish biotech spinouts&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ysios-capital-launches-inceptionbio-100m-for-spanish-biotech-spinouts-european-biotechnology-magazine/</link><pubDate>Fri, 27 Mar 2026 17:26:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ysios-capital-launches-inceptionbio-100m-for-spanish-biotech-spinouts-european-biotechnology-magazine/</guid></item><item><title><![CDATA[AAPS Announces Plenary Speakers for 2026 National Biotechnology Conference - Contract Pharma]]></title><description><![CDATA[AAPS Announces Plenary Speakers for 2026 National Biotechnology Conference&nbsp;&nbsp;Contract Pharma]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/aaps-announces-plenary-speakers-for-2026-national-biotechnology-conference-contract-pharma/</link><pubDate>Fri, 27 Mar 2026 16:11:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/aaps-announces-plenary-speakers-for-2026-national-biotechnology-conference-contract-pharma/</guid></item><item><title><![CDATA[High-resolution metagenome assembly for modern long reads with myloasm - Nature]]></title><description><![CDATA[High-resolution metagenome assembly for modern long reads with myloasm&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/high-resolution-metagenome-assembly-for-modern-long-reads-with-myloasm-nature/</link><pubDate>Fri, 27 Mar 2026 11:24:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/high-resolution-metagenome-assembly-for-modern-long-reads-with-myloasm-nature/</guid></item><item><title><![CDATA[Tozorakimab stakes claim in emerging COPD biologics race - The Pharma Letter]]></title><description><![CDATA[Tozorakimab stakes claim in emerging COPD biologics race&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/tozorakimab-stakes-claim-in-emerging-copd-biologics-race-the-pharma-letter/</link><pubDate>Fri, 27 Mar 2026 11:18:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/tozorakimab-stakes-claim-in-emerging-copd-biologics-race-the-pharma-letter/</guid></item><item><title><![CDATA[Wave hits the rocks on confounding obesity trial - The Pharma Letter]]></title><description><![CDATA[Wave hits the rocks on confounding obesity trial&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/wave-hits-the-rocks-on-confounding-obesity-trial-the-pharma-letter/</link><pubDate>Thu, 26 Mar 2026 18:31:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/wave-hits-the-rocks-on-confounding-obesity-trial-the-pharma-letter/</guid></item><item><title><![CDATA[GC Biopharma wins first LatAm nod for Barycela | Biotechnology | The Pharmaletter - The Pharma Letter]]></title><description><![CDATA[GC Biopharma wins first LatAm nod for Barycela | Biotechnology | The Pharmaletter&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/gc-biopharma-wins-first-latam-nod-for-barycela-biotechnology-the-pharmaletter-the-pharma-letter/</link><pubDate>Thu, 26 Mar 2026 18:10:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/gc-biopharma-wins-first-latam-nod-for-barycela-biotechnology-the-pharmaletter-the-pharma-letter/</guid></item><item><title><![CDATA[Investing in biotechnology with investment trusts - Mar 2026 | Investor - trustintelligence.co.uk]]></title><description><![CDATA[Investing in biotechnology with investment trusts - Mar 2026 | Investor&nbsp;&nbsp;trustintelligence.co.uk]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/investing-in-biotechnology-with-investment-trusts-mar-2026-investor-trustintelligencecouk/</link><pubDate>Thu, 26 Mar 2026 16:34:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/investing-in-biotechnology-with-investment-trusts-mar-2026-investor-trustintelligencecouk/</guid></item><item><title><![CDATA[Insilico Medicine &amp; Tenacia Biotechnology Expand AI-Driven CNS Collaboration - TradingView]]></title><description><![CDATA[Insilico Medicine &amp; Tenacia Biotechnology Expand AI-Driven CNS Collaboration&nbsp;&nbsp;TradingView]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/insilico-medicine-amp-tenacia-biotechnology-expand-ai-driven-cns-collaboration-tradingview/</link><pubDate>Thu, 26 Mar 2026 15:37:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/insilico-medicine-amp-tenacia-biotechnology-expand-ai-driven-cns-collaboration-tradingview/</guid></item><item><title><![CDATA[Insilico Medicine and Tenacia Biotechnology Expand AI-Driven CNS Collaboration with Deal Value Up to US$94.75 Million - Insilico Medicine]]></title><description><![CDATA[Insilico Medicine and Tenacia Biotechnology Expand AI-Driven CNS Collaboration with Deal Value Up to US$94.75 Million&nbsp;&nbsp;Insilico Medicine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/insilico-medicine-and-tenacia-biotechnology-expand-ai-driven-cns-collaboration-with-deal-value-up-to-us9475-million-insilico-medicine/</link><pubDate>Thu, 26 Mar 2026 08:22:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/insilico-medicine-and-tenacia-biotechnology-expand-ai-driven-cns-collaboration-with-deal-value-up-to-us9475-million-insilico-medicine/</guid></item><item><title><![CDATA[Insilico Medicine and Tenacia Biotechnology Expand AI-Driven CNS Collaboration with Deal Value Up to US$94.75 Million - EurekAlert!]]></title><description><![CDATA[Insilico Medicine and Tenacia Biotechnology Expand AI-Driven CNS Collaboration with Deal Value Up to US$94.75 Million&nbsp;&nbsp;EurekAlert!]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/insilico-medicine-and-tenacia-biotechnology-expand-ai-driven-cns-collaboration-with-deal-value-up-to-us9475-million-eurekalert/</link><pubDate>Thu, 26 Mar 2026 01:31:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/insilico-medicine-and-tenacia-biotechnology-expand-ai-driven-cns-collaboration-with-deal-value-up-to-us9475-million-eurekalert/</guid></item><item><title><![CDATA[Nautilus Biotechnology Unveils Voyager Proteomics Platform, Targets Beta Access in 2H and Launch Next Year - Yahoo Finance]]></title><description><![CDATA[Nautilus Biotechnology Unveils Voyager Proteomics Platform, Targets Beta Access in 2H and Launch Next Year&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-unveils-voyager-proteomics-platform-targets-beta-access-in-2h-and-launch-next-year-yahoo-finance/</link><pubDate>Thu, 26 Mar 2026 00:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-unveils-voyager-proteomics-platform-targets-beta-access-in-2h-and-launch-next-year-yahoo-finance/</guid></item><item><title><![CDATA[ProShares Ultra Nasdaq Biotechnology Declares Quarterly Dividend of $0.01 (NASDAQ:BIB) - MarketBeat]]></title><description><![CDATA[ProShares Ultra Nasdaq Biotechnology Declares Quarterly Dividend of $0.01 (NASDAQ:BIB)&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/proshares-ultra-nasdaq-biotechnology-declares-quarterly-dividend-of-001-nasdaqbib-marketbeat/</link><pubDate>Wed, 25 Mar 2026 23:16:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/proshares-ultra-nasdaq-biotechnology-declares-quarterly-dividend-of-001-nasdaqbib-marketbeat/</guid></item><item><title><![CDATA[Nautilus Biotechnology at Investor Summit: Innovative Proteomics Pathway By Investing.com - Investing.com]]></title><description><![CDATA[Nautilus Biotechnology at Investor Summit: Innovative Proteomics Pathway By Investing.com&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-at-investor-summit-innovative-proteomics-pathway-by-investingcom-investingcom/</link><pubDate>Wed, 25 Mar 2026 23:03:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-at-investor-summit-innovative-proteomics-pathway-by-investingcom-investingcom/</guid></item><item><title><![CDATA[AI in Biotechnology Market to Reach $22.72 Billion by 2035 - openPR.com]]></title><description><![CDATA[AI in Biotechnology Market to Reach $22.72 Billion by 2035&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-market-to-reach-2272-billion-by-2035-openprcom/</link><pubDate>Wed, 25 Mar 2026 21:20:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-market-to-reach-2272-billion-by-2035-openprcom/</guid></item><item><title><![CDATA[Landmark Proton Therapy Data Changes the Conversation; LIXTE Biotechnology (NASDAQ: LIXT) Saw It Coming - USA Today]]></title><description><![CDATA[Landmark Proton Therapy Data Changes the Conversation; LIXTE Biotechnology (NASDAQ: LIXT) Saw It Coming&nbsp;&nbsp;USA Today]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/landmark-proton-therapy-data-changes-the-conversation-lixte-biotechnology-nasdaq-lixt-saw-it-coming-usa-today/</link><pubDate>Wed, 25 Mar 2026 20:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/landmark-proton-therapy-data-changes-the-conversation-lixte-biotechnology-nasdaq-lixt-saw-it-coming-usa-today/</guid></item><item><title><![CDATA[Nautilus Biotechnology (NASDAQ:NAUT) Sets New 52-Week High - What's Next? - MarketBeat]]></title><description><![CDATA[Nautilus Biotechnology (NASDAQ:NAUT) Sets New 52-Week High - What's Next?&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-nasdaqnaut-sets-new-52-week-high-whats-next-marketbeat/</link><pubDate>Wed, 25 Mar 2026 15:02:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-nasdaqnaut-sets-new-52-week-high-whats-next-marketbeat/</guid></item><item><title><![CDATA[Insilico launches PandaClaw as AI agents reshape drug discovery - The Pharma Letter]]></title><description><![CDATA[Insilico launches PandaClaw as AI agents reshape drug discovery&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/insilico-launches-pandaclaw-as-ai-agents-reshape-drug-discovery-the-pharma-letter/</link><pubDate>Wed, 25 Mar 2026 14:54:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/insilico-launches-pandaclaw-as-ai-agents-reshape-drug-discovery-the-pharma-letter/</guid></item><item><title><![CDATA[Axogen spends $1.7M on another Vandalia site - Dayton Daily News]]></title><description><![CDATA[Axogen spends $1.7M on another Vandalia site&nbsp;&nbsp;Dayton Daily News]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/axogen-spends-17m-on-another-vandalia-site-dayton-daily-news/</link><pubDate>Wed, 25 Mar 2026 14:39:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/axogen-spends-17m-on-another-vandalia-site-dayton-daily-news/</guid></item><item><title><![CDATA[Cellgenes raises over $14m to advance stem cell pipeline - The Pharma Letter]]></title><description><![CDATA[Cellgenes raises over $14m to advance stem cell pipeline&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cellgenes-raises-over-14m-to-advance-stem-cell-pipeline-the-pharma-letter/</link><pubDate>Wed, 25 Mar 2026 13:51:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cellgenes-raises-over-14m-to-advance-stem-cell-pipeline-the-pharma-letter/</guid></item><item><title><![CDATA[Immutrin secures £65m Series A for amyloid-removing heart therapy - European Biotechnology Magazine]]></title><description><![CDATA[Immutrin secures &pound;65m Series A for amyloid-removing heart therapy&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/immutrin-secures-65m-series-a-for-amyloid-removing-heart-therapy-european-biotechnology-magazine/</link><pubDate>Wed, 25 Mar 2026 13:12:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/immutrin-secures-65m-series-a-for-amyloid-removing-heart-therapy-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist - simplywall.st]]></title><description><![CDATA[Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-and-2-other-compelling-penny-stocks-for-your-watchlist-simplywallst/</link><pubDate>Wed, 25 Mar 2026 12:13:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-and-2-other-compelling-penny-stocks-for-your-watchlist-simplywallst/</guid></item><item><title><![CDATA[Vir Biotechnology (NASDAQ:VIR) CAO Sells $70,324.32 in Stock - MarketBeat]]></title><description><![CDATA[Vir Biotechnology (NASDAQ:VIR) CAO Sells $70,324.32 in Stock&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-cao-sells-7032432-in-stock-marketbeat/</link><pubDate>Wed, 25 Mar 2026 11:48:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-cao-sells-7032432-in-stock-marketbeat/</guid></item><item><title><![CDATA[Zhengye Biotechnology Shareholders Approve Governance and Share Structure Changes at March 24 AGM - TipRanks]]></title><description><![CDATA[Zhengye Biotechnology Shareholders Approve Governance and Share Structure Changes at March 24 AGM&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/zhengye-biotechnology-shareholders-approve-governance-and-share-structure-changes-at-march-24-agm-tipranks/</link><pubDate>Wed, 25 Mar 2026 11:34:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/zhengye-biotechnology-shareholders-approve-governance-and-share-structure-changes-at-march-24-agm-tipranks/</guid></item><item><title><![CDATA[Junior Research Fellow at RCB | Biotechnology Candidates, Apply Now - BioTecNika]]></title><description><![CDATA[Junior Research Fellow at RCB | Biotechnology Candidates, Apply Now&nbsp;&nbsp;BioTecNika]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/junior-research-fellow-at-rcb-biotechnology-candidates-apply-now-biotecnika/</link><pubDate>Wed, 25 Mar 2026 09:15:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/junior-research-fellow-at-rcb-biotechnology-candidates-apply-now-biotecnika/</guid></item><item><title><![CDATA[Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist - Yahoo Finance]]></title><description><![CDATA[Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-and-2-other-compelling-penny-stocks-for-your-watchlist-yahoo-finance/</link><pubDate>Wed, 25 Mar 2026 08:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-and-2-other-compelling-penny-stocks-for-your-watchlist-yahoo-finance/</guid></item><item><title><![CDATA[Press Release: Senator Todd Young Discusses U.S. Leadership in Biotechnology at Hill &amp; Valley Forum - Quiver Quantitative]]></title><description><![CDATA[Press Release: Senator Todd Young Discusses U.S. Leadership in Biotechnology at Hill &amp; Valley Forum&nbsp;&nbsp;Quiver Quantitative]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/press-release-senator-todd-young-discusses-us-leadership-in-biotechnology-at-hill-amp-valley-forum-quiver-quantitative/</link><pubDate>Wed, 25 Mar 2026 03:23:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/press-release-senator-todd-young-discusses-us-leadership-in-biotechnology-at-hill-amp-valley-forum-quiver-quantitative/</guid></item><item><title><![CDATA[Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&amp;P Biotechnology Select Industry Index - marketscreener.com]]></title><description><![CDATA[Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/exact-sciences-corporationnasdaqcmexas-dropped-from-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Wed, 25 Mar 2026 02:11:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/exact-sciences-corporationnasdaqcmexas-dropped-from-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[PDS Biotechnology to announce Q4 and full year results on March 30 with clinical and corporate update - Traders Union]]></title><description><![CDATA[PDS Biotechnology to announce Q4 and full year results on March 30 with clinical and corporate update&nbsp;&nbsp;Traders Union]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-to-announce-q4-and-full-year-results-on-march-30-with-clinical-and-corporate-update-traders-union/</link><pubDate>Wed, 25 Mar 2026 00:55:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-to-announce-q4-and-full-year-results-on-march-30-with-clinical-and-corporate-update-traders-union/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) accounting chief sells 7,711 shares under plan - Stock Titan]]></title><description><![CDATA[Vir Biotechnology (VIR) accounting chief sells 7,711 shares under plan&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-accounting-chief-sells-7711-shares-under-plan-stock-titan/</link><pubDate>Tue, 24 Mar 2026 21:35:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-accounting-chief-sells-7711-shares-under-plan-stock-titan/</guid></item><item><title><![CDATA[Sana Biotechnology (NASDAQ:SANA) Trading Down 7.2% - Here's What Happened - MarketBeat]]></title><description><![CDATA[Sana Biotechnology (NASDAQ:SANA) Trading Down 7.2% - Here's What Happened&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-nasdaqsana-trading-down-72-heres-what-happened-marketbeat/</link><pubDate>Tue, 24 Mar 2026 21:29:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-nasdaqsana-trading-down-72-heres-what-happened-marketbeat/</guid></item><item><title><![CDATA[Incubate and the National Security Commission on Emerging Biotechnology Convene Capitol Hill Roundtable on U.S. Biotech Competitiveness - The Manila Times]]></title><description><![CDATA[Incubate and the National Security Commission on Emerging Biotechnology Convene Capitol Hill Roundtable on U.S. Biotech Competitiveness&nbsp;&nbsp;The Manila Times]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/incubate-and-the-national-security-commission-on-emerging-biotechnology-convene-capitol-hill-roundtable-on-us-biotech-competitiveness-the-manila-times/</link><pubDate>Tue, 24 Mar 2026 18:32:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/incubate-and-the-national-security-commission-on-emerging-biotechnology-convene-capitol-hill-roundtable-on-us-biotech-competitiveness-the-manila-times/</guid></item><item><title><![CDATA[Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference - marketscreener.com]]></title><description><![CDATA[Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-to-participate-in-the-investor-summit-group-virtual-conference-marketscreenercom/</link><pubDate>Tue, 24 Mar 2026 13:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-to-participate-in-the-investor-summit-group-virtual-conference-marketscreenercom/</guid></item><item><title><![CDATA[Origin Agritech Names Global Crop Biotechnology Expert Dr. Jian Zhang to Board of Directors; Welcomes Return of Dr. Z. James Chen as Chief Financial Officer - The Manila Times]]></title><description><![CDATA[Origin Agritech Names Global Crop Biotechnology Expert Dr. Jian Zhang to Board of Directors; Welcomes Return of Dr. Z. James Chen as Chief Financial Officer&nbsp;&nbsp;The Manila Times]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/origin-agritech-names-global-crop-biotechnology-expert-dr-jian-zhang-to-board-of-directors-welcomes-return-of-dr-z-james-chen-as-chief-financial-officer-the-manila-times/</link><pubDate>Tue, 24 Mar 2026 13:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/origin-agritech-names-global-crop-biotechnology-expert-dr-jian-zhang-to-board-of-directors-welcomes-return-of-dr-z-james-chen-as-chief-financial-officer-the-manila-times/</guid></item><item><title><![CDATA[Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference - Yahoo Finance]]></title><description><![CDATA[Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-to-participate-in-the-investor-summit-group-virtual-conference-yahoo-finance/</link><pubDate>Tue, 24 Mar 2026 13:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-to-participate-in-the-investor-summit-group-virtual-conference-yahoo-finance/</guid></item><item><title><![CDATA[Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference - GlobeNewswire]]></title><description><![CDATA[Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-to-participate-in-the-investor-summit-group-virtual-conference-globenewswire/</link><pubDate>Tue, 24 Mar 2026 13:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-to-participate-in-the-investor-summit-group-virtual-conference-globenewswire/</guid></item><item><title><![CDATA[Origin Agritech Names Global Crop Biotechnology Expert Dr. Jian Zhang to Board of Directors; Welcomes Return of Dr. Z. James Chen as Chief Financial Officer - Yahoo Finance]]></title><description><![CDATA[Origin Agritech Names Global Crop Biotechnology Expert Dr. Jian Zhang to Board of Directors; Welcomes Return of Dr. Z. James Chen as Chief Financial Officer&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/origin-agritech-names-global-crop-biotechnology-expert-dr-jian-zhang-to-board-of-directors-welcomes-return-of-dr-z-james-chen-as-chief-financial-officer-yahoo-finance/</link><pubDate>Tue, 24 Mar 2026 12:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/origin-agritech-names-global-crop-biotechnology-expert-dr-jian-zhang-to-board-of-directors-welcomes-return-of-dr-z-james-chen-as-chief-financial-officer-yahoo-finance/</guid></item><item><title><![CDATA[Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat]]></title><description><![CDATA[Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Recommendation of "Moderate Buy" by Brokerages&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-inc-nasdaqsana-given-average-recommendation-of-moderate-buy-by-brokerages-marketbeat/</link><pubDate>Tue, 24 Mar 2026 11:56:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-inc-nasdaqsana-given-average-recommendation-of-moderate-buy-by-brokerages-marketbeat/</guid></item><item><title><![CDATA[Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting - The Manila Times]]></title><description><![CDATA[Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting&nbsp;&nbsp;The Manila Times]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/curative-biotechnology-announces-reverse-stock-split-and-strategic-progress-toward-otcqb-uplisting-the-manila-times/</link><pubDate>Tue, 24 Mar 2026 00:10:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/curative-biotechnology-announces-reverse-stock-split-and-strategic-progress-toward-otcqb-uplisting-the-manila-times/</guid></item><item><title><![CDATA[Biosensor detects early fungal outbreaks, advances plant biotechnology - Phys.org]]></title><description><![CDATA[Biosensor detects early fungal outbreaks, advances plant biotechnology&nbsp;&nbsp;Phys.org]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biosensor-detects-early-fungal-outbreaks-advances-plant-biotechnology-physorg/</link><pubDate>Tue, 24 Mar 2026 00:10:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biosensor-detects-early-fungal-outbreaks-advances-plant-biotechnology-physorg/</guid></item><item><title><![CDATA[Insight into plant biotechnology - epo.org]]></title><description><![CDATA[Insight into plant biotechnology&nbsp;&nbsp;epo.org]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/insight-into-plant-biotechnology-epoorg/</link><pubDate>Mon, 23 Mar 2026 22:53:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/insight-into-plant-biotechnology-epoorg/</guid></item><item><title><![CDATA[Leadership change - European Biotechnology Magazine]]></title><description><![CDATA[Leadership change&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/leadership-change-european-biotechnology-magazine/</link><pubDate>Mon, 23 Mar 2026 13:19:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/leadership-change-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett As President And Chief Executive Officer - TradingView]]></title><description><![CDATA[Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett As President And Chief Executive Officer&nbsp;&nbsp;TradingView]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/damora-therapeutics-appoints-biotechnology-leader-jennifer-jarrett-as-president-and-chief-executive-officer-tradingview/</link><pubDate>Mon, 23 Mar 2026 13:11:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/damora-therapeutics-appoints-biotechnology-leader-jennifer-jarrett-as-president-and-chief-executive-officer-tradingview/</guid></item><item><title><![CDATA[Abselion names Dale Gordon as board chair - The Pharma Letter]]></title><description><![CDATA[Abselion names Dale Gordon as board chair&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/abselion-names-dale-gordon-as-board-chair-the-pharma-letter/</link><pubDate>Mon, 23 Mar 2026 12:41:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/abselion-names-dale-gordon-as-board-chair-the-pharma-letter/</guid></item><item><title><![CDATA[Earendil raises $787 million to scale AI-led biologics push - The Pharma Letter]]></title><description><![CDATA[Earendil raises $787 million to scale AI-led biologics push&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/earendil-raises-787-million-to-scale-ai-led-biologics-push-the-pharma-letter/</link><pubDate>Mon, 23 Mar 2026 11:36:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/earendil-raises-787-million-to-scale-ai-led-biologics-push-the-pharma-letter/</guid></item><item><title><![CDATA[Zenas BioPharma, Inc.(NasdaqGS: ZBIO) added to S&amp;P Biotechnology Select Industry Index - marketscreener.com]]></title><description><![CDATA[Zenas BioPharma, Inc.(NasdaqGS: ZBIO) added to S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/zenas-biopharma-incnasdaqgs-zbio-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Mon, 23 Mar 2026 04:23:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/zenas-biopharma-incnasdaqgs-zbio-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[Ocugen, Inc.(NasdaqCM: OCGN) added to S&amp;P Biotechnology Select Industry Index - marketscreener.com]]></title><description><![CDATA[Ocugen, Inc.(NasdaqCM: OCGN) added to S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ocugen-incnasdaqcm-ocgn-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Mon, 23 Mar 2026 04:23:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ocugen-incnasdaqcm-ocgn-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[Gossamer Bio, Inc.(NasdaqGS:GOSS) dropped from S&amp;P Biotechnology Select Industry Index - marketscreener.com]]></title><description><![CDATA[Gossamer Bio, Inc.(NasdaqGS:GOSS) dropped from S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/gossamer-bio-incnasdaqgsgoss-dropped-from-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Mon, 23 Mar 2026 04:07:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/gossamer-bio-incnasdaqgsgoss-dropped-from-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing - Yahoo Finance]]></title><description><![CDATA[DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/dafna-capital-trims-ishares-biotechnology-etf-within-broader-biotech-portfolio-according-to-recent-sec-filing-yahoo-finance/</link><pubDate>Sat, 21 Mar 2026 22:58:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/dafna-capital-trims-ishares-biotechnology-etf-within-broader-biotech-portfolio-according-to-recent-sec-filing-yahoo-finance/</guid></item><item><title><![CDATA[What the trend in M&amp;A means for International Biotechnology Trust - ICYMI - Yahoo Finance UK]]></title><description><![CDATA[What the trend in M&amp;A means for International Biotechnology Trust - ICYMI&nbsp;&nbsp;Yahoo Finance UK]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/what-the-trend-in-mampa-means-for-international-biotechnology-trust-icymi-yahoo-finance-uk/</link><pubDate>Sat, 21 Mar 2026 08:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/what-the-trend-in-mampa-means-for-international-biotechnology-trust-icymi-yahoo-finance-uk/</guid></item><item><title><![CDATA[Lixte Biotechnology Raises CEO Compensation Amid Leadership Support - TipRanks]]></title><description><![CDATA[Lixte Biotechnology Raises CEO Compensation Amid Leadership Support&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-raises-ceo-compensation-amid-leadership-support-tipranks/</link><pubDate>Fri, 20 Mar 2026 21:37:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-raises-ceo-compensation-amid-leadership-support-tipranks/</guid></item><item><title><![CDATA[Photos from Claflin University's Biotechnology and Innovation Center groundbreaking - The Times and Democrat]]></title><description><![CDATA[Photos from Claflin University's Biotechnology and Innovation Center groundbreaking&nbsp;&nbsp;The Times and Democrat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/photos-from-claflin-universitys-biotechnology-and-innovation-center-groundbreaking-the-times-and-democrat/</link><pubDate>Fri, 20 Mar 2026 20:35:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/photos-from-claflin-universitys-biotechnology-and-innovation-center-groundbreaking-the-times-and-democrat/</guid></item><item><title><![CDATA[Lixte Biotechnology stock faces scrutiny amid stalled pipeline progress and biotech sector volatilit - AD HOC NEWS]]></title><description><![CDATA[Lixte Biotechnology stock faces scrutiny amid stalled pipeline progress and biotech sector volatilit&nbsp;&nbsp;AD HOC NEWS]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-stock-faces-scrutiny-amid-stalled-pipeline-progress-and-biotech-sector-volatilit-ad-hoc-news/</link><pubDate>Fri, 20 Mar 2026 15:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-stock-faces-scrutiny-amid-stalled-pipeline-progress-and-biotech-sector-volatilit-ad-hoc-news/</guid></item><item><title><![CDATA[How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks - Barchart.com]]></title><description><![CDATA[How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks&nbsp;&nbsp;Barchart.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/how-is-bio-technes-stock-performance-compared-to-other-biotechnology-stocks-barchartcom/</link><pubDate>Fri, 20 Mar 2026 14:55:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/how-is-bio-technes-stock-performance-compared-to-other-biotechnology-stocks-barchartcom/</guid></item><item><title><![CDATA[What the trend in M&amp;A means for International Biotechnology Trust - ICYMI - Proactive financial news]]></title><description><![CDATA[What the trend in M&amp;A means for International Biotechnology Trust - ICYMI&nbsp;&nbsp;Proactive financial news]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/what-the-trend-in-mampa-means-for-international-biotechnology-trust-icymi-proactive-financial-news/</link><pubDate>Fri, 20 Mar 2026 13:15:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/what-the-trend-in-mampa-means-for-international-biotechnology-trust-icymi-proactive-financial-news/</guid></item><item><title><![CDATA[Research Associate Job at Dr. Reddy’s Laboratories | Biotechnology Candidates, Apply Now - BioTecNika]]></title><description><![CDATA[Research Associate Job at Dr. Reddy&rsquo;s Laboratories | Biotechnology Candidates, Apply Now&nbsp;&nbsp;BioTecNika]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/research-associate-job-at-dr-reddys-laboratories-biotechnology-candidates-apply-now-biotecnika/</link><pubDate>Fri, 20 Mar 2026 12:02:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/research-associate-job-at-dr-reddys-laboratories-biotechnology-candidates-apply-now-biotecnika/</guid></item><item><title><![CDATA[Generalist biological artificial intelligence in modeling the language of life - Nature]]></title><description><![CDATA[Generalist biological artificial intelligence in modeling the language of life&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/generalist-biological-artificial-intelligence-in-modeling-the-language-of-life-nature/</link><pubDate>Fri, 20 Mar 2026 11:56:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/generalist-biological-artificial-intelligence-in-modeling-the-language-of-life-nature/</guid></item><item><title><![CDATA[AstraZeneca deepens China push with Shanghai cell therapy base - The Pharma Letter]]></title><description><![CDATA[AstraZeneca deepens China push with Shanghai cell therapy base&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/astrazeneca-deepens-china-push-with-shanghai-cell-therapy-base-the-pharma-letter/</link><pubDate>Fri, 20 Mar 2026 11:23:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/astrazeneca-deepens-china-push-with-shanghai-cell-therapy-base-the-pharma-letter/</guid></item><item><title><![CDATA[ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Cross Below 50 Day Moving Average - What's Next? - MarketBeat]]></title><description><![CDATA[ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Cross Below 50 Day Moving Average - What's Next?&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/proshares-ultra-nasdaq-biotechnology-nasdaqbib-stock-price-cross-below-50-day-moving-average-whats-next-marketbeat/</link><pubDate>Fri, 20 Mar 2026 09:16:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/proshares-ultra-nasdaq-biotechnology-nasdaqbib-stock-price-cross-below-50-day-moving-average-whats-next-marketbeat/</guid></item><item><title><![CDATA[How Biotechnology Could Save the Banana - Seed World]]></title><description><![CDATA[How Biotechnology Could Save the Banana&nbsp;&nbsp;Seed World]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/how-biotechnology-could-save-the-banana-seed-world/</link><pubDate>Fri, 20 Mar 2026 06:42:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/how-biotechnology-could-save-the-banana-seed-world/</guid></item><item><title><![CDATA[Is the Unified Patent Court affordable for small biotechs? - European Biotechnology Magazine]]></title><description><![CDATA[Is the Unified Patent Court affordable for small biotechs?&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/is-the-unified-patent-court-affordable-for-small-biotechs-european-biotechnology-magazine/</link><pubDate>Thu, 19 Mar 2026 15:09:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/is-the-unified-patent-court-affordable-for-small-biotechs-european-biotechnology-magazine/</guid></item><item><title><![CDATA[India's Bioeconomy: A Billion-Dollar Boom in Biotechnology - Devdiscourse]]></title><description><![CDATA[India's Bioeconomy: A Billion-Dollar Boom in Biotechnology&nbsp;&nbsp;Devdiscourse]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/indias-bioeconomy-a-billion-dollar-boom-in-biotechnology-devdiscourse/</link><pubDate>Thu, 19 Mar 2026 14:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/indias-bioeconomy-a-billion-dollar-boom-in-biotechnology-devdiscourse/</guid></item><item><title><![CDATA[India has emerged as a major global biotechnology hub: Jitendra Singh - ThePrint]]></title><description><![CDATA[India has emerged as a major global biotechnology hub: Jitendra Singh&nbsp;&nbsp;ThePrint]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/india-has-emerged-as-a-major-global-biotechnology-hub-jitendra-singh-theprint/</link><pubDate>Thu, 19 Mar 2026 13:46:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/india-has-emerged-as-a-major-global-biotechnology-hub-jitendra-singh-theprint/</guid></item><item><title><![CDATA[A special look at SLAS Europe Conference - European Biotechnology Magazine]]></title><description><![CDATA[A special look at SLAS Europe Conference&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/a-special-look-at-slas-europe-conference-european-biotechnology-magazine/</link><pubDate>Thu, 19 Mar 2026 07:39:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/a-special-look-at-slas-europe-conference-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Biotechnology in the Era of Omni-Use: Technologies Without Borders and the Governance Challenges They Present - 笹川平和財団]]></title><description><![CDATA[Biotechnology in the Era of Omni-Use: Technologies Without Borders and the Governance Challenges They Present&nbsp;&nbsp;&#31545;&#24029;&#24179;&#21644;&#36001;&#22243;]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-in-the-era-of-omni-use-technologies-without-borders-and-the-governance-challenges-they-present-/</link><pubDate>Thu, 19 Mar 2026 03:57:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-in-the-era-of-omni-use-technologies-without-borders-and-the-governance-challenges-they-present-/</guid></item><item><title><![CDATA[Robotics and AI Power Biotechnology Advances at PNNL - Newswise]]></title><description><![CDATA[Robotics and AI Power Biotechnology Advances at PNNL&nbsp;&nbsp;Newswise]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/robotics-and-ai-power-biotechnology-advances-at-pnnl-newswise/</link><pubDate>Thu, 19 Mar 2026 02:15:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/robotics-and-ai-power-biotechnology-advances-at-pnnl-newswise/</guid></item><item><title><![CDATA[European Partnerships for Biotech - European Biotechnology Magazine]]></title><description><![CDATA[European Partnerships for Biotech&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/european-partnerships-for-biotech-european-biotechnology-magazine/</link><pubDate>Wed, 18 Mar 2026 16:38:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/european-partnerships-for-biotech-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Beijing Luzhu Biotechnology Posts FY Loss Before Tax Rmb150.4 Million - TradingView]]></title><description><![CDATA[Beijing Luzhu Biotechnology Posts FY Loss Before Tax Rmb150.4 Million&nbsp;&nbsp;TradingView]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/beijing-luzhu-biotechnology-posts-fy-loss-before-tax-rmb1504-million-tradingview/</link><pubDate>Wed, 18 Mar 2026 16:28:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/beijing-luzhu-biotechnology-posts-fy-loss-before-tax-rmb1504-million-tradingview/</guid></item><item><title><![CDATA[Recap AI Circular Economy Conference 2026 - European Biotechnology Magazine]]></title><description><![CDATA[Recap AI Circular Economy Conference 2026&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/recap-ai-circular-economy-conference-2026-european-biotechnology-magazine/</link><pubDate>Wed, 18 Mar 2026 16:12:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/recap-ai-circular-economy-conference-2026-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Kupando adds 10 million euros to series A raise - The Pharma Letter]]></title><description><![CDATA[Kupando adds 10 million euros to series A raise&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/kupando-adds-10-million-euros-to-series-a-raise-the-pharma-letter/</link><pubDate>Wed, 18 Mar 2026 14:28:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/kupando-adds-10-million-euros-to-series-a-raise-the-pharma-letter/</guid></item><item><title><![CDATA[PerturbAI emerges with large-scale in vivo CRISPR atlas - The Pharma Letter]]></title><description><![CDATA[PerturbAI emerges with large-scale in vivo CRISPR atlas&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/perturbai-emerges-with-large-scale-in-vivo-crispr-atlas-the-pharma-letter/</link><pubDate>Wed, 18 Mar 2026 14:18:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/perturbai-emerges-with-large-scale-in-vivo-crispr-atlas-the-pharma-letter/</guid></item><item><title><![CDATA[Biotechnology Students from CCT, CGC Landran bag top honours at TWESS 2026 - Babushahi.com]]></title><description><![CDATA[Biotechnology Students from CCT, CGC Landran bag top honours at TWESS 2026&nbsp;&nbsp;Babushahi.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-students-from-cct-cgc-landran-bag-top-honours-at-twess-2026-babushahicom/</link><pubDate>Wed, 18 Mar 2026 12:21:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-students-from-cct-cgc-landran-bag-top-honours-at-twess-2026-babushahicom/</guid></item><item><title><![CDATA[Biotech building from a venture capitalist perspective - Nature]]></title><description><![CDATA[Biotech building from a venture capitalist perspective&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotech-building-from-a-venture-capitalist-perspective-nature/</link><pubDate>Wed, 18 Mar 2026 00:57:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotech-building-from-a-venture-capitalist-perspective-nature/</guid></item><item><title><![CDATA[DOE offers funding for biotechnology projects leveraging AI - Biomass Magazine]]></title><description><![CDATA[DOE offers funding for biotechnology projects leveraging AI&nbsp;&nbsp;Biomass Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/doe-offers-funding-for-biotechnology-projects-leveraging-ai-biomass-magazine/</link><pubDate>Wed, 18 Mar 2026 00:45:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/doe-offers-funding-for-biotechnology-projects-leveraging-ai-biomass-magazine/</guid></item><item><title><![CDATA[DOE offers funding for biotechnology projects leveraging AI - Ethanol Producer Magazine]]></title><description><![CDATA[DOE offers funding for biotechnology projects leveraging AI&nbsp;&nbsp;Ethanol Producer Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/doe-offers-funding-for-biotechnology-projects-leveraging-ai-ethanol-producer-magazine/</link><pubDate>Wed, 18 Mar 2026 00:14:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/doe-offers-funding-for-biotechnology-projects-leveraging-ai-ethanol-producer-magazine/</guid></item><item><title><![CDATA[Genome editing’s third act - Nature]]></title><description><![CDATA[Genome editing&rsquo;s third act&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/genome-editings-third-act-nature/</link><pubDate>Wed, 18 Mar 2026 00:12:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/genome-editings-third-act-nature/</guid></item><item><title><![CDATA[AI turbocharges antibody hunt for binders with drug-like qualities - Nature]]></title><description><![CDATA[AI turbocharges antibody hunt for binders with drug-like qualities&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ai-turbocharges-antibody-hunt-for-binders-with-drug-like-qualities-nature/</link><pubDate>Wed, 18 Mar 2026 00:12:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ai-turbocharges-antibody-hunt-for-binders-with-drug-like-qualities-nature/</guid></item><item><title><![CDATA[Innovation and policy challenges of AI–drug hybrids - Nature]]></title><description><![CDATA[Innovation and policy challenges of AI&ndash;drug hybrids&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/innovation-and-policy-challenges-of-aidrug-hybrids-nature/</link><pubDate>Tue, 17 Mar 2026 17:46:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/innovation-and-policy-challenges-of-aidrug-hybrids-nature/</guid></item><item><title><![CDATA[Biotechnology Personalized Medicine Market: Sovereign Genomics and the Localization of Living Drugs - openPR.com]]></title><description><![CDATA[Biotechnology Personalized Medicine Market: Sovereign Genomics and the Localization of Living Drugs&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-personalized-medicine-market-sovereign-genomics-and-the-localization-of-living-drugs-openprcom/</link><pubDate>Tue, 17 Mar 2026 11:39:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-personalized-medicine-market-sovereign-genomics-and-the-localization-of-living-drugs-openprcom/</guid></item><item><title><![CDATA[Manufacturing-aware generative models enable petascale synthesis of designed DNA - Nature]]></title><description><![CDATA[Manufacturing-aware generative models enable petascale synthesis of designed DNA&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/manufacturing-aware-generative-models-enable-petascale-synthesis-of-designed-dna-nature/</link><pubDate>Tue, 17 Mar 2026 11:29:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/manufacturing-aware-generative-models-enable-petascale-synthesis-of-designed-dna-nature/</guid></item><item><title><![CDATA[Voices of biotech research - Nature]]></title><description><![CDATA[Voices of biotech research&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/voices-of-biotech-research-nature/</link><pubDate>Tue, 17 Mar 2026 08:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/voices-of-biotech-research-nature/</guid></item><item><title><![CDATA[Voices of biotech leaders - Nature]]></title><description><![CDATA[Voices of biotech leaders&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/voices-of-biotech-leaders-nature/</link><pubDate>Tue, 17 Mar 2026 08:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/voices-of-biotech-leaders-nature/</guid></item><item><title><![CDATA[India enters new era of personalised medicine driven by biotechnology and genomics - TV BRICS]]></title><description><![CDATA[India enters new era of personalised medicine driven by biotechnology and genomics&nbsp;&nbsp;TV BRICS]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/india-enters-new-era-of-personalised-medicine-driven-by-biotechnology-and-genomics-tv-brics/</link><pubDate>Mon, 16 Mar 2026 15:34:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/india-enters-new-era-of-personalised-medicine-driven-by-biotechnology-and-genomics-tv-brics/</guid></item><item><title><![CDATA[Scaling Biotechnology and Novel Foods: inside the industrial reality of food innovation - New Food magazine]]></title><description><![CDATA[Scaling Biotechnology and Novel Foods: inside the industrial reality of food innovation&nbsp;&nbsp;New Food magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/scaling-biotechnology-and-novel-foods-inside-the-industrial-reality-of-food-innovation-new-food-magazine/</link><pubDate>Mon, 16 Mar 2026 15:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/scaling-biotechnology-and-novel-foods-inside-the-industrial-reality-of-food-innovation-new-food-magazine/</guid></item><item><title><![CDATA[Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression - GlobeNewswire]]></title><description><![CDATA[Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-announces-continued-positive-clinical-results-through-14-months-from-type-1-diabetes-study-of-islet-cell-transplantation-without-immunosuppression-globenewswire/</link><pubDate>Fri, 13 Mar 2026 14:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-announces-continued-positive-clinical-results-through-14-months-from-type-1-diabetes-study-of-islet-cell-transplantation-without-immunosuppression-globenewswire/</guid></item><item><title><![CDATA[Biomolecular profiling for noninvasive health monitoring - Nature]]></title><description><![CDATA[Biomolecular profiling for noninvasive health monitoring&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biomolecular-profiling-for-noninvasive-health-monitoring-nature/</link><pubDate>Thu, 12 Mar 2026 11:25:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biomolecular-profiling-for-noninvasive-health-monitoring-nature/</guid></item><item><title><![CDATA[International Biotechnology (IBT) - Mar 2026 | Investor - trustintelligence.co.uk]]></title><description><![CDATA[International Biotechnology (IBT) - Mar 2026 | Investor&nbsp;&nbsp;trustintelligence.co.uk]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/international-biotechnology-ibt-mar-2026-investor-trustintelligencecouk/</link><pubDate>Wed, 11 Mar 2026 08:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/international-biotechnology-ibt-mar-2026-investor-trustintelligencecouk/</guid></item><item><title><![CDATA[Biotechnology company to invest $1.5 billion in Illinois plasma-processing plan - The Breeze-Courier]]></title><description><![CDATA[Biotechnology company to invest $1.5 billion in Illinois plasma-processing plan&nbsp;&nbsp;The Breeze-Courier]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-company-to-invest-15-billion-in-illinois-plasma-processing-plan-the-breeze-courier/</link><pubDate>Tue, 10 Mar 2026 12:40:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-company-to-invest-15-billion-in-illinois-plasma-processing-plan-the-breeze-courier/</guid></item><item><title><![CDATA[The promises and challenges of neoantigen cancer vaccines - Nature]]></title><description><![CDATA[The promises and challenges of neoantigen cancer vaccines&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/the-promises-and-challenges-of-neoantigen-cancer-vaccines-nature/</link><pubDate>Tue, 10 Mar 2026 12:03:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/the-promises-and-challenges-of-neoantigen-cancer-vaccines-nature/</guid></item><item><title><![CDATA[Biotechnology spinout Cytotrait secures £3M seed funding to address global food security and sustainable agriculture - The University of Manchester]]></title><description><![CDATA[Biotechnology spinout Cytotrait secures &pound;3M seed funding to address global food security and sustainable agriculture&nbsp;&nbsp;The University of Manchester]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-spinout-cytotrait-secures-3m-seed-funding-to-address-global-food-security-and-sustainable-agriculture-the-university-of-manchester/</link><pubDate>Tue, 10 Mar 2026 10:41:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-spinout-cytotrait-secures-3m-seed-funding-to-address-global-food-security-and-sustainable-agriculture-the-university-of-manchester/</guid></item><item><title><![CDATA[Synthetic membraneless organelles for biotechnology applications reviewed - Nanowerk]]></title><description><![CDATA[Synthetic membraneless organelles for biotechnology applications reviewed&nbsp;&nbsp;Nanowerk]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/synthetic-membraneless-organelles-for-biotechnology-applications-reviewed-nanowerk/</link><pubDate>Tue, 10 Mar 2026 09:59:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/synthetic-membraneless-organelles-for-biotechnology-applications-reviewed-nanowerk/</guid></item><item><title><![CDATA[Roche breast cancer drug falls short of expectations (for now) - European Biotechnology Magazine]]></title><description><![CDATA[Roche breast cancer drug falls short of expectations (for now)&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/roche-breast-cancer-drug-falls-short-of-expectations-for-now-european-biotechnology-magazine/</link><pubDate>Tue, 10 Mar 2026 08:29:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/roche-breast-cancer-drug-falls-short-of-expectations-for-now-european-biotechnology-magazine/</guid></item><item><title><![CDATA[AI in Biotechnology Market Size, Share, Growth | CAGR of 19.3% - Market.us Media]]></title><description><![CDATA[AI in Biotechnology Market Size, Share, Growth | CAGR of 19.3%&nbsp;&nbsp;Market.us Media]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-market-size-share-growth-cagr-of-193-marketus-media/</link><pubDate>Tue, 10 Mar 2026 06:38:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-market-size-share-growth-cagr-of-193-marketus-media/</guid></item><item><title><![CDATA[Giving circular value to one of the toughest waste streams with biotechnology - Circular Online]]></title><description><![CDATA[Giving circular value to one of the toughest waste streams with biotechnology&nbsp;&nbsp;Circular Online]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/giving-circular-value-to-one-of-the-toughest-waste-streams-with-biotechnology-circular-online/</link><pubDate>Mon, 09 Mar 2026 22:36:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/giving-circular-value-to-one-of-the-toughest-waste-streams-with-biotechnology-circular-online/</guid></item><item><title><![CDATA[LIXTE Biotechnology (LIXT) Advances Lead Compound in Tumor Immunogenicity Research - NewMediaWire]]></title><description><![CDATA[LIXTE Biotechnology (LIXT) Advances Lead Compound in Tumor Immunogenicity Research&nbsp;&nbsp;NewMediaWire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-lixt-advances-lead-compound-in-tumor-immunogenicity-research-newmediawire/</link><pubDate>Mon, 09 Mar 2026 21:51:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-lixt-advances-lead-compound-in-tumor-immunogenicity-research-newmediawire/</guid></item><item><title><![CDATA[Biotechnology company to invest $1.5 billion in Illinois plasma-processing plan - Capitol News Illinois]]></title><description><![CDATA[Biotechnology company to invest $1.5 billion in Illinois plasma-processing plan&nbsp;&nbsp;Capitol News Illinois]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-company-to-invest-15-billion-in-illinois-plasma-processing-plan-capitol-news-illinois/</link><pubDate>Mon, 09 Mar 2026 21:12:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-company-to-invest-15-billion-in-illinois-plasma-processing-plan-capitol-news-illinois/</guid></item><item><title><![CDATA[National Conference on Biotechnology &amp; Forensic Science held at GIS - lokmattimes.com]]></title><description><![CDATA[National Conference on Biotechnology &amp; Forensic Science held at GIS&nbsp;&nbsp;lokmattimes.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/national-conference-on-biotechnology-amp-forensic-science-held-at-gis-lokmattimescom/</link><pubDate>Mon, 09 Mar 2026 18:26:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/national-conference-on-biotechnology-amp-forensic-science-held-at-gis-lokmattimescom/</guid></item><item><title><![CDATA[Roche’s Gazyva posts strong Phase III lupus data - The Pharma Letter]]></title><description><![CDATA[Roche&rsquo;s Gazyva posts strong Phase III lupus data&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/roches-gazyva-posts-strong-phase-iii-lupus-data-the-pharma-letter/</link><pubDate>Mon, 09 Mar 2026 14:24:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/roches-gazyva-posts-strong-phase-iii-lupus-data-the-pharma-letter/</guid></item><item><title><![CDATA[Biotechnology Market Outlook 2026-2033: Size, Demand Surge, - openPR.com]]></title><description><![CDATA[Biotechnology Market Outlook 2026-2033: Size, Demand Surge,&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-market-outlook-2026-2033-size-demand-surge-openprcom/</link><pubDate>Mon, 09 Mar 2026 12:50:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-market-outlook-2026-2033-size-demand-surge-openprcom/</guid></item><item><title><![CDATA[Rapport Therapeutics and Tenacia Biotechnology Announce - GlobeNewswire]]></title><description><![CDATA[Rapport Therapeutics and Tenacia Biotechnology Announce&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/rapport-therapeutics-and-tenacia-biotechnology-announce-globenewswire/</link><pubDate>Mon, 09 Mar 2026 12:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/rapport-therapeutics-and-tenacia-biotechnology-announce-globenewswire/</guid></item><item><title><![CDATA[Turning biotechnology into hope for farmers - Bangkok Post]]></title><description><![CDATA[Turning biotechnology into hope for farmers&nbsp;&nbsp;Bangkok Post]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/turning-biotechnology-into-hope-for-farmers-bangkok-post/</link><pubDate>Sun, 08 Mar 2026 19:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/turning-biotechnology-into-hope-for-farmers-bangkok-post/</guid></item><item><title><![CDATA[Why Vir Biotechnology (VIR) Is Up 5.1% After Astellas Cancer Deal And Equity Raise News - simplywall.st]]></title><description><![CDATA[Why Vir Biotechnology (VIR) Is Up 5.1% After Astellas Cancer Deal And Equity Raise News&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/why-vir-biotechnology-vir-is-up-51-after-astellas-cancer-deal-and-equity-raise-news-simplywallst/</link><pubDate>Sun, 08 Mar 2026 16:22:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/why-vir-biotechnology-vir-is-up-51-after-astellas-cancer-deal-and-equity-raise-news-simplywallst/</guid></item><item><title><![CDATA[Green Fresh Biotechnology Issues Profit Warning for FY2025 as Net Profit Expected to Drop Significantly 1 - Minichart]]></title><description><![CDATA[Green Fresh Biotechnology Issues Profit Warning for FY2025 as Net Profit Expected to Drop Significantly 1&nbsp;&nbsp;Minichart]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/green-fresh-biotechnology-issues-profit-warning-for-fy2025-as-net-profit-expected-to-drop-significantly-1-minichart/</link><pubDate>Sat, 07 Mar 2026 04:47:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/green-fresh-biotechnology-issues-profit-warning-for-fy2025-as-net-profit-expected-to-drop-significantly-1-minichart/</guid></item><item><title><![CDATA[Can Igene Biotechnology Inc. Preferred Security stock deliver consistent earnings growth - 2025 Institutional Moves &amp; Precise Swing Trade Alerts - Na&icirc;tre et grandir]]></title><description><![CDATA[Can Igene Biotechnology Inc. Preferred Security stock deliver consistent earnings growth - 2025 Institutional Moves &amp; Precise Swing Trade Alerts&nbsp;&nbsp;Na&icirc;tre et grandir]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/can-igene-biotechnology-inc-preferred-security-stock-deliver-consistent-earnings-growth-2025-institutional-moves-amp-precise-swing-trade-alerts-naicirctre-et-grandir/</link><pubDate>Sat, 07 Mar 2026 03:51:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/can-igene-biotechnology-inc-preferred-security-stock-deliver-consistent-earnings-growth-2025-institutional-moves-amp-precise-swing-trade-alerts-naicirctre-et-grandir/</guid></item><item><title><![CDATA[Women at Gujarat Biotechnology University drive scientific research - Indiatimes]]></title><description><![CDATA[Women at Gujarat Biotechnology University drive scientific research&nbsp;&nbsp;Indiatimes]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/women-at-gujarat-biotechnology-university-drive-scientific-research-indiatimes/</link><pubDate>Sat, 07 Mar 2026 02:49:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/women-at-gujarat-biotechnology-university-drive-scientific-research-indiatimes/</guid></item><item><title><![CDATA[Amphastar Pharmaceuticals - Nanjing Pharmaceuticals enters supply agreement with Nanjing Letop Biotechnology on March 3 - SEC filing - marketscreener.com]]></title><description><![CDATA[Amphastar Pharmaceuticals - Nanjing Pharmaceuticals enters supply agreement with Nanjing Letop Biotechnology on March 3 - SEC filing&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/amphastar-pharmaceuticals-nanjing-pharmaceuticals-enters-supply-agreement-with-nanjing-letop-biotechnology-on-march-3-sec-filing-marketscreenercom/</link><pubDate>Fri, 06 Mar 2026 22:52:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/amphastar-pharmaceuticals-nanjing-pharmaceuticals-enters-supply-agreement-with-nanjing-letop-biotechnology-on-march-3-sec-filing-marketscreenercom/</guid></item><item><title><![CDATA[Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing - TradingView]]></title><description><![CDATA[Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing&nbsp;&nbsp;TradingView]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/amphastar-pharmaceuticals-nanjing-pharmaceuticals-enters-supply-agreement-with-nanjing-letop-biotechnology-on-march-3-sec-filing-tradingview/</link><pubDate>Fri, 06 Mar 2026 22:50:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/amphastar-pharmaceuticals-nanjing-pharmaceuticals-enters-supply-agreement-with-nanjing-letop-biotechnology-on-march-3-sec-filing-tradingview/</guid></item><item><title><![CDATA[TD Cowen reiterates Buy rating on Sana Biotechnology stock - Investing.com India]]></title><description><![CDATA[TD Cowen reiterates Buy rating on Sana Biotechnology stock&nbsp;&nbsp;Investing.com India]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/td-cowen-reiterates-buy-rating-on-sana-biotechnology-stock-investingcom-india/</link><pubDate>Fri, 06 Mar 2026 22:32:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/td-cowen-reiterates-buy-rating-on-sana-biotechnology-stock-investingcom-india/</guid></item><item><title><![CDATA[Sana Biotechnology: Advancing T1D and In Vivo CAR-T Programs with 2026 Catalysts and Solid Cash Runway Supporting Buy Rating - TipRanks]]></title><description><![CDATA[Sana Biotechnology: Advancing T1D and In Vivo CAR-T Programs with 2026 Catalysts and Solid Cash Runway Supporting Buy Rating&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-advancing-t1d-and-in-vivo-car-t-programs-with-2026-catalysts-and-solid-cash-runway-supporting-buy-rating-tipranks/</link><pubDate>Fri, 06 Mar 2026 19:15:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-advancing-t1d-and-in-vivo-car-t-programs-with-2026-catalysts-and-solid-cash-runway-supporting-buy-rating-tipranks/</guid></item><item><title><![CDATA[Women at Gujarat Biotechnology University drive scientific research - lokmattimes.com]]></title><description><![CDATA[Women at Gujarat Biotechnology University drive scientific research&nbsp;&nbsp;lokmattimes.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/women-at-gujarat-biotechnology-university-drive-scientific-research-lokmattimescom/</link><pubDate>Fri, 06 Mar 2026 13:40:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/women-at-gujarat-biotechnology-university-drive-scientific-research-lokmattimescom/</guid></item><item><title><![CDATA[Q1 EPS Estimate for Sana Biotechnology Lowered by Analyst - MarketBeat]]></title><description><![CDATA[Q1 EPS Estimate for Sana Biotechnology Lowered by Analyst&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/q1-eps-estimate-for-sana-biotechnology-lowered-by-analyst-marketbeat/</link><pubDate>Fri, 06 Mar 2026 13:18:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/q1-eps-estimate-for-sana-biotechnology-lowered-by-analyst-marketbeat/</guid></item><item><title><![CDATA[Biotechnology Services Market Is Going to Boom | Amgen • Genentech • Illumina - openPR.com]]></title><description><![CDATA[Biotechnology Services Market Is Going to Boom | Amgen &bull; Genentech &bull; Illumina&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-services-market-is-going-to-boom-amgen-genentech-illumina-openprcom/</link><pubDate>Fri, 06 Mar 2026 13:09:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-services-market-is-going-to-boom-amgen-genentech-illumina-openprcom/</guid></item><item><title><![CDATA[New CCO strengthens global business strategy - European Biotechnology Magazine]]></title><description><![CDATA[New CCO strengthens global business strategy&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/new-cco-strengthens-global-business-strategy-european-biotechnology-magazine/</link><pubDate>Fri, 06 Mar 2026 11:47:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/new-cco-strengthens-global-business-strategy-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Legend Strategy Completes Acquisition of 37.5% Stake in Beisheng Biotechnology - TipRanks]]></title><description><![CDATA[Legend Strategy Completes Acquisition of 37.5% Stake in Beisheng Biotechnology&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/legend-strategy-completes-acquisition-of-375-stake-in-beisheng-biotechnology-tipranks/</link><pubDate>Fri, 06 Mar 2026 09:39:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/legend-strategy-completes-acquisition-of-375-stake-in-beisheng-biotechnology-tipranks/</guid></item><item><title><![CDATA[Governing Biotechnology’s Dual-Use Security Dilemma - ORF Middle East]]></title><description><![CDATA[Governing Biotechnology&rsquo;s Dual-Use Security Dilemma&nbsp;&nbsp;ORF Middle East]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/governing-biotechnologys-dual-use-security-dilemma-orf-middle-east/</link><pubDate>Fri, 06 Mar 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/governing-biotechnologys-dual-use-security-dilemma-orf-middle-east/</guid></item><item><title><![CDATA[Eric A. Harwood, Ph.D. - Biotechnology and Life Sciences Practice Lawyer - Seattle, WA - Best Lawyers]]></title><description><![CDATA[Eric A. Harwood, Ph.D. - Biotechnology and Life Sciences Practice Lawyer - Seattle, WA&nbsp;&nbsp;Best Lawyers]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/eric-a-harwood-phd-biotechnology-and-life-sciences-practice-lawyer-seattle-wa-best-lawyers/</link><pubDate>Fri, 06 Mar 2026 06:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/eric-a-harwood-phd-biotechnology-and-life-sciences-practice-lawyer-seattle-wa-best-lawyers/</guid></item><item><title><![CDATA[FG Backs Safe Biotechnology For National Development - News Agency of Nigeria]]></title><description><![CDATA[FG Backs Safe Biotechnology For National Development&nbsp;&nbsp;News Agency of Nigeria]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/fg-backs-safe-biotechnology-for-national-development-news-agency-of-nigeria/</link><pubDate>Fri, 06 Mar 2026 01:50:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/fg-backs-safe-biotechnology-for-national-development-news-agency-of-nigeria/</guid></item><item><title><![CDATA[Sana Biotechnology (NASDAQ:SANA) Stock Price Down 9.7% After Analyst Downgrade - MarketBeat]]></title><description><![CDATA[Sana Biotechnology (NASDAQ:SANA) Stock Price Down 9.7% After Analyst Downgrade&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-nasdaqsana-stock-price-down-97-after-analyst-downgrade-marketbeat/</link><pubDate>Thu, 05 Mar 2026 21:16:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-nasdaqsana-stock-price-down-97-after-analyst-downgrade-marketbeat/</guid></item><item><title><![CDATA[HudsonAlpha Institute for Biotechnology highlights breakthrough research in diabetes, Huntington’s disease - Huntsville Business Journal]]></title><description><![CDATA[HudsonAlpha Institute for Biotechnology highlights breakthrough research in diabetes, Huntington&rsquo;s disease&nbsp;&nbsp;Huntsville Business Journal]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/hudsonalpha-institute-for-biotechnology-highlights-breakthrough-research-in-diabetes-huntingtons-disease-huntsville-business-journal/</link><pubDate>Thu, 05 Mar 2026 21:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/hudsonalpha-institute-for-biotechnology-highlights-breakthrough-research-in-diabetes-huntingtons-disease-huntsville-business-journal/</guid></item><item><title><![CDATA[Qing (Becky) Lin, Ph.D. - Biotechnology and Life Sciences Practice Lawyer - Seattle, WA - Best Lawyers]]></title><description><![CDATA[Qing (Becky) Lin, Ph.D. - Biotechnology and Life Sciences Practice Lawyer - Seattle, WA&nbsp;&nbsp;Best Lawyers]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/qing-becky-lin-phd-biotechnology-and-life-sciences-practice-lawyer-seattle-wa-best-lawyers/</link><pubDate>Thu, 05 Mar 2026 19:32:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/qing-becky-lin-phd-biotechnology-and-life-sciences-practice-lawyer-seattle-wa-best-lawyers/</guid></item><item><title><![CDATA[USITC Will Investigate State Support and Pricing Practices by Chinese Biotechnology Firms - The National Law Review]]></title><description><![CDATA[USITC Will Investigate State Support and Pricing Practices by Chinese Biotechnology Firms&nbsp;&nbsp;The National Law Review]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/usitc-will-investigate-state-support-and-pricing-practices-by-chinese-biotechnology-firms-the-national-law-review/</link><pubDate>Thu, 05 Mar 2026 18:49:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/usitc-will-investigate-state-support-and-pricing-practices-by-chinese-biotechnology-firms-the-national-law-review/</guid></item><item><title><![CDATA[USITC Launches Parallel § 332 Investigations Targeting China Trade Relations and Biotechnology Support - Morgan Lewis]]></title><description><![CDATA[USITC Launches Parallel &sect; 332 Investigations Targeting China Trade Relations and Biotechnology Support&nbsp;&nbsp;Morgan Lewis]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/usitc-launches-parallel-332-investigations-targeting-china-trade-relations-and-biotechnology-support-morgan-lewis/</link><pubDate>Thu, 05 Mar 2026 15:19:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/usitc-launches-parallel-332-investigations-targeting-china-trade-relations-and-biotechnology-support-morgan-lewis/</guid></item><item><title><![CDATA[Sana Biotechnology (NASDAQ:SANA) Cut to Hold at Zacks Research - MarketBeat]]></title><description><![CDATA[Sana Biotechnology (NASDAQ:SANA) Cut to Hold at Zacks Research&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-nasdaqsana-cut-to-hold-at-zacks-research-marketbeat/</link><pubDate>Thu, 05 Mar 2026 15:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-nasdaqsana-cut-to-hold-at-zacks-research-marketbeat/</guid></item><item><title><![CDATA[Is the Market Bullish or Bearish on MAIA Biotechnology Inc? - Benzinga]]></title><description><![CDATA[Is the Market Bullish or Bearish on MAIA Biotechnology Inc?&nbsp;&nbsp;Benzinga]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/is-the-market-bullish-or-bearish-on-maia-biotechnology-inc-benzinga/</link><pubDate>Thu, 05 Mar 2026 14:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/is-the-market-bullish-or-bearish-on-maia-biotechnology-inc-benzinga/</guid></item><item><title><![CDATA[How South San Francisco Became the Birthplace of Biotechnology - KQED]]></title><description><![CDATA[How South San Francisco Became the Birthplace of Biotechnology&nbsp;&nbsp;KQED]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/how-south-san-francisco-became-the-birthplace-of-biotechnology-kqed/</link><pubDate>Thu, 05 Mar 2026 12:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/how-south-san-francisco-became-the-birthplace-of-biotechnology-kqed/</guid></item><item><title><![CDATA[Citizens reiterates Sana Biotechnology stock rating on pipeline progress - Investing.com]]></title><description><![CDATA[Citizens reiterates Sana Biotechnology stock rating on pipeline progress&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/citizens-reiterates-sana-biotechnology-stock-rating-on-pipeline-progress-investingcom/</link><pubDate>Thu, 05 Mar 2026 11:44:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/citizens-reiterates-sana-biotechnology-stock-rating-on-pipeline-progress-investingcom/</guid></item><item><title><![CDATA[Vir Biotechnology Names CEO Marianne De Backer as President - TipRanks]]></title><description><![CDATA[Vir Biotechnology Names CEO Marianne De Backer as President&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-names-ceo-marianne-de-backer-as-president-tipranks/</link><pubDate>Wed, 04 Mar 2026 23:02:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-names-ceo-marianne-de-backer-as-president-tipranks/</guid></item><item><title><![CDATA[MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock - Yahoo Finance]]></title><description><![CDATA[MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-announces-closing-of-30-million-underwritten-public-offering-of-common-stock-yahoo-finance/</link><pubDate>Wed, 04 Mar 2026 22:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-announces-closing-of-30-million-underwritten-public-offering-of-common-stock-yahoo-finance/</guid></item><item><title><![CDATA[Sana Biotechnology Diabetes Data And CAR T Plans Shape Pipeline Outlook - simplywall.st]]></title><description><![CDATA[Sana Biotechnology Diabetes Data And CAR T Plans Shape Pipeline Outlook&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-diabetes-data-and-car-t-plans-shape-pipeline-outlook-simplywallst/</link><pubDate>Wed, 04 Mar 2026 20:40:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-diabetes-data-and-car-t-plans-shape-pipeline-outlook-simplywallst/</guid></item><item><title><![CDATA[CSUCI Students Gain Hands-On Industry Experience Through New Biotechnology Internship Pilot - edhat]]></title><description><![CDATA[CSUCI Students Gain Hands-On Industry Experience Through New Biotechnology Internship Pilot&nbsp;&nbsp;edhat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/csuci-students-gain-hands-on-industry-experience-through-new-biotechnology-internship-pilot-edhat/</link><pubDate>Wed, 04 Mar 2026 19:12:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/csuci-students-gain-hands-on-industry-experience-through-new-biotechnology-internship-pilot-edhat/</guid></item><item><title><![CDATA[Sana Biotechnology (SANA) Q4 2025 Financial Results: Net Loss and Analyst Outlook - News and Statistics - IndexBox]]></title><description><![CDATA[Sana Biotechnology (SANA) Q4 2025 Financial Results: Net Loss and Analyst Outlook - News and Statistics&nbsp;&nbsp;IndexBox]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-q4-2025-financial-results-net-loss-and-analyst-outlook-news-and-statistics-indexbox/</link><pubDate>Wed, 04 Mar 2026 17:11:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-q4-2025-financial-results-net-loss-and-analyst-outlook-news-and-statistics-indexbox/</guid></item><item><title><![CDATA[Candid lists via Rallybio reverse merger, adds $505m financing - The Pharma Letter]]></title><description><![CDATA[Candid lists via Rallybio reverse merger, adds $505m financing&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/candid-lists-via-rallybio-reverse-merger-adds-505m-financing-the-pharma-letter/</link><pubDate>Wed, 04 Mar 2026 16:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/candid-lists-via-rallybio-reverse-merger-adds-505m-financing-the-pharma-letter/</guid></item><item><title><![CDATA[Sana Biotechnology (NASDAQ:SANA) Price Target Lowered to $7.00 at HC Wainwright - MarketBeat]]></title><description><![CDATA[Sana Biotechnology (NASDAQ:SANA) Price Target Lowered to $7.00 at HC Wainwright&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-nasdaqsana-price-target-lowered-to-700-at-hc-wainwright-marketbeat/</link><pubDate>Wed, 04 Mar 2026 14:48:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-nasdaqsana-price-target-lowered-to-700-at-hc-wainwright-marketbeat/</guid></item><item><title><![CDATA[Sana Biotechnology stock price target lowered to $7 by H.C. Wainwright - Investing.com]]></title><description><![CDATA[Sana Biotechnology stock price target lowered to $7 by H.C. Wainwright&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-stock-price-target-lowered-to-7-by-hc-wainwright-investingcom/</link><pubDate>Wed, 04 Mar 2026 14:20:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-stock-price-target-lowered-to-7-by-hc-wainwright-investingcom/</guid></item><item><title><![CDATA[Sana Biotechnology: Emerging Clinical Validation and 2026 Pivotal Milestones Underpin Buy Rating - TipRanks]]></title><description><![CDATA[Sana Biotechnology: Emerging Clinical Validation and 2026 Pivotal Milestones Underpin Buy Rating&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-emerging-clinical-validation-and-2026-pivotal-milestones-underpin-buy-rating-tipranks/</link><pubDate>Wed, 04 Mar 2026 13:41:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-emerging-clinical-validation-and-2026-pivotal-milestones-underpin-buy-rating-tipranks/</guid></item><item><title><![CDATA[Assessing Vir Biotechnology (VIR) Valuation After Astellas Alliance And VIR-5500 Phase 1 Update - simplywall.st]]></title><description><![CDATA[Assessing Vir Biotechnology (VIR) Valuation After Astellas Alliance And VIR-5500 Phase 1 Update&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/assessing-vir-biotechnology-vir-valuation-after-astellas-alliance-and-vir-5500-phase-1-update-simplywallst/</link><pubDate>Wed, 04 Mar 2026 13:33:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/assessing-vir-biotechnology-vir-valuation-after-astellas-alliance-and-vir-5500-phase-1-update-simplywallst/</guid></item><item><title><![CDATA[Kyowa Kirin halts rocatinlimab trials after safety signal - The Pharma Letter]]></title><description><![CDATA[Kyowa Kirin halts rocatinlimab trials after safety signal&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/kyowa-kirin-halts-rocatinlimab-trials-after-safety-signal-the-pharma-letter/</link><pubDate>Wed, 04 Mar 2026 11:40:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/kyowa-kirin-halts-rocatinlimab-trials-after-safety-signal-the-pharma-letter/</guid></item><item><title><![CDATA[Vir Biotechnology Presents Phase I Data on Bispecific Antibody for mCRPC as Astellas Pharma Joins Collaboration - geneonline.com]]></title><description><![CDATA[Vir Biotechnology Presents Phase I Data on Bispecific Antibody for mCRPC as Astellas Pharma Joins Collaboration&nbsp;&nbsp;geneonline.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-presents-phase-i-data-on-bispecific-antibody-for-mcrpc-as-astellas-pharma-joins-collaboration-geneonlinecom/</link><pubDate>Wed, 04 Mar 2026 09:34:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-presents-phase-i-data-on-bispecific-antibody-for-mcrpc-as-astellas-pharma-joins-collaboration-geneonlinecom/</guid></item><item><title><![CDATA[Sana Biotechnology reports Q4 EPS (16c), consensus (13c) - TipRanks]]></title><description><![CDATA[Sana Biotechnology reports Q4 EPS (16c), consensus (13c)&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-reports-q4-eps-16c-consensus-13c-tipranks/</link><pubDate>Wed, 04 Mar 2026 02:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-reports-q4-eps-16c-consensus-13c-tipranks/</guid></item><item><title><![CDATA[Sana Biotechnology (NASDAQ: SANA) files ATM to raise up to $150M with TD Cowen - Stock Titan]]></title><description><![CDATA[Sana Biotechnology (NASDAQ: SANA) files ATM to raise up to $150M with TD Cowen&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-nasdaq-sana-files-atm-to-raise-up-to-150m-with-td-cowen-stock-titan/</link><pubDate>Tue, 03 Mar 2026 23:20:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-nasdaq-sana-files-atm-to-raise-up-to-150m-with-td-cowen-stock-titan/</guid></item><item><title><![CDATA[Sana Biotechnology Updates ATM Program to Support Development - TipRanks]]></title><description><![CDATA[Sana Biotechnology Updates ATM Program to Support Development&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-updates-atm-program-to-support-development-tipranks/</link><pubDate>Tue, 03 Mar 2026 22:33:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-updates-atm-program-to-support-development-tipranks/</guid></item><item><title><![CDATA[Earnings Flash (SANA) Sana Biotechnology, Inc. Posts Q4 Adjusted Loss $0.16 per Share, vs. FactSet Est of $-0.14 - marketscreener.com]]></title><description><![CDATA[Earnings Flash (SANA) Sana Biotechnology, Inc. Posts Q4 Adjusted Loss $0.16 per Share, vs. FactSet Est of $-0.14&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-flash-sana-sana-biotechnology-inc-posts-q4-adjusted-loss-016-per-share-vs-factset-est-of-014-marketscreenercom/</link><pubDate>Tue, 03 Mar 2026 22:15:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-flash-sana-sana-biotechnology-inc-posts-q4-adjusted-loss-016-per-share-vs-factset-est-of-014-marketscreenercom/</guid></item><item><title><![CDATA[Going concern risk and focused pipeline at Sana Biotechnology (NASDAQ: SANA) - Stock Titan]]></title><description><![CDATA[Going concern risk and focused pipeline at Sana Biotechnology (NASDAQ: SANA)&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/going-concern-risk-and-focused-pipeline-at-sana-biotechnology-nasdaq-sana-stock-titan/</link><pubDate>Tue, 03 Mar 2026 22:14:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/going-concern-risk-and-focused-pipeline-at-sana-biotechnology-nasdaq-sana-stock-titan/</guid></item><item><title><![CDATA[Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates - Yahoo Finance]]></title><description><![CDATA[Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-reports-fourth-quarter-and-full-year-2025-financial-results-and-business-updates-yahoo-finance/</link><pubDate>Tue, 03 Mar 2026 22:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-reports-fourth-quarter-and-full-year-2025-financial-results-and-business-updates-yahoo-finance/</guid></item><item><title><![CDATA[Anbio Biotechnology: Improved Margins, Still Priced For Growth That Isn't Showing Up - Seeking Alpha]]></title><description><![CDATA[Anbio Biotechnology: Improved Margins, Still Priced For Growth That Isn't Showing Up&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-improved-margins-still-priced-for-growth-that-isnt-showing-up-seeking-alpha/</link><pubDate>Tue, 03 Mar 2026 20:50:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-improved-margins-still-priced-for-growth-that-isnt-showing-up-seeking-alpha/</guid></item><item><title><![CDATA[PDS Biotechnology receives Nasdaq notice for minimum bid price deficiency - Investing.com Nigeria]]></title><description><![CDATA[PDS Biotechnology receives Nasdaq notice for minimum bid price deficiency&nbsp;&nbsp;Investing.com Nigeria]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-receives-nasdaq-notice-for-minimum-bid-price-deficiency-investingcom-nigeria/</link><pubDate>Tue, 03 Mar 2026 19:03:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-receives-nasdaq-notice-for-minimum-bid-price-deficiency-investingcom-nigeria/</guid></item><item><title><![CDATA[Australian consortium to develop quantum biotechnology platform to transform Alzheimer's treatment discovery - The University of Melbourne]]></title><description><![CDATA[Australian consortium to develop quantum biotechnology platform to transform Alzheimer's treatment discovery&nbsp;&nbsp;The University of Melbourne]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/australian-consortium-to-develop-quantum-biotechnology-platform-to-transform-alzheimers-treatment-discovery-the-university-of-melbourne/</link><pubDate>Tue, 03 Mar 2026 14:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/australian-consortium-to-develop-quantum-biotechnology-platform-to-transform-alzheimers-treatment-discovery-the-university-of-melbourne/</guid></item><item><title><![CDATA[Sharing big data for sustainable agri-food innovation - Nature]]></title><description><![CDATA[Sharing big data for sustainable agri-food innovation&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sharing-big-data-for-sustainable-agri-food-innovation-nature/</link><pubDate>Tue, 03 Mar 2026 13:23:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sharing-big-data-for-sustainable-agri-food-innovation-nature/</guid></item><item><title><![CDATA[MAIA Biotechnology shares drop 29% on discounted stock offering By Investing.com - Investing.com South Africa]]></title><description><![CDATA[MAIA Biotechnology shares drop 29% on discounted stock offering By Investing.com&nbsp;&nbsp;Investing.com South Africa]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-shares-drop-29-on-discounted-stock-offering-by-investingcom-investingcom-south-africa/</link><pubDate>Tue, 03 Mar 2026 12:51:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-shares-drop-29-on-discounted-stock-offering-by-investingcom-investingcom-south-africa/</guid></item><item><title><![CDATA[Agriculture Biotechnology Industry Research and Global - GlobeNewswire]]></title><description><![CDATA[Agriculture Biotechnology Industry Research and Global&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/agriculture-biotechnology-industry-research-and-global-globenewswire/</link><pubDate>Tue, 03 Mar 2026 10:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/agriculture-biotechnology-industry-research-and-global-globenewswire/</guid></item><item><title><![CDATA[Insilico Pilots the Automated AI-driven Partnering System for Biotechnology Assets and AI Platforms - Insilico Medicine]]></title><description><![CDATA[Insilico Pilots the Automated AI-driven Partnering System for Biotechnology Assets and AI Platforms&nbsp;&nbsp;Insilico Medicine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/insilico-pilots-the-automated-ai-driven-partnering-system-for-biotechnology-assets-and-ai-platforms-insilico-medicine/</link><pubDate>Tue, 03 Mar 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/insilico-pilots-the-automated-ai-driven-partnering-system-for-biotechnology-assets-and-ai-platforms-insilico-medicine/</guid></item><item><title><![CDATA[MAIA Biotechnology Prices $30 Mln Public Offering Of Shares At $1.50/shr; Stock Down - Nasdaq]]></title><description><![CDATA[MAIA Biotechnology Prices $30 Mln Public Offering Of Shares At $1.50/shr; Stock Down&nbsp;&nbsp;Nasdaq]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-prices-30-mln-public-offering-of-shares-at-150shr-stock-down-nasdaq/</link><pubDate>Tue, 03 Mar 2026 07:03:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-prices-30-mln-public-offering-of-shares-at-150shr-stock-down-nasdaq/</guid></item><item><title><![CDATA[MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock - The Manila Times]]></title><description><![CDATA[MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock&nbsp;&nbsp;The Manila Times]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-announces-pricing-of-30-million-underwritten-public-offering-of-common-stock-the-manila-times/</link><pubDate>Tue, 03 Mar 2026 05:03:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-announces-pricing-of-30-million-underwritten-public-offering-of-common-stock-the-manila-times/</guid></item><item><title><![CDATA[Cancer immunotherapy firm MAIA raises $30M for trials, costs - Stock Titan]]></title><description><![CDATA[Cancer immunotherapy firm MAIA raises $30M for trials, costs&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cancer-immunotherapy-firm-maia-raises-30m-for-trials-costs-stock-titan/</link><pubDate>Tue, 03 Mar 2026 04:48:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cancer-immunotherapy-firm-maia-raises-30m-for-trials-costs-stock-titan/</guid></item><item><title><![CDATA[MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock - Yahoo Finance]]></title><description><![CDATA[MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-announces-pricing-of-30-million-underwritten-public-offering-of-common-stock-yahoo-finance/</link><pubDate>Tue, 03 Mar 2026 04:45:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-announces-pricing-of-30-million-underwritten-public-offering-of-common-stock-yahoo-finance/</guid></item><item><title><![CDATA[Vir Biotechnology at TD Cowen Conference: Oncology Ambitions - Investing.com]]></title><description><![CDATA[Vir Biotechnology at TD Cowen Conference: Oncology Ambitions&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-at-td-cowen-conference-oncology-ambitions-investingcom/</link><pubDate>Tue, 03 Mar 2026 01:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-at-td-cowen-conference-oncology-ambitions-investingcom/</guid></item><item><title><![CDATA[RAPT Therapeutics, Inc.(NasdaqGM:RAPT) dropped from S&amp;P Biotechnology Select Industry Index - marketscreener.com]]></title><description><![CDATA[RAPT Therapeutics, Inc.(NasdaqGM:RAPT) dropped from S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/rapt-therapeutics-incnasdaqgmrapt-dropped-from-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Tue, 03 Mar 2026 01:23:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/rapt-therapeutics-incnasdaqgmrapt-dropped-from-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[Avidity Biosciences, Inc.(NasdaqGM:RNAM) dropped from S&amp;P Biotechnology Select Industry Index - marketscreener.com]]></title><description><![CDATA[Avidity Biosciences, Inc.(NasdaqGM:RNAM) dropped from S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/avidity-biosciences-incnasdaqgmrnam-dropped-from-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Tue, 03 Mar 2026 01:23:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/avidity-biosciences-incnasdaqgmrnam-dropped-from-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[Avecho Biotechnology sears crucial milestone in Phase 3 insomnia trial - BiotechDispatch]]></title><description><![CDATA[Avecho Biotechnology sears crucial milestone in Phase 3 insomnia trial&nbsp;&nbsp;BiotechDispatch]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/avecho-biotechnology-sears-crucial-milestone-in-phase-3-insomnia-trial-biotechdispatch/</link><pubDate>Tue, 03 Mar 2026 00:41:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/avecho-biotechnology-sears-crucial-milestone-in-phase-3-insomnia-trial-biotechdispatch/</guid></item><item><title><![CDATA[Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB) - The Wall Street Transcript]]></title><description><![CDATA[Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)&nbsp;&nbsp;The Wall Street Transcript]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/interview-with-the-president-and-ceo-pds-biotechnology-corporation-nasdaqpdsb-the-wall-street-transcript/</link><pubDate>Tue, 03 Mar 2026 00:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/interview-with-the-president-and-ceo-pds-biotechnology-corporation-nasdaqpdsb-the-wall-street-transcript/</guid></item><item><title><![CDATA[MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times]]></title><description><![CDATA[MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants&nbsp;&nbsp;The Manila Times]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-announces-proposed-underwritten-public-offering-of-common-stock-and-pre-funded-warrants-the-manila-times/</link><pubDate>Mon, 02 Mar 2026 23:02:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-announces-proposed-underwritten-public-offering-of-common-stock-and-pre-funded-warrants-the-manila-times/</guid></item><item><title><![CDATA[MAIA Biotechnology (NYSE: MAIA) offers common stock and pre-funded warrants - Stock Titan]]></title><description><![CDATA[MAIA Biotechnology (NYSE: MAIA) offers common stock and pre-funded warrants&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-nyse-maia-offers-common-stock-and-pre-funded-warrants-stock-titan/</link><pubDate>Mon, 02 Mar 2026 23:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-nyse-maia-offers-common-stock-and-pre-funded-warrants-stock-titan/</guid></item><item><title><![CDATA[MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants - Yahoo Finance]]></title><description><![CDATA[MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-announces-proposed-underwritten-public-offering-of-common-stock-and-pre-funded-warrants-yahoo-finance/</link><pubDate>Mon, 02 Mar 2026 23:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-announces-proposed-underwritten-public-offering-of-common-stock-and-pre-funded-warrants-yahoo-finance/</guid></item><item><title><![CDATA[Cancer immunotherapy developer MAIA plans stock sale to fund trials - Stock Titan]]></title><description><![CDATA[Cancer immunotherapy developer MAIA plans stock sale to fund trials&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cancer-immunotherapy-developer-maia-plans-stock-sale-to-fund-trials-stock-titan/</link><pubDate>Mon, 02 Mar 2026 23:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cancer-immunotherapy-developer-maia-plans-stock-sale-to-fund-trials-stock-titan/</guid></item><item><title><![CDATA[LIXTE Biotechnology (NASDAQ: LIXT) Appoints Sidney Braun as CEO of Liora Technologies Europe Subsidiary - Digital Journal]]></title><description><![CDATA[LIXTE Biotechnology (NASDAQ: LIXT) Appoints Sidney Braun as CEO of Liora Technologies Europe Subsidiary&nbsp;&nbsp;Digital Journal]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-nasdaq-lixt-appoints-sidney-braun-as-ceo-of-liora-technologies-europe-subsidiary-digital-journal/</link><pubDate>Mon, 02 Mar 2026 21:56:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-nasdaq-lixt-appoints-sidney-braun-as-ceo-of-liora-technologies-europe-subsidiary-digital-journal/</guid></item><item><title><![CDATA[Boosting Crops with Biotechnology - nsf.gov]]></title><description><![CDATA[Boosting Crops with Biotechnology&nbsp;&nbsp;nsf.gov]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/boosting-crops-with-biotechnology-nsfgov/</link><pubDate>Mon, 02 Mar 2026 18:40:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/boosting-crops-with-biotechnology-nsfgov/</guid></item><item><title><![CDATA[Boosting Crops with Biotechnology - National Science Foundation (.gov)]]></title><description><![CDATA[Boosting Crops with Biotechnology&nbsp;&nbsp;National Science Foundation (.gov)]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/boosting-crops-with-biotechnology-national-science-foundation-gov/</link><pubDate>Mon, 02 Mar 2026 18:40:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/boosting-crops-with-biotechnology-national-science-foundation-gov/</guid></item><item><title><![CDATA[Nautilus Biotechnology names Amber Faust as Vice President of Sales to drive proteomics expansion - Traders Union]]></title><description><![CDATA[Nautilus Biotechnology names Amber Faust as Vice President of Sales to drive proteomics expansion&nbsp;&nbsp;Traders Union]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-names-amber-faust-as-vice-president-of-sales-to-drive-proteomics-expansion-traders-union/</link><pubDate>Mon, 02 Mar 2026 17:46:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-names-amber-faust-as-vice-president-of-sales-to-drive-proteomics-expansion-traders-union/</guid></item><item><title><![CDATA[Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales - BioSpace]]></title><description><![CDATA[Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales&nbsp;&nbsp;BioSpace]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-appoints-proteomics-commercial-leader-amber-faust-as-vice-president-of-sales-biospace/</link><pubDate>Mon, 02 Mar 2026 16:49:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-appoints-proteomics-commercial-leader-amber-faust-as-vice-president-of-sales-biospace/</guid></item><item><title><![CDATA[Pfizer withdraws Zumrad EMA filing - The Pharma Letter]]></title><description><![CDATA[Pfizer withdraws Zumrad EMA filing&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pfizer-withdraws-zumrad-ema-filing-the-pharma-letter/</link><pubDate>Mon, 02 Mar 2026 16:26:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pfizer-withdraws-zumrad-ema-filing-the-pharma-letter/</guid></item><item><title><![CDATA[Vir Biotechnology closes $172.5 million public offering of common stock - Investing.com]]></title><description><![CDATA[Vir Biotechnology closes $172.5 million public offering of common stock&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-closes-1725-million-public-offering-of-common-stock-investingcom/</link><pubDate>Mon, 02 Mar 2026 15:37:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-closes-1725-million-public-offering-of-common-stock-investingcom/</guid></item><item><title><![CDATA[Vir Biotechnology Raises Capital Through Public Stock Offering - TipRanks]]></title><description><![CDATA[Vir Biotechnology Raises Capital Through Public Stock Offering&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-raises-capital-through-public-stock-offering-tipranks/</link><pubDate>Mon, 02 Mar 2026 15:28:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-raises-capital-through-public-stock-offering-tipranks/</guid></item><item><title><![CDATA[Vir Biotechnology completes $172.5M follow-on offering, issues 20.29M shares - TradingView]]></title><description><![CDATA[Vir Biotechnology completes $172.5M follow-on offering, issues 20.29M shares&nbsp;&nbsp;TradingView]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-completes-1725m-follow-on-offering-issues-2029m-shares-tradingview/</link><pubDate>Mon, 02 Mar 2026 15:03:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-completes-1725m-follow-on-offering-issues-2029m-shares-tradingview/</guid></item><item><title><![CDATA[Nautilus Biotechnology appoints proteomics commercial leader Amber Faust as vice president of sales - marketscreener.com]]></title><description><![CDATA[Nautilus Biotechnology appoints proteomics commercial leader Amber Faust as vice president of sales&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-appoints-proteomics-commercial-leader-amber-faust-as-vice-president-of-sales-marketscreenercom/</link><pubDate>Mon, 02 Mar 2026 14:26:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-appoints-proteomics-commercial-leader-amber-faust-as-vice-president-of-sales-marketscreenercom/</guid></item><item><title><![CDATA[Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales - The Manila Times]]></title><description><![CDATA[Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales&nbsp;&nbsp;The Manila Times]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-appoints-proteomics-commercial-leader-amber-faust-as-vice-president-of-sales-the-manila-times/</link><pubDate>Mon, 02 Mar 2026 14:09:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-appoints-proteomics-commercial-leader-amber-faust-as-vice-president-of-sales-the-manila-times/</guid></item><item><title><![CDATA[Sales veteran joins Nautilus to push single-molecule proteomics into labs - Stock Titan]]></title><description><![CDATA[Sales veteran joins Nautilus to push single-molecule proteomics into labs&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sales-veteran-joins-nautilus-to-push-single-molecule-proteomics-into-labs-stock-titan/</link><pubDate>Mon, 02 Mar 2026 14:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sales-veteran-joins-nautilus-to-push-single-molecule-proteomics-into-labs-stock-titan/</guid></item><item><title><![CDATA[UK Biotechnology Landscape and FTSE 350 Exposure Through ONT - Kalkine Media]]></title><description><![CDATA[UK Biotechnology Landscape and FTSE 350 Exposure Through ONT&nbsp;&nbsp;Kalkine Media]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/uk-biotechnology-landscape-and-ftse-350-exposure-through-ont-kalkine-media/</link><pubDate>Mon, 02 Mar 2026 13:46:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/uk-biotechnology-landscape-and-ftse-350-exposure-through-ont-kalkine-media/</guid></item><item><title><![CDATA[AI in Biotechnology Market Research and Global Forecast Report 2025-2035: Opportunities Surge Amid Predictive Modeling, Healthcare Breakthroughs and Agricultural, Environmental Advancements - Yahoo Finance]]></title><description><![CDATA[AI in Biotechnology Market Research and Global Forecast Report 2025-2035: Opportunities Surge Amid Predictive Modeling, Healthcare Breakthroughs and Agricultural, Environmental Advancements&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-market-research-and-global-forecast-report-2025-2035-opportunities-surge-amid-predictive-modeling-healthcare-breakthroughs-and-agricultural-environmental-advancements-yahoo-finance/</link><pubDate>Mon, 02 Mar 2026 13:19:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-market-research-and-global-forecast-report-2025-2035-opportunities-surge-amid-predictive-modeling-healthcare-breakthroughs-and-agricultural-environmental-advancements-yahoo-finance/</guid></item><item><title><![CDATA[AI in Biotechnology Market Research and Global Forecast - GlobeNewswire]]></title><description><![CDATA[AI in Biotechnology Market Research and Global Forecast&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-market-research-and-global-forecast-globenewswire/</link><pubDate>Mon, 02 Mar 2026 13:19:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-market-research-and-global-forecast-globenewswire/</guid></item><item><title><![CDATA[Generate IPO raises $400 million but shares sink - The Pharma Letter]]></title><description><![CDATA[Generate IPO raises $400 million but shares sink&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/generate-ipo-raises-400-million-but-shares-sink-the-pharma-letter/</link><pubDate>Mon, 02 Mar 2026 11:28:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/generate-ipo-raises-400-million-but-shares-sink-the-pharma-letter/</guid></item><item><title><![CDATA[UK Biotechnology Market Size to Reach USD 41.47 Billion by 2033, Growing at 7.22% CAGR - openPR.com]]></title><description><![CDATA[UK Biotechnology Market Size to Reach USD 41.47 Billion by 2033, Growing at 7.22% CAGR&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/uk-biotechnology-market-size-to-reach-usd-4147-billion-by-2033-growing-at-722-cagr-openprcom/</link><pubDate>Mon, 02 Mar 2026 10:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/uk-biotechnology-market-size-to-reach-usd-4147-billion-by-2033-growing-at-722-cagr-openprcom/</guid></item><item><title><![CDATA[India's Leap in Biotechnology: New cGMP Facility and National Facility for Recombinant Cells Unveiled - Devdiscourse]]></title><description><![CDATA[India's Leap in Biotechnology: New cGMP Facility and National Facility for Recombinant Cells Unveiled&nbsp;&nbsp;Devdiscourse]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/indias-leap-in-biotechnology-new-cgmp-facility-and-national-facility-for-recombinant-cells-unveiled-devdiscourse/</link><pubDate>Sun, 01 Mar 2026 04:56:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/indias-leap-in-biotechnology-new-cgmp-facility-and-national-facility-for-recombinant-cells-unveiled-devdiscourse/</guid></item><item><title><![CDATA[Artificial Intelligence Biotechnology Market Next Big Thing | Major Giants Healx, Cyclica, Iktos - openPR.com]]></title><description><![CDATA[Artificial Intelligence Biotechnology Market Next Big Thing | Major Giants Healx, Cyclica, Iktos&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/artificial-intelligence-biotechnology-market-next-big-thing-major-giants-healx-cyclica-iktos-openprcom/</link><pubDate>Sat, 28 Feb 2026 18:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/artificial-intelligence-biotechnology-market-next-big-thing-major-giants-healx-cyclica-iktos-openprcom/</guid></item><item><title><![CDATA[Russia Embraces Biotechnology As An Economic Pillar &ndash; Putin Speech - russia's pivot to asia]]></title><description><![CDATA[Russia Embraces Biotechnology As An Economic Pillar &ndash; Putin Speech&nbsp;&nbsp;russia's pivot to asia]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/russia-embraces-biotechnology-as-an-economic-pillar-ndash-putin-speech-russias-pivot-to-asia/</link><pubDate>Sat, 28 Feb 2026 15:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/russia-embraces-biotechnology-as-an-economic-pillar-ndash-putin-speech-russias-pivot-to-asia/</guid></item><item><title><![CDATA[Sana Biotechnology, Inc. (SANA): A Bull Case Theory - Yahoo Finance]]></title><description><![CDATA[Sana Biotechnology, Inc. (SANA): A Bull Case Theory&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-inc-sana-a-bull-case-theory-yahoo-finance/</link><pubDate>Sat, 28 Feb 2026 14:09:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-inc-sana-a-bull-case-theory-yahoo-finance/</guid></item><item><title><![CDATA[Puma Biotechnology (PBYI) Margin Resilience Tests Bearish Earnings Forecasts In FY 2025 Results - simplywall.st]]></title><description><![CDATA[Puma Biotechnology (PBYI) Margin Resilience Tests Bearish Earnings Forecasts In FY 2025 Results&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-pbyi-margin-resilience-tests-bearish-earnings-forecasts-in-fy-2025-results-simplywallst/</link><pubDate>Sat, 28 Feb 2026 03:37:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-pbyi-margin-resilience-tests-bearish-earnings-forecasts-in-fy-2025-results-simplywallst/</guid></item><item><title><![CDATA[Why Vir Biotechnology (VIR) Is Up 20.2% After Astellas Deal And $150 Million Equity Raise - simplywall.st]]></title><description><![CDATA[Why Vir Biotechnology (VIR) Is Up 20.2% After Astellas Deal And $150 Million Equity Raise&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/why-vir-biotechnology-vir-is-up-202-after-astellas-deal-and-150-million-equity-raise-simplywallst/</link><pubDate>Fri, 27 Feb 2026 23:38:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/why-vir-biotechnology-vir-is-up-202-after-astellas-deal-and-150-million-equity-raise-simplywallst/</guid></item><item><title><![CDATA[Earendil strikes $885 million ADC alliance with WuXi XDC - The Pharma Letter]]></title><description><![CDATA[Earendil strikes $885 million ADC alliance with WuXi XDC&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/earendil-strikes-885-million-adc-alliance-with-wuxi-xdc-the-pharma-letter/</link><pubDate>Fri, 27 Feb 2026 13:10:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/earendil-strikes-885-million-adc-alliance-with-wuxi-xdc-the-pharma-letter/</guid></item><item><title><![CDATA[Vir Biotechnology to Participate in Upcoming March 2026 Investor Conferences - BioSpace]]></title><description><![CDATA[Vir Biotechnology to Participate in Upcoming March 2026 Investor Conferences&nbsp;&nbsp;BioSpace]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-to-participate-in-upcoming-march-2026-investor-conferences-biospace/</link><pubDate>Fri, 27 Feb 2026 07:17:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-to-participate-in-upcoming-march-2026-investor-conferences-biospace/</guid></item><item><title><![CDATA[Puma Biotechnology Q4 Earnings Call Highlights - MarketBeat]]></title><description><![CDATA[Puma Biotechnology Q4 Earnings Call Highlights&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-q4-earnings-call-highlights-marketbeat/</link><pubDate>Fri, 27 Feb 2026 07:15:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-q4-earnings-call-highlights-marketbeat/</guid></item><item><title><![CDATA[Vir Biotechnology (NASDAQ:VIR) EVP Verneuil Vanina De Sells 3,117 Shares - MarketBeat]]></title><description><![CDATA[Vir Biotechnology (NASDAQ:VIR) EVP Verneuil Vanina De Sells 3,117 Shares&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-evp-verneuil-vanina-de-sells-3117-shares-marketbeat/</link><pubDate>Fri, 27 Feb 2026 01:27:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-evp-verneuil-vanina-de-sells-3117-shares-marketbeat/</guid></item><item><title><![CDATA[Insider Selling: Vir Biotechnology (NASDAQ:VIR) EVP Sells 1,889 Shares of Stock - MarketBeat]]></title><description><![CDATA[Insider Selling: Vir Biotechnology (NASDAQ:VIR) EVP Sells 1,889 Shares of Stock&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/insider-selling-vir-biotechnology-nasdaqvir-evp-sells-1889-shares-of-stock-marketbeat/</link><pubDate>Fri, 27 Feb 2026 01:27:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/insider-selling-vir-biotechnology-nasdaqvir-evp-sells-1889-shares-of-stock-marketbeat/</guid></item><item><title><![CDATA[Insider Selling: Vir Biotechnology (NASDAQ:VIR) CFO Sells 1,634 Shares of Stock - MarketBeat]]></title><description><![CDATA[Insider Selling: Vir Biotechnology (NASDAQ:VIR) CFO Sells 1,634 Shares of Stock&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/insider-selling-vir-biotechnology-nasdaqvir-cfo-sells-1634-shares-of-stock-marketbeat/</link><pubDate>Fri, 27 Feb 2026 01:27:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/insider-selling-vir-biotechnology-nasdaqvir-cfo-sells-1634-shares-of-stock-marketbeat/</guid></item><item><title><![CDATA[Vir Biotechnology Announces Significant Common Stock Offering - TipRanks]]></title><description><![CDATA[Vir Biotechnology Announces Significant Common Stock Offering&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-announces-significant-common-stock-offering-tipranks/</link><pubDate>Fri, 27 Feb 2026 01:26:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-announces-significant-common-stock-offering-tipranks/</guid></item><item><title><![CDATA[Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results - PharmiWeb.com]]></title><description><![CDATA[Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results&nbsp;&nbsp;PharmiWeb.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-reports-fourth-quarter-and-full-year-2025-financial-results-pharmiwebcom/</link><pubDate>Fri, 27 Feb 2026 01:06:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-reports-fourth-quarter-and-full-year-2025-financial-results-pharmiwebcom/</guid></item><item><title><![CDATA[SRBT Shanrong Biotechnology (PNK) falls to $0.0004 26 Feb 2026: analyst view - Meyka]]></title><description><![CDATA[SRBT Shanrong Biotechnology (PNK) falls to $0.0004 26 Feb 2026: analyst view&nbsp;&nbsp;Meyka]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/srbt-shanrong-biotechnology-pnk-falls-to-00004-26-feb-2026-analyst-view-meyka/</link><pubDate>Fri, 27 Feb 2026 00:04:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/srbt-shanrong-biotechnology-pnk-falls-to-00004-26-feb-2026-analyst-view-meyka/</guid></item><item><title><![CDATA[Vir Biotechnology (NASDAQ:VIR) EVP Verneuil Vanina De Sells 13,700 Shares - MarketBeat]]></title><description><![CDATA[Vir Biotechnology (NASDAQ:VIR) EVP Verneuil Vanina De Sells 13,700 Shares&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-evp-verneuil-vanina-de-sells-13700-shares-marketbeat/</link><pubDate>Fri, 27 Feb 2026 00:03:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-evp-verneuil-vanina-de-sells-13700-shares-marketbeat/</guid></item><item><title><![CDATA[Nautilus Biotechnology Q4 Earnings Call Highlights - Yahoo Finance]]></title><description><![CDATA[Nautilus Biotechnology Q4 Earnings Call Highlights&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-q4-earnings-call-highlights-yahoo-finance/</link><pubDate>Thu, 26 Feb 2026 23:48:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-q4-earnings-call-highlights-yahoo-finance/</guid></item><item><title><![CDATA[Earnings call transcript: Puma Biotechnology Q4 2025 beats forecasts with strong revenue growth - Investing.com]]></title><description><![CDATA[Earnings call transcript: Puma Biotechnology Q4 2025 beats forecasts with strong revenue growth&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-call-transcript-puma-biotechnology-q4-2025-beats-forecasts-with-strong-revenue-growth-investingcom/</link><pubDate>Thu, 26 Feb 2026 23:46:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-call-transcript-puma-biotechnology-q4-2025-beats-forecasts-with-strong-revenue-growth-investingcom/</guid></item><item><title><![CDATA[Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView]]></title><description><![CDATA[Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results&nbsp;&nbsp;TradingView]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-reports-fourth-quarter-and-full-year-2025-financial-results-tradingview/</link><pubDate>Thu, 26 Feb 2026 22:35:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-reports-fourth-quarter-and-full-year-2025-financial-results-tradingview/</guid></item><item><title><![CDATA[Vir CEO lines up March talks at major U.S. healthcare investor events - Stock Titan]]></title><description><![CDATA[Vir CEO lines up March talks at major U.S. healthcare investor events&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-ceo-lines-up-march-talks-at-major-us-healthcare-investor-events-stock-titan/</link><pubDate>Thu, 26 Feb 2026 22:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-ceo-lines-up-march-talks-at-major-us-healthcare-investor-events-stock-titan/</guid></item><item><title><![CDATA[Sana Biotechnology (SANA) Appoints Industry Veteran Brian Piper as New CFO - Finviz]]></title><description><![CDATA[Sana Biotechnology (SANA) Appoints Industry Veteran Brian Piper as New CFO&nbsp;&nbsp;Finviz]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-appoints-industry-veteran-brian-piper-as-new-cfo-finviz/</link><pubDate>Thu, 26 Feb 2026 20:33:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-appoints-industry-veteran-brian-piper-as-new-cfo-finviz/</guid></item><item><title><![CDATA[Leerink raises Vir Biotechnology stock price target on partnership - Investing.com]]></title><description><![CDATA[Leerink raises Vir Biotechnology stock price target on partnership&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/leerink-raises-vir-biotechnology-stock-price-target-on-partnership-investingcom/</link><pubDate>Thu, 26 Feb 2026 20:09:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/leerink-raises-vir-biotechnology-stock-price-target-on-partnership-investingcom/</guid></item><item><title><![CDATA[Nautilus Biotechnology (NASDAQ:NAUT) Announces Earnings Results - MarketBeat]]></title><description><![CDATA[Nautilus Biotechnology (NASDAQ:NAUT) Announces Earnings Results&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-nasdaqnaut-announces-earnings-results-marketbeat/</link><pubDate>Thu, 26 Feb 2026 20:03:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-nasdaqnaut-announces-earnings-results-marketbeat/</guid></item><item><title><![CDATA[Vir Biotechnology (NASDAQ:VIR) Shares Gap Down - Should You Sell? - MarketBeat]]></title><description><![CDATA[Vir Biotechnology (NASDAQ:VIR) Shares Gap Down - Should You Sell?&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-shares-gap-down-should-you-sell-marketbeat/</link><pubDate>Thu, 26 Feb 2026 18:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-shares-gap-down-should-you-sell-marketbeat/</guid></item><item><title><![CDATA[Earnings call transcript: Nautilus Biotechnology Q4 2025 shows cost cuts - Investing.com]]></title><description><![CDATA[Earnings call transcript: Nautilus Biotechnology Q4 2025 shows cost cuts&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-call-transcript-nautilus-biotechnology-q4-2025-shows-cost-cuts-investingcom/</link><pubDate>Thu, 26 Feb 2026 17:46:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-call-transcript-nautilus-biotechnology-q4-2025-shows-cost-cuts-investingcom/</guid></item><item><title><![CDATA[ARUP Creates Innovation Central Laboratory To Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners - PR Newswire]]></title><description><![CDATA[ARUP Creates Innovation Central Laboratory To Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners&nbsp;&nbsp;PR Newswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/arup-creates-innovation-central-laboratory-to-accelerate-diagnostic-innovation-for-biotechnology-and-pharmaceutical-partners-pr-newswire/</link><pubDate>Thu, 26 Feb 2026 17:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/arup-creates-innovation-central-laboratory-to-accelerate-diagnostic-innovation-for-biotechnology-and-pharmaceutical-partners-pr-newswire/</guid></item><item><title><![CDATA[Will Sana&rsquo;s New Veteran Biopharma CFO Appointment Change Sana Biotechnology's (SANA) Investment Narrative - simplywall.st]]></title><description><![CDATA[Will Sana&rsquo;s New Veteran Biopharma CFO Appointment Change Sana Biotechnology's (SANA) Investment Narrative&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/will-sanarsquos-new-veteran-biopharma-cfo-appointment-change-sana-biotechnologys-sana-investment-narrative-simplywallst/</link><pubDate>Thu, 26 Feb 2026 15:46:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/will-sanarsquos-new-veteran-biopharma-cfo-appointment-change-sana-biotechnologys-sana-investment-narrative-simplywallst/</guid></item><item><title><![CDATA[Vir Biotechnology Prices $150 Mln Public Offering At $8.50 Per Share, Stock Down - Nasdaq]]></title><description><![CDATA[Vir Biotechnology Prices $150 Mln Public Offering At $8.50 Per Share, Stock Down&nbsp;&nbsp;Nasdaq]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-prices-150-mln-public-offering-at-850-per-share-stock-down-nasdaq/</link><pubDate>Thu, 26 Feb 2026 15:44:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-prices-150-mln-public-offering-at-850-per-share-stock-down-nasdaq/</guid></item><item><title><![CDATA[Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results - GlobeNewswire]]></title><description><![CDATA[Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-reports-fourth-quarter-and-fiscal-year-2025-financial-results-globenewswire/</link><pubDate>Thu, 26 Feb 2026 14:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-reports-fourth-quarter-and-fiscal-year-2025-financial-results-globenewswire/</guid></item><item><title><![CDATA[Vir Biotechnology stock tumbles on discounted share offering By Investing.com - Investing.com UK]]></title><description><![CDATA[Vir Biotechnology stock tumbles on discounted share offering By Investing.com&nbsp;&nbsp;Investing.com UK]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-stock-tumbles-on-discounted-share-offering-by-investingcom-investingcom-uk/</link><pubDate>Thu, 26 Feb 2026 13:54:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-stock-tumbles-on-discounted-share-offering-by-investingcom-investingcom-uk/</guid></item><item><title><![CDATA[Assessing Sana Biotechnology (SANA) Valuation After The Appointment Of A New CFO - Yahoo Finance]]></title><description><![CDATA[Assessing Sana Biotechnology (SANA) Valuation After The Appointment Of A New CFO&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/assessing-sana-biotechnology-sana-valuation-after-the-appointment-of-a-new-cfo-yahoo-finance/</link><pubDate>Thu, 26 Feb 2026 10:12:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/assessing-sana-biotechnology-sana-valuation-after-the-appointment-of-a-new-cfo-yahoo-finance/</guid></item><item><title><![CDATA[Biotechnology Market: The Transition from Discovery to Engineering - openPR.com]]></title><description><![CDATA[Biotechnology Market: The Transition from Discovery to Engineering&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-market-the-transition-from-discovery-to-engineering-openprcom/</link><pubDate>Thu, 26 Feb 2026 09:45:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-market-the-transition-from-discovery-to-engineering-openprcom/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) Prices Public Offering at $8.50 Per Shar - GuruFocus]]></title><description><![CDATA[Vir Biotechnology (VIR) Prices Public Offering at $8.50 Per Shar&nbsp;&nbsp;GuruFocus]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-prices-public-offering-at-850-per-shar-gurufocus/</link><pubDate>Thu, 26 Feb 2026 09:11:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-prices-public-offering-at-850-per-shar-gurufocus/</guid></item><item><title><![CDATA[Biochips Market Outlook: Precision Diagnostics Innovation and Biotechnology Growth Opportunities - vocal.media]]></title><description><![CDATA[Biochips Market Outlook: Precision Diagnostics Innovation and Biotechnology Growth Opportunities&nbsp;&nbsp;vocal.media]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biochips-market-outlook-precision-diagnostics-innovation-and-biotechnology-growth-opportunities-vocalmedia/</link><pubDate>Thu, 26 Feb 2026 08:28:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biochips-market-outlook-precision-diagnostics-innovation-and-biotechnology-growth-opportunities-vocalmedia/</guid></item><item><title><![CDATA[Vir Biotechnology Announces Pricing of Public Offering of Common Stock - Business Wire]]></title><description><![CDATA[Vir Biotechnology Announces Pricing of Public Offering of Common Stock&nbsp;&nbsp;Business Wire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-announces-pricing-of-public-offering-of-common-stock-business-wire/</link><pubDate>Thu, 26 Feb 2026 04:31:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-announces-pricing-of-public-offering-of-common-stock-business-wire/</guid></item><item><title><![CDATA[Students explore the future of medicine in biotechnology outreach series - Tonbridge School]]></title><description><![CDATA[Students explore the future of medicine in biotechnology outreach series&nbsp;&nbsp;Tonbridge School]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/students-explore-the-future-of-medicine-in-biotechnology-outreach-series-tonbridge-school/</link><pubDate>Thu, 26 Feb 2026 00:58:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/students-explore-the-future-of-medicine-in-biotechnology-outreach-series-tonbridge-school/</guid></item><item><title><![CDATA[Portuguese biotechnology reinvents food with the support of COMPETE 2030 - The Portugal News]]></title><description><![CDATA[Portuguese biotechnology reinvents food with the support of COMPETE 2030&nbsp;&nbsp;The Portugal News]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/portuguese-biotechnology-reinvents-food-with-the-support-of-compete-2030-the-portugal-news/</link><pubDate>Wed, 25 Feb 2026 22:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/portuguese-biotechnology-reinvents-food-with-the-support-of-compete-2030-the-portugal-news/</guid></item><item><title><![CDATA[Vir Biotechnology leaps on news of Astellas collaboration - The Pharma Letter]]></title><description><![CDATA[Vir Biotechnology leaps on news of Astellas collaboration&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-leaps-on-news-of-astellas-collaboration-the-pharma-letter/</link><pubDate>Wed, 25 Feb 2026 18:12:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-leaps-on-news-of-astellas-collaboration-the-pharma-letter/</guid></item><item><title><![CDATA[Astellas, Vir Biotechnology Launch Up-to-$1.7B Prostate Cancer Collaboration - GEN - Genetic Engineering and Biotechnology News]]></title><description><![CDATA[Astellas, Vir Biotechnology Launch Up-to-$1.7B Prostate Cancer Collaboration&nbsp;&nbsp;GEN - Genetic Engineering and Biotechnology News]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/astellas-vir-biotechnology-launch-up-to-17b-prostate-cancer-collaboration-gen-genetic-engineering-and-biotechnology-news/</link><pubDate>Wed, 25 Feb 2026 17:56:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/astellas-vir-biotechnology-launch-up-to-17b-prostate-cancer-collaboration-gen-genetic-engineering-and-biotechnology-news/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) Receives Maintained Overweight Rating Fr - GuruFocus]]></title><description><![CDATA[Vir Biotechnology (VIR) Receives Maintained Overweight Rating Fr&nbsp;&nbsp;GuruFocus]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-receives-maintained-overweight-rating-fr-gurufocus/</link><pubDate>Wed, 25 Feb 2026 17:48:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-receives-maintained-overweight-rating-fr-gurufocus/</guid></item><item><title><![CDATA[Biotechnology Is the New National Security Frontier — and America Is Falling Behind - The Well News]]></title><description><![CDATA[Biotechnology Is the New National Security Frontier &mdash; and America Is Falling Behind&nbsp;&nbsp;The Well News]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-is-the-new-national-security-frontier-and-america-is-falling-behind-the-well-news/</link><pubDate>Wed, 25 Feb 2026 16:49:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-is-the-new-national-security-frontier-and-america-is-falling-behind-the-well-news/</guid></item><item><title><![CDATA[Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results - TIKR.com]]></title><description><![CDATA[Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results&nbsp;&nbsp;TIKR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-stock-skyrockets-65-on-positive-prostate-cancer-treatment-trial-results-tikrcom/</link><pubDate>Wed, 25 Feb 2026 13:58:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-stock-skyrockets-65-on-positive-prostate-cancer-treatment-trial-results-tikrcom/</guid></item><item><title><![CDATA[What are the Top 10 Trends in Biotechnology in 2026? - StartUs Insights]]></title><description><![CDATA[What are the Top 10 Trends in Biotechnology in 2026?&nbsp;&nbsp;StartUs Insights]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/what-are-the-top-10-trends-in-biotechnology-in-2026-startus-insights/</link><pubDate>Wed, 25 Feb 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/what-are-the-top-10-trends-in-biotechnology-in-2026-startus-insights/</guid></item><item><title><![CDATA[Biotechnology to power next industrial revolution; India targets $1 trillion bioeconomy by 2047: Dr Jitendra Singh - ddnews.gov.in]]></title><description><![CDATA[Biotechnology to power next industrial revolution; India targets $1 trillion bioeconomy by 2047: Dr Jitendra Singh&nbsp;&nbsp;ddnews.gov.in]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-to-power-next-industrial-revolution-india-targets-1-trillion-bioeconomy-by-2047-dr-jitendra-singh-ddnewsgovin/</link><pubDate>Wed, 25 Feb 2026 07:48:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-to-power-next-industrial-revolution-india-targets-1-trillion-bioeconomy-by-2047-dr-jitendra-singh-ddnewsgovin/</guid></item><item><title><![CDATA[Verneuil Vanina De Sells 4,445 Shares of Vir Biotechnology (NASDAQ:VIR) Stock - MarketBeat]]></title><description><![CDATA[Verneuil Vanina De Sells 4,445 Shares of Vir Biotechnology (NASDAQ:VIR) Stock&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/verneuil-vanina-de-sells-4445-shares-of-vir-biotechnology-nasdaqvir-stock-marketbeat/</link><pubDate>Wed, 25 Feb 2026 05:14:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/verneuil-vanina-de-sells-4445-shares-of-vir-biotechnology-nasdaqvir-stock-marketbeat/</guid></item><item><title><![CDATA[Assessing Vir Biotechnology (VIR) Valuation After A Strong Year To Date Share Price Rebound - simplywall.st]]></title><description><![CDATA[Assessing Vir Biotechnology (VIR) Valuation After A Strong Year To Date Share Price Rebound&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/assessing-vir-biotechnology-vir-valuation-after-a-strong-year-to-date-share-price-rebound-simplywallst/</link><pubDate>Wed, 25 Feb 2026 01:50:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/assessing-vir-biotechnology-vir-valuation-after-a-strong-year-to-date-share-price-rebound-simplywallst/</guid></item><item><title><![CDATA[The final frontier of drug development: Biotechnology and pharmaceutical innovation in low earth orbit - Daily Journal]]></title><description><![CDATA[The final frontier of drug development: Biotechnology and pharmaceutical innovation in low earth orbit&nbsp;&nbsp;Daily Journal]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/the-final-frontier-of-drug-development-biotechnology-and-pharmaceutical-innovation-in-low-earth-orbit-daily-journal/</link><pubDate>Wed, 25 Feb 2026 01:40:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/the-final-frontier-of-drug-development-biotechnology-and-pharmaceutical-innovation-in-low-earth-orbit-daily-journal/</guid></item><item><title><![CDATA[These Stocks Are Today&rsquo;s Movers: AMD, Hims &amp; Hers, Keysight, IBM, Kratos, Vir Biotechnology, Whirlpool, and More - Barron's]]></title><description><![CDATA[These Stocks Are Today&rsquo;s Movers: AMD, Hims &amp; Hers, Keysight, IBM, Kratos, Vir Biotechnology, Whirlpool, and More&nbsp;&nbsp;Barron's]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/these-stocks-are-todayrsquos-movers-amd-hims-amp-hers-keysight-ibm-kratos-vir-biotechnology-whirlpool-and-more-barrons/</link><pubDate>Tue, 24 Feb 2026 22:35:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/these-stocks-are-todayrsquos-movers-amd-hims-amp-hers-keysight-ibm-kratos-vir-biotechnology-whirlpool-and-more-barrons/</guid></item><item><title><![CDATA[Vir Biotechnology Announces Proposed Public Offering of Common Stock - Yahoo Finance]]></title><description><![CDATA[Vir Biotechnology Announces Proposed Public Offering of Common Stock&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-announces-proposed-public-offering-of-common-stock-yahoo-finance/</link><pubDate>Tue, 24 Feb 2026 22:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-announces-proposed-public-offering-of-common-stock-yahoo-finance/</guid></item><item><title><![CDATA[Vir Biotechnology: Up On Prostate Data And Astellas Deal - I'm (Long-Term) Bullish (VIR) - Seeking Alpha]]></title><description><![CDATA[Vir Biotechnology: Up On Prostate Data And Astellas Deal - I'm (Long-Term) Bullish (VIR)&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-up-on-prostate-data-and-astellas-deal-im-long-term-bullish-vir-seeking-alpha/</link><pubDate>Tue, 24 Feb 2026 19:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-up-on-prostate-data-and-astellas-deal-im-long-term-bullish-vir-seeking-alpha/</guid></item><item><title><![CDATA[Is this a good time to invest in Genus biotechnology? - The Times]]></title><description><![CDATA[Is this a good time to invest in Genus biotechnology?&nbsp;&nbsp;The Times]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/is-this-a-good-time-to-invest-in-genus-biotechnology-the-times/</link><pubDate>Tue, 24 Feb 2026 19:09:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/is-this-a-good-time-to-invest-in-genus-biotechnology-the-times/</guid></item><item><title><![CDATA[Vir Biotechnology, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance]]></title><description><![CDATA[Vir Biotechnology, Inc. Q4 2025 Earnings Call Summary&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-q4-2025-earnings-call-summary-yahoo-finance/</link><pubDate>Tue, 24 Feb 2026 18:33:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-q4-2025-earnings-call-summary-yahoo-finance/</guid></item><item><title><![CDATA[Novo Nordisk, United Biotechnology Report 19.7% Weight Loss in New Study - Meyka]]></title><description><![CDATA[Novo Nordisk, United Biotechnology Report 19.7% Weight Loss in New Study&nbsp;&nbsp;Meyka]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/novo-nordisk-united-biotechnology-report-197-weight-loss-in-new-study-meyka/</link><pubDate>Tue, 24 Feb 2026 16:54:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/novo-nordisk-united-biotechnology-report-197-weight-loss-in-new-study-meyka/</guid></item><item><title><![CDATA[Astellas Pharmaceuticals Enters $1.7 Billion Global Collaboration with Vir Biotechnology to advance PSMA-targeting PRO-XTEN - Pharmaceutical Executive]]></title><description><![CDATA[Astellas Pharmaceuticals Enters $1.7 Billion Global Collaboration with Vir Biotechnology to advance PSMA-targeting PRO-XTEN&nbsp;&nbsp;Pharmaceutical Executive]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/astellas-pharmaceuticals-enters-17-billion-global-collaboration-with-vir-biotechnology-to-advance-psma-targeting-pro-xten-pharmaceutical-executive/</link><pubDate>Tue, 24 Feb 2026 16:34:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/astellas-pharmaceuticals-enters-17-billion-global-collaboration-with-vir-biotechnology-to-advance-psma-targeting-pro-xten-pharmaceutical-executive/</guid></item><item><title><![CDATA[How a prostate cancer drug and a $1.7 billion deal landed at Vir Bio - San Francisco Business Times - The Business Journals]]></title><description><![CDATA[How a prostate cancer drug and a $1.7 billion deal landed at Vir Bio - San Francisco Business Times&nbsp;&nbsp;The Business Journals]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/how-a-prostate-cancer-drug-and-a-17-billion-deal-landed-at-vir-bio-san-francisco-business-times-the-business-journals/</link><pubDate>Tue, 24 Feb 2026 15:42:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/how-a-prostate-cancer-drug-and-a-17-billion-deal-landed-at-vir-bio-san-francisco-business-times-the-business-journals/</guid></item><item><title><![CDATA[Astellas Pharma, Vir Biotechnology Partner to Advance VIR-5500 - Contract Pharma]]></title><description><![CDATA[Astellas Pharma, Vir Biotechnology Partner to Advance VIR-5500&nbsp;&nbsp;Contract Pharma]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/astellas-pharma-vir-biotechnology-partner-to-advance-vir-5500-contract-pharma/</link><pubDate>Tue, 24 Feb 2026 15:37:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/astellas-pharma-vir-biotechnology-partner-to-advance-vir-5500-contract-pharma/</guid></item><item><title><![CDATA[FDA Moderna review sets up pivotal test for mRNA flu jabs - The Pharma Letter]]></title><description><![CDATA[FDA Moderna review sets up pivotal test for mRNA flu jabs&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/fda-moderna-review-sets-up-pivotal-test-for-mrna-flu-jabs-the-pharma-letter/</link><pubDate>Tue, 24 Feb 2026 15:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/fda-moderna-review-sets-up-pivotal-test-for-mrna-flu-jabs-the-pharma-letter/</guid></item><item><title><![CDATA[Vir Biotechnology Stock Pre-Market (+58%) : Landmark Astellas Deal &amp; Positive Cancer Data - Trefis]]></title><description><![CDATA[Vir Biotechnology Stock Pre-Market (+58%) : Landmark Astellas Deal &amp; Positive Cancer Data&nbsp;&nbsp;Trefis]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-stock-pre-market-58-landmark-astellas-deal-amp-positive-cancer-data-trefis/</link><pubDate>Tue, 24 Feb 2026 13:16:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-stock-pre-market-58-landmark-astellas-deal-amp-positive-cancer-data-trefis/</guid></item><item><title><![CDATA[Raymond James upgrades Vir Biotechnology stock rating on drug data - Investing.com UK]]></title><description><![CDATA[Raymond James upgrades Vir Biotechnology stock rating on drug data&nbsp;&nbsp;Investing.com UK]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/raymond-james-upgrades-vir-biotechnology-stock-rating-on-drug-data-investingcom-uk/</link><pubDate>Tue, 24 Feb 2026 12:54:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/raymond-james-upgrades-vir-biotechnology-stock-rating-on-drug-data-investingcom-uk/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) Surges on Astellas Partnership and Stron - GuruFocus]]></title><description><![CDATA[Vir Biotechnology (VIR) Surges on Astellas Partnership and Stron&nbsp;&nbsp;GuruFocus]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-surges-on-astellas-partnership-and-stron-gurufocus/</link><pubDate>Tue, 24 Feb 2026 12:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-surges-on-astellas-partnership-and-stron-gurufocus/</guid></item><item><title><![CDATA[York firm's cash boost as it's cancer testing kits move closer to launch - The York Press]]></title><description><![CDATA[York firm's cash boost as it's cancer testing kits move closer to launch&nbsp;&nbsp;The York Press]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/york-firms-cash-boost-as-its-cancer-testing-kits-move-closer-to-launch-the-york-press/</link><pubDate>Tue, 24 Feb 2026 11:54:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/york-firms-cash-boost-as-its-cancer-testing-kits-move-closer-to-launch-the-york-press/</guid></item><item><title><![CDATA[Novo Nordisk, United Biotechnology obesity drug trial shows 19.7% weight loss - Yahoo Finance]]></title><description><![CDATA[Novo Nordisk, United Biotechnology obesity drug trial shows 19.7% weight loss&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/novo-nordisk-united-biotechnology-obesity-drug-trial-shows-197-weight-loss-yahoo-finance/</link><pubDate>Tue, 24 Feb 2026 09:52:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/novo-nordisk-united-biotechnology-obesity-drug-trial-shows-197-weight-loss-yahoo-finance/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) Announces Strategic Collaboration with A - GuruFocus]]></title><description><![CDATA[Vir Biotechnology (VIR) Announces Strategic Collaboration with A&nbsp;&nbsp;GuruFocus]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-announces-strategic-collaboration-with-a-gurufocus/</link><pubDate>Tue, 24 Feb 2026 09:04:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-announces-strategic-collaboration-with-a-gurufocus/</guid></item><item><title><![CDATA[New lung cancer drug targets 50,000 patients with no standard care - Stock Titan]]></title><description><![CDATA[New lung cancer drug targets 50,000 patients with no standard care&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/new-lung-cancer-drug-targets-50000-patients-with-no-standard-care-stock-titan/</link><pubDate>Tue, 24 Feb 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/new-lung-cancer-drug-targets-50000-patients-with-no-standard-care-stock-titan/</guid></item><item><title><![CDATA[Assessing Sana Biotechnology (SANA) Valuation After Recent Share Price Momentum - simplywall.st]]></title><description><![CDATA[Assessing Sana Biotechnology (SANA) Valuation After Recent Share Price Momentum&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/assessing-sana-biotechnology-sana-valuation-after-recent-share-price-momentum-simplywallst/</link><pubDate>Tue, 24 Feb 2026 05:57:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/assessing-sana-biotechnology-sana-valuation-after-recent-share-price-momentum-simplywallst/</guid></item><item><title><![CDATA[Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Beats Revenue Estimates - Nasdaq]]></title><description><![CDATA[Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Beats Revenue Estimates&nbsp;&nbsp;Nasdaq]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-vir-reports-q4-loss-beats-revenue-estimates-nasdaq/</link><pubDate>Tue, 24 Feb 2026 02:55:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-vir-reports-q4-loss-beats-revenue-estimates-nasdaq/</guid></item><item><title><![CDATA[Astellas, Vir Biotechnology form partnership on prostate cancer drug - Investing.com]]></title><description><![CDATA[Astellas, Vir Biotechnology form partnership on prostate cancer drug&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/astellas-vir-biotechnology-form-partnership-on-prostate-cancer-drug-investingcom/</link><pubDate>Tue, 24 Feb 2026 01:24:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/astellas-vir-biotechnology-form-partnership-on-prostate-cancer-drug-investingcom/</guid></item><item><title><![CDATA[Earnings call transcript: Vir Biotechnology beats Q4 2025 earnings expectations - Investing.com]]></title><description><![CDATA[Earnings call transcript: Vir Biotechnology beats Q4 2025 earnings expectations&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-call-transcript-vir-biotechnology-beats-q4-2025-earnings-expectations-investingcom/</link><pubDate>Tue, 24 Feb 2026 01:10:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-call-transcript-vir-biotechnology-beats-q4-2025-earnings-expectations-investingcom/</guid></item><item><title><![CDATA[Vir Biotechnology, Astellas Forge Major Prostate Cancer Alliance - TipRanks]]></title><description><![CDATA[Vir Biotechnology, Astellas Forge Major Prostate Cancer Alliance&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-astellas-forge-major-prostate-cancer-alliance-tipranks/</link><pubDate>Tue, 24 Feb 2026 00:33:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-astellas-forge-major-prostate-cancer-alliance-tipranks/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) Surges 55% After Astellas Partnership Announcement - GuruFocus]]></title><description><![CDATA[Vir Biotechnology (VIR) Surges 55% After Astellas Partnership Announcement&nbsp;&nbsp;GuruFocus]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-surges-55-after-astellas-partnership-announcement-gurufocus/</link><pubDate>Tue, 24 Feb 2026 00:06:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-surges-55-after-astellas-partnership-announcement-gurufocus/</guid></item><item><title><![CDATA[Vir Biotechnology reports phase 1 trial results for VIR-5500 - Investing.com]]></title><description><![CDATA[Vir Biotechnology reports phase 1 trial results for VIR-5500&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-reports-phase-1-trial-results-for-vir-5500-investingcom/</link><pubDate>Mon, 23 Feb 2026 23:32:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-reports-phase-1-trial-results-for-vir-5500-investingcom/</guid></item><item><title><![CDATA[Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire]]></title><description><![CDATA[Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results&nbsp;&nbsp;Business Wire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-provides-corporate-update-and-reports-fourth-quarter-and-full-year-2025-financial-results-business-wire/</link><pubDate>Mon, 23 Feb 2026 23:14:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-provides-corporate-update-and-reports-fourth-quarter-and-full-year-2025-financial-results-business-wire/</guid></item><item><title><![CDATA[Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN - Business Wire]]></title><description><![CDATA[Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN&nbsp;&nbsp;Business Wire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-reports-positive-updated-phase-1-results-for-psma-targeting-pro-xten-business-wire/</link><pubDate>Mon, 23 Feb 2026 23:02:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-reports-positive-updated-phase-1-results-for-psma-targeting-pro-xten-business-wire/</guid></item><item><title><![CDATA[Experimental prostate cancer T-cell therapy gets $335M boost from Astellas - Stock Titan]]></title><description><![CDATA[Experimental prostate cancer T-cell therapy gets $335M boost from Astellas&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/experimental-prostate-cancer-t-cell-therapy-gets-335m-boost-from-astellas-stock-titan/</link><pubDate>Mon, 23 Feb 2026 23:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/experimental-prostate-cancer-t-cell-therapy-gets-335m-boost-from-astellas-stock-titan/</guid></item><item><title><![CDATA[Astellas Pharma Inc. and Vir Biotechnology, Inc. Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual- Masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer - marketscreener.com]]></title><description><![CDATA[Astellas Pharma Inc. and Vir Biotechnology, Inc. Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN&reg; Dual- Masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/astellas-pharma-inc-and-vir-biotechnology-inc-announce-global-strategic-collaboration-to-advance-psma-targeting-pro-xten-dual-masked-t-cell-engager-vir-5500-for-the-treatment-of-prostate-cancer-marketscreenercom/</link><pubDate>Mon, 23 Feb 2026 23:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/astellas-pharma-inc-and-vir-biotechnology-inc-announce-global-strategic-collaboration-to-advance-psma-targeting-pro-xten-dual-masked-t-cell-engager-vir-5500-for-the-treatment-of-prostate-cancer-marketscreenercom/</guid></item><item><title><![CDATA[Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer - PR Newswire]]></title><description><![CDATA[Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN&reg; Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer&nbsp;&nbsp;PR Newswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/astellas-and-vir-biotechnology-announce-global-strategic-collaboration-to-advance-psma-targeting-pro-xten-dual-masked-t-cell-engager-vir-5500-for-the-treatment-of-prostate-cancer-pr-newswire/</link><pubDate>Mon, 23 Feb 2026 23:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/astellas-and-vir-biotechnology-announce-global-strategic-collaboration-to-advance-psma-targeting-pro-xten-dual-masked-t-cell-engager-vir-5500-for-the-treatment-of-prostate-cancer-pr-newswire/</guid></item><item><title><![CDATA[Puma Biotechnology to Present at TD Cowen’s 46th Annual Health Care Conference - Yahoo Finance]]></title><description><![CDATA[Puma Biotechnology to Present at TD Cowen&rsquo;s 46th Annual Health Care Conference&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-to-present-at-td-cowens-46th-annual-health-care-conference-yahoo-finance/</link><pubDate>Mon, 23 Feb 2026 22:15:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-to-present-at-td-cowens-46th-annual-health-care-conference-yahoo-finance/</guid></item><item><title><![CDATA[York University spin-out Cizzle Biotechnology moves forwards with lung cancer-detecting test - Yorkshire Post]]></title><description><![CDATA[York University spin-out Cizzle Biotechnology moves forwards with lung cancer-detecting test&nbsp;&nbsp;Yorkshire Post]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/york-university-spin-out-cizzle-biotechnology-moves-forwards-with-lung-cancer-detecting-test-yorkshire-post/</link><pubDate>Mon, 23 Feb 2026 17:45:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/york-university-spin-out-cizzle-biotechnology-moves-forwards-with-lung-cancer-detecting-test-yorkshire-post/</guid></item><item><title><![CDATA[Vir Biotechnology earnings: Losses persist as hepatitis program advances By Investing.com - Investing.com Canada]]></title><description><![CDATA[Vir Biotechnology earnings: Losses persist as hepatitis program advances By Investing.com&nbsp;&nbsp;Investing.com Canada]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-earnings-losses-persist-as-hepatitis-program-advances-by-investingcom-investingcom-canada/</link><pubDate>Mon, 23 Feb 2026 15:48:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-earnings-losses-persist-as-hepatitis-program-advances-by-investingcom-investingcom-canada/</guid></item><item><title><![CDATA[Global Biotechnology Market Size and Forecast 2025–2033 - vocal.media]]></title><description><![CDATA[Global Biotechnology Market Size and Forecast 2025&ndash;2033&nbsp;&nbsp;vocal.media]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/global-biotechnology-market-size-and-forecast-20252033-vocalmedia/</link><pubDate>Mon, 23 Feb 2026 14:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/global-biotechnology-market-size-and-forecast-20252033-vocalmedia/</guid></item><item><title><![CDATA[Synthekine Appoints Biotechnology and Pharmaceutical Industry Veteran John A. Orwin as Chair of its Board of Directors - Business Wire]]></title><description><![CDATA[Synthekine Appoints Biotechnology and Pharmaceutical Industry Veteran John A. Orwin as Chair of its Board of Directors&nbsp;&nbsp;Business Wire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/synthekine-appoints-biotechnology-and-pharmaceutical-industry-veteran-john-a-orwin-as-chair-of-its-board-of-directors-business-wire/</link><pubDate>Mon, 23 Feb 2026 14:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/synthekine-appoints-biotechnology-and-pharmaceutical-industry-veteran-john-a-orwin-as-chair-of-its-board-of-directors-business-wire/</guid></item><item><title><![CDATA[CStone wins UK clearance for sugemalimab in lung cancer - The Pharma Letter]]></title><description><![CDATA[CStone wins UK clearance for sugemalimab in lung cancer&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cstone-wins-uk-clearance-for-sugemalimab-in-lung-cancer-the-pharma-letter/</link><pubDate>Mon, 23 Feb 2026 12:55:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cstone-wins-uk-clearance-for-sugemalimab-in-lung-cancer-the-pharma-letter/</guid></item><item><title><![CDATA[Transposable elements in the dark genome - Nature]]></title><description><![CDATA[Transposable elements in the dark genome&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/transposable-elements-in-the-dark-genome-nature/</link><pubDate>Mon, 23 Feb 2026 12:32:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/transposable-elements-in-the-dark-genome-nature/</guid></item><item><title><![CDATA[Cizzle Biotechnology's Partner in Final Stages of CLIA Process for CIZ1B Biomarker in US - marketscreener.com]]></title><description><![CDATA[Cizzle Biotechnology's Partner in Final Stages of CLIA Process for CIZ1B Biomarker in US&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cizzle-biotechnologys-partner-in-final-stages-of-clia-process-for-ciz1b-biomarker-in-us-marketscreenercom/</link><pubDate>Mon, 23 Feb 2026 12:12:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cizzle-biotechnologys-partner-in-final-stages-of-clia-process-for-ciz1b-biomarker-in-us-marketscreenercom/</guid></item><item><title><![CDATA[Cizzle Biotechnology secures additional US$3.5 million in guaranteed royalties as US launch nears - Proactive Investors]]></title><description><![CDATA[Cizzle Biotechnology secures additional US$3.5 million in guaranteed royalties as US launch nears&nbsp;&nbsp;Proactive Investors]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cizzle-biotechnology-secures-additional-us35-million-in-guaranteed-royalties-as-us-launch-nears-proactive-investors/</link><pubDate>Mon, 23 Feb 2026 12:03:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cizzle-biotechnology-secures-additional-us35-million-in-guaranteed-royalties-as-us-launch-nears-proactive-investors/</guid></item><item><title><![CDATA[Hanoi approves land lease for phase 2 of $1 bln biotechnology high-tech park - Theinvestor.vn]]></title><description><![CDATA[Hanoi approves land lease for phase 2 of $1 bln biotechnology high-tech park&nbsp;&nbsp;Theinvestor.vn]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/hanoi-approves-land-lease-for-phase-2-of-1-bln-biotechnology-high-tech-park-theinvestorvn/</link><pubDate>Mon, 23 Feb 2026 10:12:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/hanoi-approves-land-lease-for-phase-2-of-1-bln-biotechnology-high-tech-park-theinvestorvn/</guid></item><item><title><![CDATA[Vir trial drug shrinks tumors in advanced prostate cancer patients - Stock Titan]]></title><description><![CDATA[Vir trial drug shrinks tumors in advanced prostate cancer patients&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-trial-drug-shrinks-tumors-in-advanced-prostate-cancer-patients-stock-titan/</link><pubDate>Mon, 23 Feb 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-trial-drug-shrinks-tumors-in-advanced-prostate-cancer-patients-stock-titan/</guid></item><item><title><![CDATA[Cizzle Biotechnology Nears CLIA Accreditation For Early Lung Cancer Test - DirectorsTalk Interviews]]></title><description><![CDATA[Cizzle Biotechnology Nears CLIA Accreditation For Early Lung Cancer Test&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cizzle-biotechnology-nears-clia-accreditation-for-early-lung-cancer-test-directorstalk-interviews/</link><pubDate>Mon, 23 Feb 2026 08:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cizzle-biotechnology-nears-clia-accreditation-for-early-lung-cancer-test-directorstalk-interviews/</guid></item><item><title><![CDATA[[News] ams OSRAM and Ziwooo Biotechnology Announce Strategic Brand Licensing Partnership for Health &amp; Beauty Products in APAC - LEDinside]]></title><description><![CDATA[[News] ams OSRAM and Ziwooo Biotechnology Announce Strategic Brand Licensing Partnership for Health &amp; Beauty Products in APAC&nbsp;&nbsp;LEDinside]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/news-ams-osram-and-ziwooo-biotechnology-announce-strategic-brand-licensing-partnership-for-health-amp-beauty-products-in-apac-ledinside/</link><pubDate>Mon, 23 Feb 2026 06:34:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/news-ams-osram-and-ziwooo-biotechnology-announce-strategic-brand-licensing-partnership-for-health-amp-beauty-products-in-apac-ledinside/</guid></item><item><title><![CDATA[Biotechnology is set to drive the evolution of personalised medicine, say experts - The Hindu]]></title><description><![CDATA[Biotechnology is set to drive the evolution of personalised medicine, say experts&nbsp;&nbsp;The Hindu]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-is-set-to-drive-the-evolution-of-personalised-medicine-say-experts-the-hindu/</link><pubDate>Sun, 22 Feb 2026 21:10:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-is-set-to-drive-the-evolution-of-personalised-medicine-say-experts-the-hindu/</guid></item><item><title><![CDATA[Horizon Health Biotech Analytics Ethics Guidelines Biotechnology Market Size And Share | Industry Report, 2030 Horizon Health Biotech Analytics Ethics Program Australia - inva.kz]]></title><description><![CDATA[Horizon Health Biotech Analytics Ethics Guidelines Biotechnology Market Size And Share | Industry Report, 2030 Horizon Health Biotech Analytics Ethics Program Australia&nbsp;&nbsp;inva.kz]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/horizon-health-biotech-analytics-ethics-guidelines-biotechnology-market-size-and-share-industry-report-2030-horizon-health-biotech-analytics-ethics-program-australia-invakz/</link><pubDate>Sun, 22 Feb 2026 07:53:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/horizon-health-biotech-analytics-ethics-guidelines-biotechnology-market-size-and-share-industry-report-2030-horizon-health-biotech-analytics-ethics-program-australia-invakz/</guid></item><item><title><![CDATA[Generative AI and precision medicine fuel rapid growth in biotechnology sector - MSN]]></title><description><![CDATA[Generative AI and precision medicine fuel rapid growth in biotechnology sector&nbsp;&nbsp;MSN]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/generative-ai-and-precision-medicine-fuel-rapid-growth-in-biotechnology-sector-msn/</link><pubDate>Sun, 22 Feb 2026 05:47:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/generative-ai-and-precision-medicine-fuel-rapid-growth-in-biotechnology-sector-msn/</guid></item><item><title><![CDATA[Governing Biotechnology’s Dual-Use Security Dilemma – Analysis - Eurasia Review]]></title><description><![CDATA[Governing Biotechnology&rsquo;s Dual-Use Security Dilemma &ndash; Analysis&nbsp;&nbsp;Eurasia Review]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/governing-biotechnologys-dual-use-security-dilemma-analysis-eurasia-review/</link><pubDate>Sat, 21 Feb 2026 02:33:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/governing-biotechnologys-dual-use-security-dilemma-analysis-eurasia-review/</guid></item><item><title><![CDATA[Vir Biotechnology Inc expected to post a loss of 49 cents a share - Earnings Preview - TradingView]]></title><description><![CDATA[Vir Biotechnology Inc expected to post a loss of 49 cents a share - Earnings Preview&nbsp;&nbsp;TradingView]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-expected-to-post-a-loss-of-49-cents-a-share-earnings-preview-tradingview/</link><pubDate>Fri, 20 Feb 2026 23:22:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-expected-to-post-a-loss-of-49-cents-a-share-earnings-preview-tradingview/</guid></item><item><title><![CDATA[Arvinas, Inc. (ARVN) Stock Analysis: Unlocking Potential in Biotechnology with an 8.52% Upside - DirectorsTalk Interviews]]></title><description><![CDATA[Arvinas, Inc. (ARVN) Stock Analysis: Unlocking Potential in Biotechnology with an 8.52% Upside&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/arvinas-inc-arvn-stock-analysis-unlocking-potential-in-biotechnology-with-an-852-upside-directorstalk-interviews/</link><pubDate>Fri, 20 Feb 2026 18:29:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/arvinas-inc-arvn-stock-analysis-unlocking-potential-in-biotechnology-with-an-852-upside-directorstalk-interviews/</guid></item><item><title><![CDATA[5 Undervalued Biotechnology Stocks for Friday, February 20 - AAII]]></title><description><![CDATA[5 Undervalued Biotechnology Stocks for Friday, February 20&nbsp;&nbsp;AAII]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/5-undervalued-biotechnology-stocks-for-friday-february-20-aaii/</link><pubDate>Fri, 20 Feb 2026 14:35:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/5-undervalued-biotechnology-stocks-for-friday-february-20-aaii/</guid></item><item><title><![CDATA[Governing Biotechnology’s Dual-Use Security Dilemma - orfonline.org]]></title><description><![CDATA[Governing Biotechnology&rsquo;s Dual-Use Security Dilemma&nbsp;&nbsp;orfonline.org]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/governing-biotechnologys-dual-use-security-dilemma-orfonlineorg/</link><pubDate>Fri, 20 Feb 2026 14:02:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/governing-biotechnologys-dual-use-security-dilemma-orfonlineorg/</guid></item><item><title><![CDATA[NASENI-TROMENT Biotechnology Factory Receives NAFDAC’s Inspection Officers - aljazirahnews.com]]></title><description><![CDATA[NASENI-TROMENT Biotechnology Factory Receives NAFDAC&rsquo;s Inspection Officers&nbsp;&nbsp;aljazirahnews.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/naseni-troment-biotechnology-factory-receives-nafdacs-inspection-officers-aljazirahnewscom/</link><pubDate>Thu, 19 Feb 2026 22:28:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/naseni-troment-biotechnology-factory-receives-nafdacs-inspection-officers-aljazirahnewscom/</guid></item><item><title><![CDATA[Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference - Bluefield Daily Telegraph]]></title><description><![CDATA[Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference&nbsp;&nbsp;Bluefield Daily Telegraph]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-to-participate-in-the-td-cowen-46th-annual-health-care-conference-bluefield-daily-telegraph/</link><pubDate>Thu, 19 Feb 2026 22:06:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-to-participate-in-the-td-cowen-46th-annual-health-care-conference-bluefield-daily-telegraph/</guid></item><item><title><![CDATA[Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewswire]]></title><description><![CDATA[Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-to-participate-in-the-td-cowen-46th-annual-health-care-conference-globenewswire/</link><pubDate>Thu, 19 Feb 2026 22:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-to-participate-in-the-td-cowen-46th-annual-health-care-conference-globenewswire/</guid></item><item><title><![CDATA[6 Undervalued Biotechnology Stocks for Thursday, February 19 - AAII]]></title><description><![CDATA[6 Undervalued Biotechnology Stocks for Thursday, February 19&nbsp;&nbsp;AAII]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/6-undervalued-biotechnology-stocks-for-thursday-february-19-aaii/</link><pubDate>Thu, 19 Feb 2026 20:13:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/6-undervalued-biotechnology-stocks-for-thursday-february-19-aaii/</guid></item><item><title><![CDATA[Biotechnology Scientific-Research and Teaching Laboratory opens at Baku Engineering University - Azərtac]]></title><description><![CDATA[Biotechnology Scientific-Research and Teaching Laboratory opens at Baku Engineering University&nbsp;&nbsp;Az&#601;rtac]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-scientific-research-and-teaching-laboratory-opens-at-baku-engineering-university-azrtac/</link><pubDate>Thu, 19 Feb 2026 16:42:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-scientific-research-and-teaching-laboratory-opens-at-baku-engineering-university-azrtac/</guid></item><item><title><![CDATA[Lonza strengthens offering for drug developers in ADC space - The Pharma Letter]]></title><description><![CDATA[Lonza strengthens offering for drug developers in ADC space&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lonza-strengthens-offering-for-drug-developers-in-adc-space-the-pharma-letter/</link><pubDate>Thu, 19 Feb 2026 14:14:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lonza-strengthens-offering-for-drug-developers-in-adc-space-the-pharma-letter/</guid></item><item><title><![CDATA[Biotechnology &amp; Pharmaceutical Services Outsourcing to Reach - openPR.com]]></title><description><![CDATA[Biotechnology &amp; Pharmaceutical Services Outsourcing to Reach&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-amp-pharmaceutical-services-outsourcing-to-reach-openprcom/</link><pubDate>Thu, 19 Feb 2026 13:26:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-amp-pharmaceutical-services-outsourcing-to-reach-openprcom/</guid></item><item><title><![CDATA[AI in biotechnology market to hit USD 1,971M - Medical Buyer]]></title><description><![CDATA[AI in biotechnology market to hit USD 1,971M&nbsp;&nbsp;Medical Buyer]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-market-to-hit-usd-1971m-medical-buyer/</link><pubDate>Thu, 19 Feb 2026 12:20:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-market-to-hit-usd-1971m-medical-buyer/</guid></item><item><title><![CDATA[LIXTE Biotechnology appoints Sidney Braun to lead Liora subsidiary - Investing.com India]]></title><description><![CDATA[LIXTE Biotechnology appoints Sidney Braun to lead Liora subsidiary&nbsp;&nbsp;Investing.com India]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-appoints-sidney-braun-to-lead-liora-subsidiary-investingcom-india/</link><pubDate>Thu, 19 Feb 2026 11:40:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-appoints-sidney-braun-to-lead-liora-subsidiary-investingcom-india/</guid></item><item><title><![CDATA[Harnessing microalgae for the biosynthesis of molecular crystals - Nature]]></title><description><![CDATA[Harnessing microalgae for the biosynthesis of molecular crystals&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/harnessing-microalgae-for-the-biosynthesis-of-molecular-crystals-nature/</link><pubDate>Thu, 19 Feb 2026 11:12:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/harnessing-microalgae-for-the-biosynthesis-of-molecular-crystals-nature/</guid></item><item><title><![CDATA[Microalgae as cellular factories for molecular crystals - Nature]]></title><description><![CDATA[Microalgae as cellular factories for molecular crystals&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/microalgae-as-cellular-factories-for-molecular-crystals-nature/</link><pubDate>Thu, 19 Feb 2026 11:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/microalgae-as-cellular-factories-for-molecular-crystals-nature/</guid></item><item><title><![CDATA[Cosmetic Bioactive Ingredients Market Trends Driven by Clean Beauty and Biotechnology Innovations Through 2034 - industrytoday.co.uk]]></title><description><![CDATA[Cosmetic Bioactive Ingredients Market Trends Driven by Clean Beauty and Biotechnology Innovations Through 2034&nbsp;&nbsp;industrytoday.co.uk]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cosmetic-bioactive-ingredients-market-trends-driven-by-clean-beauty-and-biotechnology-innovations-through-2034-industrytodaycouk/</link><pubDate>Thu, 19 Feb 2026 09:59:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cosmetic-bioactive-ingredients-market-trends-driven-by-clean-beauty-and-biotechnology-innovations-through-2034-industrytodaycouk/</guid></item><item><title><![CDATA[Tufts Biotechnology Series: Ted Myles, a leading voice in biotech, shares his experiences with Tufts students - The Tufts Daily]]></title><description><![CDATA[Tufts Biotechnology Series: Ted Myles, a leading voice in biotech, shares his experiences with Tufts students&nbsp;&nbsp;The Tufts Daily]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/tufts-biotechnology-series-ted-myles-a-leading-voice-in-biotech-shares-his-experiences-with-tufts-students-the-tufts-daily/</link><pubDate>Thu, 19 Feb 2026 08:03:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/tufts-biotechnology-series-ted-myles-a-leading-voice-in-biotech-shares-his-experiences-with-tufts-students-the-tufts-daily/</guid></item><item><title><![CDATA[Amrita hosts the International SPARC Symposium, bringing together global leaders in Biotechnology, AI, and - ET Edge Insights]]></title><description><![CDATA[Amrita hosts the International SPARC Symposium, bringing together global leaders in Biotechnology, AI, and&nbsp;&nbsp;ET Edge Insights]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/amrita-hosts-the-international-sparc-symposium-bringing-together-global-leaders-in-biotechnology-ai-and-et-edge-insights/</link><pubDate>Thu, 19 Feb 2026 02:42:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/amrita-hosts-the-international-sparc-symposium-bringing-together-global-leaders-in-biotechnology-ai-and-et-edge-insights/</guid></item><item><title><![CDATA[Sabatini, Vir Biotechnology SVP, sells $11918 in stock - Investing.com]]></title><description><![CDATA[Sabatini, Vir Biotechnology SVP, sells $11918 in stock&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sabatini-vir-biotechnology-svp-sells-11918-in-stock-investingcom/</link><pubDate>Wed, 18 Feb 2026 21:58:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sabatini-vir-biotechnology-svp-sells-11918-in-stock-investingcom/</guid></item><item><title><![CDATA[LIXTE Biotechnology (NASDAQ: LIXT) Appoints Sidney Braun as CEO of Liora Technologies Europe Subsidiary - TipRanks]]></title><description><![CDATA[LIXTE Biotechnology (NASDAQ: LIXT) Appoints Sidney Braun as CEO of Liora Technologies Europe Subsidiary&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-nasdaq-lixt-appoints-sidney-braun-as-ceo-of-liora-technologies-europe-subsidiary-tipranks/</link><pubDate>Wed, 18 Feb 2026 18:07:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-nasdaq-lixt-appoints-sidney-braun-as-ceo-of-liora-technologies-europe-subsidiary-tipranks/</guid></item><item><title><![CDATA[Axol buys Newcells’ ophthalmology business to grow drug discovery portfolio - European Biotechnology Magazine]]></title><description><![CDATA[Axol buys Newcells&rsquo; ophthalmology business to grow drug discovery portfolio&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/axol-buys-newcells-ophthalmology-business-to-grow-drug-discovery-portfolio-european-biotechnology-magazine/</link><pubDate>Wed, 18 Feb 2026 16:35:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/axol-buys-newcells-ophthalmology-business-to-grow-drug-discovery-portfolio-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Plant Biotechnology Market Size to Hit USD 158.64 Billion by 2035 - Precedence Research]]></title><description><![CDATA[Plant Biotechnology Market Size to Hit USD 158.64 Billion by 2035&nbsp;&nbsp;Precedence Research]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/plant-biotechnology-market-size-to-hit-usd-15864-billion-by-2035-precedence-research/</link><pubDate>Wed, 18 Feb 2026 14:37:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/plant-biotechnology-market-size-to-hit-usd-15864-billion-by-2035-precedence-research/</guid></item><item><title><![CDATA[New Liora Europe CEO to help advance proton therapy for cancer - Stock Titan]]></title><description><![CDATA[New Liora Europe CEO to help advance proton therapy for cancer&nbsp;&nbsp;Stock Titan]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/new-liora-europe-ceo-to-help-advance-proton-therapy-for-cancer-stock-titan/</link><pubDate>Wed, 18 Feb 2026 14:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/new-liora-europe-ceo-to-help-advance-proton-therapy-for-cancer-stock-titan/</guid></item><item><title><![CDATA[LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary - Yahoo Finance]]></title><description><![CDATA[LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-appoints-sidney-braun-as-ceo-of-its-liora-technologies-europe-ltd-subsidiary-yahoo-finance/</link><pubDate>Wed, 18 Feb 2026 14:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-appoints-sidney-braun-as-ceo-of-its-liora-technologies-europe-ltd-subsidiary-yahoo-finance/</guid></item><item><title><![CDATA[Boehringer drops inhaled gene therapy for cystic fibrosis - European Biotechnology Magazine]]></title><description><![CDATA[Boehringer drops inhaled gene therapy for cystic fibrosis&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/boehringer-drops-inhaled-gene-therapy-for-cystic-fibrosis-european-biotechnology-magazine/</link><pubDate>Wed, 18 Feb 2026 13:56:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/boehringer-drops-inhaled-gene-therapy-for-cystic-fibrosis-european-biotechnology-magazine/</guid></item><item><title><![CDATA[US settlement: Has Bayer untied the Monsanto knot? - European Biotechnology Magazine]]></title><description><![CDATA[US settlement: Has Bayer untied the Monsanto knot?&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/us-settlement-has-bayer-untied-the-monsanto-knot-european-biotechnology-magazine/</link><pubDate>Wed, 18 Feb 2026 12:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/us-settlement-has-bayer-untied-the-monsanto-knot-european-biotechnology-magazine/</guid></item><item><title><![CDATA[International Biotechnology (LON:IBT) Shares Pass Above Two Hundred Day Moving Average - Here's Why - MarketBeat]]></title><description><![CDATA[International Biotechnology (LON:IBT) Shares Pass Above Two Hundred Day Moving Average - Here's Why&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/international-biotechnology-lonibt-shares-pass-above-two-hundred-day-moving-average-heres-why-marketbeat/</link><pubDate>Wed, 18 Feb 2026 09:12:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/international-biotechnology-lonibt-shares-pass-above-two-hundred-day-moving-average-heres-why-marketbeat/</guid></item><item><title><![CDATA[China set to become global hub for biotechnology-based manufacturing - TV BRICS]]></title><description><![CDATA[China set to become global hub for biotechnology-based manufacturing&nbsp;&nbsp;TV BRICS]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/china-set-to-become-global-hub-for-biotechnology-based-manufacturing-tv-brics/</link><pubDate>Wed, 18 Feb 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/china-set-to-become-global-hub-for-biotechnology-based-manufacturing-tv-brics/</guid></item><item><title><![CDATA[The Recent Rash of Biotechnology Risks: A Call to Fortify Force Capability - Institute for National Strategic Studies (INSS)]]></title><description><![CDATA[The Recent Rash of Biotechnology Risks: A Call to Fortify Force Capability&nbsp;&nbsp;Institute for National Strategic Studies (INSS)]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/the-recent-rash-of-biotechnology-risks-a-call-to-fortify-force-capability-institute-for-national-strategic-studies-inss/</link><pubDate>Wed, 18 Feb 2026 03:13:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/the-recent-rash-of-biotechnology-risks-a-call-to-fortify-force-capability-institute-for-national-strategic-studies-inss/</guid></item><item><title><![CDATA[Generative AI and precision medicine fuel rapid growth in biotechnology sector - Healthcare Asia Magazine]]></title><description><![CDATA[Generative AI and precision medicine fuel rapid growth in biotechnology sector&nbsp;&nbsp;Healthcare Asia Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/generative-ai-and-precision-medicine-fuel-rapid-growth-in-biotechnology-sector-healthcare-asia-magazine/</link><pubDate>Wed, 18 Feb 2026 02:19:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/generative-ai-and-precision-medicine-fuel-rapid-growth-in-biotechnology-sector-healthcare-asia-magazine/</guid></item><item><title><![CDATA[AeroVironment Secures Major Defense Contracts, Expanding Drones and Biotechnology - StocksToTrade]]></title><description><![CDATA[AeroVironment Secures Major Defense Contracts, Expanding Drones and Biotechnology&nbsp;&nbsp;StocksToTrade]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/aerovironment-secures-major-defense-contracts-expanding-drones-and-biotechnology-stockstotrade/</link><pubDate>Tue, 17 Feb 2026 22:04:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/aerovironment-secures-major-defense-contracts-expanding-drones-and-biotechnology-stockstotrade/</guid></item><item><title><![CDATA[GelMEDIX: $13 Million Seed Funding Closed For Vision Restoration Biotechnology Platform - Pulse 2.0]]></title><description><![CDATA[GelMEDIX: $13 Million Seed Funding Closed For Vision Restoration Biotechnology Platform&nbsp;&nbsp;Pulse 2.0]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/gelmedix-13-million-seed-funding-closed-for-vision-restoration-biotechnology-platform-pulse-20/</link><pubDate>Tue, 17 Feb 2026 18:53:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/gelmedix-13-million-seed-funding-closed-for-vision-restoration-biotechnology-platform-pulse-20/</guid></item><item><title><![CDATA[Sana Biotechnology, Inc. Appoints Brian Piper as Executive Vice President - marketscreener.com]]></title><description><![CDATA[Sana Biotechnology, Inc. Appoints Brian Piper as Executive Vice President&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-inc-appoints-brian-piper-as-executive-vice-president-marketscreenercom/</link><pubDate>Tue, 17 Feb 2026 18:20:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-inc-appoints-brian-piper-as-executive-vice-president-marketscreenercom/</guid></item><item><title><![CDATA[The Biotechnology Renaissance: AI and Capital Collide in a Multi-Trillion Dollar Pivot - FinancialContent]]></title><description><![CDATA[The Biotechnology Renaissance: AI and Capital Collide in a Multi-Trillion Dollar Pivot&nbsp;&nbsp;FinancialContent]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/the-biotechnology-renaissance-ai-and-capital-collide-in-a-multi-trillion-dollar-pivot-financialcontent/</link><pubDate>Tue, 17 Feb 2026 18:04:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/the-biotechnology-renaissance-ai-and-capital-collide-in-a-multi-trillion-dollar-pivot-financialcontent/</guid></item><item><title><![CDATA[CubaseBio secures €5.9m to scale 3D spatial transcriptomics - European Biotechnology Magazine]]></title><description><![CDATA[CubaseBio secures &euro;5.9m to scale 3D spatial transcriptomics&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cubasebio-secures-59m-to-scale-3d-spatial-transcriptomics-european-biotechnology-magazine/</link><pubDate>Tue, 17 Feb 2026 17:51:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cubasebio-secures-59m-to-scale-3d-spatial-transcriptomics-european-biotechnology-magazine/</guid></item><item><title><![CDATA[AI in Biotechnology Market Size to Reach USD 1,971 Million by 2031 | Valuates Reports - PR Newswire UK]]></title><description><![CDATA[AI in Biotechnology Market Size to Reach USD 1,971 Million by 2031 | Valuates Reports&nbsp;&nbsp;PR Newswire UK]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-market-size-to-reach-usd-1971-million-by-2031-valuates-reports-pr-newswire-uk/</link><pubDate>Tue, 17 Feb 2026 17:24:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-market-size-to-reach-usd-1971-million-by-2031-valuates-reports-pr-newswire-uk/</guid></item><item><title><![CDATA[Democratizing CRISPR? Legal complexity, access and the right to science - Nature]]></title><description><![CDATA[Democratizing CRISPR? Legal complexity, access and the right to science&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/democratizing-crispr-legal-complexity-access-and-the-right-to-science-nature/</link><pubDate>Tue, 17 Feb 2026 17:18:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/democratizing-crispr-legal-complexity-access-and-the-right-to-science-nature/</guid></item><item><title><![CDATA[Sana Biotechnology stock falls after naming new CFO - Investing.com]]></title><description><![CDATA[Sana Biotechnology stock falls after naming new CFO&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-stock-falls-after-naming-new-cfo-investingcom/</link><pubDate>Tue, 17 Feb 2026 16:37:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-stock-falls-after-naming-new-cfo-investingcom/</guid></item><item><title><![CDATA[GSK wins EC approval for Exdensur in severe asthma and CRSwNP - The Pharma Letter]]></title><description><![CDATA[GSK wins EC approval for Exdensur in severe asthma and CRSwNP&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/gsk-wins-ec-approval-for-exdensur-in-severe-asthma-and-crswnp-the-pharma-letter/</link><pubDate>Tue, 17 Feb 2026 16:36:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/gsk-wins-ec-approval-for-exdensur-in-severe-asthma-and-crswnp-the-pharma-letter/</guid></item><item><title><![CDATA[What the Cresco supercomputer is for: from nuclear energy to biotechnology - Il Sole 24 ORE]]></title><description><![CDATA[What the Cresco supercomputer is for: from nuclear energy to biotechnology&nbsp;&nbsp;Il Sole 24 ORE]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/what-the-cresco-supercomputer-is-for-from-nuclear-energy-to-biotechnology-il-sole-24-ore/</link><pubDate>Tue, 17 Feb 2026 15:41:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/what-the-cresco-supercomputer-is-for-from-nuclear-energy-to-biotechnology-il-sole-24-ore/</guid></item><item><title><![CDATA[Sana Biotechnology Names Brian Piper as New CFO - TipRanks]]></title><description><![CDATA[Sana Biotechnology Names Brian Piper as New CFO&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-names-brian-piper-as-new-cfo-tipranks/</link><pubDate>Tue, 17 Feb 2026 15:29:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-names-brian-piper-as-new-cfo-tipranks/</guid></item><item><title><![CDATA[Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer - GlobeNewswire]]></title><description><![CDATA[Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-appoints-brian-piper-as-executive-vice-president-chief-financial-officer-globenewswire/</link><pubDate>Tue, 17 Feb 2026 15:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-appoints-brian-piper-as-executive-vice-president-chief-financial-officer-globenewswire/</guid></item><item><title><![CDATA[Agricultural Biotechnology Market to Reach USD 632.93 Billion - openPR.com]]></title><description><![CDATA[Agricultural Biotechnology Market to Reach USD 632.93 Billion&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/agricultural-biotechnology-market-to-reach-usd-63293-billion-openprcom/</link><pubDate>Tue, 17 Feb 2026 10:50:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/agricultural-biotechnology-market-to-reach-usd-63293-billion-openprcom/</guid></item><item><title><![CDATA[Ultragenyx cuts 10% of workforce as it targets 2027 profitability - The Pharma Letter]]></title><description><![CDATA[Ultragenyx cuts 10% of workforce as it targets 2027 profitability&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ultragenyx-cuts-10-of-workforce-as-it-targets-2027-profitability-the-pharma-letter/</link><pubDate>Mon, 16 Feb 2026 12:39:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ultragenyx-cuts-10-of-workforce-as-it-targets-2027-profitability-the-pharma-letter/</guid></item><item><title><![CDATA[Clinical progress of engineered cellular immunotherapies for autoimmunity - Nature]]></title><description><![CDATA[Clinical progress of engineered cellular immunotherapies for autoimmunity&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/clinical-progress-of-engineered-cellular-immunotherapies-for-autoimmunity-nature/</link><pubDate>Mon, 16 Feb 2026 11:24:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/clinical-progress-of-engineered-cellular-immunotherapies-for-autoimmunity-nature/</guid></item><item><title><![CDATA[Global biotechnology leader joins the Novo Nordisk Foundation as Vice President - Novo Nordisk Fonden]]></title><description><![CDATA[Global biotechnology leader joins the Novo Nordisk Foundation as Vice President&nbsp;&nbsp;Novo Nordisk Fonden]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/global-biotechnology-leader-joins-the-novo-nordisk-foundation-as-vice-president-novo-nordisk-fonden/</link><pubDate>Mon, 16 Feb 2026 10:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/global-biotechnology-leader-joins-the-novo-nordisk-foundation-as-vice-president-novo-nordisk-fonden/</guid></item><item><title><![CDATA[DST endeavouring to chart out futuristics roadmap for biotechnology - Daily Excelsior]]></title><description><![CDATA[DST endeavouring to chart out futuristics roadmap for biotechnology&nbsp;&nbsp;Daily Excelsior]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/dst-endeavouring-to-chart-out-futuristics-roadmap-for-biotechnology-daily-excelsior/</link><pubDate>Mon, 16 Feb 2026 00:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/dst-endeavouring-to-chart-out-futuristics-roadmap-for-biotechnology-daily-excelsior/</guid></item><item><title><![CDATA[17 Biotechnology Stocks with More Than 50% Upside - Insider Monkey]]></title><description><![CDATA[17 Biotechnology Stocks with More Than 50% Upside&nbsp;&nbsp;Insider Monkey]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/17-biotechnology-stocks-with-more-than-50-upside-insider-monkey/</link><pubDate>Sun, 15 Feb 2026 23:45:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/17-biotechnology-stocks-with-more-than-50-upside-insider-monkey/</guid></item><item><title><![CDATA[Jammu and Kashmir Sets Sights on Transformative Biotechnology Policy - Devdiscourse]]></title><description><![CDATA[Jammu and Kashmir Sets Sights on Transformative Biotechnology Policy&nbsp;&nbsp;Devdiscourse]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/jammu-and-kashmir-sets-sights-on-transformative-biotechnology-policy-devdiscourse/</link><pubDate>Sun, 15 Feb 2026 16:21:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/jammu-and-kashmir-sets-sights-on-transformative-biotechnology-policy-devdiscourse/</guid></item><item><title><![CDATA[DST Charts Futuristic Biotechnology Roadmap, Policy for J&amp;K - Brighter Kashmir]]></title><description><![CDATA[DST Charts Futuristic Biotechnology Roadmap, Policy for J&amp;K&nbsp;&nbsp;Brighter Kashmir]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/dst-charts-futuristic-biotechnology-roadmap-policy-for-jampk-brighter-kashmir/</link><pubDate>Sun, 15 Feb 2026 15:26:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/dst-charts-futuristic-biotechnology-roadmap-policy-for-jampk-brighter-kashmir/</guid></item><item><title><![CDATA[Insect Biotechnology Market Anticipated to Achieve USD 9.0 Billion, Recording a Notable 11.8% CAGR Through 2035 - industrytoday.co.uk]]></title><description><![CDATA[Insect Biotechnology Market Anticipated to Achieve USD 9.0 Billion, Recording a Notable 11.8% CAGR Through 2035&nbsp;&nbsp;industrytoday.co.uk]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/insect-biotechnology-market-anticipated-to-achieve-usd-90-billion-recording-a-notable-118-cagr-through-2035-industrytodaycouk/</link><pubDate>Sun, 15 Feb 2026 09:51:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/insect-biotechnology-market-anticipated-to-achieve-usd-90-billion-recording-a-notable-118-cagr-through-2035-industrytodaycouk/</guid></item><item><title><![CDATA[Freya Biosciences Gains Visibility With Nature Biotechnology Feature on Microbiome Therapeutics - TipRanks]]></title><description><![CDATA[Freya Biosciences Gains Visibility With Nature Biotechnology Feature on Microbiome Therapeutics&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/freya-biosciences-gains-visibility-with-nature-biotechnology-feature-on-microbiome-therapeutics-tipranks/</link><pubDate>Sat, 14 Feb 2026 14:19:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/freya-biosciences-gains-visibility-with-nature-biotechnology-feature-on-microbiome-therapeutics-tipranks/</guid></item><item><title><![CDATA[ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Down 27.9% in January - MarketBeat]]></title><description><![CDATA[ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Down 27.9% in January&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/proshares-ultra-nasdaq-biotechnology-nasdaqbib-short-interest-down-279-in-january-marketbeat/</link><pubDate>Sat, 14 Feb 2026 13:39:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/proshares-ultra-nasdaq-biotechnology-nasdaqbib-short-interest-down-279-in-january-marketbeat/</guid></item><item><title><![CDATA[Amrita Hosts International SPARC Symposium Bringing Together Global Leaders in Biotechnology, AI, and Translational Health Research - Dainik Jagran MP CG]]></title><description><![CDATA[Amrita Hosts International SPARC Symposium Bringing Together Global Leaders in Biotechnology, AI, and Translational Health Research&nbsp;&nbsp;Dainik Jagran MP CG]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/amrita-hosts-international-sparc-symposium-bringing-together-global-leaders-in-biotechnology-ai-and-translational-health-research-dainik-jagran-mp-cg/</link><pubDate>Sat, 14 Feb 2026 08:36:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/amrita-hosts-international-sparc-symposium-bringing-together-global-leaders-in-biotechnology-ai-and-translational-health-research-dainik-jagran-mp-cg/</guid></item><item><title><![CDATA[America’s Key to Biotechnology Leadership? AI-Ready Biodata. - Center for a New American Security | CNAS]]></title><description><![CDATA[America&rsquo;s Key to Biotechnology Leadership? AI-Ready Biodata.&nbsp;&nbsp;Center for a New American Security | CNAS]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/americas-key-to-biotechnology-leadership-ai-ready-biodata-center-for-a-new-american-security-cnas/</link><pubDate>Fri, 13 Feb 2026 19:20:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/americas-key-to-biotechnology-leadership-ai-ready-biodata-center-for-a-new-american-security-cnas/</guid></item><item><title><![CDATA[America’s Key to Biotechnology Leadership? AI-Ready Biodata. - Center for a New American Security]]></title><description><![CDATA[America&rsquo;s Key to Biotechnology Leadership? AI-Ready Biodata.&nbsp;&nbsp;Center for a New American Security]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/americas-key-to-biotechnology-leadership-ai-ready-biodata-center-for-a-new-american-security/</link><pubDate>Fri, 13 Feb 2026 19:20:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/americas-key-to-biotechnology-leadership-ai-ready-biodata-center-for-a-new-american-security/</guid></item><item><title><![CDATA[Odisha invites applications for biotechnology research &amp; innovation fellowship - Times of India]]></title><description><![CDATA[Odisha invites applications for biotechnology research &amp; innovation fellowship&nbsp;&nbsp;Times of India]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/odisha-invites-applications-for-biotechnology-research-amp-innovation-fellowship-times-of-india/</link><pubDate>Fri, 13 Feb 2026 17:33:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/odisha-invites-applications-for-biotechnology-research-amp-innovation-fellowship-times-of-india/</guid></item><item><title><![CDATA[Is Sana Biotechnology (SANA) Ready to Balance FDA Scrutiny With Its Cash-Intensive Gene Therapy Vision? - simplywall.st]]></title><description><![CDATA[Is Sana Biotechnology (SANA) Ready to Balance FDA Scrutiny With Its Cash-Intensive Gene Therapy Vision?&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/is-sana-biotechnology-sana-ready-to-balance-fda-scrutiny-with-its-cash-intensive-gene-therapy-vision-simplywallst/</link><pubDate>Fri, 13 Feb 2026 16:26:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/is-sana-biotechnology-sana-ready-to-balance-fda-scrutiny-with-its-cash-intensive-gene-therapy-vision-simplywallst/</guid></item><item><title><![CDATA[America’s Key to Biotechnology Leadership? AI-Ready Biodata. - Just Security]]></title><description><![CDATA[America&rsquo;s Key to Biotechnology Leadership? AI-Ready Biodata.&nbsp;&nbsp;Just Security]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/americas-key-to-biotechnology-leadership-ai-ready-biodata-just-security/</link><pubDate>Fri, 13 Feb 2026 14:36:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/americas-key-to-biotechnology-leadership-ai-ready-biodata-just-security/</guid></item><item><title><![CDATA[Nanjing Anji Biotechnology synthesizes new OGDH inhibitors - BioWorld MedTech]]></title><description><![CDATA[Nanjing Anji Biotechnology synthesizes new OGDH inhibitors&nbsp;&nbsp;BioWorld MedTech]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nanjing-anji-biotechnology-synthesizes-new-ogdh-inhibitors-bioworld-medtech/</link><pubDate>Fri, 13 Feb 2026 14:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nanjing-anji-biotechnology-synthesizes-new-ogdh-inhibitors-bioworld-medtech/</guid></item><item><title><![CDATA[Sana Biotechnology: A Small, Speculative Play (NASDAQ:SANA) - Seeking Alpha]]></title><description><![CDATA[Sana Biotechnology: A Small, Speculative Play (NASDAQ:SANA)&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-a-small-speculative-play-nasdaqsana-seeking-alpha/</link><pubDate>Fri, 13 Feb 2026 09:24:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-a-small-speculative-play-nasdaqsana-seeking-alpha/</guid></item><item><title><![CDATA[Vir Biotechnology, Inc. (VIR) Stock Analysis: A 111.85% Potential Upside Amidst Challenging Metrics - DirectorsTalk Interviews]]></title><description><![CDATA[Vir Biotechnology, Inc. (VIR) Stock Analysis: A 111.85% Potential Upside Amidst Challenging Metrics&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-vir-stock-analysis-a-11185-potential-upside-amidst-challenging-metrics-directorstalk-interviews/</link><pubDate>Fri, 13 Feb 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-vir-stock-analysis-a-11185-potential-upside-amidst-challenging-metrics-directorstalk-interviews/</guid></item><item><title><![CDATA[Freya Biosciences Featured in Nature Biotechnology for Microbiome Therapeutics in Women’s Health - TipRanks]]></title><description><![CDATA[Freya Biosciences Featured in Nature Biotechnology for Microbiome Therapeutics in Women&rsquo;s Health&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/freya-biosciences-featured-in-nature-biotechnology-for-microbiome-therapeutics-in-womens-health-tipranks/</link><pubDate>Fri, 13 Feb 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/freya-biosciences-featured-in-nature-biotechnology-for-microbiome-therapeutics-in-womens-health-tipranks/</guid></item><item><title><![CDATA[Altimmune, Inc. (ALT) Stock Analysis: Exploring A Potential 286% Upside In Biotechnology - DirectorsTalk Interviews]]></title><description><![CDATA[Altimmune, Inc. (ALT) Stock Analysis: Exploring A Potential 286% Upside In Biotechnology&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/altimmune-inc-alt-stock-analysis-exploring-a-potential-286-upside-in-biotechnology-directorstalk-interviews/</link><pubDate>Fri, 13 Feb 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/altimmune-inc-alt-stock-analysis-exploring-a-potential-286-upside-in-biotechnology-directorstalk-interviews/</guid></item><item><title><![CDATA[LIXTE Biotechnology (LIXT) Bringing First-in-Class Approach to Chemo and Immunotherapy - NewMediaWire]]></title><description><![CDATA[LIXTE Biotechnology (LIXT) Bringing First-in-Class Approach to Chemo and Immunotherapy&nbsp;&nbsp;NewMediaWire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-lixt-bringing-first-in-class-approach-to-chemo-and-immunotherapy-newmediawire/</link><pubDate>Thu, 12 Feb 2026 21:45:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-lixt-bringing-first-in-class-approach-to-chemo-and-immunotherapy-newmediawire/</guid></item><item><title><![CDATA[3 Undervalued Biotechnology Stocks for Thursday, February 12 - AAII.com]]></title><description><![CDATA[3 Undervalued Biotechnology Stocks for Thursday, February 12&nbsp;&nbsp;AAII.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/3-undervalued-biotechnology-stocks-for-thursday-february-12-aaiicom/</link><pubDate>Thu, 12 Feb 2026 18:51:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/3-undervalued-biotechnology-stocks-for-thursday-february-12-aaiicom/</guid></item><item><title><![CDATA[3 Undervalued Biotechnology Stocks for Thursday, February 12 - AAII]]></title><description><![CDATA[3 Undervalued Biotechnology Stocks for Thursday, February 12&nbsp;&nbsp;AAII]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/3-undervalued-biotechnology-stocks-for-thursday-february-12-aaii/</link><pubDate>Thu, 12 Feb 2026 18:51:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/3-undervalued-biotechnology-stocks-for-thursday-february-12-aaii/</guid></item><item><title><![CDATA[Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Yahoo Finance]]></title><description><![CDATA[Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Stock's On An Uptrend: Are Strong Financials Guiding The Market?&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-incs-nasdaqpbyi-stocks-on-an-uptrend-are-strong-financials-guiding-the-market-yahoo-finance/</link><pubDate>Thu, 12 Feb 2026 11:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-incs-nasdaqpbyi-stocks-on-an-uptrend-are-strong-financials-guiding-the-market-yahoo-finance/</guid></item><item><title><![CDATA[Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results - Yahoo Finance]]></title><description><![CDATA[Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2025-financial-results-yahoo-finance/</link><pubDate>Thu, 12 Feb 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2025-financial-results-yahoo-finance/</guid></item><item><title><![CDATA[Odisha offers Rs 30,000/month fellowships for research in biotechnology &amp; allied sciences - Times of India]]></title><description><![CDATA[Odisha offers Rs 30,000/month fellowships for research in biotechnology &amp; allied sciences&nbsp;&nbsp;Times of India]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/odisha-offers-rs-30000month-fellowships-for-research-in-biotechnology-amp-allied-sciences-times-of-india/</link><pubDate>Wed, 11 Feb 2026 19:29:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/odisha-offers-rs-30000month-fellowships-for-research-in-biotechnology-amp-allied-sciences-times-of-india/</guid></item><item><title><![CDATA[Teacher Feature: IRC biotechnology educator has most requested class on campus - WPEC]]></title><description><![CDATA[Teacher Feature: IRC biotechnology educator has most requested class on campus&nbsp;&nbsp;WPEC]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/teacher-feature-irc-biotechnology-educator-has-most-requested-class-on-campus-wpec/</link><pubDate>Wed, 11 Feb 2026 16:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/teacher-feature-irc-biotechnology-educator-has-most-requested-class-on-campus-wpec/</guid></item><item><title><![CDATA[How Invesco Dynamic Biotechnology &amp; Genome Etf (PBE) Affects Rotational Strategy Timing - Stock Traders Daily]]></title><description><![CDATA[How Invesco Dynamic Biotechnology &amp; Genome Etf (PBE) Affects Rotational Strategy Timing&nbsp;&nbsp;Stock Traders Daily]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/how-invesco-dynamic-biotechnology-amp-genome-etf-pbe-affects-rotational-strategy-timing-stock-traders-daily/</link><pubDate>Wed, 11 Feb 2026 15:42:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/how-invesco-dynamic-biotechnology-amp-genome-etf-pbe-affects-rotational-strategy-timing-stock-traders-daily/</guid></item><item><title><![CDATA[Global Agriculture Biotechnology Market Set for Strong Growth Through 2030 | North America Leading Innovation - Yahoo Finance]]></title><description><![CDATA[Global Agriculture Biotechnology Market Set for Strong Growth Through 2030 | North America Leading Innovation&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/global-agriculture-biotechnology-market-set-for-strong-growth-through-2030-north-america-leading-innovation-yahoo-finance/</link><pubDate>Wed, 11 Feb 2026 14:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/global-agriculture-biotechnology-market-set-for-strong-growth-through-2030-north-america-leading-innovation-yahoo-finance/</guid></item><item><title><![CDATA[The future of biotechnology is growing on Scotland’s farms - World Bio Market Insights]]></title><description><![CDATA[The future of biotechnology is growing on Scotland&rsquo;s farms&nbsp;&nbsp;World Bio Market Insights]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/the-future-of-biotechnology-is-growing-on-scotlands-farms-world-bio-market-insights/</link><pubDate>Wed, 11 Feb 2026 13:21:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/the-future-of-biotechnology-is-growing-on-scotlands-farms-world-bio-market-insights/</guid></item><item><title><![CDATA[US regulator refuses to review Moderna flu vaccine filing - The Pharma Letter]]></title><description><![CDATA[US regulator refuses to review Moderna flu vaccine filing&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/us-regulator-refuses-to-review-moderna-flu-vaccine-filing-the-pharma-letter/</link><pubDate>Wed, 11 Feb 2026 13:18:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/us-regulator-refuses-to-review-moderna-flu-vaccine-filing-the-pharma-letter/</guid></item><item><title><![CDATA[Fujifilm opens $500 million UK biologics facility - The Pharma Letter]]></title><description><![CDATA[Fujifilm opens $500 million UK biologics facility&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/fujifilm-opens-500-million-uk-biologics-facility-the-pharma-letter/</link><pubDate>Wed, 11 Feb 2026 13:12:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/fujifilm-opens-500-million-uk-biologics-facility-the-pharma-letter/</guid></item><item><title><![CDATA[LIXTE Biotechnology (LIXT) Aligns Liora and LiGHT System With LB-100 to Push Frontier of Cancer Treatment - NewMediaWire]]></title><description><![CDATA[LIXTE Biotechnology (LIXT) Aligns Liora and LiGHT System With LB-100 to Push Frontier of Cancer Treatment&nbsp;&nbsp;NewMediaWire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-lixt-aligns-liora-and-light-system-with-lb-100-to-push-frontier-of-cancer-treatment-newmediawire/</link><pubDate>Tue, 10 Feb 2026 22:56:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-lixt-aligns-liora-and-light-system-with-lb-100-to-push-frontier-of-cancer-treatment-newmediawire/</guid></item><item><title><![CDATA[LIXTE Biotechnology (LIXT) Aligns Liora and LiGHT System With LB-100 to Push Frontier of Cancer Treatment - Yahoo Finance]]></title><description><![CDATA[LIXTE Biotechnology (LIXT) Aligns Liora and LiGHT System With LB-100 to Push Frontier of Cancer Treatment&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-lixt-aligns-liora-and-light-system-with-lb-100-to-push-frontier-of-cancer-treatment-yahoo-finance/</link><pubDate>Tue, 10 Feb 2026 21:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-lixt-aligns-liora-and-light-system-with-lb-100-to-push-frontier-of-cancer-treatment-yahoo-finance/</guid></item><item><title><![CDATA[LIXTE Biotechnology (NASDAQ: LIXT) Aligns Liora and LiGHT System With LB-100 to Push Frontier of Cancer Treatment - Digital Journal]]></title><description><![CDATA[LIXTE Biotechnology (NASDAQ: LIXT) Aligns Liora and LiGHT System With LB-100 to Push Frontier of Cancer Treatment&nbsp;&nbsp;Digital Journal]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-nasdaq-lixt-aligns-liora-and-light-system-with-lb-100-to-push-frontier-of-cancer-treatment-digital-journal/</link><pubDate>Tue, 10 Feb 2026 19:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-nasdaq-lixt-aligns-liora-and-light-system-with-lb-100-to-push-frontier-of-cancer-treatment-digital-journal/</guid></item><item><title><![CDATA[This Memo sticks: CSL bites in Switzerland for antibody collaboration - European Biotechnology Magazine]]></title><description><![CDATA[This Memo sticks: CSL bites in Switzerland for antibody collaboration&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/this-memo-sticks-csl-bites-in-switzerland-for-antibody-collaboration-european-biotechnology-magazine/</link><pubDate>Tue, 10 Feb 2026 18:29:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/this-memo-sticks-csl-bites-in-switzerland-for-antibody-collaboration-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Zhengye Biotechnology issues letter to shareholders - TipRanks]]></title><description><![CDATA[Zhengye Biotechnology issues letter to shareholders&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/zhengye-biotechnology-issues-letter-to-shareholders-tipranks/</link><pubDate>Tue, 10 Feb 2026 16:44:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/zhengye-biotechnology-issues-letter-to-shareholders-tipranks/</guid></item><item><title><![CDATA[Zhengye Biotechnology Holding Limited Issues 2026 Chairman’s Letter to Shareholders - GlobeNewswire]]></title><description><![CDATA[Zhengye Biotechnology Holding Limited Issues 2026 Chairman&rsquo;s Letter to Shareholders&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/zhengye-biotechnology-holding-limited-issues-2026-chairmans-letter-to-shareholders-globenewswire/</link><pubDate>Tue, 10 Feb 2026 14:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/zhengye-biotechnology-holding-limited-issues-2026-chairmans-letter-to-shareholders-globenewswire/</guid></item><item><title><![CDATA[United States Biotechnology Market to hit US$ 1.5 Trillion - openPR.com]]></title><description><![CDATA[United States Biotechnology Market to hit US$ 1.5 Trillion&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/united-states-biotechnology-market-to-hit-us-15-trillion-openprcom/</link><pubDate>Tue, 10 Feb 2026 13:34:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/united-states-biotechnology-market-to-hit-us-15-trillion-openprcom/</guid></item><item><title><![CDATA[US FDA rejection sends Regenxbio shares sharply lower - The Pharma Letter]]></title><description><![CDATA[US FDA rejection sends Regenxbio shares sharply lower&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/us-fda-rejection-sends-regenxbio-shares-sharply-lower-the-pharma-letter/</link><pubDate>Tue, 10 Feb 2026 13:21:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/us-fda-rejection-sends-regenxbio-shares-sharply-lower-the-pharma-letter/</guid></item><item><title><![CDATA[NIST Allocates Over $3 Million to Small Businesses Advancing AI, Biotechnology, Semiconductors, Quantum and More - National Institute of Standards and Technology (.gov)]]></title><description><![CDATA[NIST Allocates Over $3 Million to Small Businesses Advancing AI, Biotechnology, Semiconductors, Quantum and More&nbsp;&nbsp;National Institute of Standards and Technology (.gov)]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nist-allocates-over-3-million-to-small-businesses-advancing-ai-biotechnology-semiconductors-quantum-and-more-national-institute-of-standards-and-technology-gov/</link><pubDate>Tue, 10 Feb 2026 13:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nist-allocates-over-3-million-to-small-businesses-advancing-ai-biotechnology-semiconductors-quantum-and-more-national-institute-of-standards-and-technology-gov/</guid></item><item><title><![CDATA[Identifying 3D signal overlaps in spatial transcriptomics data with ovrlpy - Nature]]></title><description><![CDATA[Identifying 3D signal overlaps in spatial transcriptomics data with ovrlpy&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/identifying-3d-signal-overlaps-in-spatial-transcriptomics-data-with-ovrlpy-nature/</link><pubDate>Tue, 10 Feb 2026 12:09:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/identifying-3d-signal-overlaps-in-spatial-transcriptomics-data-with-ovrlpy-nature/</guid></item><item><title><![CDATA[Developmentally inspired synthetic kidney engineering - Nature]]></title><description><![CDATA[Developmentally inspired synthetic kidney engineering&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/developmentally-inspired-synthetic-kidney-engineering-nature/</link><pubDate>Tue, 10 Feb 2026 11:46:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/developmentally-inspired-synthetic-kidney-engineering-nature/</guid></item><item><title><![CDATA[Self-powered stenosis diagnosis via a magnetoelastic vascular graft - Nature]]></title><description><![CDATA[Self-powered stenosis diagnosis via a magnetoelastic vascular graft&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/self-powered-stenosis-diagnosis-via-a-magnetoelastic-vascular-graft-nature/</link><pubDate>Tue, 10 Feb 2026 11:39:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/self-powered-stenosis-diagnosis-via-a-magnetoelastic-vascular-graft-nature/</guid></item><item><title><![CDATA[Hemodynamics-driven magnetoelastic vascular grafts for stenosis diagnosis - Nature]]></title><description><![CDATA[Hemodynamics-driven magnetoelastic vascular grafts for stenosis diagnosis&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/hemodynamics-driven-magnetoelastic-vascular-grafts-for-stenosis-diagnosis-nature/</link><pubDate>Tue, 10 Feb 2026 11:39:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/hemodynamics-driven-magnetoelastic-vascular-grafts-for-stenosis-diagnosis-nature/</guid></item><item><title><![CDATA[AI-enabled vascular grafts monitor blood flow - Nature]]></title><description><![CDATA[AI-enabled vascular grafts monitor blood flow&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ai-enabled-vascular-grafts-monitor-blood-flow-nature/</link><pubDate>Tue, 10 Feb 2026 11:39:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ai-enabled-vascular-grafts-monitor-blood-flow-nature/</guid></item><item><title><![CDATA[Puma Biotechnology (NASDAQ:PBYI) Shares Pass Above 200-Day Moving Average - What's Next? - MarketBeat]]></title><description><![CDATA[Puma Biotechnology (NASDAQ:PBYI) Shares Pass Above 200-Day Moving Average - What's Next?&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-nasdaqpbyi-shares-pass-above-200-day-moving-average-whats-next-marketbeat/</link><pubDate>Tue, 10 Feb 2026 09:59:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-nasdaqpbyi-shares-pass-above-200-day-moving-average-whats-next-marketbeat/</guid></item><item><title><![CDATA[International Biotechnology (LON:IBT) Share Price Crosses Above 200 Day Moving Average - Time to Sell? - MarketBeat]]></title><description><![CDATA[International Biotechnology (LON:IBT) Share Price Crosses Above 200 Day Moving Average - Time to Sell?&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/international-biotechnology-lonibt-share-price-crosses-above-200-day-moving-average-time-to-sell-marketbeat/</link><pubDate>Tue, 10 Feb 2026 09:56:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/international-biotechnology-lonibt-share-price-crosses-above-200-day-moving-average-time-to-sell-marketbeat/</guid></item><item><title><![CDATA[Vir Biotechnology to unveil Q4 and full year 2025 earnings results - Traders Union]]></title><description><![CDATA[Vir Biotechnology to unveil Q4 and full year 2025 earnings results&nbsp;&nbsp;Traders Union]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-to-unveil-q4-and-full-year-2025-earnings-results-traders-union/</link><pubDate>Mon, 09 Feb 2026 22:20:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-to-unveil-q4-and-full-year-2025-earnings-results-traders-union/</guid></item><item><title><![CDATA[Vir Biotechnology to Host Conference Call for Fourth Quarter and Full Year 2025 Financial Results - Business Wire]]></title><description><![CDATA[Vir Biotechnology to Host Conference Call for Fourth Quarter and Full Year 2025 Financial Results&nbsp;&nbsp;Business Wire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-to-host-conference-call-for-fourth-quarter-and-full-year-2025-financial-results-business-wire/</link><pubDate>Mon, 09 Feb 2026 22:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-to-host-conference-call-for-fourth-quarter-and-full-year-2025-financial-results-business-wire/</guid></item><item><title><![CDATA[LIXTE Biotechnology (LIXT) Positions LB-100 to Expand Effectiveness of Standard Cancer Treatment - Yahoo Finance]]></title><description><![CDATA[LIXTE Biotechnology (LIXT) Positions LB-100 to Expand Effectiveness of Standard Cancer Treatment&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-lixt-positions-lb-100-to-expand-effectiveness-of-standard-cancer-treatment-yahoo-finance/</link><pubDate>Mon, 09 Feb 2026 21:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-lixt-positions-lb-100-to-expand-effectiveness-of-standard-cancer-treatment-yahoo-finance/</guid></item><item><title><![CDATA[Marine Biotechnology Market to Reach USD 10.37 Billion by 2032, - openPR.com]]></title><description><![CDATA[Marine Biotechnology Market to Reach USD 10.37 Billion by 2032,&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/marine-biotechnology-market-to-reach-usd-1037-billion-by-2032-openprcom/</link><pubDate>Mon, 09 Feb 2026 15:53:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/marine-biotechnology-market-to-reach-usd-1037-billion-by-2032-openprcom/</guid></item><item><title><![CDATA[Lilly deepens Innovent ties with $350 million oncology and immunology pact - The Pharma Letter]]></title><description><![CDATA[Lilly deepens Innovent ties with $350 million oncology and immunology pact&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lilly-deepens-innovent-ties-with-350-million-oncology-and-immunology-pact-the-pharma-letter/</link><pubDate>Mon, 09 Feb 2026 14:53:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lilly-deepens-innovent-ties-with-350-million-oncology-and-immunology-pact-the-pharma-letter/</guid></item><item><title><![CDATA[Vir Biotechnology (NASDAQ:VIR) Earns Buy Rating from Needham &amp; Company LLC - MarketBeat]]></title><description><![CDATA[Vir Biotechnology (NASDAQ:VIR) Earns Buy Rating from Needham &amp; Company LLC&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-earns-buy-rating-from-needham-amp-company-llc-marketbeat/</link><pubDate>Mon, 09 Feb 2026 14:17:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-earns-buy-rating-from-needham-amp-company-llc-marketbeat/</guid></item><item><title><![CDATA[China Resources Pharma Launches RMB1.42 Billion Tender to Sell Tianmai Biotechnology Stake - TipRanks]]></title><description><![CDATA[China Resources Pharma Launches RMB1.42 Billion Tender to Sell Tianmai Biotechnology Stake&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/china-resources-pharma-launches-rmb142-billion-tender-to-sell-tianmai-biotechnology-stake-tipranks/</link><pubDate>Mon, 09 Feb 2026 13:13:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/china-resources-pharma-launches-rmb142-billion-tender-to-sell-tianmai-biotechnology-stake-tipranks/</guid></item><item><title><![CDATA[Nano-Biotechnology Market to Reach US$ 270.56 Billion by 2033 - openPR.com]]></title><description><![CDATA[Nano-Biotechnology Market to Reach US$ 270.56 Billion by 2033&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nano-biotechnology-market-to-reach-us-27056-billion-by-2033-openprcom/</link><pubDate>Mon, 09 Feb 2026 12:41:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nano-biotechnology-market-to-reach-us-27056-billion-by-2033-openprcom/</guid></item><item><title><![CDATA[A Mexican biotechnology company turns microalgae into climate change solutions - Noticias Ambientales]]></title><description><![CDATA[A Mexican biotechnology company turns microalgae into climate change solutions&nbsp;&nbsp;Noticias Ambientales]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/a-mexican-biotechnology-company-turns-microalgae-into-climate-change-solutions-noticias-ambientales/</link><pubDate>Mon, 09 Feb 2026 11:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/a-mexican-biotechnology-company-turns-microalgae-into-climate-change-solutions-noticias-ambientales/</guid></item><item><title><![CDATA[Massive explosion in biotechnology company at China's Shanxi Province, 8 killed after trapped in Debris; what was the cause? - DNA India]]></title><description><![CDATA[Massive explosion in biotechnology company at China's Shanxi Province, 8 killed after trapped in Debris; what was the cause?&nbsp;&nbsp;DNA India]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/massive-explosion-in-biotechnology-company-at-chinas-shanxi-province-8-killed-after-trapped-in-debris-what-was-the-cause-dna-india/</link><pubDate>Mon, 09 Feb 2026 02:18:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/massive-explosion-in-biotechnology-company-at-chinas-shanxi-province-8-killed-after-trapped-in-debris-what-was-the-cause-dna-india/</guid></item><item><title><![CDATA[Arrowhead Pharmaceuticals, Inc.(NasdaqGS: ARWR) added to S&amp;P 400 - Biotechnology - marketscreener.com]]></title><description><![CDATA[Arrowhead Pharmaceuticals, Inc.(NasdaqGS: ARWR) added to S&amp;P 400 - Biotechnology&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/arrowhead-pharmaceuticals-incnasdaqgs-arwr-added-to-sampp-400-biotechnology-marketscreenercom/</link><pubDate>Mon, 09 Feb 2026 01:27:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/arrowhead-pharmaceuticals-incnasdaqgs-arwr-added-to-sampp-400-biotechnology-marketscreenercom/</guid></item><item><title><![CDATA[Eight Killed in Explosion at Biotechnology Factory in Northern China - Jordan News]]></title><description><![CDATA[Eight Killed in Explosion at Biotechnology Factory in Northern China&nbsp;&nbsp;Jordan News]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/eight-killed-in-explosion-at-biotechnology-factory-in-northern-china-jordan-news/</link><pubDate>Sun, 08 Feb 2026 18:59:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/eight-killed-in-explosion-at-biotechnology-factory-in-northern-china-jordan-news/</guid></item><item><title><![CDATA[Deadly explosion at Chinese biotechnology plant kills 8 - خبرگزاری صدای افغان(آوا)]]></title><description><![CDATA[Deadly explosion at Chinese biotechnology plant kills 8&nbsp;&nbsp;&#1582;&#1576;&#1585;&#1711;&#1586;&#1575;&#1585;&#1740; &#1589;&#1583;&#1575;&#1740; &#1575;&#1601;&#1594;&#1575;&#1606;(&#1570;&#1608;&#1575;)]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/deadly-explosion-at-chinese-biotechnology-plant-kills-8-/</link><pubDate>Sun, 08 Feb 2026 18:45:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/deadly-explosion-at-chinese-biotechnology-plant-kills-8-/</guid></item><item><title><![CDATA[Biotechnology to steer accelerated green growth of the future, say experts - The Hindu]]></title><description><![CDATA[Biotechnology to steer accelerated green growth of the future, say experts&nbsp;&nbsp;The Hindu]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-to-steer-accelerated-green-growth-of-the-future-say-experts-the-hindu/</link><pubDate>Sun, 08 Feb 2026 17:44:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-to-steer-accelerated-green-growth-of-the-future-say-experts-the-hindu/</guid></item><item><title><![CDATA[Explosion occurres at biotechnology company in China: eight people killed, dark yellow - Українські Новини]]></title><description><![CDATA[Explosion occurres at biotechnology company in China: eight people killed, dark yellow&nbsp;&nbsp;&#1059;&#1082;&#1088;&#1072;&#1111;&#1085;&#1089;&#1100;&#1082;&#1110; &#1053;&#1086;&#1074;&#1080;&#1085;&#1080;]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/explosion-occurres-at-biotechnology-company-in-china-eight-people-killed-dark-yellow-/</link><pubDate>Sun, 08 Feb 2026 13:03:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/explosion-occurres-at-biotechnology-company-in-china-eight-people-killed-dark-yellow-/</guid></item><item><title><![CDATA[D.E.S.I.G.N. for BioE3 challenge opens nationwide, invites school students to pitch biotechnology solutio - Times of India]]></title><description><![CDATA[D.E.S.I.G.N. for BioE3 challenge opens nationwide, invites school students to pitch biotechnology solutio&nbsp;&nbsp;Times of India]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/design-for-bioe3-challenge-opens-nationwide-invites-school-students-to-pitch-biotechnology-solutio-times-of-india/</link><pubDate>Sun, 08 Feb 2026 11:57:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/design-for-bioe3-challenge-opens-nationwide-invites-school-students-to-pitch-biotechnology-solutio-times-of-india/</guid></item><item><title><![CDATA[Nature of Things: Beer – the first biotechnology - Daily Republic]]></title><description><![CDATA[Nature of Things: Beer &ndash; the first biotechnology&nbsp;&nbsp;Daily Republic]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nature-of-things-beer-the-first-biotechnology-daily-republic/</link><pubDate>Sun, 08 Feb 2026 11:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nature-of-things-beer-the-first-biotechnology-daily-republic/</guid></item><item><title><![CDATA[China Biotechnology Plant Blast Kills 8 in Shanxi - Khaama Press]]></title><description><![CDATA[China Biotechnology Plant Blast Kills 8 in Shanxi&nbsp;&nbsp;Khaama Press]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/china-biotechnology-plant-blast-kills-8-in-shanxi-khaama-press/</link><pubDate>Sun, 08 Feb 2026 09:14:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/china-biotechnology-plant-blast-kills-8-in-shanxi-khaama-press/</guid></item><item><title><![CDATA[5 dead in explosion at biotechnology workshop in Shanxi - China Daily]]></title><description><![CDATA[5 dead in explosion at biotechnology workshop in Shanxi&nbsp;&nbsp;China Daily]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/5-dead-in-explosion-at-biotechnology-workshop-in-shanxi-china-daily/</link><pubDate>Sat, 07 Feb 2026 07:10:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/5-dead-in-explosion-at-biotechnology-workshop-in-shanxi-china-daily/</guid></item><item><title><![CDATA[Congratulations to Holmdel Teen: Biotechnology High School Senior Annika Raj Honored With Jersey Shore YMCA Youth Changemaker Award - TAPinto]]></title><description><![CDATA[Congratulations to Holmdel Teen: Biotechnology High School Senior Annika Raj Honored With Jersey Shore YMCA Youth Changemaker Award&nbsp;&nbsp;TAPinto]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/congratulations-to-holmdel-teen-biotechnology-high-school-senior-annika-raj-honored-with-jersey-shore-ymca-youth-changemaker-award-tapinto/</link><pubDate>Fri, 06 Feb 2026 20:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/congratulations-to-holmdel-teen-biotechnology-high-school-senior-annika-raj-honored-with-jersey-shore-ymca-youth-changemaker-award-tapinto/</guid></item><item><title><![CDATA[Charles R. Drew University Launches Support Program for Biotechnology Entrepreneurs - The Journal of Blacks in Higher Education]]></title><description><![CDATA[Charles R. Drew University Launches Support Program for Biotechnology Entrepreneurs&nbsp;&nbsp;The Journal of Blacks in Higher Education]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/charles-r-drew-university-launches-support-program-for-biotechnology-entrepreneurs-the-journal-of-blacks-in-higher-education/</link><pubDate>Fri, 06 Feb 2026 19:43:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/charles-r-drew-university-launches-support-program-for-biotechnology-entrepreneurs-the-journal-of-blacks-in-higher-education/</guid></item><item><title><![CDATA[Kelun-Biotech expands label in China breast cancer market - The Pharma Letter]]></title><description><![CDATA[Kelun-Biotech expands label in China breast cancer market&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/kelun-biotech-expands-label-in-china-breast-cancer-market-the-pharma-letter/</link><pubDate>Fri, 06 Feb 2026 17:14:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/kelun-biotech-expands-label-in-china-breast-cancer-market-the-pharma-letter/</guid></item><item><title><![CDATA[Research into innovative biotechnology materials. - Mercedes-Benz Group]]></title><description><![CDATA[Research into innovative biotechnology materials.&nbsp;&nbsp;Mercedes-Benz Group]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/research-into-innovative-biotechnology-materials-mercedes-benz-group/</link><pubDate>Fri, 06 Feb 2026 13:50:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/research-into-innovative-biotechnology-materials-mercedes-benz-group/</guid></item><item><title><![CDATA[Research into innovative biotechnology materials. - Mercedes-Benz]]></title><description><![CDATA[Research into innovative biotechnology materials.&nbsp;&nbsp;Mercedes-Benz]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/research-into-innovative-biotechnology-materials-mercedes-benz/</link><pubDate>Fri, 06 Feb 2026 13:50:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/research-into-innovative-biotechnology-materials-mercedes-benz/</guid></item><item><title><![CDATA[Single-round evolution of RNA aptamers with GRAPE-LM - Nature]]></title><description><![CDATA[Single-round evolution of RNA aptamers with GRAPE-LM&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/single-round-evolution-of-rna-aptamers-with-grape-lm-nature/</link><pubDate>Fri, 06 Feb 2026 13:28:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/single-round-evolution-of-rna-aptamers-with-grape-lm-nature/</guid></item><item><title><![CDATA[ASARI - Postdoctoral Position in Algal Biotechnology job with MOHAMMED VI POLYTECHNIC UNIVERSITY | 407088 - Times Higher Education]]></title><description><![CDATA[ASARI - Postdoctoral Position in Algal Biotechnology job with MOHAMMED VI POLYTECHNIC UNIVERSITY | 407088&nbsp;&nbsp;Times Higher Education]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/asari-postdoctoral-position-in-algal-biotechnology-job-with-mohammed-vi-polytechnic-university-407088-times-higher-education/</link><pubDate>Fri, 06 Feb 2026 13:04:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/asari-postdoctoral-position-in-algal-biotechnology-job-with-mohammed-vi-polytechnic-university-407088-times-higher-education/</guid></item><item><title><![CDATA[Applications are open for investment support in digital technologies and biotechnology. - Sul Informação]]></title><description><![CDATA[Applications are open for investment support in digital technologies and biotechnology.&nbsp;&nbsp;Sul Informa&ccedil;&atilde;o]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/applications-are-open-for-investment-support-in-digital-technologies-and-biotechnology-sul-informao/</link><pubDate>Fri, 06 Feb 2026 13:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/applications-are-open-for-investment-support-in-digital-technologies-and-biotechnology-sul-informao/</guid></item><item><title><![CDATA[Cambridge clears path for £3 billion infrastructure boost - The Pharma Letter]]></title><description><![CDATA[Cambridge clears path for &pound;3 billion infrastructure boost&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cambridge-clears-path-for-3-billion-infrastructure-boost-the-pharma-letter/</link><pubDate>Fri, 06 Feb 2026 12:07:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cambridge-clears-path-for-3-billion-infrastructure-boost-the-pharma-letter/</guid></item><item><title><![CDATA[Agricultural Biotechnology Market Demand, Growth, and Future - openPR.com]]></title><description><![CDATA[Agricultural Biotechnology Market Demand, Growth, and Future&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/agricultural-biotechnology-market-demand-growth-and-future-openprcom/</link><pubDate>Fri, 06 Feb 2026 10:52:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/agricultural-biotechnology-market-demand-growth-and-future-openprcom/</guid></item><item><title><![CDATA[ICGEB South African Women in Biotechnology Programme SAWBP – Postdoctoral Fellowship 2026 for South African women Researchers. - Opportunities For Africans]]></title><description><![CDATA[ICGEB South African Women in Biotechnology Programme SAWBP &ndash; Postdoctoral Fellowship 2026 for South African women Researchers.&nbsp;&nbsp;Opportunities For Africans]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/icgeb-south-african-women-in-biotechnology-programme-sawbp-postdoctoral-fellowship-2026-for-south-african-women-researchers-opportunities-for-africans/</link><pubDate>Fri, 06 Feb 2026 07:49:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/icgeb-south-african-women-in-biotechnology-programme-sawbp-postdoctoral-fellowship-2026-for-south-african-women-researchers-opportunities-for-africans/</guid></item><item><title><![CDATA[Vir Biotechnology: The Low-Down On The Readouts Ahead - Seeking Alpha]]></title><description><![CDATA[Vir Biotechnology: The Low-Down On The Readouts Ahead&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-the-low-down-on-the-readouts-ahead-seeking-alpha/</link><pubDate>Fri, 06 Feb 2026 03:24:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-the-low-down-on-the-readouts-ahead-seeking-alpha/</guid></item><item><title><![CDATA[Oz Medicann Group Strengthens Australia’s Role in Global Biotechnology Through a Strategic Partnership with NeoCannBio. – Get The Word Out - Press Release Distribution Australia]]></title><description><![CDATA[Oz Medicann Group Strengthens Australia&rsquo;s Role in Global Biotechnology Through a Strategic Partnership with NeoCannBio. &ndash; Get The Word Out&nbsp;&nbsp;Press Release Distribution Australia]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/oz-medicann-group-strengthens-australias-role-in-global-biotechnology-through-a-strategic-partnership-with-neocannbio-get-the-word-out-press-release-distribution-australia/</link><pubDate>Fri, 06 Feb 2026 01:48:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/oz-medicann-group-strengthens-australias-role-in-global-biotechnology-through-a-strategic-partnership-with-neocannbio-get-the-word-out-press-release-distribution-australia/</guid></item><item><title><![CDATA[PIUG 2026 Joint Annual and Biotechnology Conference - IPWatchdog.com]]></title><description><![CDATA[PIUG 2026 Joint Annual and Biotechnology Conference&nbsp;&nbsp;IPWatchdog.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/piug-2026-joint-annual-and-biotechnology-conference-ipwatchdogcom/</link><pubDate>Thu, 05 Feb 2026 23:34:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/piug-2026-joint-annual-and-biotechnology-conference-ipwatchdogcom/</guid></item><item><title><![CDATA[NSCEB Fact Sheet Offers Biotechnology Solutions for Critical Minerals - lawbc.com]]></title><description><![CDATA[NSCEB Fact Sheet Offers Biotechnology Solutions for Critical Minerals&nbsp;&nbsp;lawbc.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nsceb-fact-sheet-offers-biotechnology-solutions-for-critical-minerals-lawbccom/</link><pubDate>Thu, 05 Feb 2026 22:25:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nsceb-fact-sheet-offers-biotechnology-solutions-for-critical-minerals-lawbccom/</guid></item><item><title><![CDATA[Improving the Odds: How LIXTE Biotechnology (LIXT) Is Working to Make Cancer Therapies More Effective - Yahoo Finance]]></title><description><![CDATA[Improving the Odds: How LIXTE Biotechnology (LIXT) Is Working to Make Cancer Therapies More Effective&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/improving-the-odds-how-lixte-biotechnology-lixt-is-working-to-make-cancer-therapies-more-effective-yahoo-finance/</link><pubDate>Thu, 05 Feb 2026 20:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/improving-the-odds-how-lixte-biotechnology-lixt-is-working-to-make-cancer-therapies-more-effective-yahoo-finance/</guid></item><item><title><![CDATA[Sana Biotechnology’s Hypoimmune Platform Shows Promise in Type-1 Diabetes Treatment - AD HOC NEWS]]></title><description><![CDATA[Sana Biotechnology&rsquo;s Hypoimmune Platform Shows Promise in Type-1 Diabetes Treatment&nbsp;&nbsp;AD HOC NEWS]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnologys-hypoimmune-platform-shows-promise-in-type-1-diabetes-treatment-ad-hoc-news/</link><pubDate>Thu, 05 Feb 2026 20:11:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnologys-hypoimmune-platform-shows-promise-in-type-1-diabetes-treatment-ad-hoc-news/</guid></item><item><title><![CDATA[Kos biotechnology fund invests in sector consultancy Epikast - eKathimerini.com]]></title><description><![CDATA[Kos biotechnology fund invests in sector consultancy Epikast&nbsp;&nbsp;eKathimerini.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/kos-biotechnology-fund-invests-in-sector-consultancy-epikast-ekathimerinicom/</link><pubDate>Thu, 05 Feb 2026 18:48:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/kos-biotechnology-fund-invests-in-sector-consultancy-epikast-ekathimerinicom/</guid></item><item><title><![CDATA[Nautilus Biotechnology explores multiomics to mitigate space travel effects - Traders Union]]></title><description><![CDATA[Nautilus Biotechnology explores multiomics to mitigate space travel effects&nbsp;&nbsp;Traders Union]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-explores-multiomics-to-mitigate-space-travel-effects-traders-union/</link><pubDate>Thu, 05 Feb 2026 18:16:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-explores-multiomics-to-mitigate-space-travel-effects-traders-union/</guid></item><item><title><![CDATA[Webinar on biotechnology education to be held on February 8 - thehindu.com]]></title><description><![CDATA[Webinar on biotechnology education to be held on February 8&nbsp;&nbsp;thehindu.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/webinar-on-biotechnology-education-to-be-held-on-february-8-thehinducom/</link><pubDate>Thu, 05 Feb 2026 16:24:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/webinar-on-biotechnology-education-to-be-held-on-february-8-thehinducom/</guid></item><item><title><![CDATA[Medicine, where do the non-admitted go? One in three to biotechnology. Here are the chosen related courses - Il Sole 24 ORE]]></title><description><![CDATA[Medicine, where do the non-admitted go? One in three to biotechnology. Here are the chosen related courses&nbsp;&nbsp;Il Sole 24 ORE]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/medicine-where-do-the-non-admitted-go-one-in-three-to-biotechnology-here-are-the-chosen-related-courses-il-sole-24-ore/</link><pubDate>Thu, 05 Feb 2026 15:29:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/medicine-where-do-the-non-admitted-go-one-in-three-to-biotechnology-here-are-the-chosen-related-courses-il-sole-24-ore/</guid></item><item><title><![CDATA[Zhengye Biotechnology Holding L (ZYBT): An Investor Outlook on its Market Position and Challenges - DirectorsTalk Interviews]]></title><description><![CDATA[Zhengye Biotechnology Holding L (ZYBT): An Investor Outlook on its Market Position and Challenges&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/zhengye-biotechnology-holding-l-zybt-an-investor-outlook-on-its-market-position-and-challenges-directorstalk-interviews/</link><pubDate>Thu, 05 Feb 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/zhengye-biotechnology-holding-l-zybt-an-investor-outlook-on-its-market-position-and-challenges-directorstalk-interviews/</guid></item><item><title><![CDATA[Webinar on biotechnology education to be held on February 8 - The Hindu]]></title><description><![CDATA[Webinar on biotechnology education to be held on February 8&nbsp;&nbsp;The Hindu]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/webinar-on-biotechnology-education-to-be-held-on-february-8-the-hindu/</link><pubDate>Thu, 05 Feb 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/webinar-on-biotechnology-education-to-be-held-on-february-8-the-hindu/</guid></item><item><title><![CDATA[NSCEB Fact Sheet Offers Biotechnology Solutions for Critical Minerals - Bergeson &amp; Campbell]]></title><description><![CDATA[NSCEB Fact Sheet Offers Biotechnology Solutions for Critical Minerals&nbsp;&nbsp;Bergeson &amp; Campbell]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nsceb-fact-sheet-offers-biotechnology-solutions-for-critical-minerals-bergeson-amp-campbell/</link><pubDate>Thu, 05 Feb 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nsceb-fact-sheet-offers-biotechnology-solutions-for-critical-minerals-bergeson-amp-campbell/</guid></item><item><title><![CDATA[Anbio Biotechnology (NNNN) Stock Analysis: Navigating Challenges with Global Reach in Rapid Diagnostics - DirectorsTalk Interviews]]></title><description><![CDATA[Anbio Biotechnology (NNNN) Stock Analysis: Navigating Challenges with Global Reach in Rapid Diagnostics&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-nnnn-stock-analysis-navigating-challenges-with-global-reach-in-rapid-diagnostics-directorstalk-interviews/</link><pubDate>Thu, 05 Feb 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-nnnn-stock-analysis-navigating-challenges-with-global-reach-in-rapid-diagnostics-directorstalk-interviews/</guid></item><item><title><![CDATA[OECD Paper Compares Regulatory Environments for Biotechnology and Biosolutions between the EU and United States - lawbc.com]]></title><description><![CDATA[OECD Paper Compares Regulatory Environments for Biotechnology and Biosolutions between the EU and United States&nbsp;&nbsp;lawbc.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/oecd-paper-compares-regulatory-environments-for-biotechnology-and-biosolutions-between-the-eu-and-united-states-lawbccom/</link><pubDate>Thu, 05 Feb 2026 01:21:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/oecd-paper-compares-regulatory-environments-for-biotechnology-and-biosolutions-between-the-eu-and-united-states-lawbccom/</guid></item><item><title><![CDATA[Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule - TradingView]]></title><description><![CDATA[Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule&nbsp;&nbsp;TradingView]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-tradingview/</link><pubDate>Wed, 04 Feb 2026 23:58:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-tradingview/</guid></item><item><title><![CDATA[Biotechnology for agro-industries and the bioeconomy: challenges for European expansion - INRAE]]></title><description><![CDATA[Biotechnology for agro-industries and the bioeconomy: challenges for European expansion&nbsp;&nbsp;INRAE]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-for-agro-industries-and-the-bioeconomy-challenges-for-european-expansion-inrae/</link><pubDate>Wed, 04 Feb 2026 20:49:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-for-agro-industries-and-the-bioeconomy-challenges-for-european-expansion-inrae/</guid></item><item><title><![CDATA[J&amp;K Ingredients, biotechnology company partner on freshness - Food Business News]]></title><description><![CDATA[J&amp;K Ingredients, biotechnology company partner on freshness&nbsp;&nbsp;Food Business News]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/jampk-ingredients-biotechnology-company-partner-on-freshness-food-business-news/</link><pubDate>Wed, 04 Feb 2026 20:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/jampk-ingredients-biotechnology-company-partner-on-freshness-food-business-news/</guid></item><item><title><![CDATA[Vir Biotechnology (NASDAQ:VIR) Director Vicki Sato Sells 22,000 Shares - MarketBeat]]></title><description><![CDATA[Vir Biotechnology (NASDAQ:VIR) Director Vicki Sato Sells 22,000 Shares&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-director-vicki-sato-sells-22000-shares-marketbeat/</link><pubDate>Tue, 03 Feb 2026 21:07:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-nasdaqvir-director-vicki-sato-sells-22000-shares-marketbeat/</guid></item><item><title><![CDATA[Investor Mood: How does Puma Biotechnology Inc. compare to its peers - Risk Management &amp; Risk Controlled Stock Alerts - baoquankhu1.vn]]></title><description><![CDATA[Investor Mood: How does Puma Biotechnology Inc. compare to its peers - Risk Management &amp; Risk Controlled Stock Alerts&nbsp;&nbsp;baoquankhu1.vn]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/investor-mood-how-does-puma-biotechnology-inc-compare-to-its-peers-risk-management-amp-risk-controlled-stock-alerts-baoquankhu1vn/</link><pubDate>Tue, 03 Feb 2026 20:37:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/investor-mood-how-does-puma-biotechnology-inc-compare-to-its-peers-risk-management-amp-risk-controlled-stock-alerts-baoquankhu1vn/</guid></item><item><title><![CDATA[Vir Biotechnology director Sato sells $169k in stock By Investing.com - Investing.com India]]></title><description><![CDATA[Vir Biotechnology director Sato sells $169k in stock By Investing.com&nbsp;&nbsp;Investing.com India]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-director-sato-sells-169k-in-stock-by-investingcom-investingcom-india/</link><pubDate>Tue, 03 Feb 2026 19:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-director-sato-sells-169k-in-stock-by-investingcom-investingcom-india/</guid></item><item><title><![CDATA[Vir Biotechnology director Sato sells $169k in stock - Investing.com]]></title><description><![CDATA[Vir Biotechnology director Sato sells $169k in stock&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-director-sato-sells-169k-in-stock-investingcom/</link><pubDate>Tue, 03 Feb 2026 18:58:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-director-sato-sells-169k-in-stock-investingcom/</guid></item><item><title><![CDATA[Biotechnology Sector Faces Headwinds as Key ETF Navigates Challenges - AD HOC NEWS]]></title><description><![CDATA[Biotechnology Sector Faces Headwinds as Key ETF Navigates Challenges&nbsp;&nbsp;AD HOC NEWS]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-sector-faces-headwinds-as-key-etf-navigates-challenges-ad-hoc-news/</link><pubDate>Tue, 03 Feb 2026 16:33:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-sector-faces-headwinds-as-key-etf-navigates-challenges-ad-hoc-news/</guid></item><item><title><![CDATA[How can enhanced research and development facilities in biotechnology support the ‘Make in India’ initiative? - The Avenue Mail]]></title><description><![CDATA[How can enhanced research and development facilities in biotechnology support the &lsquo;Make in India&rsquo; initiative?&nbsp;&nbsp;The Avenue Mail]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/how-can-enhanced-research-and-development-facilities-in-biotechnology-support-the-make-in-india-initiative-the-avenue-mail/</link><pubDate>Tue, 03 Feb 2026 13:28:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/how-can-enhanced-research-and-development-facilities-in-biotechnology-support-the-make-in-india-initiative-the-avenue-mail/</guid></item><item><title><![CDATA[Zelluna promotes Emilie Gauthy to chief technology officer - The Pharma Letter]]></title><description><![CDATA[Zelluna promotes Emilie Gauthy to chief technology officer&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/zelluna-promotes-emilie-gauthy-to-chief-technology-officer-the-pharma-letter/</link><pubDate>Tue, 03 Feb 2026 13:22:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/zelluna-promotes-emilie-gauthy-to-chief-technology-officer-the-pharma-letter/</guid></item><item><title><![CDATA[WuXi licenses trispecific immune engager to Vertex - The Pharma Letter]]></title><description><![CDATA[WuXi licenses trispecific immune engager to Vertex&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/wuxi-licenses-trispecific-immune-engager-to-vertex-the-pharma-letter/</link><pubDate>Tue, 03 Feb 2026 13:22:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/wuxi-licenses-trispecific-immune-engager-to-vertex-the-pharma-letter/</guid></item><item><title><![CDATA[Wave regains WVE-006 rights, speeds AATD strategy - The Pharma Letter]]></title><description><![CDATA[Wave regains WVE-006 rights, speeds AATD strategy&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/wave-regains-wve-006-rights-speeds-aatd-strategy-the-pharma-letter/</link><pubDate>Tue, 03 Feb 2026 12:11:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/wave-regains-wve-006-rights-speeds-aatd-strategy-the-pharma-letter/</guid></item><item><title><![CDATA[SK bioscience in-licenses RSV preventive antibody from Gates MRI - The Pharma Letter]]></title><description><![CDATA[SK bioscience in-licenses RSV preventive antibody from Gates MRI&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sk-bioscience-in-licenses-rsv-preventive-antibody-from-gates-mri-the-pharma-letter/</link><pubDate>Tue, 03 Feb 2026 11:59:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sk-bioscience-in-licenses-rsv-preventive-antibody-from-gates-mri-the-pharma-letter/</guid></item><item><title><![CDATA[East Knox FFA shines in state biotech contest - Your Ohio News]]></title><description><![CDATA[East Knox FFA shines in state biotech contest&nbsp;&nbsp;Your Ohio News]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/east-knox-ffa-shines-in-state-biotech-contest-your-ohio-news/</link><pubDate>Tue, 03 Feb 2026 11:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/east-knox-ffa-shines-in-state-biotech-contest-your-ohio-news/</guid></item><item><title><![CDATA[United States Organ-On-Chip Market Merges Biotechnology - openPR.com]]></title><description><![CDATA[United States Organ-On-Chip Market Merges Biotechnology&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/united-states-organ-on-chip-market-merges-biotechnology-openprcom/</link><pubDate>Tue, 03 Feb 2026 10:54:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/united-states-organ-on-chip-market-merges-biotechnology-openprcom/</guid></item><item><title><![CDATA[Sartorius returns to a path of profitable growth in 2025 - European Biotechnology Magazine]]></title><description><![CDATA[Sartorius returns to a path of profitable growth in 2025&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sartorius-returns-to-a-path-of-profitable-growth-in-2025-european-biotechnology-magazine/</link><pubDate>Tue, 03 Feb 2026 09:29:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sartorius-returns-to-a-path-of-profitable-growth-in-2025-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Scholar Rock Holding Corporation (SRRK): Biotechnology Innovator with Promising Upside and Robust Buy Ratings - DirectorsTalk Interviews]]></title><description><![CDATA[Scholar Rock Holding Corporation (SRRK): Biotechnology Innovator with Promising Upside and Robust Buy Ratings&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/scholar-rock-holding-corporation-srrk-biotechnology-innovator-with-promising-upside-and-robust-buy-ratings-directorstalk-interviews/</link><pubDate>Tue, 03 Feb 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/scholar-rock-holding-corporation-srrk-biotechnology-innovator-with-promising-upside-and-robust-buy-ratings-directorstalk-interviews/</guid></item><item><title><![CDATA[CG Oncology, Inc. (CGON) Stock Analysis: Biotechnology Innovator with a 45.78% Potential Upside - DirectorsTalk Interviews]]></title><description><![CDATA[CG Oncology, Inc. (CGON) Stock Analysis: Biotechnology Innovator with a 45.78% Potential Upside&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cg-oncology-inc-cgon-stock-analysis-biotechnology-innovator-with-a-4578-potential-upside-directorstalk-interviews/</link><pubDate>Tue, 03 Feb 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cg-oncology-inc-cgon-stock-analysis-biotechnology-innovator-with-a-4578-potential-upside-directorstalk-interviews/</guid></item><item><title><![CDATA[Arcellx, Inc. (ACLX) Stock Analysis: Unveiling A 61.73% Potential Upside In Biotechnology - DirectorsTalk Interviews]]></title><description><![CDATA[Arcellx, Inc. (ACLX) Stock Analysis: Unveiling A 61.73% Potential Upside In Biotechnology&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/arcellx-inc-aclx-stock-analysis-unveiling-a-6173-potential-upside-in-biotechnology-directorstalk-interviews/</link><pubDate>Tue, 03 Feb 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/arcellx-inc-aclx-stock-analysis-unveiling-a-6173-potential-upside-in-biotechnology-directorstalk-interviews/</guid></item><item><title><![CDATA[CBIS Secures $1 Million Federal Grant to Advance Biotechnology Research and Translation - Rensselaer Polytechnic Institute (RPI)]]></title><description><![CDATA[CBIS Secures $1 Million Federal Grant to Advance Biotechnology Research and Translation&nbsp;&nbsp;Rensselaer Polytechnic Institute (RPI)]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cbis-secures-1-million-federal-grant-to-advance-biotechnology-research-and-translation-rensselaer-polytechnic-institute-rpi/</link><pubDate>Mon, 02 Feb 2026 18:22:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cbis-secures-1-million-federal-grant-to-advance-biotechnology-research-and-translation-rensselaer-polytechnic-institute-rpi/</guid></item><item><title><![CDATA[Delaware Biotechnology Institute director appointed - University of Delaware]]></title><description><![CDATA[Delaware Biotechnology Institute director appointed&nbsp;&nbsp;University of Delaware]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/delaware-biotechnology-institute-director-appointed-university-of-delaware/</link><pubDate>Mon, 02 Feb 2026 17:26:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/delaware-biotechnology-institute-director-appointed-university-of-delaware/</guid></item><item><title><![CDATA[National Academies Welcome Inaugural Cohort of Biotechnology Regulatory Fellowship Fellows - National Academies of Sciences, Engineering, and Medicine]]></title><description><![CDATA[National Academies Welcome Inaugural Cohort of Biotechnology Regulatory Fellowship Fellows&nbsp;&nbsp;National Academies of Sciences, Engineering, and Medicine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/national-academies-welcome-inaugural-cohort-of-biotechnology-regulatory-fellowship-fellows-national-academies-of-sciences-engineering-and-medicine/</link><pubDate>Mon, 02 Feb 2026 17:07:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/national-academies-welcome-inaugural-cohort-of-biotechnology-regulatory-fellowship-fellows-national-academies-of-sciences-engineering-and-medicine/</guid></item><item><title><![CDATA[Reprogramming CRISPR–Cas enzymes for customized genome editing - Nature]]></title><description><![CDATA[Reprogramming CRISPR&ndash;Cas enzymes for customized genome editing&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/reprogramming-crisprcas-enzymes-for-customized-genome-editing-nature/</link><pubDate>Mon, 02 Feb 2026 17:06:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/reprogramming-crisprcas-enzymes-for-customized-genome-editing-nature/</guid></item><item><title><![CDATA[Illumina buys SomaLogic in bid to expand proteomics reach - The Pharma Letter]]></title><description><![CDATA[Illumina buys SomaLogic in bid to expand proteomics reach&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/illumina-buys-somalogic-in-bid-to-expand-proteomics-reach-the-pharma-letter/</link><pubDate>Mon, 02 Feb 2026 15:39:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/illumina-buys-somalogic-in-bid-to-expand-proteomics-reach-the-pharma-letter/</guid></item><item><title><![CDATA[Origami and Ipsen join forces on protein degradation in neuroscience - European Biotechnology Magazine]]></title><description><![CDATA[Origami and Ipsen join forces on protein degradation in neuroscience&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/origami-and-ipsen-join-forces-on-protein-degradation-in-neuroscience-european-biotechnology-magazine/</link><pubDate>Mon, 02 Feb 2026 12:41:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/origami-and-ipsen-join-forces-on-protein-degradation-in-neuroscience-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Customizing CRISPR–Cas PAM specificity with protein language models - Nature]]></title><description><![CDATA[Customizing CRISPR&ndash;Cas PAM specificity with protein language models&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/customizing-crisprcas-pam-specificity-with-protein-language-models-nature/</link><pubDate>Mon, 02 Feb 2026 12:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/customizing-crisprcas-pam-specificity-with-protein-language-models-nature/</guid></item><item><title><![CDATA[Global Biotechnology Market Size, Share, Forecast &amp; Technology Analysis Report 2025-2033 - openPR.com]]></title><description><![CDATA[Global Biotechnology Market Size, Share, Forecast &amp; Technology Analysis Report 2025-2033&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/global-biotechnology-market-size-share-forecast-amp-technology-analysis-report-2025-2033-openprcom/</link><pubDate>Mon, 02 Feb 2026 09:52:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/global-biotechnology-market-size-share-forecast-amp-technology-analysis-report-2025-2033-openprcom/</guid></item><item><title><![CDATA[Kos Biotechnology Partners Makes First Investment While Leading Epikast Financing Round - Pulse 2.0]]></title><description><![CDATA[Kos Biotechnology Partners Makes First Investment While Leading Epikast Financing Round&nbsp;&nbsp;Pulse 2.0]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/kos-biotechnology-partners-makes-first-investment-while-leading-epikast-financing-round-pulse-20/</link><pubDate>Sun, 01 Feb 2026 04:31:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/kos-biotechnology-partners-makes-first-investment-while-leading-epikast-financing-round-pulse-20/</guid></item><item><title><![CDATA[PDS Biotechnology: Regulatory Agreement Paves Way for Accelerated Cancer Therapy Review - AD HOC NEWS]]></title><description><![CDATA[PDS Biotechnology: Regulatory Agreement Paves Way for Accelerated Cancer Therapy Review&nbsp;&nbsp;AD HOC NEWS]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-regulatory-agreement-paves-way-for-accelerated-cancer-therapy-review-ad-hoc-news/</link><pubDate>Sat, 31 Jan 2026 15:25:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-regulatory-agreement-paves-way-for-accelerated-cancer-therapy-review-ad-hoc-news/</guid></item><item><title><![CDATA[International Biotechnology (LON:IBT) Stock Passes Above 200 Day Moving Average - Here's Why - MarketBeat]]></title><description><![CDATA[International Biotechnology (LON:IBT) Stock Passes Above 200 Day Moving Average - Here's Why&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/international-biotechnology-lonibt-stock-passes-above-200-day-moving-average-heres-why-marketbeat/</link><pubDate>Sat, 31 Jan 2026 09:34:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/international-biotechnology-lonibt-stock-passes-above-200-day-moving-average-heres-why-marketbeat/</guid></item><item><title><![CDATA[Editorial: Exploration of marine microorganisms for sustainable biotechnology - Frontiers]]></title><description><![CDATA[Editorial: Exploration of marine microorganisms for sustainable biotechnology&nbsp;&nbsp;Frontiers]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/editorial-exploration-of-marine-microorganisms-for-sustainable-biotechnology-frontiers/</link><pubDate>Fri, 30 Jan 2026 22:51:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/editorial-exploration-of-marine-microorganisms-for-sustainable-biotechnology-frontiers/</guid></item><item><title><![CDATA[Kos Biotechnology Partners Announces Inaugural Investment, Leads Epikast's Financing Round - PR Newswire]]></title><description><![CDATA[Kos Biotechnology Partners Announces Inaugural Investment, Leads Epikast's Financing Round&nbsp;&nbsp;PR Newswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/kos-biotechnology-partners-announces-inaugural-investment-leads-epikasts-financing-round-pr-newswire/</link><pubDate>Fri, 30 Jan 2026 19:04:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/kos-biotechnology-partners-announces-inaugural-investment-leads-epikasts-financing-round-pr-newswire/</guid></item><item><title><![CDATA[Sana Biotechnology (SANA) Is Up 5.46% in One Week: What You Should Know - Nasdaq]]></title><description><![CDATA[Sana Biotechnology (SANA) Is Up 5.46% in One Week: What You Should Know&nbsp;&nbsp;Nasdaq]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-is-up-546-in-one-week-what-you-should-know-nasdaq/</link><pubDate>Fri, 30 Jan 2026 18:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-is-up-546-in-one-week-what-you-should-know-nasdaq/</guid></item><item><title><![CDATA[J&amp;K partners with biotechnology company - Bakingbusiness.com]]></title><description><![CDATA[J&amp;K partners with biotechnology company&nbsp;&nbsp;Bakingbusiness.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/jampk-partners-with-biotechnology-company-bakingbusinesscom/</link><pubDate>Fri, 30 Jan 2026 14:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/jampk-partners-with-biotechnology-company-bakingbusinesscom/</guid></item><item><title><![CDATA[As US food aid retreats, can BRICS+ and biotechnology fill the world’s food security gap? - Peterson Institute for International Economics]]></title><description><![CDATA[As US food aid retreats, can BRICS+ and biotechnology fill the world&rsquo;s food security gap?&nbsp;&nbsp;Peterson Institute for International Economics]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/as-us-food-aid-retreats-can-brics-and-biotechnology-fill-the-worlds-food-security-gap-peterson-institute-for-international-economics/</link><pubDate>Fri, 30 Jan 2026 13:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/as-us-food-aid-retreats-can-brics-and-biotechnology-fill-the-worlds-food-security-gap-peterson-institute-for-international-economics/</guid></item><item><title><![CDATA[US regulator accepts Summit filing for ivonescimab combo - The Pharma Letter]]></title><description><![CDATA[US regulator accepts Summit filing for ivonescimab combo&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/us-regulator-accepts-summit-filing-for-ivonescimab-combo-the-pharma-letter/</link><pubDate>Fri, 30 Jan 2026 12:48:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/us-regulator-accepts-summit-filing-for-ivonescimab-combo-the-pharma-letter/</guid></item><item><title><![CDATA[Agomab Therapeutics sets terms for Nasdaq IPO - The Pharma Letter]]></title><description><![CDATA[Agomab Therapeutics sets terms for Nasdaq IPO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/agomab-therapeutics-sets-terms-for-nasdaq-ipo-the-pharma-letter/</link><pubDate>Fri, 30 Jan 2026 12:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/agomab-therapeutics-sets-terms-for-nasdaq-ipo-the-pharma-letter/</guid></item><item><title><![CDATA[Humacyte, Inc. (HUMA) Stock Analysis: Biotechnology Innovator with a 648% Potential Upside - DirectorsTalk Interviews]]></title><description><![CDATA[Humacyte, Inc. (HUMA) Stock Analysis: Biotechnology Innovator with a 648% Potential Upside&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/humacyte-inc-huma-stock-analysis-biotechnology-innovator-with-a-648-potential-upside-directorstalk-interviews/</link><pubDate>Fri, 30 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/humacyte-inc-huma-stock-analysis-biotechnology-innovator-with-a-648-potential-upside-directorstalk-interviews/</guid></item><item><title><![CDATA[NSCEB Paper Outlines Policy Options to Modernize Oversight of Biotechnology Products - Bergeson &amp; Campbell]]></title><description><![CDATA[NSCEB Paper Outlines Policy Options to Modernize Oversight of Biotechnology Products&nbsp;&nbsp;Bergeson &amp; Campbell]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nsceb-paper-outlines-policy-options-to-modernize-oversight-of-biotechnology-products-bergeson-amp-campbell/</link><pubDate>Fri, 30 Jan 2026 03:33:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nsceb-paper-outlines-policy-options-to-modernize-oversight-of-biotechnology-products-bergeson-amp-campbell/</guid></item><item><title><![CDATA[Taiwan's strategic embrace of biotechnology - nhk.or.jp]]></title><description><![CDATA[Taiwan's strategic embrace of biotechnology&nbsp;&nbsp;nhk.or.jp]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/taiwans-strategic-embrace-of-biotechnology-nhkorjp/</link><pubDate>Fri, 30 Jan 2026 02:55:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/taiwans-strategic-embrace-of-biotechnology-nhkorjp/</guid></item><item><title><![CDATA[Biotechnology Firm to Relocate HQ in Boston - Commercial Search]]></title><description><![CDATA[Biotechnology Firm to Relocate HQ in Boston&nbsp;&nbsp;Commercial Search]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-firm-to-relocate-hq-in-boston-commercial-search/</link><pubDate>Thu, 29 Jan 2026 14:03:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-firm-to-relocate-hq-in-boston-commercial-search/</guid></item><item><title><![CDATA[UCSD, Allele Biotechnology Developing 3D-Printed Liver Transplants - San Diego Business Journal]]></title><description><![CDATA[UCSD, Allele Biotechnology Developing 3D-Printed Liver Transplants&nbsp;&nbsp;San Diego Business Journal]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ucsd-allele-biotechnology-developing-3d-printed-liver-transplants-san-diego-business-journal/</link><pubDate>Thu, 29 Jan 2026 14:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ucsd-allele-biotechnology-developing-3d-printed-liver-transplants-san-diego-business-journal/</guid></item><item><title><![CDATA[WuXi Biologics, Sinorda team up on bispecific antibody for IBD - The Pharma Letter]]></title><description><![CDATA[WuXi Biologics, Sinorda team up on bispecific antibody for IBD&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/wuxi-biologics-sinorda-team-up-on-bispecific-antibody-for-ibd-the-pharma-letter/</link><pubDate>Thu, 29 Jan 2026 13:40:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/wuxi-biologics-sinorda-team-up-on-bispecific-antibody-for-ibd-the-pharma-letter/</guid></item><item><title><![CDATA[John Gurdon 1933–2025 - Nature]]></title><description><![CDATA[John Gurdon 1933&ndash;2025&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/john-gurdon-19332025-nature/</link><pubDate>Thu, 29 Jan 2026 12:27:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/john-gurdon-19332025-nature/</guid></item><item><title><![CDATA[Sanofi ends 2025 on a high, but trims R&amp;D priorities - European Biotechnology Magazine]]></title><description><![CDATA[Sanofi ends 2025 on a high, but trims R&amp;D priorities&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sanofi-ends-2025-on-a-high-but-trims-rampd-priorities-european-biotechnology-magazine/</link><pubDate>Thu, 29 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sanofi-ends-2025-on-a-high-but-trims-rampd-priorities-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Oxford team engineer quantum-enabled proteins, opening a new frontier in biotechnology - India Education Diary]]></title><description><![CDATA[Oxford team engineer quantum-enabled proteins, opening a new frontier in biotechnology&nbsp;&nbsp;India Education Diary]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/oxford-team-engineer-quantum-enabled-proteins-opening-a-new-frontier-in-biotechnology-india-education-diary/</link><pubDate>Thu, 29 Jan 2026 08:06:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/oxford-team-engineer-quantum-enabled-proteins-opening-a-new-frontier-in-biotechnology-india-education-diary/</guid></item><item><title><![CDATA[CBSE Board Exams 2026: Check Important Questions From Biotechnology Question Paper - NDTV]]></title><description><![CDATA[CBSE Board Exams 2026: Check Important Questions From Biotechnology Question Paper&nbsp;&nbsp;NDTV]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cbse-board-exams-2026-check-important-questions-from-biotechnology-question-paper-ndtv/</link><pubDate>Thu, 29 Jan 2026 07:17:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cbse-board-exams-2026-check-important-questions-from-biotechnology-question-paper-ndtv/</guid></item><item><title><![CDATA[Charting the future of marine biotechnology: educational strategies for empowering Europe’s blue bioeconomy workforce - Frontiers]]></title><description><![CDATA[Charting the future of marine biotechnology: educational strategies for empowering Europe&rsquo;s blue bioeconomy workforce&nbsp;&nbsp;Frontiers]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/charting-the-future-of-marine-biotechnology-educational-strategies-for-empowering-europes-blue-bioeconomy-workforce-frontiers/</link><pubDate>Wed, 28 Jan 2026 22:56:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/charting-the-future-of-marine-biotechnology-educational-strategies-for-empowering-europes-blue-bioeconomy-workforce-frontiers/</guid></item><item><title><![CDATA[Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage - The Manila Times]]></title><description><![CDATA[Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage&nbsp;&nbsp;The Manila Times]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/siren-biotechnology-announces-fda-clearance-of-first-ind-advancing-company-to-clinical-stage-the-manila-times/</link><pubDate>Wed, 28 Jan 2026 18:04:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/siren-biotechnology-announces-fda-clearance-of-first-ind-advancing-company-to-clinical-stage-the-manila-times/</guid></item><item><title><![CDATA[Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage - GlobeNewswire]]></title><description><![CDATA[Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/siren-biotechnology-announces-fda-clearance-of-first-ind-advancing-company-to-clinical-stage-globenewswire/</link><pubDate>Wed, 28 Jan 2026 18:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/siren-biotechnology-announces-fda-clearance-of-first-ind-advancing-company-to-clinical-stage-globenewswire/</guid></item><item><title><![CDATA[China again: Boehringer turns to Shanghai for IBD bispecific - European Biotechnology Magazine]]></title><description><![CDATA[China again: Boehringer turns to Shanghai for IBD bispecific&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/china-again-boehringer-turns-to-shanghai-for-ibd-bispecific-european-biotechnology-magazine/</link><pubDate>Wed, 28 Jan 2026 13:57:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/china-again-boehringer-turns-to-shanghai-for-ibd-bispecific-european-biotechnology-magazine/</guid></item><item><title><![CDATA[AV’s UES Awarded $75 Million Task Order Extending Contract to Advance Biotechnology and Smart Materials for the U.S. Air Force – Company Announcement - FT.com - Financial Times]]></title><description><![CDATA[AV&rsquo;s UES Awarded $75 Million Task Order Extending Contract to Advance Biotechnology and Smart Materials for the U.S. Air Force &ndash; Company Announcement - FT.com&nbsp;&nbsp;Financial Times]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/avs-ues-awarded-75-million-task-order-extending-contract-to-advance-biotechnology-and-smart-materials-for-the-us-air-force-company-announcement-ftcom-financial-times/</link><pubDate>Wed, 28 Jan 2026 13:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/avs-ues-awarded-75-million-task-order-extending-contract-to-advance-biotechnology-and-smart-materials-for-the-us-air-force-company-announcement-ftcom-financial-times/</guid></item><item><title><![CDATA[Agricultural Biotechnology Market Surges at 8.7% CAGR by 2031: Innovations Fueling Sustainable Farming Revolution - industrytoday.co.uk]]></title><description><![CDATA[Agricultural Biotechnology Market Surges at 8.7% CAGR by 2031: Innovations Fueling Sustainable Farming Revolution&nbsp;&nbsp;industrytoday.co.uk]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/agricultural-biotechnology-market-surges-at-87-cagr-by-2031-innovations-fueling-sustainable-farming-revolution-industrytodaycouk/</link><pubDate>Wed, 28 Jan 2026 09:25:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/agricultural-biotechnology-market-surges-at-87-cagr-by-2031-innovations-fueling-sustainable-farming-revolution-industrytodaycouk/</guid></item><item><title><![CDATA[Supporting Research and Development in Biotechnology and Biosolutions (Denmark) - fundsforNGOs]]></title><description><![CDATA[Supporting Research and Development in Biotechnology and Biosolutions (Denmark)&nbsp;&nbsp;fundsforNGOs]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/supporting-research-and-development-in-biotechnology-and-biosolutions-denmark-fundsforngos/</link><pubDate>Wed, 28 Jan 2026 06:41:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/supporting-research-and-development-in-biotechnology-and-biosolutions-denmark-fundsforngos/</guid></item><item><title><![CDATA[How whey powers the next wave of innovation - DairyReporter.com]]></title><description><![CDATA[How whey powers the next wave of innovation&nbsp;&nbsp;DairyReporter.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/how-whey-powers-the-next-wave-of-innovation-dairyreportercom/</link><pubDate>Tue, 27 Jan 2026 17:19:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/how-whey-powers-the-next-wave-of-innovation-dairyreportercom/</guid></item><item><title><![CDATA[Chinese TCR-T biotech NewCure raises $28 million - The Pharma Letter]]></title><description><![CDATA[Chinese TCR-T biotech NewCure raises $28 million&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/chinese-tcr-t-biotech-newcure-raises-28-million-the-pharma-letter/</link><pubDate>Tue, 27 Jan 2026 12:07:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/chinese-tcr-t-biotech-newcure-raises-28-million-the-pharma-letter/</guid></item><item><title><![CDATA[China approves first hepatitis D treatment, from Huahui - The Pharma Letter]]></title><description><![CDATA[China approves first hepatitis D treatment, from Huahui&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/china-approves-first-hepatitis-d-treatment-from-huahui-the-pharma-letter/</link><pubDate>Tue, 27 Jan 2026 12:07:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/china-approves-first-hepatitis-d-treatment-from-huahui-the-pharma-letter/</guid></item><item><title><![CDATA[Single-cell proteomic landscape of the developing human brain - Nature]]></title><description><![CDATA[Single-cell proteomic landscape of the developing human brain&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/single-cell-proteomic-landscape-of-the-developing-human-brain-nature/</link><pubDate>Tue, 27 Jan 2026 11:24:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/single-cell-proteomic-landscape-of-the-developing-human-brain-nature/</guid></item><item><title><![CDATA[Some Biotechnology Product Reviews Have Gotten Faster, Despite Changing Regulations - The Breakthrough Institute]]></title><description><![CDATA[Some Biotechnology Product Reviews Have Gotten Faster, Despite Changing Regulations&nbsp;&nbsp;The Breakthrough Institute]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/some-biotechnology-product-reviews-have-gotten-faster-despite-changing-regulations-the-breakthrough-institute/</link><pubDate>Tue, 27 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/some-biotechnology-product-reviews-have-gotten-faster-despite-changing-regulations-the-breakthrough-institute/</guid></item><item><title><![CDATA[Guosen Securities 2026 Investment Strategy for Pharmaceutical and Biotechnology Industry: Focus on Innovation Overseas and Emphasize New Technological Directions - 富途牛牛]]></title><description><![CDATA[Guosen Securities 2026 Investment Strategy for Pharmaceutical and Biotechnology Industry: Focus on Innovation Overseas and Emphasize New Technological Directions&nbsp;&nbsp;&#23500;&#36884;&#29275;&#29275;]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/guosen-securities-2026-investment-strategy-for-pharmaceutical-and-biotechnology-industry-focus-on-innovation-overseas-and-emphasize-new-technological-directions-/</link><pubDate>Tue, 27 Jan 2026 04:11:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/guosen-securities-2026-investment-strategy-for-pharmaceutical-and-biotechnology-industry-focus-on-innovation-overseas-and-emphasize-new-technological-directions-/</guid></item><item><title><![CDATA[Earnings due 28 Jan 2026: AVE.AX stock Avecho Biotechnology ASX eyes catalyst - Meyka]]></title><description><![CDATA[Earnings due 28 Jan 2026: AVE.AX stock Avecho Biotechnology ASX eyes catalyst&nbsp;&nbsp;Meyka]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-due-28-jan-2026-aveax-stock-avecho-biotechnology-asx-eyes-catalyst-meyka/</link><pubDate>Tue, 27 Jan 2026 03:06:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/earnings-due-28-jan-2026-aveax-stock-avecho-biotechnology-asx-eyes-catalyst-meyka/</guid></item><item><title><![CDATA[Watch Vir Biotechnology CEO Sees Progress in the Fight Against Cancer - Bloomberg.com]]></title><description><![CDATA[Watch Vir Biotechnology CEO Sees Progress in the Fight Against Cancer&nbsp;&nbsp;Bloomberg.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/watch-vir-biotechnology-ceo-sees-progress-in-the-fight-against-cancer-bloombergcom/</link><pubDate>Mon, 26 Jan 2026 18:40:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/watch-vir-biotechnology-ceo-sees-progress-in-the-fight-against-cancer-bloombergcom/</guid></item><item><title><![CDATA[Watch Vir Biotechnology CEO Sees Progress in the Fight Against Cancer - Bloomberg]]></title><description><![CDATA[Watch Vir Biotechnology CEO Sees Progress in the Fight Against Cancer&nbsp;&nbsp;Bloomberg]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/watch-vir-biotechnology-ceo-sees-progress-in-the-fight-against-cancer-bloomberg/</link><pubDate>Mon, 26 Jan 2026 18:40:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/watch-vir-biotechnology-ceo-sees-progress-in-the-fight-against-cancer-bloomberg/</guid></item><item><title><![CDATA[HanchorBio taps WuXi to industrialize fusion-protein pipeline - The Pharma Letter]]></title><description><![CDATA[HanchorBio taps WuXi to industrialize fusion-protein pipeline&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/hanchorbio-taps-wuxi-to-industrialize-fusion-protein-pipeline-the-pharma-letter/</link><pubDate>Mon, 26 Jan 2026 17:44:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/hanchorbio-taps-wuxi-to-industrialize-fusion-protein-pipeline-the-pharma-letter/</guid></item><item><title><![CDATA[/C O R R E C T I O N -- SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD/ - PR Newswire]]></title><description><![CDATA[/C O R R E C T I O N -- SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD/&nbsp;&nbsp;PR Newswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/c-o-r-r-e-c-t-i-o-n-shanghai-moyom-biotechnology-co-ltd-pr-newswire/</link><pubDate>Mon, 26 Jan 2026 15:48:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/c-o-r-r-e-c-t-i-o-n-shanghai-moyom-biotechnology-co-ltd-pr-newswire/</guid></item><item><title><![CDATA[Shandong Boan Biotechnology’s Controlling Shareholder to Complete H-Share Transfer - TipRanks]]></title><description><![CDATA[Shandong Boan Biotechnology&rsquo;s Controlling Shareholder to Complete H-Share Transfer&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/shandong-boan-biotechnologys-controlling-shareholder-to-complete-h-share-transfer-tipranks/</link><pubDate>Mon, 26 Jan 2026 15:09:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/shandong-boan-biotechnologys-controlling-shareholder-to-complete-h-share-transfer-tipranks/</guid></item><item><title><![CDATA[Blue Biotechnology Market Size to Hit USD 12.26 Billion by - GlobeNewswire]]></title><description><![CDATA[Blue Biotechnology Market Size to Hit USD 12.26 Billion by&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/blue-biotechnology-market-size-to-hit-usd-1226-billion-by-globenewswire/</link><pubDate>Mon, 26 Jan 2026 15:02:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/blue-biotechnology-market-size-to-hit-usd-1226-billion-by-globenewswire/</guid></item><item><title><![CDATA[DU concludes 11th Int’l Plant Tissue Culture, Biotechnology conference 2026 - dhakatribune.com]]></title><description><![CDATA[DU concludes 11th Int&rsquo;l Plant Tissue Culture, Biotechnology conference 2026&nbsp;&nbsp;dhakatribune.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/du-concludes-11th-intl-plant-tissue-culture-biotechnology-conference-2026-dhakatribunecom/</link><pubDate>Mon, 26 Jan 2026 14:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/du-concludes-11th-intl-plant-tissue-culture-biotechnology-conference-2026-dhakatribunecom/</guid></item><item><title><![CDATA[DU concludes 11th Int’l Plant Tissue Culture, Biotechnology conference 2026 - Dhaka Tribune]]></title><description><![CDATA[DU concludes 11th Int&rsquo;l Plant Tissue Culture, Biotechnology conference 2026&nbsp;&nbsp;Dhaka Tribune]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/du-concludes-11th-intl-plant-tissue-culture-biotechnology-conference-2026-dhaka-tribune/</link><pubDate>Mon, 26 Jan 2026 14:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/du-concludes-11th-intl-plant-tissue-culture-biotechnology-conference-2026-dhaka-tribune/</guid></item><item><title><![CDATA[Anbio Biotechnology Strengthens Board Oversight With Appointment of Michael Zhang as Audit Committee Chair - TipRanks]]></title><description><![CDATA[Anbio Biotechnology Strengthens Board Oversight With Appointment of Michael Zhang as Audit Committee Chair&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-strengthens-board-oversight-with-appointment-of-michael-zhang-as-audit-committee-chair-tipranks/</link><pubDate>Mon, 26 Jan 2026 12:57:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-strengthens-board-oversight-with-appointment-of-michael-zhang-as-audit-committee-chair-tipranks/</guid></item><item><title><![CDATA[A Syrian woman’s passion for science blossoms in the world of biotechnology - United Kingdom for UNHCR]]></title><description><![CDATA[A Syrian woman&rsquo;s passion for science blossoms in the world of biotechnology&nbsp;&nbsp;United Kingdom for UNHCR]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/a-syrian-womans-passion-for-science-blossoms-in-the-world-of-biotechnology-united-kingdom-for-unhcr/</link><pubDate>Mon, 26 Jan 2026 12:32:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/a-syrian-womans-passion-for-science-blossoms-in-the-world-of-biotechnology-united-kingdom-for-unhcr/</guid></item><item><title><![CDATA[AGRONOVA Biotech Integrates Asfertglobal to Expand Global Agricultural Biotechnology Platform - iGrow News]]></title><description><![CDATA[AGRONOVA Biotech Integrates Asfertglobal to Expand Global Agricultural Biotechnology Platform&nbsp;&nbsp;iGrow News]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/agronova-biotech-integrates-asfertglobal-to-expand-global-agricultural-biotechnology-platform-igrow-news/</link><pubDate>Mon, 26 Jan 2026 11:20:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/agronova-biotech-integrates-asfertglobal-to-expand-global-agricultural-biotechnology-platform-igrow-news/</guid></item><item><title><![CDATA[Biotechnology Instrument Market Anticipated to Reach 120.0 USD Billion, at a Notable 4.1% CAGR by 2035 - industrytoday.co.uk]]></title><description><![CDATA[Biotechnology Instrument Market Anticipated to Reach 120.0 USD Billion, at a Notable 4.1% CAGR by 2035&nbsp;&nbsp;industrytoday.co.uk]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-instrument-market-anticipated-to-reach-1200-usd-billion-at-a-notable-41-cagr-by-2035-industrytodaycouk/</link><pubDate>Mon, 26 Jan 2026 11:13:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-instrument-market-anticipated-to-reach-1200-usd-billion-at-a-notable-41-cagr-by-2035-industrytodaycouk/</guid></item><item><title><![CDATA[/C O R R E C T I O N -- SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD/ - Yahoo Finance]]></title><description><![CDATA[/C O R R E C T I O N -- SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD/&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/c-o-r-r-e-c-t-i-o-n-shanghai-moyom-biotechnology-co-ltd-yahoo-finance/</link><pubDate>Mon, 26 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/c-o-r-r-e-c-t-i-o-n-shanghai-moyom-biotechnology-co-ltd-yahoo-finance/</guid></item><item><title><![CDATA[Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel's 'Poetics of Time' Brand Positioning - The Manila Times]]></title><description><![CDATA[Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel's 'Poetics of Time' Brand Positioning&nbsp;&nbsp;The Manila Times]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/moyom-biotechnology-announces-strategic-partnership-with-wpp-group-to-elevate-aphranels-poetics-of-time-brand-positioning-the-manila-times/</link><pubDate>Mon, 26 Jan 2026 07:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/moyom-biotechnology-announces-strategic-partnership-with-wpp-group-to-elevate-aphranels-poetics-of-time-brand-positioning-the-manila-times/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) Is Up 24.8% After Strong SOLSTICE Combo Data In Hepatitis Delta Trial - Has The Bull Case Changed? - simplywall.st]]></title><description><![CDATA[Vir Biotechnology (VIR) Is Up 24.8% After Strong SOLSTICE Combo Data In Hepatitis Delta Trial - Has The Bull Case Changed?&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-is-up-248-after-strong-solstice-combo-data-in-hepatitis-delta-trial-has-the-bull-case-changed-simplywallst/</link><pubDate>Mon, 26 Jan 2026 01:44:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-is-up-248-after-strong-solstice-combo-data-in-hepatitis-delta-trial-has-the-bull-case-changed-simplywallst/</guid></item><item><title><![CDATA[UK retains Europe’s top biotech VC spot despite 2025 slowdown - European Biotechnology Magazine]]></title><description><![CDATA[UK retains Europe&rsquo;s top biotech VC spot despite 2025 slowdown&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/uk-retains-europes-top-biotech-vc-spot-despite-2025-slowdown-european-biotechnology-magazine/</link><pubDate>Mon, 26 Jan 2026 01:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/uk-retains-europes-top-biotech-vc-spot-despite-2025-slowdown-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Experts highlight evolving career pathways in biotechnology - The Hindu]]></title><description><![CDATA[Experts highlight evolving career pathways in biotechnology&nbsp;&nbsp;The Hindu]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/experts-highlight-evolving-career-pathways-in-biotechnology-the-hindu/</link><pubDate>Sun, 25 Jan 2026 22:19:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/experts-highlight-evolving-career-pathways-in-biotechnology-the-hindu/</guid></item><item><title><![CDATA[Nature of Things: Solano College’s Industrial Biotechnology begins 30th year - dailyrepublic.com]]></title><description><![CDATA[Nature of Things: Solano College&rsquo;s Industrial Biotechnology begins 30th year&nbsp;&nbsp;dailyrepublic.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nature-of-things-solano-colleges-industrial-biotechnology-begins-30th-year-dailyrepubliccom/</link><pubDate>Sun, 25 Jan 2026 11:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nature-of-things-solano-colleges-industrial-biotechnology-begins-30th-year-dailyrepubliccom/</guid></item><item><title><![CDATA[3-day int’l confce on biotechnology begins at DU - New Age BD]]></title><description><![CDATA[3-day int&rsquo;l confce on biotechnology begins at DU&nbsp;&nbsp;New Age BD]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/3-day-intl-confce-on-biotechnology-begins-at-du-new-age-bd/</link><pubDate>Sat, 24 Jan 2026 19:42:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/3-day-intl-confce-on-biotechnology-begins-at-du-new-age-bd/</guid></item><item><title><![CDATA[3-day int'l conference on biotechnology begins at DU - Bangladesh Sangbad Sangstha (BSS)]]></title><description><![CDATA[3-day int'l conference on biotechnology begins at DU&nbsp;&nbsp;Bangladesh Sangbad Sangstha (BSS)]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/3-day-intl-conference-on-biotechnology-begins-at-du-bangladesh-sangbad-sangstha-bss/</link><pubDate>Sat, 24 Jan 2026 14:07:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/3-day-intl-conference-on-biotechnology-begins-at-du-bangladesh-sangbad-sangstha-bss/</guid></item><item><title><![CDATA[The Hindu , VIT Chennai to organise webinar series on careers in biotechnology in industry - The Hindu]]></title><description><![CDATA[The Hindu , VIT Chennai to organise webinar series on careers in biotechnology in industry&nbsp;&nbsp;The Hindu]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/the-hindu-vit-chennai-to-organise-webinar-series-on-careers-in-biotechnology-in-industry-the-hindu/</link><pubDate>Fri, 23 Jan 2026 18:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/the-hindu-vit-chennai-to-organise-webinar-series-on-careers-in-biotechnology-in-industry-the-hindu/</guid></item><item><title><![CDATA[Centre for Biotechnology in Kerala identifies new neural stem cells - madhyamamonline.com]]></title><description><![CDATA[Centre for Biotechnology in Kerala identifies new neural stem cells&nbsp;&nbsp;madhyamamonline.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/centre-for-biotechnology-in-kerala-identifies-new-neural-stem-cells-madhyamamonlinecom/</link><pubDate>Fri, 23 Jan 2026 17:58:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/centre-for-biotechnology-in-kerala-identifies-new-neural-stem-cells-madhyamamonlinecom/</guid></item><item><title><![CDATA[London-based Ellipses licenses another oncologic asset from Chinese pharma - European Biotechnology Magazine]]></title><description><![CDATA[London-based Ellipses licenses another oncologic asset from Chinese pharma&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/london-based-ellipses-licenses-another-oncologic-asset-from-chinese-pharma-european-biotechnology-magazine/</link><pubDate>Fri, 23 Jan 2026 16:25:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/london-based-ellipses-licenses-another-oncologic-asset-from-chinese-pharma-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) Is Up 19.4% After Strong Dual-Therapy Data in Hepatitis Delta Trial - Yahoo Finance]]></title><description><![CDATA[Vir Biotechnology (VIR) Is Up 19.4% After Strong Dual-Therapy Data in Hepatitis Delta Trial&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-is-up-194-after-strong-dual-therapy-data-in-hepatitis-delta-trial-yahoo-finance/</link><pubDate>Fri, 23 Jan 2026 16:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-is-up-194-after-strong-dual-therapy-data-in-hepatitis-delta-trial-yahoo-finance/</guid></item><item><title><![CDATA[Health Care Stocks Steady, iShares Biotechnology ETF Inactive - Intellectia AI]]></title><description><![CDATA[Health Care Stocks Steady, iShares Biotechnology ETF Inactive&nbsp;&nbsp;Intellectia AI]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/health-care-stocks-steady-ishares-biotechnology-etf-inactive-intellectia-ai/</link><pubDate>Fri, 23 Jan 2026 15:10:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/health-care-stocks-steady-ishares-biotechnology-etf-inactive-intellectia-ai/</guid></item><item><title><![CDATA[Curative Biotechnology Announces Canadian Patent Allowance - The Manila Times]]></title><description><![CDATA[Curative Biotechnology Announces Canadian Patent Allowance&nbsp;&nbsp;The Manila Times]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/curative-biotechnology-announces-canadian-patent-allowance-the-manila-times/</link><pubDate>Fri, 23 Jan 2026 15:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/curative-biotechnology-announces-canadian-patent-allowance-the-manila-times/</guid></item><item><title><![CDATA[Celcuity Inc. (CELC) Stock Analysis: Exploring the Biotechnology Innovator’s Growth Potential - directorstalkinterviews.com]]></title><description><![CDATA[Celcuity Inc. (CELC) Stock Analysis: Exploring the Biotechnology Innovator&rsquo;s Growth Potential&nbsp;&nbsp;directorstalkinterviews.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/celcuity-inc-celc-stock-analysis-exploring-the-biotechnology-innovators-growth-potential-directorstalkinterviewscom/</link><pubDate>Fri, 23 Jan 2026 13:34:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/celcuity-inc-celc-stock-analysis-exploring-the-biotechnology-innovators-growth-potential-directorstalkinterviewscom/</guid></item><item><title><![CDATA[Celcuity Inc. (CELC) Stock Analysis: Exploring the Biotechnology Innovator’s Growth Potential - DirectorsTalk Interviews]]></title><description><![CDATA[Celcuity Inc. (CELC) Stock Analysis: Exploring the Biotechnology Innovator&rsquo;s Growth Potential&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/celcuity-inc-celc-stock-analysis-exploring-the-biotechnology-innovators-growth-potential-directorstalk-interviews/</link><pubDate>Fri, 23 Jan 2026 13:34:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/celcuity-inc-celc-stock-analysis-exploring-the-biotechnology-innovators-growth-potential-directorstalk-interviews/</guid></item><item><title><![CDATA[Microalgae Biotechnology Market Projected to Reach US$ - GlobeNewswire]]></title><description><![CDATA[Microalgae Biotechnology Market Projected to Reach US$&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/microalgae-biotechnology-market-projected-to-reach-us-globenewswire/</link><pubDate>Fri, 23 Jan 2026 13:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/microalgae-biotechnology-market-projected-to-reach-us-globenewswire/</guid></item><item><title><![CDATA[Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat]]></title><description><![CDATA[Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-nasdaqvir-given-average-recommendation-of-moderate-buy-by-brokerages-marketbeat/</link><pubDate>Fri, 23 Jan 2026 13:21:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-inc-nasdaqvir-given-average-recommendation-of-moderate-buy-by-brokerages-marketbeat/</guid></item><item><title><![CDATA[PureTech Health plc (PRTC): Biotechnology Gem with a Staggering Revenue Growth of 542.70% - DirectorsTalk Interviews]]></title><description><![CDATA[PureTech Health plc (PRTC): Biotechnology Gem with a Staggering Revenue Growth of 542.70%&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puretech-health-plc-prtc-biotechnology-gem-with-a-staggering-revenue-growth-of-54270-directorstalk-interviews/</link><pubDate>Fri, 23 Jan 2026 13:04:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puretech-health-plc-prtc-biotechnology-gem-with-a-staggering-revenue-growth-of-54270-directorstalk-interviews/</guid></item><item><title><![CDATA[Enhertu pushes deeper into China’s gastric cancer market - The Pharma Letter]]></title><description><![CDATA[Enhertu pushes deeper into China&rsquo;s gastric cancer market&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/enhertu-pushes-deeper-into-chinas-gastric-cancer-market-the-pharma-letter/</link><pubDate>Fri, 23 Jan 2026 12:48:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/enhertu-pushes-deeper-into-chinas-gastric-cancer-market-the-pharma-letter/</guid></item><item><title><![CDATA[A Look At Vir Biotechnology (VIR) Valuation After New SOLSTICE Trial Data And Pipeline Updates - simplywall.st]]></title><description><![CDATA[A Look At Vir Biotechnology (VIR) Valuation After New SOLSTICE Trial Data And Pipeline Updates&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/a-look-at-vir-biotechnology-vir-valuation-after-new-solstice-trial-data-and-pipeline-updates-simplywallst/</link><pubDate>Fri, 23 Jan 2026 10:52:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/a-look-at-vir-biotechnology-vir-valuation-after-new-solstice-trial-data-and-pipeline-updates-simplywallst/</guid></item><item><title><![CDATA[International Biotechnology (LON:IBT) Stock Price Passes Above 200 Day Moving Average - Here's Why - MarketBeat]]></title><description><![CDATA[International Biotechnology (LON:IBT) Stock Price Passes Above 200 Day Moving Average - Here's Why&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/international-biotechnology-lonibt-stock-price-passes-above-200-day-moving-average-heres-why-marketbeat/</link><pubDate>Fri, 23 Jan 2026 10:28:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/international-biotechnology-lonibt-stock-price-passes-above-200-day-moving-average-heres-why-marketbeat/</guid></item><item><title><![CDATA[Top 20 Work-From-Home Jobs in Biotechnology &amp; Life Sciences - BioTecNika]]></title><description><![CDATA[Top 20 Work-From-Home Jobs in Biotechnology &amp; Life Sciences&nbsp;&nbsp;BioTecNika]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/top-20-work-from-home-jobs-in-biotechnology-amp-life-sciences-biotecnika/</link><pubDate>Fri, 23 Jan 2026 09:29:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/top-20-work-from-home-jobs-in-biotechnology-amp-life-sciences-biotecnika/</guid></item><item><title><![CDATA[Tyra Biosciences (TYRA) Stock Report: Biotechnology Innovator with an 8.61% Upside Potential - DirectorsTalk Interviews]]></title><description><![CDATA[Tyra Biosciences (TYRA) Stock Report: Biotechnology Innovator with an 8.61% Upside Potential&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/tyra-biosciences-tyra-stock-report-biotechnology-innovator-with-an-861-upside-potential-directorstalk-interviews/</link><pubDate>Fri, 23 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/tyra-biosciences-tyra-stock-report-biotechnology-innovator-with-an-861-upside-potential-directorstalk-interviews/</guid></item><item><title><![CDATA[CureVac N.V. (CVAC) Investor Outlook: Navigating the Biotechnology Terrain Amidst Strategic Acquisitions - DirectorsTalk Interviews]]></title><description><![CDATA[CureVac N.V. (CVAC) Investor Outlook: Navigating the Biotechnology Terrain Amidst Strategic Acquisitions&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/curevac-nv-cvac-investor-outlook-navigating-the-biotechnology-terrain-amidst-strategic-acquisitions-directorstalk-interviews/</link><pubDate>Fri, 23 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/curevac-nv-cvac-investor-outlook-navigating-the-biotechnology-terrain-amidst-strategic-acquisitions-directorstalk-interviews/</guid></item><item><title><![CDATA[SIF hands over UG Biotechnology Centre site to contractors - Ghanaian Times]]></title><description><![CDATA[SIF hands over UG Biotechnology Centre site to contractors&nbsp;&nbsp;Ghanaian Times]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sif-hands-over-ug-biotechnology-centre-site-to-contractors-ghanaian-times/</link><pubDate>Fri, 23 Jan 2026 08:06:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sif-hands-over-ug-biotechnology-centre-site-to-contractors-ghanaian-times/</guid></item><item><title><![CDATA[What’s at stake as Europe attempts to depoliticize its agricultural biotechnology regulations and bring them more in accord with science - Genetic Literacy Project]]></title><description><![CDATA[What&rsquo;s at stake as Europe attempts to depoliticize its agricultural biotechnology regulations and bring them more in accord with science&nbsp;&nbsp;Genetic Literacy Project]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/whats-at-stake-as-europe-attempts-to-depoliticize-its-agricultural-biotechnology-regulations-and-bring-them-more-in-accord-with-science-genetic-literacy-project/</link><pubDate>Fri, 23 Jan 2026 06:06:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/whats-at-stake-as-europe-attempts-to-depoliticize-its-agricultural-biotechnology-regulations-and-bring-them-more-in-accord-with-science-genetic-literacy-project/</guid></item><item><title><![CDATA[What&rsquo;s the MACD signal for Nautilus Biotechnology Inc. - Earnings Recap Report &amp; AI Enhanced Trading Signals - mfd.ru]]></title><description><![CDATA[What&rsquo;s the MACD signal for Nautilus Biotechnology Inc. - Earnings Recap Report &amp; AI Enhanced Trading Signals&nbsp;&nbsp;mfd.ru]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/whatrsquos-the-macd-signal-for-nautilus-biotechnology-inc-earnings-recap-report-amp-ai-enhanced-trading-signals-mfdru/</link><pubDate>Thu, 22 Jan 2026 19:06:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/whatrsquos-the-macd-signal-for-nautilus-biotechnology-inc-earnings-recap-report-amp-ai-enhanced-trading-signals-mfdru/</guid></item><item><title><![CDATA[PDS Biotechnology eyes 20-year protection for PDS0101 - Traders Union]]></title><description><![CDATA[PDS Biotechnology eyes 20-year protection for PDS0101&nbsp;&nbsp;Traders Union]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-eyes-20-year-protection-for-pds0101-traders-union/</link><pubDate>Thu, 22 Jan 2026 17:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-eyes-20-year-protection-for-pds0101-traders-union/</guid></item><item><title><![CDATA[SIF hands over UG Biotechnology Centre site to contractors - GhanaWeb]]></title><description><![CDATA[SIF hands over UG Biotechnology Centre site to contractors&nbsp;&nbsp;GhanaWeb]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sif-hands-over-ug-biotechnology-centre-site-to-contractors-ghanaweb/</link><pubDate>Thu, 22 Jan 2026 17:06:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sif-hands-over-ug-biotechnology-centre-site-to-contractors-ghanaweb/</guid></item><item><title><![CDATA[PDS Biotechnology Secures Key Patent Strengthening PDS0101 Protection - TipRanks]]></title><description><![CDATA[PDS Biotechnology Secures Key Patent Strengthening PDS0101 Protection&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-secures-key-patent-strengthening-pds0101-protection-tipranks/</link><pubDate>Thu, 22 Jan 2026 15:21:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-secures-key-patent-strengthening-pds0101-protection-tipranks/</guid></item><item><title><![CDATA[Global Biotechnology Market Size and Forecast 2025–2033: Innovation Reshaping the Future of Science, Healthcare, and Industry - vocal.media]]></title><description><![CDATA[Global Biotechnology Market Size and Forecast 2025&ndash;2033: Innovation Reshaping the Future of Science, Healthcare, and Industry&nbsp;&nbsp;vocal.media]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/global-biotechnology-market-size-and-forecast-20252033-innovation-reshaping-the-future-of-science-healthcare-and-industry-vocalmedia/</link><pubDate>Thu, 22 Jan 2026 14:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/global-biotechnology-market-size-and-forecast-20252033-innovation-reshaping-the-future-of-science-healthcare-and-industry-vocalmedia/</guid></item><item><title><![CDATA[How First Trust Nyse Arca Biotechnology Index Fund (FBT) Affects Rotational Strategy Timing - Stock Traders Daily]]></title><description><![CDATA[How First Trust Nyse Arca Biotechnology Index Fund (FBT) Affects Rotational Strategy Timing&nbsp;&nbsp;Stock Traders Daily]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/how-first-trust-nyse-arca-biotechnology-index-fund-fbt-affects-rotational-strategy-timing-stock-traders-daily/</link><pubDate>Thu, 22 Jan 2026 13:28:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/how-first-trust-nyse-arca-biotechnology-index-fund-fbt-affects-rotational-strategy-timing-stock-traders-daily/</guid></item><item><title><![CDATA[Gilead Sciences publishes Trodelvy-Keytruda data in NEJM - The Pharma Letter]]></title><description><![CDATA[Gilead Sciences publishes Trodelvy-Keytruda data in NEJM&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/gilead-sciences-publishes-trodelvy-keytruda-data-in-nejm-the-pharma-letter/</link><pubDate>Thu, 22 Jan 2026 13:14:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/gilead-sciences-publishes-trodelvy-keytruda-data-in-nejm-the-pharma-letter/</guid></item><item><title><![CDATA[Resolve M Therapeutics exits stealth with immune platform - The Pharma Letter]]></title><description><![CDATA[Resolve M Therapeutics exits stealth with immune platform&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/resolve-m-therapeutics-exits-stealth-with-immune-platform-the-pharma-letter/</link><pubDate>Thu, 22 Jan 2026 13:04:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/resolve-m-therapeutics-exits-stealth-with-immune-platform-the-pharma-letter/</guid></item><item><title><![CDATA[The dawn of in vivo immune cell engineering in oncology - Nature]]></title><description><![CDATA[The dawn of in vivo immune cell engineering in oncology&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/the-dawn-of-in-vivo-immune-cell-engineering-in-oncology-nature/</link><pubDate>Thu, 22 Jan 2026 11:33:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/the-dawn-of-in-vivo-immune-cell-engineering-in-oncology-nature/</guid></item><item><title><![CDATA[Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 6.3% - What's Next? - MarketBeat]]></title><description><![CDATA[Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 6.3% - What's Next?&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-nasdaqnaut-stock-price-up-63-whats-next-marketbeat/</link><pubDate>Thu, 22 Jan 2026 09:16:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nautilus-biotechnology-nasdaqnaut-stock-price-up-63-whats-next-marketbeat/</guid></item><item><title><![CDATA[Board reshuffle at Rentschler - European Biotechnology Magazine]]></title><description><![CDATA[Board reshuffle at Rentschler&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/board-reshuffle-at-rentschler-european-biotechnology-magazine/</link><pubDate>Thu, 22 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/board-reshuffle-at-rentschler-european-biotechnology-magazine/</guid></item><item><title><![CDATA[United States Animal Biotechnology Market Developed Across Genomics, Vaccines, and Cloning - openPR.com]]></title><description><![CDATA[United States Animal Biotechnology Market Developed Across Genomics, Vaccines, and Cloning&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/united-states-animal-biotechnology-market-developed-across-genomics-vaccines-and-cloning-openprcom/</link><pubDate>Thu, 22 Jan 2026 08:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/united-states-animal-biotechnology-market-developed-across-genomics-vaccines-and-cloning-openprcom/</guid></item><item><title><![CDATA[LIXTE Biotechnology Holdings (NASDAQ: LIXT) Sponsors Good Health Mind, Body and Soul Summit - Digital Journal]]></title><description><![CDATA[LIXTE Biotechnology Holdings (NASDAQ: LIXT) Sponsors Good Health Mind, Body and Soul Summit&nbsp;&nbsp;Digital Journal]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-holdings-nasdaq-lixt-sponsors-good-health-mind-body-and-soul-summit-digital-journal/</link><pubDate>Wed, 21 Jan 2026 18:57:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-holdings-nasdaq-lixt-sponsors-good-health-mind-body-and-soul-summit-digital-journal/</guid></item><item><title><![CDATA[Samsung Biologics posts 35% Q4 revenue rise as plants run full - The Pharma Letter]]></title><description><![CDATA[Samsung Biologics posts 35% Q4 revenue rise as plants run full&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/samsung-biologics-posts-35-q4-revenue-rise-as-plants-run-full-the-pharma-letter/</link><pubDate>Wed, 21 Jan 2026 18:44:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/samsung-biologics-posts-35-q4-revenue-rise-as-plants-run-full-the-pharma-letter/</guid></item><item><title><![CDATA[Oxford team engineer quantum-enabled proteins, opening a new frontier in biotechnology - EurekAlert!]]></title><description><![CDATA[Oxford team engineer quantum-enabled proteins, opening a new frontier in biotechnology&nbsp;&nbsp;EurekAlert!]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/oxford-team-engineer-quantum-enabled-proteins-opening-a-new-frontier-in-biotechnology-eurekalert/</link><pubDate>Wed, 21 Jan 2026 17:16:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/oxford-team-engineer-quantum-enabled-proteins-opening-a-new-frontier-in-biotechnology-eurekalert/</guid></item><item><title><![CDATA[Takeover rumours at Qiagen fuel share price surge - European Biotechnology Magazine]]></title><description><![CDATA[Takeover rumours at Qiagen fuel share price surge&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/takeover-rumours-at-qiagen-fuel-share-price-surge-european-biotechnology-magazine/</link><pubDate>Wed, 21 Jan 2026 14:02:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/takeover-rumours-at-qiagen-fuel-share-price-surge-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Biotechnology Market to Reach USD 5.08 Trillion by 2033 | CAGR - openPR.com]]></title><description><![CDATA[Biotechnology Market to Reach USD 5.08 Trillion by 2033 | CAGR&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-market-to-reach-usd-508-trillion-by-2033-cagr-openprcom/</link><pubDate>Wed, 21 Jan 2026 11:50:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-market-to-reach-usd-508-trillion-by-2033-cagr-openprcom/</guid></item><item><title><![CDATA[Quantum-enabled proteins open a new frontier in biotechnology - Phys.org]]></title><description><![CDATA[Quantum-enabled proteins open a new frontier in biotechnology&nbsp;&nbsp;Phys.org]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/quantum-enabled-proteins-open-a-new-frontier-in-biotechnology-physorg/</link><pubDate>Wed, 21 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/quantum-enabled-proteins-open-a-new-frontier-in-biotechnology-physorg/</guid></item><item><title><![CDATA[Oxford Team Engineer Quantum-enabled Proteins, Opening a New Frontier in Biotechnology - The Quantum Insider]]></title><description><![CDATA[Oxford Team Engineer Quantum-enabled Proteins, Opening a New Frontier in Biotechnology&nbsp;&nbsp;The Quantum Insider]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/oxford-team-engineer-quantum-enabled-proteins-opening-a-new-frontier-in-biotechnology-the-quantum-insider/</link><pubDate>Wed, 21 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/oxford-team-engineer-quantum-enabled-proteins-opening-a-new-frontier-in-biotechnology-the-quantum-insider/</guid></item><item><title><![CDATA[Oxford team engineer quantum-enabled proteins, opening a new frontier in biotechnology - University of Oxford]]></title><description><![CDATA[Oxford team engineer quantum-enabled proteins, opening a new frontier in biotechnology&nbsp;&nbsp;University of Oxford]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/oxford-team-engineer-quantum-enabled-proteins-opening-a-new-frontier-in-biotechnology-university-of-oxford/</link><pubDate>Wed, 21 Jan 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/oxford-team-engineer-quantum-enabled-proteins-opening-a-new-frontier-in-biotechnology-university-of-oxford/</guid></item><item><title><![CDATA[Oxford team engineer quantum-enabled proteins, opening a new frontier in biotechnology - ox.ac.uk]]></title><description><![CDATA[Oxford team engineer quantum-enabled proteins, opening a new frontier in biotechnology&nbsp;&nbsp;ox.ac.uk]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/oxford-team-engineer-quantum-enabled-proteins-opening-a-new-frontier-in-biotechnology-oxacuk/</link><pubDate>Wed, 21 Jan 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/oxford-team-engineer-quantum-enabled-proteins-opening-a-new-frontier-in-biotechnology-oxacuk/</guid></item><item><title><![CDATA[MAIA Biotechnology outlines 2026 goals for ateganosine program - TipRanks]]></title><description><![CDATA[MAIA Biotechnology outlines 2026 goals for ateganosine program&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-outlines-2026-goals-for-ateganosine-program-tipranks/</link><pubDate>Tue, 20 Jan 2026 23:07:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-outlines-2026-goals-for-ateganosine-program-tipranks/</guid></item><item><title><![CDATA[MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum - Yahoo Finance]]></title><description><![CDATA[MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-advances-ateganosine-cancer-treatment-program-outlines-targeted-2026-clinical-milestones-and-growth-momentum-yahoo-finance/</link><pubDate>Tue, 20 Jan 2026 16:15:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-advances-ateganosine-cancer-treatment-program-outlines-targeted-2026-clinical-milestones-and-growth-momentum-yahoo-finance/</guid></item><item><title><![CDATA[LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29 - GlobeNewswire]]></title><description><![CDATA[LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-attending-the-dealflow-discovery-conference-january-28-29-globenewswire/</link><pubDate>Tue, 20 Jan 2026 14:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-attending-the-dealflow-discovery-conference-january-28-29-globenewswire/</guid></item><item><title><![CDATA[Alteogen grants GSK’s Tesaro global rights to ALT-B4 - The Pharma Letter]]></title><description><![CDATA[Alteogen grants GSK&rsquo;s Tesaro global rights to ALT-B4&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/alteogen-grants-gsks-tesaro-global-rights-to-alt-b4-the-pharma-letter/</link><pubDate>Tue, 20 Jan 2026 13:06:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/alteogen-grants-gsks-tesaro-global-rights-to-alt-b4-the-pharma-letter/</guid></item><item><title><![CDATA[Biotechnology Market Size to Surpass USD 9.06 Trillion by 2035 - GlobeNewswire]]></title><description><![CDATA[Biotechnology Market Size to Surpass USD 9.06 Trillion by 2035&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-market-size-to-surpass-usd-906-trillion-by-2035-globenewswire/</link><pubDate>Tue, 20 Jan 2026 12:52:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-market-size-to-surpass-usd-906-trillion-by-2035-globenewswire/</guid></item><item><title><![CDATA[Valneva withdraws US filings for Ixchiq chikungunya vaccine after FDA hold - The Pharma Letter]]></title><description><![CDATA[Valneva withdraws US filings for Ixchiq chikungunya vaccine after FDA hold&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/valneva-withdraws-us-filings-for-ixchiq-chikungunya-vaccine-after-fda-hold-the-pharma-letter/</link><pubDate>Tue, 20 Jan 2026 11:31:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/valneva-withdraws-us-filings-for-ixchiq-chikungunya-vaccine-after-fda-hold-the-pharma-letter/</guid></item><item><title><![CDATA[Recursion Pharmaceuticals (RXRX) Investor Outlook: Unveiling a 49.89% Potential Upside in Biotechnology - DirectorsTalk Interviews]]></title><description><![CDATA[Recursion Pharmaceuticals (RXRX) Investor Outlook: Unveiling a 49.89% Potential Upside in Biotechnology&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/recursion-pharmaceuticals-rxrx-investor-outlook-unveiling-a-4989-potential-upside-in-biotechnology-directorstalk-interviews/</link><pubDate>Tue, 20 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/recursion-pharmaceuticals-rxrx-investor-outlook-unveiling-a-4989-potential-upside-in-biotechnology-directorstalk-interviews/</guid></item><item><title><![CDATA[Merus N.V. (MRUS) Stock Analysis: Biotechnology Innovator With 7.78% Upside Potential - DirectorsTalk Interviews]]></title><description><![CDATA[Merus N.V. (MRUS) Stock Analysis: Biotechnology Innovator With 7.78% Upside Potential&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/merus-nv-mrus-stock-analysis-biotechnology-innovator-with-778-upside-potential-directorstalk-interviews/</link><pubDate>Tue, 20 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/merus-nv-mrus-stock-analysis-biotechnology-innovator-with-778-upside-potential-directorstalk-interviews/</guid></item><item><title><![CDATA[Avacta Group Plc FTSE AIM All Share Focused Update on Biotechnology Operations - Kalkine Media]]></title><description><![CDATA[Avacta Group Plc FTSE AIM All Share Focused Update on Biotechnology Operations&nbsp;&nbsp;Kalkine Media]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/avacta-group-plc-ftse-aim-all-share-focused-update-on-biotechnology-operations-kalkine-media/</link><pubDate>Tue, 20 Jan 2026 08:36:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/avacta-group-plc-ftse-aim-all-share-focused-update-on-biotechnology-operations-kalkine-media/</guid></item><item><title><![CDATA[ImmunityBio flags durable remissions for off-the-shelf CAR-NK - The Pharma Letter]]></title><description><![CDATA[ImmunityBio flags durable remissions for off-the-shelf CAR-NK&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/immunitybio-flags-durable-remissions-for-off-the-shelf-car-nk-the-pharma-letter/</link><pubDate>Mon, 19 Jan 2026 14:48:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/immunitybio-flags-durable-remissions-for-off-the-shelf-car-nk-the-pharma-letter/</guid></item><item><title><![CDATA[Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips (NASDAQ:SANA) - Seeking Alpha]]></title><description><![CDATA[Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips (NASDAQ:SANA)&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-stock-promising-t1d-science-but-wait-for-dips-nasdaqsana-seeking-alpha/</link><pubDate>Mon, 19 Jan 2026 13:40:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-stock-promising-t1d-science-but-wait-for-dips-nasdaqsana-seeking-alpha/</guid></item><item><title><![CDATA[Fresh from the biotech pipeline: FDA turmoil overshadows 2025 approvals - Nature]]></title><description><![CDATA[Fresh from the biotech pipeline: FDA turmoil overshadows 2025 approvals&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/fresh-from-the-biotech-pipeline-fda-turmoil-overshadows-2025-approvals-nature/</link><pubDate>Mon, 19 Jan 2026 12:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/fresh-from-the-biotech-pipeline-fda-turmoil-overshadows-2025-approvals-nature/</guid></item><item><title><![CDATA[Genmab and AbbVie’s epcoritamab fails in phase 3 lymphoma study - European Biotechnology Magazine]]></title><description><![CDATA[Genmab and AbbVie&rsquo;s epcoritamab fails in phase 3 lymphoma study&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/genmab-and-abbvies-epcoritamab-fails-in-phase-3-lymphoma-study-european-biotechnology-magazine/</link><pubDate>Mon, 19 Jan 2026 10:04:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/genmab-and-abbvies-epcoritamab-fails-in-phase-3-lymphoma-study-european-biotechnology-magazine/</guid></item><item><title><![CDATA[CONESTOGA COLLEGE New BioHub connects industry with biotechnology applied research - Education News Canada]]></title><description><![CDATA[CONESTOGA COLLEGE New BioHub connects industry with biotechnology applied research&nbsp;&nbsp;Education News Canada]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/conestoga-college-new-biohub-connects-industry-with-biotechnology-applied-research-education-news-canada/</link><pubDate>Mon, 19 Jan 2026 06:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/conestoga-college-new-biohub-connects-industry-with-biotechnology-applied-research-education-news-canada/</guid></item><item><title><![CDATA[Sana Biotechnology Stock Gains Momentum from Clinical Progress - AD HOC NEWS]]></title><description><![CDATA[Sana Biotechnology Stock Gains Momentum from Clinical Progress&nbsp;&nbsp;AD HOC NEWS]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-stock-gains-momentum-from-clinical-progress-ad-hoc-news/</link><pubDate>Sun, 18 Jan 2026 07:43:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-stock-gains-momentum-from-clinical-progress-ad-hoc-news/</guid></item><item><title><![CDATA[Will UP421&rsquo;s One-Year Data and 2026 Pipeline Goals Change Sana Biotechnology's (SANA) Narrative - simplywall.st]]></title><description><![CDATA[Will UP421&rsquo;s One-Year Data and 2026 Pipeline Goals Change Sana Biotechnology's (SANA) Narrative&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/will-up421rsquos-one-year-data-and-2026-pipeline-goals-change-sana-biotechnologys-sana-narrative-simplywallst/</link><pubDate>Sun, 18 Jan 2026 01:33:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/will-up421rsquos-one-year-data-and-2026-pipeline-goals-change-sana-biotechnologys-sana-narrative-simplywallst/</guid></item><item><title><![CDATA[Science at the Frontiers of the Future: Space and Marine Biotechnology - Sanskriti IAS]]></title><description><![CDATA[Science at the Frontiers of the Future: Space and Marine Biotechnology&nbsp;&nbsp;Sanskriti IAS]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/science-at-the-frontiers-of-the-future-space-and-marine-biotechnology-sanskriti-ias/</link><pubDate>Sat, 17 Jan 2026 14:15:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/science-at-the-frontiers-of-the-future-space-and-marine-biotechnology-sanskriti-ias/</guid></item><item><title><![CDATA[Cellyan Biotechnology receives Nasdaq minimum bid price deficiency notice - Investing.com]]></title><description><![CDATA[Cellyan Biotechnology receives Nasdaq minimum bid price deficiency notice&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cellyan-biotechnology-receives-nasdaq-minimum-bid-price-deficiency-notice-investingcom/</link><pubDate>Fri, 16 Jan 2026 23:02:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cellyan-biotechnology-receives-nasdaq-minimum-bid-price-deficiency-notice-investingcom/</guid></item><item><title><![CDATA[Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency - marketscreener.com]]></title><description><![CDATA[Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cellyan-biotechnology-co-ltd-receives-nasdaq-notice-of-bid-price-deficiency-marketscreenercom/</link><pubDate>Fri, 16 Jan 2026 22:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cellyan-biotechnology-co-ltd-receives-nasdaq-notice-of-bid-price-deficiency-marketscreenercom/</guid></item><item><title><![CDATA[Genetic Engineering: Manipulation of an organism’s genes using biotechnology - Rising Kashmir]]></title><description><![CDATA[Genetic Engineering: Manipulation of an organism&rsquo;s genes using biotechnology&nbsp;&nbsp;Rising Kashmir]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/genetic-engineering-manipulation-of-an-organisms-genes-using-biotechnology-rising-kashmir/</link><pubDate>Fri, 16 Jan 2026 20:18:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/genetic-engineering-manipulation-of-an-organisms-genes-using-biotechnology-rising-kashmir/</guid></item><item><title><![CDATA[Biotechnology, National Security, and US-China Policy - The US-China Business Council]]></title><description><![CDATA[Biotechnology, National Security, and US-China Policy&nbsp;&nbsp;The US-China Business Council]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-national-security-and-us-china-policy-the-us-china-business-council/</link><pubDate>Fri, 16 Jan 2026 19:46:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-national-security-and-us-china-policy-the-us-china-business-council/</guid></item><item><title><![CDATA[Fancy smelling like a Greek goddess? - Nature]]></title><description><![CDATA[Fancy smelling like a Greek goddess?&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/fancy-smelling-like-a-greek-goddess-nature/</link><pubDate>Fri, 16 Jan 2026 17:56:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/fancy-smelling-like-a-greek-goddess-nature/</guid></item><item><title><![CDATA[Sana Biotechnology (SANA) Valuation Check After J.P. Morgan Conference Cell Therapy Updates - simplywall.st]]></title><description><![CDATA[Sana Biotechnology (SANA) Valuation Check After J.P. Morgan Conference Cell Therapy Updates&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-valuation-check-after-jp-morgan-conference-cell-therapy-updates-simplywallst/</link><pubDate>Fri, 16 Jan 2026 17:42:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-sana-valuation-check-after-jp-morgan-conference-cell-therapy-updates-simplywallst/</guid></item><item><title><![CDATA[Sustainability of gap funding programs aimed at commercializing academic innovation - Nature]]></title><description><![CDATA[Sustainability of gap funding programs aimed at commercializing academic innovation&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sustainability-of-gap-funding-programs-aimed-at-commercializing-academic-innovation-nature/</link><pubDate>Fri, 16 Jan 2026 17:36:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sustainability-of-gap-funding-programs-aimed-at-commercializing-academic-innovation-nature/</guid></item><item><title><![CDATA[Mapping the science–technology translational landscape in biomedicine - Nature]]></title><description><![CDATA[Mapping the science&ndash;technology translational landscape in biomedicine&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/mapping-the-sciencetechnology-translational-landscape-in-biomedicine-nature/</link><pubDate>Fri, 16 Jan 2026 17:36:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/mapping-the-sciencetechnology-translational-landscape-in-biomedicine-nature/</guid></item><item><title><![CDATA[Shanxi Giant Biotechnology Co., Ltd. Receives Medical Device Registration Certificate of the People's Republic of China - marketscreener.com]]></title><description><![CDATA[Shanxi Giant Biotechnology Co., Ltd. Receives Medical Device Registration Certificate of the People's Republic of China&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/shanxi-giant-biotechnology-co-ltd-receives-medical-device-registration-certificate-of-the-peoples-republic-of-china-marketscreenercom/</link><pubDate>Thu, 15 Jan 2026 11:36:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/shanxi-giant-biotechnology-co-ltd-receives-medical-device-registration-certificate-of-the-peoples-republic-of-china-marketscreenercom/</guid></item><item><title><![CDATA[Pivotal Ajovy data published in NEJM - The Pharma Letter]]></title><description><![CDATA[Pivotal Ajovy data published in NEJM&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pivotal-ajovy-data-published-in-nejm-the-pharma-letter/</link><pubDate>Thu, 15 Jan 2026 11:25:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pivotal-ajovy-data-published-in-nejm-the-pharma-letter/</guid></item><item><title><![CDATA[Return as new Chief Financial Officer - European Biotechnology Magazine]]></title><description><![CDATA[Return as new Chief Financial Officer&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/return-as-new-chief-financial-officer-european-biotechnology-magazine/</link><pubDate>Thu, 15 Jan 2026 10:31:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/return-as-new-chief-financial-officer-european-biotechnology-magazine/</guid></item><item><title><![CDATA[How AI and Biotechnology Are Changing the Health Industry - Technology Org]]></title><description><![CDATA[How AI and Biotechnology Are Changing the Health Industry&nbsp;&nbsp;Technology Org]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/how-ai-and-biotechnology-are-changing-the-health-industry-technology-org/</link><pubDate>Thu, 15 Jan 2026 07:41:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/how-ai-and-biotechnology-are-changing-the-health-industry-technology-org/</guid></item><item><title><![CDATA[Marine and Space Biotechnology: India&rsquo;s Next Strategic Frontier - Vajiram &amp; Ravi]]></title><description><![CDATA[Marine and Space Biotechnology: India&rsquo;s Next Strategic Frontier&nbsp;&nbsp;Vajiram &amp; Ravi]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/marine-and-space-biotechnology-indiarsquos-next-strategic-frontier-vajiram-amp-ravi/</link><pubDate>Thu, 15 Jan 2026 07:40:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/marine-and-space-biotechnology-indiarsquos-next-strategic-frontier-vajiram-amp-ravi/</guid></item><item><title><![CDATA[Saudi's SFDA: 83% growth in clinical research for biotechnology products in 2025 - ZAWYA]]></title><description><![CDATA[Saudi's SFDA: 83% growth in clinical research for biotechnology products in 2025&nbsp;&nbsp;ZAWYA]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/saudis-sfda-83-growth-in-clinical-research-for-biotechnology-products-in-2025-zawya/</link><pubDate>Thu, 15 Jan 2026 05:13:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/saudis-sfda-83-growth-in-clinical-research-for-biotechnology-products-in-2025-zawya/</guid></item><item><title><![CDATA[What is futuristic marine and space biotechnology? | Explained - The Hindu]]></title><description><![CDATA[What is futuristic marine and space biotechnology? | Explained&nbsp;&nbsp;The Hindu]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/what-is-futuristic-marine-and-space-biotechnology-explained-the-hindu/</link><pubDate>Thu, 15 Jan 2026 04:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/what-is-futuristic-marine-and-space-biotechnology-explained-the-hindu/</guid></item><item><title><![CDATA[Franklin Biotechnology Discovery Fund Q3 2025 Commentary - Seeking Alpha]]></title><description><![CDATA[Franklin Biotechnology Discovery Fund Q3 2025 Commentary&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/franklin-biotechnology-discovery-fund-q3-2025-commentary-seeking-alpha/</link><pubDate>Wed, 14 Jan 2026 20:20:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/franklin-biotechnology-discovery-fund-q3-2025-commentary-seeking-alpha/</guid></item><item><title><![CDATA[Sana Biotechnology Highlights Diabetes Cell Therapy Advances at Conference - TipRanks]]></title><description><![CDATA[Sana Biotechnology Highlights Diabetes Cell Therapy Advances at Conference&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-highlights-diabetes-cell-therapy-advances-at-conference-tipranks/</link><pubDate>Wed, 14 Jan 2026 19:19:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-highlights-diabetes-cell-therapy-advances-at-conference-tipranks/</guid></item><item><title><![CDATA[Sana Biotechnology, Inc. Updates on Key Programs at J.P. Morgan Conference - TradingView — Track All Markets]]></title><description><![CDATA[Sana Biotechnology, Inc. Updates on Key Programs at J.P. Morgan Conference&nbsp;&nbsp;TradingView &mdash; Track All Markets]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-inc-updates-on-key-programs-at-jp-morgan-conference-tradingview-track-all-markets/</link><pubDate>Wed, 14 Jan 2026 18:53:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-inc-updates-on-key-programs-at-jp-morgan-conference-tradingview-track-all-markets/</guid></item><item><title><![CDATA[How one biotechnology company is working to extend the lifespan of dogs - DVM360]]></title><description><![CDATA[How one biotechnology company is working to extend the lifespan of dogs&nbsp;&nbsp;DVM360]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/how-one-biotechnology-company-is-working-to-extend-the-lifespan-of-dogs-dvm360/</link><pubDate>Wed, 14 Jan 2026 15:12:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/how-one-biotechnology-company-is-working-to-extend-the-lifespan-of-dogs-dvm360/</guid></item><item><title><![CDATA[SFDA vs EMA: What Biotech Leaders need to Know - European Biotechnology Magazine]]></title><description><![CDATA[SFDA vs EMA: What Biotech Leaders need to Know&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sfda-vs-ema-what-biotech-leaders-need-to-know-european-biotechnology-magazine/</link><pubDate>Wed, 14 Jan 2026 14:57:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sfda-vs-ema-what-biotech-leaders-need-to-know-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Agricultural Biotechnology Emerges as a Key Driver of Sustainable and Climate-Resilient Farming - openPR.com]]></title><description><![CDATA[Agricultural Biotechnology Emerges as a Key Driver of Sustainable and Climate-Resilient Farming&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/agricultural-biotechnology-emerges-as-a-key-driver-of-sustainable-and-climate-resilient-farming-openprcom/</link><pubDate>Wed, 14 Jan 2026 14:37:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/agricultural-biotechnology-emerges-as-a-key-driver-of-sustainable-and-climate-resilient-farming-openprcom/</guid></item><item><title><![CDATA[JPM: Almirall maps out a busy 2026 for dermatology R&amp;D - The Pharma Letter]]></title><description><![CDATA[JPM: Almirall maps out a busy 2026 for dermatology R&amp;D&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/jpm-almirall-maps-out-a-busy-2026-for-dermatology-rampd-the-pharma-letter/</link><pubDate>Wed, 14 Jan 2026 12:23:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/jpm-almirall-maps-out-a-busy-2026-for-dermatology-rampd-the-pharma-letter/</guid></item><item><title><![CDATA[Vet Varsity Highlights Global Career Pathways in Biotechnology - :: India News Calling ::]]></title><description><![CDATA[Vet Varsity Highlights Global Career Pathways in Biotechnology&nbsp;&nbsp;:: India News Calling ::]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vet-varsity-highlights-global-career-pathways-in-biotechnology-india-news-calling-/</link><pubDate>Wed, 14 Jan 2026 12:10:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vet-varsity-highlights-global-career-pathways-in-biotechnology-india-news-calling-/</guid></item><item><title><![CDATA[Aurora Therapeutics - The Pharma Letter]]></title><description><![CDATA[Aurora Therapeutics&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/aurora-therapeutics-the-pharma-letter/</link><pubDate>Wed, 14 Jan 2026 09:40:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/aurora-therapeutics-the-pharma-letter/</guid></item><item><title><![CDATA[Call for Proposal at Department of Biotechnology | Apply Now For BIO-GRID 2026 - BioTecNika]]></title><description><![CDATA[Call for Proposal at Department of Biotechnology | Apply Now For BIO-GRID 2026&nbsp;&nbsp;BioTecNika]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/call-for-proposal-at-department-of-biotechnology-apply-now-for-bio-grid-2026-biotecnika/</link><pubDate>Wed, 14 Jan 2026 08:53:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/call-for-proposal-at-department-of-biotechnology-apply-now-for-bio-grid-2026-biotecnika/</guid></item><item><title><![CDATA[MAIA Biotechnology Highlights Strategy in New Investor Presentation - TipRanks]]></title><description><![CDATA[MAIA Biotechnology Highlights Strategy in New Investor Presentation&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-highlights-strategy-in-new-investor-presentation-tipranks/</link><pubDate>Tue, 13 Jan 2026 23:52:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/maia-biotechnology-highlights-strategy-in-new-investor-presentation-tipranks/</guid></item><item><title><![CDATA[European Congress of Biotechnology - The Pharma Letter]]></title><description><![CDATA[European Congress of Biotechnology&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/european-congress-of-biotechnology-the-pharma-letter/</link><pubDate>Tue, 13 Jan 2026 18:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/european-congress-of-biotechnology-the-pharma-letter/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) Advances in Hepatitis Delta Treatment - GuruFocus]]></title><description><![CDATA[Vir Biotechnology (VIR) Advances in Hepatitis Delta Treatment&nbsp;&nbsp;GuruFocus]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-advances-in-hepatitis-delta-treatment-gurufocus/</link><pubDate>Tue, 13 Jan 2026 17:32:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-advances-in-hepatitis-delta-treatment-gurufocus/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) Reports Positive Trial Results in Hepati - GuruFocus]]></title><description><![CDATA[Vir Biotechnology (VIR) Reports Positive Trial Results in Hepati&nbsp;&nbsp;GuruFocus]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-reports-positive-trial-results-in-hepati-gurufocus/</link><pubDate>Tue, 13 Jan 2026 16:59:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-vir-reports-positive-trial-results-in-hepati-gurufocus/</guid></item><item><title><![CDATA[LIXTE Biotechnology (LIXT) Enhances Visibility with New Communications Strategy - GuruFocus]]></title><description><![CDATA[LIXTE Biotechnology (LIXT) Enhances Visibility with New Communications Strategy&nbsp;&nbsp;GuruFocus]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-lixt-enhances-visibility-with-new-communications-strategy-gurufocus/</link><pubDate>Tue, 13 Jan 2026 15:35:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-lixt-enhances-visibility-with-new-communications-strategy-gurufocus/</guid></item><item><title><![CDATA[Ukraine adjusting domestic biotechnology policies to align with EU regulations - Oils &amp; Fats International]]></title><description><![CDATA[Ukraine adjusting domestic biotechnology policies to align with EU regulations&nbsp;&nbsp;Oils &amp; Fats International]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ukraine-adjusting-domestic-biotechnology-policies-to-align-with-eu-regulations-oils-amp-fats-international/</link><pubDate>Tue, 13 Jan 2026 15:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ukraine-adjusting-domestic-biotechnology-policies-to-align-with-eu-regulations-oils-amp-fats-international/</guid></item><item><title><![CDATA[Genome Editing Market Demand Surges Across Biotechnology - openPR.com]]></title><description><![CDATA[Genome Editing Market Demand Surges Across Biotechnology&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/genome-editing-market-demand-surges-across-biotechnology-openprcom/</link><pubDate>Tue, 13 Jan 2026 14:57:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/genome-editing-market-demand-surges-across-biotechnology-openprcom/</guid></item><item><title><![CDATA[IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc. - GlobeNewswire]]></title><description><![CDATA[IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc.&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ibn-initiates-coverage-of-lixte-biotechnology-holdings-inc-globenewswire/</link><pubDate>Tue, 13 Jan 2026 14:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ibn-initiates-coverage-of-lixte-biotechnology-holdings-inc-globenewswire/</guid></item><item><title><![CDATA[New CFB inhibitors disclosed in Guangzhou Runer Ophthalmic Biotechnology patent - BioWorld MedTech]]></title><description><![CDATA[New CFB inhibitors disclosed in Guangzhou Runer Ophthalmic Biotechnology patent&nbsp;&nbsp;BioWorld MedTech]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/new-cfb-inhibitors-disclosed-in-guangzhou-runer-ophthalmic-biotechnology-patent-bioworld-medtech/</link><pubDate>Tue, 13 Jan 2026 14:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/new-cfb-inhibitors-disclosed-in-guangzhou-runer-ophthalmic-biotechnology-patent-bioworld-medtech/</guid></item><item><title><![CDATA[2026: A year of reckoning for BioNTech - European Biotechnology Magazine]]></title><description><![CDATA[2026: A year of reckoning for BioNTech&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/2026-a-year-of-reckoning-for-biontech-european-biotechnology-magazine/</link><pubDate>Tue, 13 Jan 2026 12:17:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/2026-a-year-of-reckoning-for-biontech-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Donald Danforth Plant Science Center Joins International Crop Biotechnology Initiative in Rwanda - iGrow News]]></title><description><![CDATA[Donald Danforth Plant Science Center Joins International Crop Biotechnology Initiative in Rwanda&nbsp;&nbsp;iGrow News]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/donald-danforth-plant-science-center-joins-international-crop-biotechnology-initiative-in-rwanda-igrow-news/</link><pubDate>Tue, 13 Jan 2026 11:16:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/donald-danforth-plant-science-center-joins-international-crop-biotechnology-initiative-in-rwanda-igrow-news/</guid></item><item><title><![CDATA[Leveraging Japan’s Appetite for U.S. Investment and Partnership in Pharmaceuticals and Biotechnology - CSIS | Center for Strategic and International Studies]]></title><description><![CDATA[Leveraging Japan&rsquo;s Appetite for U.S. Investment and Partnership in Pharmaceuticals and Biotechnology&nbsp;&nbsp;CSIS | Center for Strategic and International Studies]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/leveraging-japans-appetite-for-us-investment-and-partnership-in-pharmaceuticals-and-biotechnology-csis-center-for-strategic-and-international-studies/</link><pubDate>Tue, 13 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/leveraging-japans-appetite-for-us-investment-and-partnership-in-pharmaceuticals-and-biotechnology-csis-center-for-strategic-and-international-studies/</guid></item><item><title><![CDATA[CN Aims to Further Expand Biotechnology/ Foreign-Owned Hospital Pilot Programs During '15th 5-Yr Plan' Period: MOC - AASTOCKS.com]]></title><description><![CDATA[CN Aims to Further Expand Biotechnology/ Foreign-Owned Hospital Pilot Programs During '15th 5-Yr Plan' Period: MOC&nbsp;&nbsp;AASTOCKS.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cn-aims-to-further-expand-biotechnology-foreign-owned-hospital-pilot-programs-during-15th-5-yr-plan-period-moc-aastockscom/</link><pubDate>Tue, 13 Jan 2026 08:34:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cn-aims-to-further-expand-biotechnology-foreign-owned-hospital-pilot-programs-during-15th-5-yr-plan-period-moc-aastockscom/</guid></item><item><title><![CDATA[AtaiBeckley Added to the Nasdaq Biotechnology Index - Investing News Network]]></title><description><![CDATA[AtaiBeckley Added to the Nasdaq Biotechnology Index&nbsp;&nbsp;Investing News Network]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ataibeckley-added-to-the-nasdaq-biotechnology-index-investing-news-network/</link><pubDate>Tue, 13 Jan 2026 04:38:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ataibeckley-added-to-the-nasdaq-biotechnology-index-investing-news-network/</guid></item><item><title><![CDATA[Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 202 - PharmiWeb.com]]></title><description><![CDATA[Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 202&nbsp;&nbsp;PharmiWeb.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-provides-updates-on-chronic-hepatitis-delta-and-oncology-programs-and-upcoming-202-pharmiwebcom/</link><pubDate>Mon, 12 Jan 2026 17:07:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-provides-updates-on-chronic-hepatitis-delta-and-oncology-programs-and-upcoming-202-pharmiwebcom/</guid></item><item><title><![CDATA[Ai Technology Group and AVM Biotechnology Provide Merger and Operational Update - GlobeNewswire]]></title><description><![CDATA[Ai Technology Group and AVM Biotechnology Provide Merger and Operational Update&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ai-technology-group-and-avm-biotechnology-provide-merger-and-operational-update-globenewswire/</link><pubDate>Mon, 12 Jan 2026 15:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ai-technology-group-and-avm-biotechnology-provide-merger-and-operational-update-globenewswire/</guid></item><item><title><![CDATA[Vir Biotechnology advances hepatitis delta program and cash runway - TipRanks]]></title><description><![CDATA[Vir Biotechnology advances hepatitis delta program and cash runway&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-advances-hepatitis-delta-program-and-cash-runway-tipranks/</link><pubDate>Mon, 12 Jan 2026 14:39:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-advances-hepatitis-delta-program-and-cash-runway-tipranks/</guid></item><item><title><![CDATA[Vir Biotechnology provides updates on chronic hepatitis Delta and oncology programs and upcoming 2026 clinical milestones - marketscreener.com]]></title><description><![CDATA[Vir Biotechnology provides updates on chronic hepatitis Delta and oncology programs and upcoming 2026 clinical milestones&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-provides-updates-on-chronic-hepatitis-delta-and-oncology-programs-and-upcoming-2026-clinical-milestones-marketscreenercom/</link><pubDate>Mon, 12 Jan 2026 14:14:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-provides-updates-on-chronic-hepatitis-delta-and-oncology-programs-and-upcoming-2026-clinical-milestones-marketscreenercom/</guid></item><item><title><![CDATA[Vir Biotechnology reports positive hepatitis delta trial data - StreetInsider]]></title><description><![CDATA[Vir Biotechnology reports positive hepatitis delta trial data&nbsp;&nbsp;StreetInsider]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-reports-positive-hepatitis-delta-trial-data-streetinsider/</link><pubDate>Mon, 12 Jan 2026 14:09:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/vir-biotechnology-reports-positive-hepatitis-delta-trial-data-streetinsider/</guid></item><item><title><![CDATA[Targeted delivery of genome editors in vivo - Nature]]></title><description><![CDATA[Targeted delivery of genome editors in vivo&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/targeted-delivery-of-genome-editors-in-vivo-nature/</link><pubDate>Mon, 12 Jan 2026 11:27:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/targeted-delivery-of-genome-editors-in-vivo-nature/</guid></item><item><title><![CDATA[Smith Stan buys MAIA Biotechnology shares worth $9,958 - Investing.com]]></title><description><![CDATA[Smith Stan buys MAIA Biotechnology shares worth $9,958&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/smith-stan-buys-maia-biotechnology-shares-worth-9958-investingcom/</link><pubDate>Mon, 12 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/smith-stan-buys-maia-biotechnology-shares-worth-9958-investingcom/</guid></item><item><title><![CDATA[FluoSphera - The Pharma Letter]]></title><description><![CDATA[FluoSphera&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/fluosphera-the-pharma-letter/</link><pubDate>Mon, 12 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/fluosphera-the-pharma-letter/</guid></item><item><title><![CDATA[South Dakota Mines professor receives international biotechnology award - KOTA Territory News]]></title><description><![CDATA[South Dakota Mines professor receives international biotechnology award&nbsp;&nbsp;KOTA Territory News]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/south-dakota-mines-professor-receives-international-biotechnology-award-kota-territory-news/</link><pubDate>Sat, 10 Jan 2026 23:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/south-dakota-mines-professor-receives-international-biotechnology-award-kota-territory-news/</guid></item><item><title><![CDATA[AI in Biotechnology: Everything Students Need to Know - BioTecNika]]></title><description><![CDATA[AI in Biotechnology: Everything Students Need to Know&nbsp;&nbsp;BioTecNika]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-everything-students-need-to-know-biotecnika/</link><pubDate>Sat, 10 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-everything-students-need-to-know-biotecnika/</guid></item><item><title><![CDATA[PDS Biotechnology Updates Phase 3 Trial Design for PDS0101 - TipRanks]]></title><description><![CDATA[PDS Biotechnology Updates Phase 3 Trial Design for PDS0101&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-updates-phase-3-trial-design-for-pds0101-tipranks/</link><pubDate>Fri, 09 Jan 2026 15:21:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pds-biotechnology-updates-phase-3-trial-design-for-pds0101-tipranks/</guid></item><item><title><![CDATA[Here's Why This Biotechnology Skyrocketed by 439% in December - Nasdaq]]></title><description><![CDATA[Here's Why This Biotechnology Skyrocketed by 439% in December&nbsp;&nbsp;Nasdaq]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/heres-why-this-biotechnology-skyrocketed-by-439-in-december-nasdaq/</link><pubDate>Fri, 09 Jan 2026 12:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/heres-why-this-biotechnology-skyrocketed-by-439-in-december-nasdaq/</guid></item><item><title><![CDATA[Here's Why This Biotechnology Skyrocketed by 439% in December - The Motley Fool]]></title><description><![CDATA[Here's Why This Biotechnology Skyrocketed by 439% in December&nbsp;&nbsp;The Motley Fool]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/heres-why-this-biotechnology-skyrocketed-by-439-in-december-the-motley-fool/</link><pubDate>Fri, 09 Jan 2026 11:41:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/heres-why-this-biotechnology-skyrocketed-by-439-in-december-the-motley-fool/</guid></item><item><title><![CDATA[Food Biotechnology Market Size to Exceed USD 85.20 Billion - GlobeNewswire]]></title><description><![CDATA[Food Biotechnology Market Size to Exceed USD 85.20 Billion&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/food-biotechnology-market-size-to-exceed-usd-8520-billion-globenewswire/</link><pubDate>Fri, 09 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/food-biotechnology-market-size-to-exceed-usd-8520-billion-globenewswire/</guid></item><item><title><![CDATA[What farmers think about using crop biotechnology to boost photosynthesis in rice and potato - Nature]]></title><description><![CDATA[What farmers think about using crop biotechnology to boost photosynthesis in rice and potato&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/what-farmers-think-about-using-crop-biotechnology-to-boost-photosynthesis-in-rice-and-potato-nature/</link><pubDate>Wed, 07 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/what-farmers-think-about-using-crop-biotechnology-to-boost-photosynthesis-in-rice-and-potato-nature/</guid></item><item><title><![CDATA[Biotechnology Instruments Market Projected to Reach US$ 141.70 Billion by 2035 | Astute Analytica - Yahoo Finance]]></title><description><![CDATA[Biotechnology Instruments Market Projected to Reach US$ 141.70 Billion by 2035 | Astute Analytica&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-instruments-market-projected-to-reach-us-14170-billion-by-2035-astute-analytica-yahoo-finance/</link><pubDate>Wed, 07 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-instruments-market-projected-to-reach-us-14170-billion-by-2035-astute-analytica-yahoo-finance/</guid></item><item><title><![CDATA[Discover the Top 10 Trends in Biotechnology &amp; Innovations in 2026 - StartUs Insights]]></title><description><![CDATA[Discover the Top 10 Trends in Biotechnology &amp; Innovations in 2026&nbsp;&nbsp;StartUs Insights]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/discover-the-top-10-trends-in-biotechnology-amp-innovations-in-2026-startus-insights/</link><pubDate>Tue, 06 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/discover-the-top-10-trends-in-biotechnology-amp-innovations-in-2026-startus-insights/</guid></item><item><title><![CDATA[Advances in biotechnology - EFSA]]></title><description><![CDATA[Advances in biotechnology&nbsp;&nbsp;EFSA]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/advances-in-biotechnology-efsa/</link><pubDate>Tue, 06 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/advances-in-biotechnology-efsa/</guid></item><item><title><![CDATA[A Year of Progress in Biotechnology - Information Technology and Innovation Foundation (ITIF)]]></title><description><![CDATA[A Year of Progress in Biotechnology&nbsp;&nbsp;Information Technology and Innovation Foundation (ITIF)]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/a-year-of-progress-in-biotechnology-information-technology-and-innovation-foundation-itif/</link><pubDate>Mon, 05 Jan 2026 17:24:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/a-year-of-progress-in-biotechnology-information-technology-and-innovation-foundation-itif/</guid></item><item><title><![CDATA[China's Otovia banks new cash for deafness gene therapy - The Pharma Letter]]></title><description><![CDATA[China's Otovia banks new cash for deafness gene therapy&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/chinas-otovia-banks-new-cash-for-deafness-gene-therapy-the-pharma-letter/</link><pubDate>Mon, 05 Jan 2026 13:48:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/chinas-otovia-banks-new-cash-for-deafness-gene-therapy-the-pharma-letter/</guid></item><item><title><![CDATA[Integrated experimental and AI innovations for RNA structure determination - Nature]]></title><description><![CDATA[Integrated experimental and AI innovations for RNA structure determination&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/integrated-experimental-and-ai-innovations-for-rna-structure-determination-nature/</link><pubDate>Mon, 05 Jan 2026 11:36:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/integrated-experimental-and-ai-innovations-for-rna-structure-determination-nature/</guid></item><item><title><![CDATA[Sanofi seeks to widen Tzield’s reach with US priority review - The Pharma Letter]]></title><description><![CDATA[Sanofi seeks to widen Tzield&rsquo;s reach with US priority review&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sanofi-seeks-to-widen-tzields-reach-with-us-priority-review-the-pharma-letter/</link><pubDate>Mon, 05 Jan 2026 11:31:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sanofi-seeks-to-widen-tzields-reach-with-us-priority-review-the-pharma-letter/</guid></item><item><title><![CDATA[Moving beyond monogenic disorders in clinical healthcare - Nature]]></title><description><![CDATA[Moving beyond monogenic disorders in clinical healthcare&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/moving-beyond-monogenic-disorders-in-clinical-healthcare-nature/</link><pubDate>Mon, 05 Jan 2026 11:20:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/moving-beyond-monogenic-disorders-in-clinical-healthcare-nature/</guid></item><item><title><![CDATA[Axsome Therapeutics - The Pharma Letter]]></title><description><![CDATA[Axsome Therapeutics&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/axsome-therapeutics-the-pharma-letter/</link><pubDate>Mon, 05 Jan 2026 10:22:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/axsome-therapeutics-the-pharma-letter/</guid></item><item><title><![CDATA[A Year of Progress in Biotechnology - Information Technology and Innovation Foundation]]></title><description><![CDATA[A Year of Progress in Biotechnology&nbsp;&nbsp;Information Technology and Innovation Foundation]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/a-year-of-progress-in-biotechnology-information-technology-and-innovation-foundation/</link><pubDate>Mon, 05 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/a-year-of-progress-in-biotechnology-information-technology-and-innovation-foundation/</guid></item><item><title><![CDATA[A Year of Progress in Biotechnology | Blogs | Jan 5, 2026 - Information Technology and Innovation Foundation (ITIF)]]></title><description><![CDATA[A Year of Progress in Biotechnology | Blogs | Jan 5, 2026&nbsp;&nbsp;Information Technology and Innovation Foundation (ITIF)]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/a-year-of-progress-in-biotechnology-blogs-jan-5-2026-information-technology-and-innovation-foundation-itif/</link><pubDate>Mon, 05 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/a-year-of-progress-in-biotechnology-blogs-jan-5-2026-information-technology-and-innovation-foundation-itif/</guid></item><item><title><![CDATA[How biotechnology is turning the tide on UK water systems battling climate change - Water Magazine]]></title><description><![CDATA[How biotechnology is turning the tide on UK water systems battling climate change&nbsp;&nbsp;Water Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/how-biotechnology-is-turning-the-tide-on-uk-water-systems-battling-climate-change-water-magazine/</link><pubDate>Mon, 05 Jan 2026 05:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/how-biotechnology-is-turning-the-tide-on-uk-water-systems-battling-climate-change-water-magazine/</guid></item><item><title><![CDATA[Gene editing in Indonesia: can new biotechnology solve old agricultural problems? - The Conversation]]></title><description><![CDATA[Gene editing in Indonesia: can new biotechnology solve old agricultural problems?&nbsp;&nbsp;The Conversation]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/gene-editing-in-indonesia-can-new-biotechnology-solve-old-agricultural-problems-the-conversation/</link><pubDate>Mon, 05 Jan 2026 03:11:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/gene-editing-in-indonesia-can-new-biotechnology-solve-old-agricultural-problems-the-conversation/</guid></item><item><title><![CDATA[Compilation Highlights Biotechnology Trends and Innovations of 2025 Released by BioCentury - geneonline.com]]></title><description><![CDATA[Compilation Highlights Biotechnology Trends and Innovations of 2025 Released by BioCentury&nbsp;&nbsp;geneonline.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/compilation-highlights-biotechnology-trends-and-innovations-of-2025-released-by-biocentury-geneonlinecom/</link><pubDate>Sat, 03 Jan 2026 08:38:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/compilation-highlights-biotechnology-trends-and-innovations-of-2025-released-by-biocentury-geneonlinecom/</guid></item><item><title><![CDATA[Protein Engineering for Pharmaceutical Biotechnology Training Course: Understand How to Advance Ther - PharmiWeb.com]]></title><description><![CDATA[Protein Engineering for Pharmaceutical Biotechnology Training Course: Understand How to Advance Ther&nbsp;&nbsp;PharmiWeb.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/protein-engineering-for-pharmaceutical-biotechnology-training-course-understand-how-to-advance-ther-pharmiwebcom/</link><pubDate>Sat, 03 Jan 2026 03:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/protein-engineering-for-pharmaceutical-biotechnology-training-course-understand-how-to-advance-ther-pharmiwebcom/</guid></item><item><title><![CDATA[Protein Engineering for Pharmaceutical Biotechnology Training Course: Understand How to Advance Therapeutic Development and Industrial Applications (Jan 21st - Jan 22nd, 2026) - ResearchAndMarkets.com - Bluefield Daily Telegraph]]></title><description><![CDATA[Protein Engineering for Pharmaceutical Biotechnology Training Course: Understand How to Advance Therapeutic Development and Industrial Applications (Jan 21st - Jan 22nd, 2026) - ResearchAndMarkets.com&nbsp;&nbsp;Bluefield Daily Telegraph]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/protein-engineering-for-pharmaceutical-biotechnology-training-course-understand-how-to-advance-therapeutic-development-and-industrial-applications-jan-21st-jan-22nd-2026-researchandmarketscom-bluefield-daily-telegraph/</link><pubDate>Fri, 02 Jan 2026 20:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/protein-engineering-for-pharmaceutical-biotechnology-training-course-understand-how-to-advance-therapeutic-development-and-industrial-applications-jan-21st-jan-22nd-2026-researchandmarketscom-bluefield-daily-telegraph/</guid></item><item><title><![CDATA[Corcept setback as relacorilant filing for hypercortisolism is rejected - The Pharma Letter]]></title><description><![CDATA[Corcept setback as relacorilant filing for hypercortisolism is rejected&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/corcept-setback-as-relacorilant-filing-for-hypercortisolism-is-rejected-the-pharma-letter/</link><pubDate>Fri, 02 Jan 2026 19:45:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/corcept-setback-as-relacorilant-filing-for-hypercortisolism-is-rejected-the-pharma-letter/</guid></item><item><title><![CDATA[Pfizer discloses death in long-term Hympavzi study after thrombotic stroke - The Pharma Letter]]></title><description><![CDATA[Pfizer discloses death in long-term Hympavzi study after thrombotic stroke&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/pfizer-discloses-death-in-long-term-hympavzi-study-after-thrombotic-stroke-the-pharma-letter/</link><pubDate>Fri, 02 Jan 2026 15:06:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/pfizer-discloses-death-in-long-term-hympavzi-study-after-thrombotic-stroke-the-pharma-letter/</guid></item><item><title><![CDATA[Troubleshooting common errors in assemblies of long-read metagenomes - Nature]]></title><description><![CDATA[Troubleshooting common errors in assemblies of long-read metagenomes&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/troubleshooting-common-errors-in-assemblies-of-long-read-metagenomes-nature/</link><pubDate>Fri, 02 Jan 2026 12:43:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/troubleshooting-common-errors-in-assemblies-of-long-read-metagenomes-nature/</guid></item><item><title><![CDATA[Single-strand deaminase-assisted editing for functional RNA manipulation - Nature]]></title><description><![CDATA[Single-strand deaminase-assisted editing for functional RNA manipulation&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/single-strand-deaminase-assisted-editing-for-functional-rna-manipulation-nature/</link><pubDate>Fri, 02 Jan 2026 12:43:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/single-strand-deaminase-assisted-editing-for-functional-rna-manipulation-nature/</guid></item><item><title><![CDATA[Predicting small molecule–RNA interactions without RNA tertiary structures - Nature]]></title><description><![CDATA[Predicting small molecule&ndash;RNA interactions without RNA tertiary structures&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/predicting-small-moleculerna-interactions-without-rna-tertiary-structures-nature/</link><pubDate>Fri, 02 Jan 2026 11:31:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/predicting-small-moleculerna-interactions-without-rna-tertiary-structures-nature/</guid></item><item><title><![CDATA[Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Promising 110.6% Potential Upside - DirectorsTalk Interviews]]></title><description><![CDATA[Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Promising 110.6% Potential Upside&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-inc-sana-stock-analysis-exploring-a-promising-1106-potential-upside-directorstalk-interviews/</link><pubDate>Fri, 02 Jan 2026 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-inc-sana-stock-analysis-exploring-a-promising-1106-potential-upside-directorstalk-interviews/</guid></item><item><title><![CDATA[Global Biotechnology and Pharmaceutical Services Outsourcing Market Poised to Hit USD 111.86 Billion by 2032, Fueled by Increasing R&amp;D Outsourcing, at a CAGR of 5.6% - industrytoday.co.uk]]></title><description><![CDATA[Global Biotechnology and Pharmaceutical Services Outsourcing Market Poised to Hit USD 111.86 Billion by 2032, Fueled by Increasing R&amp;D Outsourcing, at a CAGR of 5.6%&nbsp;&nbsp;industrytoday.co.uk]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/global-biotechnology-and-pharmaceutical-services-outsourcing-market-poised-to-hit-usd-11186-billion-by-2032-fueled-by-increasing-rampd-outsourcing-at-a-cagr-of-56-industrytodaycouk/</link><pubDate>Thu, 01 Jan 2026 17:28:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/global-biotechnology-and-pharmaceutical-services-outsourcing-market-poised-to-hit-usd-11186-billion-by-2032-fueled-by-increasing-rampd-outsourcing-at-a-cagr-of-56-industrytodaycouk/</guid></item><item><title><![CDATA[Anbio Biotechnology's (NASDAQ:NNNN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Yahoo Finance]]></title><description><![CDATA[Anbio Biotechnology's (NASDAQ:NNNN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnologys-nasdaqnnnn-financials-are-too-obscure-to-link-with-current-share-price-momentum-whats-in-store-for-the-stock-yahoo-finance/</link><pubDate>Thu, 01 Jan 2026 13:18:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnologys-nasdaqnnnn-financials-are-too-obscure-to-link-with-current-share-price-momentum-whats-in-store-for-the-stock-yahoo-finance/</guid></item><item><title><![CDATA[Anbio Biotechnology (NASDAQ:NNNN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - simplywall.st]]></title><description><![CDATA[Anbio Biotechnology (NASDAQ:NNNN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?&nbsp;&nbsp;simplywall.st]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-nasdaqnnnn-stock-is-going-strong-but-fundamentals-look-uncertain-what-lies-ahead-simplywallst/</link><pubDate>Thu, 01 Jan 2026 12:29:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-nasdaqnnnn-stock-is-going-strong-but-fundamentals-look-uncertain-what-lies-ahead-simplywallst/</guid></item><item><title><![CDATA[BIOSECURE Act Becomes Law, Limiting Grants With &ldquo;Biotechnology Companies of Concern&rdquo; - Latham &amp; Watkins LLP]]></title><description><![CDATA[BIOSECURE Act Becomes Law, Limiting Grants With &ldquo;Biotechnology Companies of Concern&rdquo;&nbsp;&nbsp;Latham &amp; Watkins LLP]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biosecure-act-becomes-law-limiting-grants-with-ldquobiotechnology-companies-of-concernrdquo-latham-amp-watkins-llp/</link><pubDate>Wed, 31 Dec 2025 20:14:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biosecure-act-becomes-law-limiting-grants-with-ldquobiotechnology-companies-of-concernrdquo-latham-amp-watkins-llp/</guid></item><item><title><![CDATA[Cellyan Biotechnology Boosts Share Capital and Completes Name Change After December AGM - TipRanks]]></title><description><![CDATA[Cellyan Biotechnology Boosts Share Capital and Completes Name Change After December AGM&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/cellyan-biotechnology-boosts-share-capital-and-completes-name-change-after-december-agm-tipranks/</link><pubDate>Wed, 31 Dec 2025 15:45:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/cellyan-biotechnology-boosts-share-capital-and-completes-name-change-after-december-agm-tipranks/</guid></item><item><title><![CDATA[Apply Online For Scientist Positions At Research Institute of Biotechnology Hyderabad - NDTV]]></title><description><![CDATA[Apply Online For Scientist Positions At Research Institute of Biotechnology Hyderabad&nbsp;&nbsp;NDTV]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/apply-online-for-scientist-positions-at-research-institute-of-biotechnology-hyderabad-ndtv/</link><pubDate>Wed, 31 Dec 2025 11:21:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/apply-online-for-scientist-positions-at-research-institute-of-biotechnology-hyderabad-ndtv/</guid></item><item><title><![CDATA[Anbio Biotechnology Posts Higher Margins and Profits Despite Revenue Dip in First Half of 2025 - TipRanks]]></title><description><![CDATA[Anbio Biotechnology Posts Higher Margins and Profits Despite Revenue Dip in First Half of 2025&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-posts-higher-margins-and-profits-despite-revenue-dip-in-first-half-of-2025-tipranks/</link><pubDate>Tue, 30 Dec 2025 23:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/anbio-biotechnology-posts-higher-margins-and-profits-despite-revenue-dip-in-first-half-of-2025-tipranks/</guid></item><item><title><![CDATA[Why Anbio Biotechnology Class A Shares Are Sliding - TipRanks]]></title><description><![CDATA[Why Anbio Biotechnology Class A Shares Are Sliding&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/why-anbio-biotechnology-class-a-shares-are-sliding-tipranks/</link><pubDate>Tue, 30 Dec 2025 18:43:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/why-anbio-biotechnology-class-a-shares-are-sliding-tipranks/</guid></item><item><title><![CDATA[6th Edition of Euro-Global Conference on Biotechnology and Bioengineering - Austin Monthly Magazine]]></title><description><![CDATA[6th Edition of Euro-Global Conference on Biotechnology and Bioengineering&nbsp;&nbsp;Austin Monthly Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/6th-edition-of-euro-global-conference-on-biotechnology-and-bioengineering-austin-monthly-magazine/</link><pubDate>Tue, 30 Dec 2025 01:17:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/6th-edition-of-euro-global-conference-on-biotechnology-and-bioengineering-austin-monthly-magazine/</guid></item><item><title><![CDATA[S&amp;T Minister Dr Jitendra Singh inaugurates Biotechnology Research and Innovation Council (BRIC) Secretariat - BioSpectrum India]]></title><description><![CDATA[S&amp;T Minister Dr Jitendra Singh inaugurates Biotechnology Research and Innovation Council (BRIC) Secretariat&nbsp;&nbsp;BioSpectrum India]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sampt-minister-dr-jitendra-singh-inaugurates-biotechnology-research-and-innovation-council-bric-secretariat-biospectrum-india/</link><pubDate>Mon, 29 Dec 2025 18:21:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sampt-minister-dr-jitendra-singh-inaugurates-biotechnology-research-and-innovation-council-bric-secretariat-biospectrum-india/</guid></item><item><title><![CDATA[Top issues in South Korea’s biotechnology sector in 2025 - BioWorld MedTech]]></title><description><![CDATA[Top issues in South Korea&rsquo;s biotechnology sector in 2025&nbsp;&nbsp;BioWorld MedTech]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/top-issues-in-south-koreas-biotechnology-sector-in-2025-bioworld-medtech/</link><pubDate>Mon, 29 Dec 2025 18:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/top-issues-in-south-koreas-biotechnology-sector-in-2025-bioworld-medtech/</guid></item><item><title><![CDATA[FDA approves globally first obesity pill - European Biotechnology Magazine]]></title><description><![CDATA[FDA approves globally first obesity pill&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/fda-approves-globally-first-obesity-pill-european-biotechnology-magazine/</link><pubDate>Mon, 29 Dec 2025 16:27:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/fda-approves-globally-first-obesity-pill-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Bodhi Tree Biotechnology Inc SEC 10-K Report - TradingView — Track All Markets]]></title><description><![CDATA[Bodhi Tree Biotechnology Inc SEC 10-K Report&nbsp;&nbsp;TradingView &mdash; Track All Markets]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/bodhi-tree-biotechnology-inc-sec-10-k-report-tradingview-track-all-markets/</link><pubDate>Mon, 29 Dec 2025 16:25:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/bodhi-tree-biotechnology-inc-sec-10-k-report-tradingview-track-all-markets/</guid></item><item><title><![CDATA[Mexico Biotechnology Market Size, Share, Latest Insights and Forecast 2026-2034 - openPR.com]]></title><description><![CDATA[Mexico Biotechnology Market Size, Share, Latest Insights and Forecast 2026-2034&nbsp;&nbsp;openPR.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/mexico-biotechnology-market-size-share-latest-insights-and-forecast-2026-2034-openprcom/</link><pubDate>Mon, 29 Dec 2025 13:04:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/mexico-biotechnology-market-size-share-latest-insights-and-forecast-2026-2034-openprcom/</guid></item><item><title><![CDATA[BSc Biotechnology and BSc Microbiology: Which Career Path Should You Choose? - Jagran Josh]]></title><description><![CDATA[BSc Biotechnology and BSc Microbiology: Which Career Path Should You Choose?&nbsp;&nbsp;Jagran Josh]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/bsc-biotechnology-and-bsc-microbiology-which-career-path-should-you-choose-jagran-josh/</link><pubDate>Mon, 29 Dec 2025 09:36:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/bsc-biotechnology-and-bsc-microbiology-which-career-path-should-you-choose-jagran-josh/</guid></item><item><title><![CDATA[AI Expected to Transform Biotechnology Industry by 2033 Through Drug Discovery and Personalized Medicine - geneonline.com]]></title><description><![CDATA[AI Expected to Transform Biotechnology Industry by 2033 Through Drug Discovery and Personalized Medicine&nbsp;&nbsp;geneonline.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ai-expected-to-transform-biotechnology-industry-by-2033-through-drug-discovery-and-personalized-medicine-geneonlinecom/</link><pubDate>Mon, 29 Dec 2025 09:36:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ai-expected-to-transform-biotechnology-industry-by-2033-through-drug-discovery-and-personalized-medicine-geneonlinecom/</guid></item><item><title><![CDATA[AI in Biotechnology: Transforming Drug Discovery and Personalized Medicine by 2033 - BioTecNika]]></title><description><![CDATA[AI in Biotechnology: Transforming Drug Discovery and Personalized Medicine by 2033&nbsp;&nbsp;BioTecNika]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-transforming-drug-discovery-and-personalized-medicine-by-2033-biotecnika/</link><pubDate>Mon, 29 Dec 2025 08:41:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/ai-in-biotechnology-transforming-drug-discovery-and-personalized-medicine-by-2033-biotecnika/</guid></item><item><title><![CDATA[Top Biotechnology Startups And Companies In The UK - Business Connect Magazine]]></title><description><![CDATA[Top Biotechnology Startups And Companies In The UK&nbsp;&nbsp;Business Connect Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/top-biotechnology-startups-and-companies-in-the-uk-business-connect-magazine/</link><pubDate>Mon, 29 Dec 2025 05:55:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/top-biotechnology-startups-and-companies-in-the-uk-business-connect-magazine/</guid></item><item><title><![CDATA[Gustavo Monnerat: Nature Biotechnology Editorial on the Most Impactful Advances in Biotechnology in 2025 - Oncodaily]]></title><description><![CDATA[Gustavo Monnerat: Nature Biotechnology Editorial on the Most Impactful Advances in Biotechnology in 2025&nbsp;&nbsp;Oncodaily]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/gustavo-monnerat-nature-biotechnology-editorial-on-the-most-impactful-advances-in-biotechnology-in-2025-oncodaily/</link><pubDate>Sun, 28 Dec 2025 17:23:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/gustavo-monnerat-nature-biotechnology-editorial-on-the-most-impactful-advances-in-biotechnology-in-2025-oncodaily/</guid></item><item><title><![CDATA[Sana Biotechnology Showcases Successful In Vivo Gene Editing of Stem Cells in Nature Publication - Yahoo Finance UK]]></title><description><![CDATA[Sana Biotechnology Showcases Successful In Vivo Gene Editing of Stem Cells in Nature Publication&nbsp;&nbsp;Yahoo Finance UK]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-showcases-successful-in-vivo-gene-editing-of-stem-cells-in-nature-publication-yahoo-finance-uk/</link><pubDate>Sun, 28 Dec 2025 16:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-showcases-successful-in-vivo-gene-editing-of-stem-cells-in-nature-publication-yahoo-finance-uk/</guid></item><item><title><![CDATA[Sana Biotechnology Showcases Successful In Vivo Gene Editing of Stem Cells in Nature Publication - Yahoo Finance]]></title><description><![CDATA[Sana Biotechnology Showcases Successful In Vivo Gene Editing of Stem Cells in Nature Publication&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-showcases-successful-in-vivo-gene-editing-of-stem-cells-in-nature-publication-yahoo-finance/</link><pubDate>Sun, 28 Dec 2025 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/sana-biotechnology-showcases-successful-in-vivo-gene-editing-of-stem-cells-in-nature-publication-yahoo-finance/</guid></item><item><title><![CDATA[Medical physics and biotechnology: highlights of 2025 - Physics World]]></title><description><![CDATA[Medical physics and biotechnology: highlights of 2025&nbsp;&nbsp;Physics World]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/medical-physics-and-biotechnology-highlights-of-2025-physics-world/</link><pubDate>Sat, 27 Dec 2025 11:03:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/medical-physics-and-biotechnology-highlights-of-2025-physics-world/</guid></item><item><title><![CDATA[Chile Sets 10-Year Strategy to Build Quantum And Biotechnology Industries - The Quantum Insider]]></title><description><![CDATA[Chile Sets 10-Year Strategy to Build Quantum And Biotechnology Industries&nbsp;&nbsp;The Quantum Insider]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/chile-sets-10-year-strategy-to-build-quantum-and-biotechnology-industries-the-quantum-insider/</link><pubDate>Sat, 27 Dec 2025 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/chile-sets-10-year-strategy-to-build-quantum-and-biotechnology-industries-the-quantum-insider/</guid></item><item><title><![CDATA[NSCEB Assesses Future of U.S.-China Biotechnology Competition - The National Law Review]]></title><description><![CDATA[NSCEB Assesses Future of U.S.-China Biotechnology Competition&nbsp;&nbsp;The National Law Review]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nsceb-assesses-future-of-us-china-biotechnology-competition-the-national-law-review/</link><pubDate>Thu, 25 Dec 2025 00:14:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nsceb-assesses-future-of-us-china-biotechnology-competition-the-national-law-review/</guid></item><item><title><![CDATA[NSCEB Assesses Future of U.S.-China Biotechnology Competition - Bergeson &amp; Campbell]]></title><description><![CDATA[NSCEB Assesses Future of U.S.-China Biotechnology Competition&nbsp;&nbsp;Bergeson &amp; Campbell]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/nsceb-assesses-future-of-us-china-biotechnology-competition-bergeson-amp-campbell/</link><pubDate>Wed, 24 Dec 2025 22:46:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/nsceb-assesses-future-of-us-china-biotechnology-competition-bergeson-amp-campbell/</guid></item><item><title><![CDATA[Building a legacy of innovation in biotechnology and drug discovery - Drug Discovery News]]></title><description><![CDATA[Building a legacy of innovation in biotechnology and drug discovery&nbsp;&nbsp;Drug Discovery News]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/building-a-legacy-of-innovation-in-biotechnology-and-drug-discovery-drug-discovery-news/</link><pubDate>Tue, 23 Dec 2025 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/building-a-legacy-of-innovation-in-biotechnology-and-drug-discovery-drug-discovery-news/</guid></item><item><title><![CDATA[Lixte Biotechnology Announces New Registered Direct Offering - TipRanks]]></title><description><![CDATA[Lixte Biotechnology Announces New Registered Direct Offering&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-announces-new-registered-direct-offering-tipranks/</link><pubDate>Mon, 22 Dec 2025 23:49:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-announces-new-registered-direct-offering-tipranks/</guid></item><item><title><![CDATA[Lixte Biotechnology Signs Multiple Material Agreements - TradingView — Track All Markets]]></title><description><![CDATA[Lixte Biotechnology Signs Multiple Material Agreements&nbsp;&nbsp;TradingView &mdash; Track All Markets]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-signs-multiple-material-agreements-tradingview-track-all-markets/</link><pubDate>Mon, 22 Dec 2025 23:33:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-signs-multiple-material-agreements-tradingview-track-all-markets/</guid></item><item><title><![CDATA[Puma Biotechnology Added to Nasdaq Biotechnology Index - marketscreener.com]]></title><description><![CDATA[Puma Biotechnology Added to Nasdaq Biotechnology Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-added-to-nasdaq-biotechnology-index-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 23:32:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-added-to-nasdaq-biotechnology-index-marketscreenercom/</guid></item><item><title><![CDATA[Abivax is the top performing biotechnology stock YTD - MSN]]></title><description><![CDATA[Abivax is the top performing biotechnology stock YTD&nbsp;&nbsp;MSN]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/abivax-is-the-top-performing-biotechnology-stock-ytd-msn/</link><pubDate>Mon, 22 Dec 2025 23:02:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/abivax-is-the-top-performing-biotechnology-stock-ytd-msn/</guid></item><item><title><![CDATA[Lixte Biotechnology stock falls after $4.3 million direct offering - Investing.com]]></title><description><![CDATA[Lixte Biotechnology stock falls after $4.3 million direct offering&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-stock-falls-after-43-million-direct-offering-investingcom/</link><pubDate>Mon, 22 Dec 2025 22:56:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/lixte-biotechnology-stock-falls-after-43-million-direct-offering-investingcom/</guid></item><item><title><![CDATA[Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering - marketscreener.com]]></title><description><![CDATA[Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.&rsquo;s $4.3 Million Registered Direct Offering&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/spartan-capital-securities-llc-serves-as-placement-agent-in-lixte-biotechnology-holdings-incs-43-million-registered-direct-offering-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 22:49:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/spartan-capital-securities-llc-serves-as-placement-agent-in-lixte-biotechnology-holdings-incs-43-million-registered-direct-offering-marketscreenercom/</guid></item><item><title><![CDATA[Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering - Yahoo Finance Australia]]></title><description><![CDATA[Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.&rsquo;s $4.3 Million Registered Direct Offering&nbsp;&nbsp;Yahoo Finance Australia]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/spartan-capital-securities-llc-serves-as-placement-agent-in-lixte-biotechnology-holdings-incs-43-million-registered-direct-offering-yahoo-finance-australia/</link><pubDate>Mon, 22 Dec 2025 22:48:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/spartan-capital-securities-llc-serves-as-placement-agent-in-lixte-biotechnology-holdings-incs-43-million-registered-direct-offering-yahoo-finance-australia/</guid></item><item><title><![CDATA[Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI) - The AI Journal]]></title><description><![CDATA[Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)&nbsp;&nbsp;The AI Journal]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-added-to-the-nasdaq-biotechnology-index-nbi-the-ai-journal/</link><pubDate>Mon, 22 Dec 2025 22:16:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/puma-biotechnology-added-to-the-nasdaq-biotechnology-index-nbi-the-ai-journal/</guid></item><item><title><![CDATA[European Commission Proposes Biotech Act to Boost Health Biotechnology in the EU - Crowell &amp; Moring LLP]]></title><description><![CDATA[European Commission Proposes Biotech Act to Boost Health Biotechnology in the EU&nbsp;&nbsp;Crowell &amp; Moring LLP]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/european-commission-proposes-biotech-act-to-boost-health-biotechnology-in-the-eu-crowell-amp-moring-llp/</link><pubDate>Mon, 22 Dec 2025 16:51:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/european-commission-proposes-biotech-act-to-boost-health-biotechnology-in-the-eu-crowell-amp-moring-llp/</guid></item><item><title><![CDATA[Gujarat signs pact with BCIL to strengthen state biotechnology ecosystem - The Indian Express]]></title><description><![CDATA[Gujarat signs pact with BCIL to strengthen state biotechnology ecosystem&nbsp;&nbsp;The Indian Express]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/gujarat-signs-pact-with-bcil-to-strengthen-state-biotechnology-ecosystem-the-indian-express/</link><pubDate>Mon, 22 Dec 2025 15:28:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/gujarat-signs-pact-with-bcil-to-strengthen-state-biotechnology-ecosystem-the-indian-express/</guid></item><item><title><![CDATA[AAPS National Biotechnology Conference Scheduled for May 2026 at Sheraton San Diego Resort - geneonline.com]]></title><description><![CDATA[AAPS National Biotechnology Conference Scheduled for May 2026 at Sheraton San Diego Resort&nbsp;&nbsp;geneonline.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/aaps-national-biotechnology-conference-scheduled-for-may-2026-at-sheraton-san-diego-resort-geneonlinecom/</link><pubDate>Mon, 22 Dec 2025 13:34:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/aaps-national-biotechnology-conference-scheduled-for-may-2026-at-sheraton-san-diego-resort-geneonlinecom/</guid></item><item><title><![CDATA[Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to NASDAQ Biotechnology Index - marketscreener.com]]></title><description><![CDATA[Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to NASDAQ Biotechnology Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/black-diamond-therapeutics-incnasdaqgsbdtx-added-to-nasdaq-biotechnology-index-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 12:11:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/black-diamond-therapeutics-incnasdaqgsbdtx-added-to-nasdaq-biotechnology-index-marketscreenercom/</guid></item><item><title><![CDATA[Aardvark Therapeutics, Inc.(NasdaqGS: AARD) added to NASDAQ Biotechnology Index - marketscreener.com]]></title><description><![CDATA[Aardvark Therapeutics, Inc.(NasdaqGS: AARD) added to NASDAQ Biotechnology Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/aardvark-therapeutics-incnasdaqgs-aard-added-to-nasdaq-biotechnology-index-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 12:11:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/aardvark-therapeutics-incnasdaqgs-aard-added-to-nasdaq-biotechnology-index-marketscreenercom/</guid></item><item><title><![CDATA[Bicara Therapeutics Inc.(NasdaqGM: BCAX) added to NASDAQ Biotechnology Index - marketscreener.com]]></title><description><![CDATA[Bicara Therapeutics Inc.(NasdaqGM: BCAX) added to NASDAQ Biotechnology Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/bicara-therapeutics-incnasdaqgm-bcax-added-to-nasdaq-biotechnology-index-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 12:10:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/bicara-therapeutics-incnasdaqgm-bcax-added-to-nasdaq-biotechnology-index-marketscreenercom/</guid></item><item><title><![CDATA[Atai Beckley N.V.(NasdaqGM: ATAI) added to NASDAQ Biotechnology Index - marketscreener.com]]></title><description><![CDATA[Atai Beckley N.V.(NasdaqGM: ATAI) added to NASDAQ Biotechnology Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/atai-beckley-nvnasdaqgm-atai-added-to-nasdaq-biotechnology-index-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 12:10:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/atai-beckley-nvnasdaqgm-atai-added-to-nasdaq-biotechnology-index-marketscreenercom/</guid></item><item><title><![CDATA[Aclaris Therapeutics, Inc.(NasdaqGS: ACRS) added to NASDAQ Biotechnology Index - marketscreener.com]]></title><description><![CDATA[Aclaris Therapeutics, Inc.(NasdaqGS: ACRS) added to NASDAQ Biotechnology Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/aclaris-therapeutics-incnasdaqgs-acrs-added-to-nasdaq-biotechnology-index-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 12:10:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/aclaris-therapeutics-incnasdaqgs-acrs-added-to-nasdaq-biotechnology-index-marketscreenercom/</guid></item><item><title><![CDATA[Contineum Therapeutics, Inc.(NasdaqGS: CTNM) added to NASDAQ Biotechnology Index - marketscreener.com]]></title><description><![CDATA[Contineum Therapeutics, Inc.(NasdaqGS: CTNM) added to NASDAQ Biotechnology Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/contineum-therapeutics-incnasdaqgs-ctnm-added-to-nasdaq-biotechnology-index-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 12:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/contineum-therapeutics-incnasdaqgs-ctnm-added-to-nasdaq-biotechnology-index-marketscreenercom/</guid></item><item><title><![CDATA[Amgen Inc (NASDAQ:AMGN) Nasdaq Index Biotechnology Leadership Focus - Kalkine Media]]></title><description><![CDATA[Amgen Inc (NASDAQ:AMGN) Nasdaq Index Biotechnology Leadership Focus&nbsp;&nbsp;Kalkine Media]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/amgen-inc-nasdaqamgn-nasdaq-index-biotechnology-leadership-focus-kalkine-media/</link><pubDate>Mon, 22 Dec 2025 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/amgen-inc-nasdaqamgn-nasdaq-index-biotechnology-leadership-focus-kalkine-media/</guid></item><item><title><![CDATA[Gujarat Biotechnology University Contributes to Nanoparticle-Based Alzheimer’s Research Breakthrough - Digital Health News]]></title><description><![CDATA[Gujarat Biotechnology University Contributes to Nanoparticle-Based Alzheimer&rsquo;s Research Breakthrough&nbsp;&nbsp;Digital Health News]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/gujarat-biotechnology-university-contributes-to-nanoparticle-based-alzheimers-research-breakthrough-digital-health-news/</link><pubDate>Mon, 22 Dec 2025 08:36:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/gujarat-biotechnology-university-contributes-to-nanoparticle-based-alzheimers-research-breakthrough-digital-health-news/</guid></item><item><title><![CDATA[Bicara Therapeutics Inc.(NasdaqGM:BCAX) added to S&amp;P Biotechnology Select Industry Index - marketscreener.com]]></title><description><![CDATA[Bicara Therapeutics Inc.(NasdaqGM:BCAX) added to S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/bicara-therapeutics-incnasdaqgmbcax-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 02:18:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/bicara-therapeutics-incnasdaqgmbcax-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to S&amp;P Biotechnology Select Industry Index - marketscreener.com]]></title><description><![CDATA[Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/monte-rosa-therapeutics-incnasdaqgsglue-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 02:17:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/monte-rosa-therapeutics-incnasdaqgsglue-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[Invivyd, Inc.(NasdaqGM: IVVD) added to S&amp;P Biotechnology Select Industry Index - marketscreener.com]]></title><description><![CDATA[Invivyd, Inc.(NasdaqGM: IVVD) added to S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/invivyd-incnasdaqgm-ivvd-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 02:17:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/invivyd-incnasdaqgm-ivvd-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[Kodiak Sciences Inc.(NasdaqGM: KOD) added to S&amp;P Biotechnology Select Industry Index - marketscreener.com]]></title><description><![CDATA[Kodiak Sciences Inc.(NasdaqGM: KOD) added to S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/kodiak-sciences-incnasdaqgm-kod-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 02:16:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/kodiak-sciences-incnasdaqgm-kod-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[4D Molecular Therapeutics, Inc.(NasdaqGS:FDMT) added to S&amp;P Biotechnology Select Industry Index - marketscreener.com]]></title><description><![CDATA[4D Molecular Therapeutics, Inc.(NasdaqGS:FDMT) added to S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/4d-molecular-therapeutics-incnasdaqgsfdmt-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 02:16:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/4d-molecular-therapeutics-incnasdaqgsfdmt-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[Prothena Corporation plc(NasdaqGS:PRTA) added to S&amp;P Biotechnology Select Industry Index - marketscreener.com]]></title><description><![CDATA[Prothena Corporation plc(NasdaqGS:PRTA) added to S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/prothena-corporation-plcnasdaqgsprta-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 02:15:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/prothena-corporation-plcnasdaqgsprta-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[ATyr Pharma, Inc.(NasdaqCM:ATYR) dropped from S&amp;P Biotechnology Select Industry Index - marketscreener.com]]></title><description><![CDATA[ATyr Pharma, Inc.(NasdaqCM:ATYR) dropped from S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/atyr-pharma-incnasdaqcmatyr-dropped-from-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 02:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/atyr-pharma-incnasdaqcmatyr-dropped-from-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[Arcturus Therapeutics Holdings Inc.(NasdaqGM:ARCT) dropped from S&amp;P Biotechnology Select Industry Index - marketscreener.com]]></title><description><![CDATA[Arcturus Therapeutics Holdings Inc.(NasdaqGM:ARCT) dropped from S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;marketscreener.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/arcturus-therapeutics-holdings-incnasdaqgmarct-dropped-from-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Mon, 22 Dec 2025 02:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/arcturus-therapeutics-holdings-incnasdaqgmarct-dropped-from-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks - ts2.tech]]></title><description><![CDATA[Biotechnology Stocks Week Ahead (Dec. 22&ndash;26, 2025): BioMarin&ndash;Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks&nbsp;&nbsp;ts2.tech]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-stocks-week-ahead-dec-2226-2025-biomarinamicus-deal-cytokinetics-fda-win-ipo-filings-and-drug-price-policy-risks-ts2tech/</link><pubDate>Sun, 21 Dec 2025 14:56:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/biotechnology-stocks-week-ahead-dec-2226-2025-biomarinamicus-deal-cytokinetics-fda-win-ipo-filings-and-drug-price-policy-risks-ts2tech/</guid></item><item><title><![CDATA[Offworld Biotechnology Glovebox Operations: DNA Nano Therapeutics-Mission 2 - astrobiology.com]]></title><description><![CDATA[Offworld Biotechnology Glovebox Operations: DNA Nano Therapeutics-Mission 2&nbsp;&nbsp;astrobiology.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/offworld-biotechnology-glovebox-operations-dna-nano-therapeutics-mission-2-astrobiologycom/</link><pubDate>Sun, 21 Dec 2025 10:22:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/offworld-biotechnology-glovebox-operations-dna-nano-therapeutics-mission-2-astrobiologycom/</guid></item><item><title><![CDATA[Trump Administration tables new version of Biosecure Act - European Biotechnology Magazine]]></title><description><![CDATA[Trump Administration tables new version of Biosecure Act&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/trump-administration-tables-new-version-of-biosecure-act-european-biotechnology-magazine/</link><pubDate>Sat, 20 Dec 2025 09:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/trump-administration-tables-new-version-of-biosecure-act-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Aclaris Therapeutics Added to Nasdaq Biotechnology Index Effective December 19, 2025 - Quiver Quantitative]]></title><description><![CDATA[Aclaris Therapeutics Added to Nasdaq Biotechnology Index Effective December 19, 2025&nbsp;&nbsp;Quiver Quantitative]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/aclaris-therapeutics-added-to-nasdaq-biotechnology-index-effective-december-19-2025-quiver-quantitative/</link><pubDate>Fri, 19 Dec 2025 22:14:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/aclaris-therapeutics-added-to-nasdaq-biotechnology-index-effective-december-19-2025-quiver-quantitative/</guid></item><item><title><![CDATA[Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI) - GlobeNewswire]]></title><description><![CDATA[Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/aclaris-therapeutics-added-to-the-nasdaq-biotechnology-index-nbi-globenewswire/</link><pubDate>Fri, 19 Dec 2025 22:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/aclaris-therapeutics-added-to-the-nasdaq-biotechnology-index-nbi-globenewswire/</guid></item><item><title><![CDATA[Can MAIA Biotechnology Inc. stock double in next 5 years - Portfolio Gains Report &amp; Capital Efficiency Focused Ideas - Donan&#305;mHaber]]></title><description><![CDATA[Can MAIA Biotechnology Inc. stock double in next 5 years - Portfolio Gains Report &amp; Capital Efficiency Focused Ideas&nbsp;&nbsp;Donan&#305;mHaber]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/can-maia-biotechnology-inc-stock-double-in-next-5-years-portfolio-gains-report-amp-capital-efficiency-focused-ideas-donan305mhaber/</link><pubDate>Fri, 19 Dec 2025 17:28:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/can-maia-biotechnology-inc-stock-double-in-next-5-years-portfolio-gains-report-amp-capital-efficiency-focused-ideas-donan305mhaber/</guid></item><item><title><![CDATA[Why Nautilus Biotechnology Inc. stock remains on buy lists - 2025 Market WrapUp &amp; Community Consensus Picks - B&ouml;l&uuml;m Sonu Canavar&#305;]]></title><description><![CDATA[Why Nautilus Biotechnology Inc. stock remains on buy lists - 2025 Market WrapUp &amp; Community Consensus Picks&nbsp;&nbsp;B&ouml;l&uuml;m Sonu Canavar&#305;]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/why-nautilus-biotechnology-inc-stock-remains-on-buy-lists-2025-market-wrapup-amp-community-consensus-picks-boumlluumlm-sonu-canavar305/</link><pubDate>Fri, 19 Dec 2025 17:12:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/why-nautilus-biotechnology-inc-stock-remains-on-buy-lists-2025-market-wrapup-amp-community-consensus-picks-boumlluumlm-sonu-canavar305/</guid></item><item><title><![CDATA[Can Sana Biotechnology Inc. stock maintain operating margins - Weekly Market Report &amp; Stepwise Entry/Exit Trade Alerts - Donan&#305;mHaber]]></title><description><![CDATA[Can Sana Biotechnology Inc. stock maintain operating margins - Weekly Market Report &amp; Stepwise Entry/Exit Trade Alerts&nbsp;&nbsp;Donan&#305;mHaber]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/can-sana-biotechnology-inc-stock-maintain-operating-margins-weekly-market-report-amp-stepwise-entryexit-trade-alerts-donan305mhaber/</link><pubDate>Fri, 19 Dec 2025 17:11:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/can-sana-biotechnology-inc-stock-maintain-operating-margins-weekly-market-report-amp-stepwise-entryexit-trade-alerts-donan305mhaber/</guid></item><item><title><![CDATA[Senate Advances Bill to Restrict Certain Biotechnology Firms Amid Biosecurity Concerns - geneonline.com]]></title><description><![CDATA[Senate Advances Bill to Restrict Certain Biotechnology Firms Amid Biosecurity Concerns&nbsp;&nbsp;geneonline.com]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/senate-advances-bill-to-restrict-certain-biotechnology-firms-amid-biosecurity-concerns-geneonlinecom/</link><pubDate>Fri, 19 Dec 2025 15:40:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/senate-advances-bill-to-restrict-certain-biotechnology-firms-amid-biosecurity-concerns-geneonlinecom/</guid></item><item><title><![CDATA[Why Lixte Biotechnology Holdings Inc. stock is a value investor pick - July 2025 Trade Ideas &amp; Scalable Portfolio Growth Ideas - Donan&#305;mHaber]]></title><description><![CDATA[Why Lixte Biotechnology Holdings Inc. stock is a value investor pick - July 2025 Trade Ideas &amp; Scalable Portfolio Growth Ideas&nbsp;&nbsp;Donan&#305;mHaber]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/why-lixte-biotechnology-holdings-inc-stock-is-a-value-investor-pick-july-2025-trade-ideas-amp-scalable-portfolio-growth-ideas-donan305mhaber/</link><pubDate>Fri, 19 Dec 2025 15:34:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/why-lixte-biotechnology-holdings-inc-stock-is-a-value-investor-pick-july-2025-trade-ideas-amp-scalable-portfolio-growth-ideas-donan305mhaber/</guid></item><item><title><![CDATA[Will PDS Biotechnology Corporation stock continue upward momentum - 2025 Institutional Moves &amp; Daily Market Momentum Tracking - B&ouml;l&uuml;m Sonu Canavar&#305;]]></title><description><![CDATA[Will PDS Biotechnology Corporation stock continue upward momentum - 2025 Institutional Moves &amp; Daily Market Momentum Tracking&nbsp;&nbsp;B&ouml;l&uuml;m Sonu Canavar&#305;]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/will-pds-biotechnology-corporation-stock-continue-upward-momentum-2025-institutional-moves-amp-daily-market-momentum-tracking-boumlluumlm-sonu-canavar305/</link><pubDate>Fri, 19 Dec 2025 15:03:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/will-pds-biotechnology-corporation-stock-continue-upward-momentum-2025-institutional-moves-amp-daily-market-momentum-tracking-boumlluumlm-sonu-canavar305/</guid></item><item><title><![CDATA[Why Lixte Biotechnology Holdings Inc. stock is a value investor pick - July 2025 Breakouts &amp; Daily Risk Controlled Trade Plans - Donan&#305;mHaber]]></title><description><![CDATA[Why Lixte Biotechnology Holdings Inc. stock is a value investor pick - July 2025 Breakouts &amp; Daily Risk Controlled Trade Plans&nbsp;&nbsp;Donan&#305;mHaber]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/why-lixte-biotechnology-holdings-inc-stock-is-a-value-investor-pick-july-2025-breakouts-amp-daily-risk-controlled-trade-plans-donan305mhaber/</link><pubDate>Fri, 19 Dec 2025 14:08:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/why-lixte-biotechnology-holdings-inc-stock-is-a-value-investor-pick-july-2025-breakouts-amp-daily-risk-controlled-trade-plans-donan305mhaber/</guid></item><item><title><![CDATA[Will ProShares Trust ProShares UltraShort Nasdaq Biotechnology stock return to pre crisis levels - Rate Hike &amp; High Win Rate Trade Alerts - Donan&#305;mHaber]]></title><description><![CDATA[Will ProShares Trust ProShares UltraShort Nasdaq Biotechnology stock return to pre crisis levels - Rate Hike &amp; High Win Rate Trade Alerts&nbsp;&nbsp;Donan&#305;mHaber]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/will-proshares-trust-proshares-ultrashort-nasdaq-biotechnology-stock-return-to-pre-crisis-levels-rate-hike-amp-high-win-rate-trade-alerts-donan305mhaber/</link><pubDate>Fri, 19 Dec 2025 13:50:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/will-proshares-trust-proshares-ultrashort-nasdaq-biotechnology-stock-return-to-pre-crisis-levels-rate-hike-amp-high-win-rate-trade-alerts-donan305mhaber/</guid></item><item><title><![CDATA[What sentiment indicators say about Unity Biotechnology Inc. stock - Quarterly Performance Summary &amp; Daily Technical Stock Forecast Reports - Donan&#305;mHaber]]></title><description><![CDATA[What sentiment indicators say about Unity Biotechnology Inc. stock - Quarterly Performance Summary &amp; Daily Technical Stock Forecast Reports&nbsp;&nbsp;Donan&#305;mHaber]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/what-sentiment-indicators-say-about-unity-biotechnology-inc-stock-quarterly-performance-summary-amp-daily-technical-stock-forecast-reports-donan305mhaber/</link><pubDate>Fri, 19 Dec 2025 13:41:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/what-sentiment-indicators-say-about-unity-biotechnology-inc-stock-quarterly-performance-summary-amp-daily-technical-stock-forecast-reports-donan305mhaber/</guid></item><item><title><![CDATA[Can Sana Biotechnology Inc. stock sustain revenue growth - 2025 Technical Patterns &amp; Real-Time Market Sentiment Reports - Donan&#305;mHaber]]></title><description><![CDATA[Can Sana Biotechnology Inc. stock sustain revenue growth - 2025 Technical Patterns &amp; Real-Time Market Sentiment Reports&nbsp;&nbsp;Donan&#305;mHaber]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/can-sana-biotechnology-inc-stock-sustain-revenue-growth-2025-technical-patterns-amp-real-time-market-sentiment-reports-donan305mhaber/</link><pubDate>Fri, 19 Dec 2025 13:24:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/can-sana-biotechnology-inc-stock-sustain-revenue-growth-2025-technical-patterns-amp-real-time-market-sentiment-reports-donan305mhaber/</guid></item><item><title><![CDATA[Can Vir Biotechnology Inc. stock sustain revenue growth - Quarterly Portfolio Summary &amp; AI Forecast for Swing Trade Picks - Donan&#305;mHaber]]></title><description><![CDATA[Can Vir Biotechnology Inc. stock sustain revenue growth - Quarterly Portfolio Summary &amp; AI Forecast for Swing Trade Picks&nbsp;&nbsp;Donan&#305;mHaber]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/can-vir-biotechnology-inc-stock-sustain-revenue-growth-quarterly-portfolio-summary-amp-ai-forecast-for-swing-trade-picks-donan305mhaber/</link><pubDate>Fri, 19 Dec 2025 13:03:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/can-vir-biotechnology-inc-stock-sustain-revenue-growth-quarterly-portfolio-summary-amp-ai-forecast-for-swing-trade-picks-donan305mhaber/</guid></item><item><title><![CDATA[Abivax Shares Jump 7.17% Midday, Supported by Entry into Nasdaq Biotechnology Index - idéal investisseur]]></title><description><![CDATA[Abivax Shares Jump 7.17% Midday, Supported by Entry into Nasdaq Biotechnology Index&nbsp;&nbsp;id&eacute;al investisseur]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/abivax-shares-jump-717-midday-supported-by-entry-into-nasdaq-biotechnology-index-idal-investisseur/</link><pubDate>Fri, 19 Dec 2025 12:23:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/abivax-shares-jump-717-midday-supported-by-entry-into-nasdaq-biotechnology-index-idal-investisseur/</guid></item><item><title><![CDATA[ETF Watch: Is Nautilus Biotechnology Inc. stock a safe buy before earnings - July 2025 Retail &amp; Step-by-Step Trade Execution Guides - Donan&#305;mHaber]]></title><description><![CDATA[ETF Watch: Is Nautilus Biotechnology Inc. stock a safe buy before earnings - July 2025 Retail &amp; Step-by-Step Trade Execution Guides&nbsp;&nbsp;Donan&#305;mHaber]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/etf-watch-is-nautilus-biotechnology-inc-stock-a-safe-buy-before-earnings-july-2025-retail-amp-step-by-step-trade-execution-guides-donan305mhaber/</link><pubDate>Fri, 19 Dec 2025 12:21:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/etf-watch-is-nautilus-biotechnology-inc-stock-a-safe-buy-before-earnings-july-2025-retail-amp-step-by-step-trade-execution-guides-donan305mhaber/</guid></item><item><title><![CDATA[Machine learning enables scalable and systematic hierarchical virus taxonomy - Nature]]></title><description><![CDATA[Machine learning enables scalable and systematic hierarchical virus taxonomy&nbsp;&nbsp;Nature]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/machine-learning-enables-scalable-and-systematic-hierarchical-virus-taxonomy-nature/</link><pubDate>Fri, 19 Dec 2025 11:46:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/machine-learning-enables-scalable-and-systematic-hierarchical-virus-taxonomy-nature/</guid></item><item><title><![CDATA[Can MAIA Biotechnology Inc. stock maintain operating margins - July 2025 Intraday Action &amp; Expert Approved Momentum Ideas - B&ouml;l&uuml;m Sonu Canavar&#305;]]></title><description><![CDATA[Can MAIA Biotechnology Inc. stock maintain operating margins - July 2025 Intraday Action &amp; Expert Approved Momentum Ideas&nbsp;&nbsp;B&ouml;l&uuml;m Sonu Canavar&#305;]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/can-maia-biotechnology-inc-stock-maintain-operating-margins-july-2025-intraday-action-amp-expert-approved-momentum-ideas-boumlluumlm-sonu-canavar305/</link><pubDate>Fri, 19 Dec 2025 11:45:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/can-maia-biotechnology-inc-stock-maintain-operating-margins-july-2025-intraday-action-amp-expert-approved-momentum-ideas-boumlluumlm-sonu-canavar305/</guid></item><item><title><![CDATA[Egetis Therapeutics AB submits rolling NDA for tiratricol - European Biotechnology Magazine]]></title><description><![CDATA[Egetis Therapeutics AB submits rolling NDA for tiratricol&nbsp;&nbsp;European Biotechnology Magazine]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/egetis-therapeutics-ab-submits-rolling-nda-for-tiratricol-european-biotechnology-magazine/</link><pubDate>Fri, 19 Dec 2025 11:41:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/egetis-therapeutics-ab-submits-rolling-nda-for-tiratricol-european-biotechnology-magazine/</guid></item><item><title><![CDATA[Will Unity Biotechnology Inc. stock split attract more investors - Long Setup &amp; Growth-Oriented Investment Plans - &#1059;&#1083;&#1087;&#1088;&#1072;&#1074;&#1076;&#1072;]]></title><description><![CDATA[Will Unity Biotechnology Inc. stock split attract more investors - Long Setup &amp; Growth-Oriented Investment Plans&nbsp;&nbsp;&#1059;&#1083;&#1087;&#1088;&#1072;&#1074;&#1076;&#1072;]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/will-unity-biotechnology-inc-stock-split-attract-more-investors-long-setup-amp-growth-oriented-investment-plans-10591083108710881072107410761072/</link><pubDate>Fri, 19 Dec 2025 11:37:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/will-unity-biotechnology-inc-stock-split-attract-more-investors-long-setup-amp-growth-oriented-investment-plans-10591083108710881072107410761072/</guid></item><item><title><![CDATA[Japan and Kyrgyzstan discuss prospects for cooperation in biotechnology - 24.KG]]></title><description><![CDATA[Japan and Kyrgyzstan discuss prospects for cooperation in biotechnology&nbsp;&nbsp;24.KG]]></description><link>https://www.newslocker.com/en-uk/profession/biotechnology/japan-and-kyrgyzstan-discuss-prospects-for-cooperation-in-biotechnology-24kg/</link><pubDate>Fri, 19 Dec 2025 10:11:00 +0100</pubDate><guid>https://www.newslocker.com/en-uk/profession/biotechnology/japan-and-kyrgyzstan-discuss-prospects-for-cooperation-in-biotechnology-24kg/</guid></item></channel></rss>